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ABSTRACT
The permanent nature of chronic disease may impair patients’ psycho-social and physical 
well being, may change their attitude towards life goals and influence major life changing 
decisions (MLCDs) over time. Very little information is available in the literature about 
the long term impact of chronic diseases, particularly their influence on MLCDs. The aim 
of this study was to investigate the influence of chronic diseases on MLCDs and to 
develop a standardised tool for use across all chronic conditions to assess the impact of 
disease on MLCDs.
675 patients (100 from 6 specialties: cardiovascular, rheumatoid, diabetes, cystic fibrosis, 
chronic obstructive pulmonary disease, nephrology and 75 from dermatology) from the 
University Hospital of Wales, Cardiff and University Hospital Llandough, Llandough 
were invited to take part. The data was obtained through surveys, interviews and focus 
group discussions and this was reduced to core items through “content analysis”. In a 
further study, 225 patients from the seven specialties were asked to complete the MLCDP 
(version la) and, factor analysis was applied to confirm the breadth and depth of the 
allocated domains and to determine construct validity of the MLCDP.
385 (57%) patients of 675 took part in the first phase of the study. Themes and statements 
generated from 316 (82%) evaluable responses (postal survey=258, individual 
interviews=50, focus group=8) were used for the development of the MLCD Profile. The 
most frequently reported MLCDs concerned early retirement, having children, job, career 
choice, relationships, housing, moving abroad and education. The correlation between the 
patients’ age and the total number of reported MLCDs was significant (rs = -0.46, 
p=<0.001, n=308) showing negative relationship. In total, 41 affected MLCD themes 
were identified and grouped into 15 core MLCD categories. The working definition of 
health-related “Major Life Changing Decision” was also developed. The 45-item draft 
profile was grouped into six MLCD domains. 19 clinicians took part in the “content 
validation” stage and there was good agreement among the panel members for their 
ratings of language clarity, relevance, completeness and scaling. (Interclass correlation 
coefficient=0.71, p=<0.0001, 0=0.61-0.78, kappa coefficient=0.81, p=<0.0001, 
0=0.69-0.93). This led to a new 41-item version of the MLCDP (version la), covering 
five MLCD domains: education, job/career, family/relationships, social and physical. 210 
patients (30 from each of the seven specialties) were recruited into the second phase 
completed the MLCDP and data were analysed using factor analysis. The Cronbach’s 
alpha value of 0.8 indicated good reliability. Several items were made redundant as a 
result of factor analysis; this analysis supported the evidence of construct validity. Item 
prevalence ranking helped to retain conceptually important items at this stage. This 
profile was easy to complete for most patients (n=131, 97%) and mean completion time 
was 5.7 minutes. A 32-item version of the MLCDP (version 2) was finally developed, 
which requires future examination of its other psychometric properties.
The MLCDP is potentially of benefit in alerting clinicians to the long term impact of a 
chronic disease on patients, and as a tool to assess the true burden of chronic diseases on 
individuals’ long term quality of life. Clinicians’ knowledge about the influence of 
chronic diseases on MLCDs is important to provide better and timely guidance to 
patients, to support better treatment decisions and eventually to lead to better health 
outcomes. This study also proposed strategies for patients to consider when taking 
MLCDs. Such support might result in more appropriate decision-taking and improved 
health outcomes.
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CHAPTER 1
General Introduction
BACKGROUND
Disease is one of the major factors that has a great effect on an individual’s QoL. 
There has been a focus on the evaluation of disease impact and patients’ resulting 
concerns in the area of HRQoL research. The medical world uses its own term 
“Health-Related Quality of Life” (HRQoL) to describe the specific dimensions only 
related to health status (Halioua et al. 2000). Knowledge about the concept of HRQoL 
is vital (Flanagan 1982) for the scientific evaluation of disease impact on patients’ 
lives and response to treatment.
“Human life is our life, it is not an external but internal, not an impersonal but 
personal, not an objective but subjective process” (Kroner 1936, p. 205).
Kroner’s quote is very simple and precise and also supports the view that QoL means 
different things to different people according to their circumstances and needs. This 
personal predilection is the key to individuals’ emotional well-being, their happiness 
or sadness. Important priorities in life for some people might be career, family, job, 
education, children and even the “small things” such as for example fishing, dancing, 
travelling, driving, sports, eating out or going clubbing. For others, house keeping, 
taking care of the family, gardening, charitable work, music and cooking might be 
more important. The majority of these elements reflect life style and individuality, and 
people try to find peace and happiness in these activities. A majority of people might 
consider strong economy, financial stability, services (health, education, and 
transport), high standard of living, good health, cultural activities, and quality time 
with family as components of better QoL. Having a good balance between work and 
leisure for a better life might be more important to the younger generation than to the 
more elderly. Moral values and security based on observance of rules and regulations, 
security, religion and spirituality might be more important to an older generation.
Therefore, individual perspectives and circumstances determine an individual’s QoL, 
such as, health, education, job, financial status, and standard of living. However, there 
is no fixed rule or universally accepted concept of QoL that could be applicable to all 
people. For example, giving up a highly paid job for less stressful work might be the 
most likely choice for the majority of people as a first reaction. However, giving up a 
well paid but stressful job is not easy as there may be other benefits attached to it,
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such as financial advantage to the family, children and their future. Therefore, the 
decision is difficult; some might prefer less money to have better family relationships 
but some might prefer to sacrifice quality in their personal life to provide a better 
standard of living for their family members. Even for a single person, a change of job 
means change and adaptation in life style. It is clear that what we value is most 
important and having a good life style and being mentally healthy might be more 
valuable than having financial stability. In all circumstances happiness seems relevant 
to a good QoL. However, to achieve a good QoL it is necessary to take into account 
that individual preferences are most important.
The concept of QoL consisting of both subjective (personal appraisal) and objective 
(life conditions) dimensions (Felce 1997) has been seen by many as a “perceived” 
(WHOQOL Group 1998), or “subjective” concept (Sullivan 1992; Revicki et al. 
2000). Hunt (1988) stated that subjective or perceived health perception is based upon 
an individual’s experience of mental, physical and social events as they impinge upon 
feelings of wellbeing. Therefore, any factor outside traditional QoL dimensions 
(physical, psychological and social) such as family effects or major life changing 
decisions, which could impact on the quality of a patients’ life, should also be 
considered for evaluation and targeted for improvement. This argument supports the 
concept of “what things are important in people’s lives?” highlighted by Bowling in 
her survey (Bowling 1995). The evaluation of fixed traditional psychological, 
physical and social domains may not reflect overall subjective well-being. Certain 
elements and influential factors in life can help develop the specific character of an 
individual and create a unique human attitude towards life, such as health, education, 
job, finance, religion, spirituality, family, parents/child relationship, divorce, daily 
hard work and quality time, politics, social attitude, culture, language, war, 
occupation, imprisonment, stress and the environment. Quality of life is therefore 
influenced not only by what we do but the way in which we perform life activities and 
take important decisions in different circumstances. This behaviour gives a specific 
character to our life that is unique to each individual. HRQoL concerns the state of an 
individual, affected by disease, illness or injury, and any change to their daily living, 
choices/preferences, important life decision or their disease impact over time should 
be evaluated from a broader health-related perspective. Knowledge about how 
patients live their lives and take important life decisions under the influence of
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different circumstances and life events is vital. In particular, knowledge about the 
influence of chronic diseases on major life changing decisions is important to achieve 
better patient health outcomes. Therefore the first step towards this investigation was 
to carry out a detailed literature review particularly encompassing patients’ whole 
lives.
REVIEW OF THE LITERATURE
The main purpose of this review was to see whether or not there is any relevant 
information available in the literature regarding the influence of chronic disease on 
MLCDs, to what extent this problem exists and how patients take their MLCDs while 
suffering from long term health problems. Therefore, search terms (Table 1.1) were 
carefully discussed and selected in order to make sure that the broader health 
perspective of patients related to coping, social support and adaptation to chronic 
illness should be included for initial conceptualisation of the research area. For 
example, search terms “living with disease”, coping with disease”, “patient 
adaptation” and “influence on quality of life” were specifically included. At the 
review planning stage the area related to “clinical decision making” was also 
discussed as a search term but this search term was not included because this area is 
directly related to clinicians and their decisions for better management for patients 
and nothing to do with the patients’ life decisions while suffering from chronic 
diseases.
The search strategy was carefully formulated to retrieve appropriate publications and 
to reduce the chances of missing important relevant information related to the 
research area. The literature search involved three stages: Identification of key search 
terms, selection of databases and searching parameters and evaluation of references 
(Figure 1.1).
Figure 1.1: Searching strategy
Identification of key 
search term s
Selection of databases and 
searching parameters
Searching Technique
Evaluation of references
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The key search terms were selected to gain a broad perspective and to ensure a wide 
coverage of the literature. The terms included Quality of Life, life changing decision, 
and long term impact. The Wolter Kulwar, OvidSP MEDLINE(R) (1950 to April 
Week 4 2008) database (formerly known as Ovid) was selected for the initial 
comprehensive literature search. A literature search using Google Scholar and the 
Cardiff University Library Voyager and electronic journals portal was also carried 
out. This portal includes Adis Online, Alpha Med Press, American Association for 
Cancer Research, American Medical Association Journals and the JSTOR database 
for old literature. Another Meta Search was carried out in Cardiff University 
Electronic Resources-Metalib on 28 January 2010 for the term “life changing 
decisions”. Metalib resources, in a medicine search, include Cochrane Library 
(Wiely), Embase: Excerpta Medica (Ovid), PubMed, Web of Science and Zetoc. A 
separate questionnaire and item search was also carried out in February and March 
2010 of the “Compendium of Quality of Life instruments” (Salek 1998, 2007). This 
compendium describes over 150 questionnaires, profiles and inventories and covers 
general, disease specific, group specific and economic specific instruments.
A review of published studies and articles was conducted. The aim and methodology 
given in the abstract of the articles of each study identified was read to determine its 
relevance. Important and relevant articles were then retrieved from the main database. 
From the OvidSP MEDLINE(R) database, 4251 articles were retrieved for close 
inspection to identify any study with potential relevance to our research concept. 
Articles were obtained with a number of combinations of different selected key terms 
(Table 1.1). Those articles which cover areas close to our key search terms were 
selected to be included in the review of the research topic “influence of chronic 
diseases on major life changing decisions”. 3397 articles were identified from a 
separate search using a combination of “Quality of Life” and other descriptors such as 
“prospective study”, “long-term study”, “qualitative study”, “longitudinal study”, 
“cohort study” and “follow-up study”. When the term “life changing decisions” was 
entered in the Cardiff University Metalib (Medicine) resource (Figure 1.2) 1941 
articles were retrieved. The instrument search revealed that the majority of the 
selected instruments covered the core QoL domains of physical, psychological, social 
and emotional aspects. Other identified domains were personal care, support, outlook, 
symptoms’ status, level of independence, environment, spiritual/religious/personal
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beliefs, pain, sleep and energy level. In a detailed review of widely used and well 
validated questionnaires (Table 1.2) and within the vast variety of other health-related 
instruments that were reviewed, we identified no domain, indicator or item 
specifically covered the impact of disease on major life changing decisions.
Only two articles matched the term “major life changing decisions”. One article was 
related to psychology (Bauer et al. 2005) and the second article was related to 
neuroeconomics (Bems et al. 2007). The searching techniques used were also useful 
for the retrieval of other articles relevant to different aspects of the review such as 
Quality of Life and health assessment domains, Quality of Life indicators, chronic 
diseases and patient perceptions, philosophical concepts and qualitative assessment 
techniques. Studies were excluded if they were not published in the English language.
Table 1.1: Search results of different individual and combined terms
Single or combined terms used in searches Number of retrieved
references
Life changing decisions 2
Patient decisions 93
Personal decisions 45
Family decisions 52
Change in life style 115
Patient fear 95
Patient opinions 73
Patient suggestions 12
Patient views 133
Patient recommendations 39
Patient experiences 480
Patient account 249
Patient perceptions 711
Patient feelings 19
Patient adaptations 1
Patient diary 93
Influence on Quality of Life 368
Long illness 44
Living with disease 95
Coping with disease 74
Quality of Life over time 70
Long term impact 1255
Quality of Life, long-term impact and disease: combined search 60
Disease, influence, impact, family and decisions: combined search 73
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Figure 1.2: Metalib resource result for the term “life changing decisions”
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T able 1.2: M ajor  ( >oL instruments and their dom ains
Instruments Items Domains
The PULSES profile 
(Moskowitz and McCann 1957)
6 Physical functioning, Social and mental status
Barthel Index
(Mahoney and Barthel 1965)
10 Functional independence, Personal care, Mobility
Index o f  Activity o f Daily Living 
(Katz et al. 1963)
6 Physical functioning
The Rapid Disability Rating Scale 
(Linn and Linn 1982)
18 Functional capacity, Mental status
The General Health Questionnaire 
(Goldberg 1972)
60 Somatic symptoms, Anxiety and insomnia, Social 
dysfunction, Severe depression
The Functional Aspect o f  Cancer Therapy 
- General (FACT-G)
(Celia et al. 1993)
22 Physical well-being, Social and family well-being, 
Emotional well-being, Functional well-being
QoL Index 
(Spitzer et al. 1981)
5 Activity, Daily living, Health, Support, Outlook
The Functional Status Questionnaire 
(Jette et al. 1986)
34 Physical function, Psychological function, Work 
performance, Social activity, Quality o f  social 
interaction
The Duke Health Profile 
(Parkerson et al. 1990)
17 Symptoms status, Physical function, Emotional 
function, Social function
The M acMaster Health Index 
Questionnaire 
(Chambers et al. 1976)
59 Physical, Emotional, Social function
The World Health Organization QoL 
Scale
(WHOQOL Group 1994)
100 Physical health, Psychological, Level o f 
independence, Social relation, Environment, 
Spiritual/religion/ personal beliefs
The Sickness Impact Profile 
(Bergner et al. 1976)
136 Physical, Psychosocial, Independent categories
The Nottingham Health Profile 
(Hunt et al. 1981)
45 Part I: Physical ability, Pain, Sleep, Social isolation, 
Emotional reactions, Energy level 
Part II: 7 item handicap indicators
The Short-Form-36 Health Survey (Ware 
et al. 2000)
36 Physical functioning, Role limitations due to 
physical health problem, Bodily pain, Social 
functioning, General mental health, Role limitation 
due to emotional problems, Vitality, Energy or 
fatigue, General health perception
The EuroQoL EQ-5D Quality o f Life 
Scale (EuroQoL Group 1990)
5 Mobility, Self-care, Usual activities, 
Pain/discomfort, Anxiety/depression
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CHRONIC DISEASES AND MAJOR LIFE CHANGING 
DECISIONS
Influence of chronic diseases on patients’ lives
The impact of chronic diseases on patients’ lives can be considerable and the severity 
of patients’ health directly influences their Health-related quality of life (HRQoL). 
According to the WHO definition, “Health is the state of complete physical, mental 
and social well-being and not merely the absence of disease and infirmity”(WHO 
1946, p. 2, 1958, p. 495). This definition has been a subject of wide criticism and has 
been scrutinised from positive and negative health and illness perspectives (Downie et 
al. 1996). The definition of Sigerist (1941, p. 100) “Health is therefore, not simply the 
absence of disease: it is something positive, a joyful attitude towards life, and a 
cheerful acceptance of the responsibilities that life puts on the individual” seems 
similar but has a clear subjective approach, including life satisfaction within a broader 
perspective. Barnett (1991, p. 41C) described illness as a “subjective perception by a 
patient of an unusual/unpleasant feeling that may lead to differential behaviour 
patterns”. The WHO definition is very simple and has more positive elements of 
health, yet it is very effective and provides an initial platform for the creation of a 
more comprehensive definition. The earlier part of the WHO definition, that is 
“complete physical, mental and social well being” has a direct association with 
impairment, disability and handicap, but it is possible to argue about what constitutes 
physical, mental and social well being, and that is why it has become a debatable 
definition for many researchers. HRQoL is more than the evaluation of these 
traditional dimensions. Patients’ behaviour, perceptions and experiences are equally 
important for the complete assessment of HRQoL.
Chronic diseases can cause serious impairment, disability and handicap and affect the 
lives of patients over considerable periods of time. The WHO first published the 
International Classification of Impairment, Disability and handicap (ICIDH) in 1980. 
In the ICIDH manual, these terms were described as consequences of disease (WHO 
1980). The WHO described the concepts of these important terms in order to clarify 
terminology and to use them in the ICIDH model:
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Impairment: In the context of health experience impairment is any loss or 
abnormality of psychological, physiological and anatomical structure or function. 
Disability: In the context of health experience a disability is any restriction or lack 
(resulting from an impairment) of ability to perfonn an activity in the manner or 
within the range considered normal for a human being.
Handicap: In the context of health experience a handicap is a disadvantage for a 
given individual, resulting from an impairment or a disability, that limits or prevents 
the fulfilment of a role that is normal (depending on age, sex, and social and cultural 
factors) for that individual.
In the light of the above classification if as an example we apply these terms to 
patients who are suffering from severe psoriasis, scaling will be the impairment, palm 
involvement (unable to use the hand) will be the disability and the effect of this on the 
patient’s social setting will result in handicap (Chren and Weinstock 2004). These 
terms are interconnected to each other and technically the assessment of disability 
cannot be carried out without the assessment of disease impairment. Similarly, 
handicap results from an impairment and disability. Therefore, the evaluation of 
impairment and disability is necessary for the assessment of handicap.
Growing criticism lead to a process of revision of the ICIDH. The new classification 
ICIDH-2 has been developed to eliminate the conceptual deficiencies within the 
original ICIDH. Inclusion of activity, participation and contextual factors 
(environmental and personal) in ICIDH-2 improved the classification (WHO 1999). 
The ICIDH-2 has now been superseded by the new WHO International Classification 
of Functioning, Disability and Health (ICF). This classification was approved by the 
World Health Assembly on 22 May 2001 (WHO 2001). In September 2007, WHO 
published the Children and Youth version of the International Classification of 
Functioning, Disability and Health (ICF-CY) (WHO 2007).
The literature concerning HRQoL is mainly focused on the current impact of chronic 
disease on patients’ QoL and the disease burden on health system. The following brief 
review of chronic diseases and their impact on patients’ lives will provide us with an 
initial platform for in-depth discussion and will be helpful for background 
understanding of “the influence of chronic diseases on major life changing decisions”.
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Rheumatoid Arthritis
Living with rheumatoid arthritis (RA) is a “tightrope between freedom and a life 
sentence”(Ryan 2006, p. 193).
Rheumatoid arthritis is a serious disabling disease and the single largest cause of 
disability in the UK (Badley and Tenant 1993). RA affects around 1% of the adult 
population all over the world (WHO Technical Report Series 919 2003). Its financial 
burden to healthcare systems and on patients is immense (Meenan et al. 1978; Stone 
1984; Cooper 2000). The most obvious impact of RA is physical disability but 
challenges with daily living also result in a psychological and social impact on 
patients’ HRQoL (Yelin et al. 1987a). Similarly, loss of sexual satisfaction (Blake et 
al. 1987) may result in the break up of a relationship. It has been reported (Yelin et al. 
1987a; Yelin et al. 1987b) that patients with RA experience more losses in functional 
ability than people without arthritis in every domain of life activities, such as work, 
leisure and social activities. Loss of ability to work has been the worst affected area 
among working people because of the obvious functional disability caused by RA 
(Yelin et al. 1987a; Yelin et al. 1987b).
Cardiovascular Disorders
Cardiovascular diseases such as congestive heart failure (Juenger et al. 2002), 
myocardial infarction (Roebuck et al. 2001), hypertension (Fletcher and Bulpitt 1993) 
and angina (VandenBurg 1993) have significant impact on patients’ HRQoL. 
Psychological distress caused by heart problems affects sexual activity. Impaired 
sexual functioning limits the QoL of up to 75% of post-myocardial infarct patients. 
Depression and anxiety among cardiac patients is also associated with poor health 
(Javadi et al. 2004). In a study carried out by Juenger et al (2002) comparisons were 
carried out between congestive heart failure and other chronic diseases (hepatitis C, 
chronic haemodialysis and major depression). Levels of heart failure were evaluated 
with the New York Heart Association (NYHA) Functional Classification and HRQoL 
assessment with the SF-36 (German version). The congestive heart failure patients 
showed a global reduction in QoL in all the SF-36 scales compared with the general 
population. Physical and emotional role functioning were the most affected areas. 
Patients with congestive heart failure showed the same pattern of reduced QoL as 
patients on chronic haemodialysis. Patients with chronic hepatitis C had higher scores
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in physical functioning, role functioning physical and general health than the heart 
failure population. Patients with more advanced congestive heart failure (NYHA class 
III) had similar scores to patients with major depression on the mental health scales 
(Juenger et al. 2002). Heart failure not only impaired patients’ physical, role and 
social functioning (Carels 2004) but also affects the QoL of partners (Luttik et al.
2007). Health-related problems and difficult life issues faced by chronic heart failure 
patients, such as debilitating physical symptoms, role changes, frequent 
hospitalisations, forced retirement and financial stress can lead to depression and 
ultimately reduction in the QoL of patients and their partners (Martensson et al. 
2003).
Angina pectoris affects 2-3% of the population. It is one of the most common and 
costly health problems in the UK and consumed over 1% of all NHS expenditure in 
the year 2000 (Stewart et al. 2003). Patients with angina also experience reductions in 
their functional role and poor QoL (Lyons et al. 1994; Gandjour and Lauterbach 1999; 
Lewin 1999; Stewart et al. 2003). In patients with hypertension, antihypertensive 
treatment and associated side effects may contribute towards poor QoL (Hill et al. 
1985; Fletcher etal. 1989).
Diabetes
Diabetes significantly reduces the QoL of patients, in particular the burden of 
psychosocial issues may have a major impact on self care behaviour. Diabetes 
management demands many decisions being taken on a daily basis, making such self 
management very challenging for patients. Evidence concerning a possible link 
between increased disease duration and decreased QoL is conflicting and arguments 
concerning such a relationship have not yet been resolved (Rubin and Peyrot 1999). 
Due to the demanding nature of the disease and its significant burden on the lives of 
patients, Rubin (2000) described it as “diabetes overwhelmus”. Diabetes can 
significantly compromise physical, psychological and social functioning. Disease 
complications and resulting change in life style significantly contribute towards 
impaired physical functioning and hence impaired QoL. For example, advanced 
systemic involvement, chronic pain, amputation and a complete change in routine 
activities due to the diabetes regimen may all affect QoL. The chronic nature of the 
disease, constant treatment demands and the onset of multiple complications may
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result in patients feeling hopeless and emotionally depressed. Even hypo and 
hyperglycaemic episodes may contribute to a constant depressive mood. Patients have 
to adopt a new life style to overcome their management problems and to improve 
daily self care. Change in life style and daily habits can increase pressure on the 
person and family which in turn may cause serious effects on relationships resulting 
in patients feeling socially isolated (Polonsky 2000). Improved social support may 
help patients with diabetes to manage metabolic control, to better self care and to 
adjust to their altered psychosocial status (Goz et al. 2007).
The Diabetes Quality of Life Measure (DQOL) (Jacobson 1994), the Diabetes 
Specific Quality of Life Scale (DSQOLS) (Bott et al. 1998), the Quality of Life 
Clinical Trial Questionnaire-Revised (DQLCTQ-R) (Shen et al. 1999), the Appraisal 
of Diabetes Scale (ADS) (Carey et al. 1991), the Questionnaire on Stress in Patients 
with Diabetes-Revised (QSD-R) (Herschbach et al. 1997) and the Audit of Diabetes- 
Dependent Quality of Life (ADDQoL) (Bradley et al. 1999) have all been used in 
studies to assess different aspects and domains related to the QoL of patients with 
diabetes.
Cystic Fibrosis
Cystic Fibrosis (CF) is one of the commonest life-threatening diseases affecting 8,000 
children in the UK (Cystic Fibrosis Trust 2008) and 30,000 in the United States 
(Cystic Fibrosis Foundation 2008). Each week in the UK, five children are bom with 
CF and three young people die due to CF (Cystic Fibrosis Trust 2008). In 1938, 80% 
of babies bom with CF died within the first week of life (Congleton et al. 1996). In 
the 1950s, few babies lived to attend elementary school (Cystic Fibrosis Foundation
2008). Nowadays, due to advances in management and proper care, the majority of 
CF patients survive into adulthood (Abbott et al. 1997). It was reported in 1998 on the 
basis of epidemiological analysis that of children bom in 1990 with CF, more then 
90% will reach adulthood and have a life expectancy of 40 years (Staab et al. 1998). 
Despite improved management techniques and longer life expectancey, progressive 
lung involvement and chronic airway limitation have a major impact on the QoL of 
patients with CF (de-Jong et al. 1997). Health-related quality of life perception and 
behaviour (Brown et al. 1994; Gee et al. 2003), depression (Riekert et al. 2007), 
clinical assessment trials (Abbott and Hart 2005) and impact of lung transplantation
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(Busschbach et al. 1994; Vermeulen et al. 2004) have been studied in CF patients to 
determine the impacts of CF on patients’ lives.
Respiratory Disorders
Chronic obstructive pulmonary disease (COPD) is a common long-term chronic 
condition. Nearly three million adults die each year of COPD. COPD causes a 
substantial amount of financial burden to healthcare systems (Soriano et al. 2000). In 
2004 in England and Wales 23,204 patients died due to COPD. In the United 
Kingdom the cost of lost productivity due to COPD is estimated at between £600 
million and £1.5 billion per year (Halpin and Miravitlles 2006). The burden of COPD 
on HRQoL is immense (Guyatt et al. 1987). Severe disease symptoms and reduced 
lung function (Fletcher and Peto 1977), frequent treatment and hospital admission 
(Halpin and Miravitlles 2006) and reduced physical functioning can cause 
considerable impact on patients’ QoL (Gosselink and Decramer 1998) and ultimately 
may lead to social isolation and depression (van-Ede et al. 1999). In one study, it was 
reported that even mild COPD can cause significant impairment in HRQoL (Ferrer et 
al. 1997).
Asthma is another common chronic conditions; it affects approximately 4 to 11 % of 
the population and its worldwide prevalence has risen during the last decade (Braido 
et al. 2007). Asthma is associated with significant morbidity (Mannino et al. 2002) 
whereby, chronicity, severity and sudden attacks can severely affect patients’ QoL 
(Schier et al. 1998). Relief of symptoms and strategies to improve patients’ QoL may 
help in successful management (Jones 1995). However, psychosocial factors can 
influence health outcomes (Janson et al. 1994).
Chronic Kidney Disease
Chronic kidney disease (CKD) is an important cause of morbidity and mortality 
worldwide. Very little information is available concerning impairment of QoL in 
CKD patients (Perlman et al. 2005). Maintenance of QoL at different stages of CKD 
is very important (Kalender et al. 2007). Chronic kidney disease with complications 
caused by co-morbid conditions can affect the functioning and well-being of patients 
significantly and those on dialysis may have more impairment of QoL which may 
lead to an impact on the family (Fowler and Bass 2006).
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Psoriasis
Psoriasis is a chronic inflammatory skin disorder and around 2 to 3 % of the world 
population are affected by this disabling condition (Finlay and Ortonne 2004; 
Kormeili et al. 2004). The financial implications of psoriasis are very high and in the 
USA alone approximately $1.6 billion to $3.2 billion is the amount estimated that is 
required for out-patient treatment alone (Feldman et al. 1997). Jayaprakasam et al 
(2002) concluded in one study comparing disease severity and QoL that the impact of 
common skin diseases on HRQoL may not correlate with severity. In another study, 
Heydendael et al (2004) suggested that there was no significant correlation between 
disease severity and QoL. However, they found a significant correlation between 
disease visibility and QoL impairment (Heydendael et al. 2004).
Mental stress has negative impacts on psoriasis. In the majority of cases, psoriasis 
patients have noted stressful incidents before a recurrence or exacerbation of their 
psoriasis, for example, family stress, death in the family, an accident, hospitalisation, 
exams or sexual assault (Gupta and Gupta 2003). In the opinion of Sulzberger and 
Zaidens (1948) there is a relationship between traumatic emotional events and early 
outbreak of psoriasis; similarly, in a large number of patients, stress is associated with 
exacerbation of psoriasis (Sulzberger and Zaidens 1948). A constantly stressful life 
with high emotions, anxiety and embarrassment along with physical and social 
impairment may lead to serious depression. In a few patients, the catalogue of 
psychological stressors is serious enough to push patients towards suicidal thinking. 
In severely disabling disorders, such as psoriasis, a complete assessment of the overall 
disability is very important because psychiatric co-morbidity may correlate with the 
risks of a psychiatric emergency such as suicide. Intervention may help reduce the 
progression and recurrence of such psychological problems (Gupta and Gupta 2003). 
Physical impacts are mainly related to signs, symptoms and daily activities. The most 
common functional activity related problems which may be affected are walking, 
carrying, climbing stairs and daily routine work (Korte et al. 2004). In a National 
Psoriasis Foundation patient-membership survey (Krueger et al. 2001) a considerable 
number of patients reported problems performing daily activities. In particular, older 
patients faced more problems performing daily functional activities, such as using 
hands (19%) and walking (14%) (Krueger et al. 2001). Finlay and Coles (1995) found 
that out of 369 psoriasis patients, 46% patients were working and of these 59% lost
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time at work (20 days per annum) simply because of their psoriasis. 34% of patients, 
among those not working or retired, reported psoriasis as one of the main factors 
resulting in their inability to work. Concerning the impacts on the social lives of 
patients, the main affected activities involve skin exposure (different choice of 
clothes, beach and swimwear), sports, socialising in public, sexual behaviour and 
going to the hairdresser. Psoriasis can cause serious damage to relationships with 
family, friends, partner and neighbours and in terms of personal contact at work 
(Korte et al. 2004). Furthermore, 30% to 70% of psoriatic patients encounter serious 
sexual problems (Gupta and Gupta 1997) which in turn may lead to mental distress in 
some patients. Gupta and Gupta (1997) noted that 49 out of 120 patients reported 
reduced sexual activity regardless of age, sex, marital status or duration of psoriasis. 
When measured, psychological problems scored high, in the range of clinical 
depression, suggesting that psoriasis can have a devastating impact on QoL.
Atopic Eczema
Atopic eczema is a chronic skin disorder which affects 10% of children in early 
childhood. It is more common in children under 5 years of age (Daud et al. 1993). In 
adults, prevalence and incidence is not completely established but a life-time 
prevalence of around 1% to 5.1% has been reported (Schafer 2006). Atopic eczema 
severely affects the QoL of patients and their family members (Lawson et al. 1998). 
The psychological impacts are very high in patients suffering from eczema. It has 
been reported that approximately 70% of patients are living a stressful life (Gupta and 
Gupta 2003). Atopic eczema in children could result in severe depression in the 
mother which could harm the mother and child relationship, whereas in adults, atopic 
eczema is related to anxiety and anger. Pruritus plays a major role in eczema and is 
directly related to the mental distress (Gupta and Gupta 2003). In 1998, Lawson et al 
(1998) prepared a 10-item Dermatitis Family Impact (DFI) questionnaire to assess the 
QoL of families affected by childhood atopic dermatitis. In the initial study, 74% 
parents felt a burden of extra care, 71% parents reported mental distress 
(psychological pressure, feelings of guilt, frustration, resentment and helplessness), 
66% reported a change in their normal life (no pets, diet, and restricted use of 
household products), and 63% of siblings were losing sleep. Other negative impacts 
on the families were because of an affected child facing bullying at school, a change 
in child behaviour, reduced leisure activities and the financial burden. Foo and
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Schofield (2000) also used the DFI to assess the family impact and found that severity 
of eczema in newly referred patients was related to family impact and that the family 
impact was reduced by effective treatment. They also suggested that the family 
impact might be higher in young children.
Acne
Acne is a very common skin disorder. It is so common that almost every person has 
acne at some stage and most of the time it is easily ignored. Teenagers are the most 
affected by acne with a recorded highest incidence of acne at the age of 16 to 18 years 
(Finlay 1992). Goulden et al (1997) noticed an increasing number of acne cases in 
adults over the age of 25 years. In a study in Leeds (Goulden et al. 1997) 300 adults 
(129 men and 171 women) over the age of 25 were interviewed and the acne severity 
grading with scaring was recorded. Fifty eight percent of women and 47% of men 
were affected by acne and the highest incidence was between the ages of 25 and 34 
years. Acne occurs on highly visible areas of the body and so can cause extremely 
high psychological distress to sufferers (Finlay 1992). Mental distress is significantly 
increased with exacerbation and scaring. It has been reported that the psychological 
impacts of acne are similar to the psychological impacts of asthma, seizures, diabetes 
and arthritis (Gupta and Gupta 2003). According to Cotterill and Cunliffe (1997), 
continuous long term suffering may lead to a long term psychological impact such as 
depression. Depressive syndromes, alcoholism and personality disorders in patients 
with poor socio-economic status may lead to suicidal thoughts or actual suicide 
(Cotterill and Cunliffe 1997). The most serious social impact of acne is on 
employment and on patients’ careers. Application to join the army might be refused 
because acne may be exacerbated in tropical areas. Employers may not offer a job to a 
candidate because of his or her appearance due to acne. Acne can seriously damage 
relationships and social activities, such as family life, sports, hobbies and leisure 
activities. Because of its visibility, its appearance and the resulting lack of confidence, 
acne patients may face difficulty making new friends and building relationships 
(Finlay 1992).
Vitiligo
Vitiligo is one of the most visibly debilitating skin disorders, particularly in people 
with darker skin. Approximately 1% to 4% of the world’s population is affected by
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vitiligo. In India, it has been ranked as the third major health problem after leprosy 
and malaria and is regarded as “white leprosy” (Parsad et al. 2003). The estimated 
prevalence of vitiligo in the United States is around 1% (Kovacs 1998). Vitiligo has 
severe social consequences and patients feel embarrassed, depressed and stigmatized. 
Women with vitiligo have less chance of getting married and married women might 
even face divorce in India because of vitiligo (Parsad et al. 2003). Vitiligo has a 
serious impact on patients’ QoL. One patient described vitiligo as “worse than having 
diabetes” (Austin 2004).
Hair Loss
Hair loss and alopecia areata can have as severe as impact on QoL as psoriasis and 
atopic eczema (Williamson et al. 1997). Williamson et al (1997) carried out a study to 
assess the level of handicap in patients with hair loss. Seventy adult patients 
completed the DLQI and a depression questionnaire (CESD-10) along with utility 
questions. For the purpose of long term assessment, the time frame for questions in 
the DLQI was modified from the “previous week” “to the previous year”. The 
previous week mean DLQI was 8.3, whereas, the “previous year” DLQI mean score 
was 12.5, which suggested a significant variation in disability over a one-year time 
span. The main reported areas were self-consciousness and problems with social and 
leisure activities. The CESD-10 score was 12.7 (range 0-25) suggesting considerable 
mental distress (Williamson et al. 1997). Hay et al (2000) found that women with 
alopecia areata rated their condition extremely embarrassing. They also concluded 
that the range of impacts of alopecia areata on QoL is similar to other chronic skin 
disorders.
Other Chronic Debilitating Skin Disorders
The visibility of any skin disorder can cause some degree of disability. However, in 
some conditions, skin related disability is more severe than others. Chronic skin 
disorders, such as Darier’s disease, Hailey-Hailey disease, port wine stains and 
Behcet’s disease can also cause serious impairment of QoL. Harris et al (1995; 1996) 
and Burge and Wilkinson (1992) reported that most patients with Darier’s disease and 
Hailey-Hailey disease live normal lives. Lanigan and Cotterill (1989) found a 
significant psychological morbidity in port wine stain patients. The majority of the 
patients experienced stigmatisation, difficulty in relationships, embarrassment,
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anxiety and depression. Blackford et al (1997) conducted the first large survey (335 
patients) to measure the QoL in patients with Behcet’s syndrome. They found a 
significant level of disability with the most affected aspects being “symptoms and 
feelings” and “personal relationships”.
Conceptualisation of Health-Related Major Life Changing Decisions
In the development of any new concept, initial psychological, social and philosophical 
conceptualisation is necessary to understand and define the idea. Initial 
conceptualisation not only provides the basis for the rationale but also unfolds the 
complex and intricate nature of a subject, allowing for a more specific, realistic and 
logical approach for future progress. There is a lack of understanding up to now about 
“Major Life Changing Decisions” (MLCDs) in the area of health, including a lack of 
knowledge about the influence of patients’ personality and attitude, what constitutes 
long-term impact, and how chronic disease impacts on patients’ lives and behaviour. 
A systematic approach to these areas will help in the understanding of the patients’ 
personality and attitude in different circumstances and situations, particularly at the 
time of important life events and subsequently the nature of the major life decisions 
that people make. Along with “human psychology” and “diseases long term impact”, 
the exploration of some wider but interrelated concepts such as “life course, life 
transitions and life goals concepts in the health realm” and “life events and illness 
concept” will enhance understanding of the conceptualisation of disease influence on 
major life changing decisions.
Life changing decisions and human psychology
Psychologists have gained considerable knowledge about human behaviour under 
difficult conditions (Seligman 2000), but their understanding of illness related human 
behaviour is at an early stage. Most literature on life change refers to life events and 
related change, and psychologists find it hard to get reliable information on life 
change (Heatherton and Nichols 1994). “Life changing decisions” has been studied in 
psychology as “crystallization of desire and discontent” (Bauer et al. 2005) but very 
limited information is available in the health realm. This concept might have a 
different implication in a health and illness paradigm but may help the understanding 
of the relationships between illness and life changing decisions.
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Life changing decisions are complex and may lead to a different life course. It is 
obvious that the life decisions that people make are normally intended to gain the 
desirable outcome of a better life. However, not every life decision turns out to be a 
positive or a correct decision. It has been suggested that the reasons for making life 
decisions are connected to the life path that a person is following and the broader 
concepts of personality and well being (Bauer et al. 2005). “Crystallization of desire” 
is a style of life changing decision making in which people give more emphasis to the 
future rather than to the present or past. Whereas an escape from an undesirable past 
is observed as a “crystallization of discontent”. It has been suggested that people have 
to face crystallization of discontent before making any life changing decision (Bauer 
et al. 2005). This means there is a realisation that the past was undesirable but a 
desirable future is still possible. This seems very close to formulating a coping or 
future strategy after any negative life event. For example, clinicians are aware that 
after the diagnosis of a chronic or life threatening condition, acceptance is always a 
great challenge for patients. They search all available avenues for a cure and may take 
a considerable time to realise that they might have to live with the condition for the 
rest of their lives. Subsequently patients go through a process of denial, 
depression/anger, acceptance and adjustment (Lee 2005). A change in attitude to 
acceptance may give a patient motivation for the future but life changing decisions 
and related choices may remain very limited due to the constant illness and related 
factors (severity, depression, treatment etc). Therefore, the desired future outcome 
may not be as successful as for disease free individuals. In human psychology, it has 
been recognised that people with a positive attitude and who are happy have many 
goals and purposes in life (Emmons 1986). Therefore, it is possible that the specific 
individual circumstances and personality of an individual may influence the nature 
and approach to life changing decisions. This theory is supported by the factual 
observation of Baumeister et al (2001) that “bad is stronger than good”. They 
suggested that bad (negative) life events have a greater and more intense impact on 
individuals than good (positive) life events. People always react strongly to negative 
events. The intensity of response may differ due to the type of negative life events that 
people face. For example, the response to imminent death will be immediate, whereas 
the reaction to the diagnosis of a chronic disease will be long term and the response 
may be reflected in subsequent life changing decisions. In psychology, task method,
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life narratives and memories were used to understand personal striving, personality 
and behaviour in chance situations, adaptations to death or in crises (Langer and Roth 
1975; Emmons 1986; Moffitt and Singer 1994; McAdams 1995; Bauer and Bonanno 
2001a, b). Life change has also been studied as regret about early adult life choices as 
motivation for life changes in later life (Stewart and Vandewater 1999). It is difficult 
to understand what constitutes regret as people take their decisions according to their 
own circumstances and available opportunities. It is very difficult to analyse the 
contribution or regret as a motivation for future change when important life decisions 
are based on health grounds.
Disease Long Term Impact
It is important to understand the long term impacts of chronic disease as these impacts 
may change over a period of time. The first step towards this quest is to be able to 
define chronicity or long term impact. Most dictionaries and websites do not specify a 
particular time span to these terms. The reason is obvious, as diseases may have 
different time frames for acuteness or chronicity. For example, in acute urticaria, an 
urticarial reaction and recurrence may occur for a few hours to several weeks, but for 
usually less than 30 days and in chronic urticaria hives appeared daily for more than 
30 days (Wolff et al. 2005). The Japanese Respiratory Society published guidelines to 
define “acute” and “chronic” cough to improve diagnosis and treatment. According to 
this guideline, an acute cough lasts less than 3 weeks. A prolonged cough lasts 3 to 8 
weeks and a chronic cough lasts more than 8 weeks (The Japanese Respiratory 
Society 2006).
There is however no fixed definition of the duration of acute and chronic disease. The 
definition of chronic disease by the U.S. National Centre for Health Statistics, 
“chronic diseases generally cannot be prevented by vaccines or cured by medication, 
nor do they just disappear” (U.S. Department of Health and Human Services 2004). It 
is generally considered that diseases with a history of more than three months and 
have no complete cure, or diseases that persist for a long period of time, fall under the 
term of long term or chronic disease. Permanent impact or an impact which affects 
patients for many years or throughout their lives due to illness could be described as a 
long term impact. Several studies have assessed the QoL impact on patients who had 
suffered from chronic diseases for a long period of time. These include: the
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assessment of the impacts of psoriasis on 369 patients by Finlay and Coles (1995), a 
survey by Rapp et al (1999), The National Psoriasis Foundation Patients Membership 
Survey (Krueger et al. 2001), the Nordic Psoriasis Association Survey (Zachariae et 
al. 2004), the International Quality of Life Assessment Project in eight countries 
(Alonso et al. 2004), the impact of asthma in the Australian population study (Ampon 
et al. 2005), 29 chronic conditions general health population survey in Finland (Saami 
et al. 2006), chronic obstructive pulmonary disease patients’ experience (Barnett
2005), and maintenance haemodialysis: patients’ experience (Hagren et al. 2005). 
However, these studies were not specifically designed to assess the long term impact.
Generally when a disease progresses, immediate or short term impacts may lead to 
more serious impacts, which may affect patients throughout their lives. Therefore, 
small frequent impacts caused by chronic diseases could be viewed as long term 
impacts. For example, psychologically, anxiety may turn into depression or suicidal 
thinking. Physically, impacts related to signs and symptoms (itch and pain) may lead 
to constant sleep disturbance and hence lack of fitness and loss of days from work. 
Socially, constant illness and reduced sexual drive may cause a break up of a 
friendship or marriage; also, absence of leisure activities may lead to complete 
isolation and serious mental distress. On the other hand, some initial impacts may 
affect patients throughout their lives. Rudolph et al (2008) measured the long term 
functional status in 42 patients with Guillain-Barre syndrome at a median of six years 
after disease onset and compared this group with 50 healthy individuals. There was 
decreased physical functioning in patients and no difference between patients with < 6 
years and >6 years follow up.
At the moment, we have more understanding of specific psychological, physical and 
social impacts associated with chronic disorders. These impacts cause patients 
impairment, disability and handicap, captured fortuitously thorough several similar 
studies primarily evaluating current impact. Similarly, in follow up studies the 
assessment of disease impact mainly concerns current impacts, and the changes which 
have occurred in that over a period of time (Huurre and Aro 2002; Beattie et al. 2003; 
Heald et al. 2004; Sillanpaa et al. 2004; Chen et al. 2006; Kuriya et al. 2008; Husser 
and Roberto 2009; Saha et al. 2009). For example, if the impact of a disease were 
measured at the time of diagnosis and then 20 years later patients are asked how their
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illness has affected their lives; this would be a record of two sets of current impact on 
two different occasions. Even if patients are asked how the disease has affected them 
over the previous year, this may not reflect the type of impact that the patient has 
faced over the 20 years course of the disease. Patients might have experienced 
different disease impacts after 5, 10 or 15 years. To more appropriately record the 
long term impact, it might be better to ask patients how their illness has affected them 
over the last 20 years. Such a holistic exploratory retrospective approach may provide 
a completely new insight into the different nature of the long term impacts faced by 
patients during different stages of their life and might reveal new domains in which 
life is affected.
Unaeze et al (2006) published an 11-year prospective study in which they evaluated 
the long term impacts of psoriasis on HRQoL. A total of 484 patients were 
interviewed in 1993 and then again in 2004. The Impacts of Psoriasis questionnaire 
(IPSO) was used for the assessment. This study showed that the impacts of psoriasis 
on HRQoL decreased over time. Social impacts were stable or slightly improved 
(social activity, travel and making new friends). Unattractiveness, embarrassment, and 
the feeling of being outcast were the most affected areas. After 11 years, these areas 
were improved considerably, particularly the feeling of unattractiveness. The question 
concerning “Not enjoying activities” scored very low a decade ago, but the score 
increased several fold by 2004. “Not feeling better after treatment” and “Causes 
family friction” scored high, which indicates the increased severity of impact in these 
areas (Unaeze et al. 2006).
This study (Unaeze et al. 2006) was designed to evaluate the long term impacts of 
psoriasis and provides a foundation for future research. However, identification of 
pitfalls may be helpful in future studies. For example, the sample size of 484 subjects 
represents a high drop out rate. Initially, 867 patients entered the study and completed 
the IPSO but by 2004, 221 patients had died (25%) and 171 patients were not able to 
be followed up. This is a genuine problem in long-term follow-up studies. 
Furthermore, most of the patients were between 45 and 55 years of age. This might be 
an influential factor contributing to a decreased score in some impacts, as older people 
might adjust to the situation more easily than younger people. Severity, intervention 
and gender data in such studies could yield more information. The IPSO items mainly
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assess current impacts at the time of administration. The questionnaire asks patients to 
report current impacts or disease impacts during the past month and assess the 
psychosocial impact of psoriasis on a patient’s life (Nijsten et al. 2006). In this study 
researchers recorded the change in known impact at a particular time (2004) after 11 
years, but did not record the overall impact over the intervening 11 years and in what 
ways the disease impacted on patients’ lives over that period. Therefore, along with a 
follow up or prospective research strategy, a novel, refined holistic and exploratory 
retrospective approach is necessary for the assessment of the true nature of the long 
term impact of disease on patients’ lives.
The long-term influence of eczema on patients’ QoL over the past few years was 
assessed in a study by Finlay (1996). Ninety-two eczema patients were evaluated and 
80% of the patients reported effects on their family life. Working patients lost around 
£5000 (estimated median) over the previous year. Other impacts identified were 
effects on sexual relationships (57%), choice of career (51%) and 52% reported 
effects on long term personal friendships/relationships (Finlay 1996).
Childhood disorders and level o f  long term impacts
The impacts of chronic disorders, particularly those of genetic disorders or of 
childhood conditions, have two dimensions, one related to the child and the other 
related to the parents. For example in atopic dermatitis, it is difficult to establish the 
level of psychological, physical and social impacts in preschool children. Before 
school age children have little understanding or ability to express how their skin 
condition has affected them. Children begin to understand when they start school; and 
over time, they try to understand what is wrong with their skin, why their skin is 
different from others and why they have to use moisturisers or protective clothing. 
This continuous thinking about their skin condition may cause a great deal of 
confusion, distress and problems with learning. Confusion and lack of concentration 
are clearly short term impacts. However, these problems may lead to long term 
impacts of poor academic performance and hence inability of affected children to 
reach their full potential in their life and career. This is because by high school age 
children normally fully understand about their illnesses, and as children grow up, long 
term impacts start appearing, such as they may feel depressed due to a lack of 
physical and social activities, difficulty in making new friends, bullying at school,
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avoiding sports or swimming because of physical disability or due to their 
appearance. Growth retardation and learning disability could be considered to be long 
term impacts.
Treatment related long term impact
Chronic illnesses require continuous long term treatment in order to control the 
disease and reduce the patients’ disability to a reasonable level so that patients are 
able to perform normal day-to-day activities. To achieve this goal requires constant 
active treatment, monitoring and follow up. However, long term treatment has its own 
disadvantages, which may cause further adverse impacts on patients’ QoL. There 
have been advances in pharmacological as well as surgical treatments in recent years. 
It is possible to assess the long term impact of these new approaches on patients’ 
lives. It is even possible to measure the long term impact of cancer and the impact of 
advanced therapy on functioning and the psychosocial aspects of patients’ lives (Redd 
and Jacobsen 1988). A large amount of information is available about the long term 
impact of management (medical/surgical) on patients HRQoL and its long term 
impact on patients’ lives (Terrell et al. 1998; Svedlund et al. 1999; Sin et al. 2002; 
Halonen et al. 2003; Engel et al. 2004; Vartanian et al. 2004; Constantinides et al. 
2006; Domhoffer et al. 2008; Koivunen and Lukkarinen 2008; Lundberg et al. 2008).
Life course, life transitions, life goals, life events and the concept of health
These concepts are widely discussed and studied in the fields of psychology, 
sociology and in the epidemiology of personality and behaviour. Knowledge of these 
concepts is also essential from a health perspective and may provide a better 
understanding concerning the concept of health and life decisions. However, there is 
very little information concerning these areas in the health-related literature.
Life course: The “Life course” concept is not a new concept in behavioural research. 
It concerns different aspects of life studied in psychology, health, sociology and in 
personality and attitude related subjects (Kuh et al. 2003). In the health sciences, this 
concept has been studied in relation to chronic disease epidemiology, a discipline 
which explores the relationship between the timing of disease exposure and outcome 
within the life course of individuals (Lynch and Smith 2005). Ben-Shlome and Kuh 
(2002, p. 258) defined life course approach to chronic disease related epidemiological
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approach as “the study of long term effects on chronic disease risk of physical and 
social exposure during gestation, childhood, adolescence, young adulthood and later 
adult life”. During the course of life, the risk of developing chronic diseases may 
increase due to negative social circumstances (Mishra et al. 2009) and an 
accumulation of disadvantages may have an influence on QoL in early old age (Blane 
et al. 2004). A Course of Life (CoL) questionnaire (Brenninkmeijer et al. 2009) has 
been described to assess the timing of developmental milestones in young adults 
(aged= 18-30 years) who have grown up with chronic or life threatening diseases and 
the CoL has been used to compare this group with a control group of healthy 
individuals. Items of questionnaires of such nature are largely grouped into three 
scales (development of autonomy, psychosexual development and social 
development) and two risk behaviour scales (antisocial behaviour, and substance use 
and gambling). These questionnaire items have been used along with quality of life 
questionnaires to assess the life development and achievement of patients suffering 
from various conditions, such as atopic eczema (Brenninkmeijer et al. 2009), 
phenylketonuria (Bosch et al. 2007), congenital hyperthyroidism (Veer et al. 2008), 
and survivors of childhood cancer, patients with anorectal malformations, 
Hirschsprung’s disease, patients with oesophageal atresia and patients with end-stage 
renal disease (Stam et al. 2006) and childhood vitiligo (Homan et al. 2008).
Recently, Kimball et al (2010) reviewed the long term impact of psoriasis and 
proposed the concept of “Cumulative Life Course Impairment” (CLCI). This 
speciality specific modified concept of health and life course epidemiology results 
from an interaction between “(a) the burden of stigmatization and physical and 
psychological co-morbidities and (b) coping strategies and external factors” (Kimball 
et al. 2010). The concept of CLCI appears to be relevant concerning long term impact 
of psoriasis but may not be generalisable across other medical specialities. In 
particular, stigmatisation which overlaps with psychological co-morbidities is more 
relevant to skin conditions for aesthetic reasons. Stigmatisation may not be relevant to 
patients who are suffering from non dermatological chronic conditions. The concept 
of CLCI as described by Kimball et al (2010) does not specifically address the impact 
of psoriasis on MLCDs. However, if a MLCD is influenced by psoriasis, this may 
contribute to CLCI, and indeed it may be that influences on MLCD are of equal or 
greater importance than stigmatisation and coping strategies in contributing to CLCI.
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Life transition: People go through many transitions in their lifetime (Heatherton and 
Nichols 1994). “Life transition” is a delicate concept of self-reflection and concerns 
realising the potential and creative opportunity for development. It is not necessary 
that all life transitions (voluntary or involuntary) guarantee any happiness or meaning 
to life (Bauer and McAdams 2004b). A transition in life is the change from one stage 
of life to another or a shift of life from one situation to another situation; either due to 
a natural progression of life or due to consequences of life events or the important 
decisions that people make. This change could be from a negative to a positive or 
from a positive to a negative situation. Life stages and changes in role (son, daughter, 
husband, wife, parents, grand-parents) are clearly example of life transition. However 
in addition any major change in life due to an individual’s circumstances and life 
events can be a part of life transition. When undergoing a life transition, it is often 
difficult to forget about the previous stage or phase of life and both good and bad 
memories may re-emerge time and time again. In particular, in a phase where 
someone is having a bad time, that person normally finds it difficult to forget previous 
happy memories. The life transition concept also provides insight in to the concept of 
a new beginning. For example, the diagnosis of a chronic disease results in an 
undesirable negative life transition from a disease free life stage to a life phase living 
with disease, and long term illness can make it more difficult for patients to forget 
about their previous good life and to move forward (Bridges 1980). Another area of 
interest concerns the origin of a life transition, whether it is related to a specific life 
event, circumstance or situation.
Life goals: Elliot and Sheldon (1998) defined personal goals as the “consciously 
articulated, personally meaningful objectives that individuals pursue in their daily 
lives and operationalise in terms of personal projects, personal strivings and life 
tasks”. At an early stage of life people normally set different life goals, objectives and 
priorities according to what they want to achieve in the future and setting out goals to 
which a person aspires gives a sense of purpose to life (Elliot and Sheldon 1998). 
Bauer and McAdams (2004a) reached a more or less similar understanding, and stated 
that goals reveal what people want and how they want to achieve them in life, but 
they more specifically linked goals to “personal growth” and coined the term “growth 
goals”. This term describes life goals that are normally connected to life stages and
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roles and denote a positive attitude towards life and positive behaviour. Education, 
career, relationships and family (marriage, having children), travelling, life style 
change (weight loss, quit smoking and alcohol habits) and gaining financial stability 
are examples of different aspects of life where people set personal life goals and 
positive targets to achieve a better QoL in the future. It is a matter for each individual 
what sort of objectives they want to set for their life. However, circumstances and life 
events such as death of a partner, accidents, onset of chronic disease or financial 
instability may change personal goals and individuals’ priorities. For example, 
changes in a desirable career pathway or a decision not to move abroad due to 
disability or ill health are undesirable deviations from pre-defined life goals. Whereas 
job promotion may change life goals overnight and provide an opportunity to set new 
life goals, directly linked to financial stability.
Life events and Illness concept
There has been much research to assess the impact of stressful life events and 
depression, covering a vast array of social and psychological subjects. Life events and 
associated stress may cause serious health problems (Graham and Stevenson 1963; 
Rahe et al. 1964). The concept of “Life event” has a different conceptual meaning 
from life stages, life transitions and life goals. Life events can occur at any stage of 
life. The timing of life events, as suggested in the epidemiology literature concerning 
life course (Lynch and Smith 2005), is also important and may have several 
implications for individuals’ lives. Liefs (1948) work, related to life events and 
health, was probably the first in this area.
In 1967, Holmes and Rahe (1967) developed the Social Readjustment Rating Scale 
(SRRS) to measure the association between stressful life events and the onset of 
illness and their ground breaking work set the standard for future research (Lin et al. 
1979; Tausig 1982). They described 43 important life events and established arbitrary 
“Life Changing Units” as scoring units for each stressful life event that occurred. The 
subjects were asked to assign an arbitrary scale value (weighting) to life events 
according to an event occurrence and its severity. The highest value of 100 units was 
given to “Death of a spouse”, 73 to “Divorce”, 65 to “Marital separation”, 63 to “Jail 
term”, 53 to “Personal injury or illness” and to “Death of close family member”, 20 to 
“Change in working hours” and “Change in residence”. Lower scores of 16, 13, 12
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and 11 were given to “Change in eating habits”, “Vocation”, “Christmas” and “Minor 
violation of law”, respectively. In the SRRS not all events included are related to 
negative aspects of life. For example, “Marital reconciliation” (45), “Gain of a new 
family member” (39) and “Outstanding personal achievement” (28) are not stressful 
events but may require some social readjustment. A score of <150 indicates a 30 
percent chance or low probability of developing a stress-related illness, a score 150 to 
299 indicates a 50 percent chance and a score of >300 indicates an 80 percent chance 
of illness. This scale provides a list of important life events which may cause stress 
related illness. Our study however is examining the reverse of this, whether illness 
can result in major life events or influence major life changing decisions.
Psycho-social stressors are sources of life events and several aspects, such as the 
relationship between life events and illness, life events and stressor, social support, 
life adjustment and association with physical and mental symptomatology, have been 
explored in detail (Paykel et al. 1969; Myers et al. 1972; Rahe 1975; Paykel 1979; 
Brown and Harris 1987). Important life events can alter people’s lives forever in both 
negative and positive ways and can be defined as “negative life events” (death, 
divorce, separation, abortion, bankruptcy, prison sentence, chronic illness) and 
“positive life events” (marriage, birth, job, higher education) (Table 1.3).
Life events and chronic strain such as barriers to achieving life goals, inequitable 
rewards from roles, excessive or insufficient demands from the environment, 
frustration of role expectation and economic deprivation are defined as stressors. Life 
events can lead to chronic strain and vice versa (Kiecolt 1994). Some life events, such 
as divorce or separation appear to be negative in nature but might turn out to be 
positive events and may result in happiness in someone’s life.
Kiecolt (1994) explained that life events do not always produce psychological 
distress, particularly if relief can be obtained from a negative life event such as 
divorce after marital conflict. Conversely, apparently positive life events such as 
moving house or moving to another country or change of employment might be 
disastrous for some people. Therefore, the positive or negative natures of some life 
events are also connected to the individual’s special circumstances and their perceived 
value.
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Table 1.3: Important negative and positive life events
Negative Life Events Positive Life Events
Death Marriage
Chronic illness Birth
Limb amputation Cure (from disease, addiction)
Loss of an organ or part of a body Employment
(eye, tongue etc) Education
Lost job Moving house (to a better house)
Bankruptcy Moving to another country (for a better
Addiction future)
Crime
Prison sentence
Environmental disaster
War
Divorce
Separation
Miscarriage
The diagnosis of a chronic condition, such as cancer, is not only a life-changing event 
for the patient but also for the family. Similarly, a life event can also have an affect 
on an individual’s health and health behaviour (Clark et al. 2004; McFarland et al.
2006). Disease and the concept of “life event” has also been studied in relation to 
disability in rheumatoid arthritis (Guillemin et al. 1995; Smedstad et al. 1995), 
psoriasis (Poikolainen et al. 1994), chronic urticaria (Malhotra and Mehta 2008), 
alopecia areata (Perini et al. 1984), hospital admissions for asthma (Wainwright et al.
2007) and schizophrenia (Norman and Malla 1993).
People always need support in their difficult times and because of life changing 
events people may turn to spirituality for comfort, hope and relief. Activities such as 
music therapy, touch, humour, guided imagery, story telling, aromatherapy and 
prayer are regarded as part of spiritual care and are included in complementary and 
alternative medicine (Elkins and Cavendish 2004). People’s behaviour after a life 
event is a psycho-reactionary action but Paykel et al (1969) suggested that 
personality, coping strategies and previous experience may influence this reactionary 
action. Most studies in this area are related to understanding the role of life events as 
triggering factors of illness and to exploring the long term influence of stressful life 
events and associated illnesses.
29
Minor life decisions
Minor or routine decisions are those decisions which people normally take on a daily 
basis. The majority of these decisions are of little individual importance but they are 
required on a day to day basis to allow life to run smoothly. The consequences and 
implication of the majority of the minor decisions are generally short term and may 
not alter life significantly. Minor decisions could be seen as decisions which might 
lead to a short-term change in life. Routine daily decisions such as selection of 
transport (bus, train or airplane), selection of coffee, sandwich or wine from a long list 
of menu choices, decisions about which restaurant to go to or the venue selection for a 
marriage or christening of a child could have an impact on daily life for a short period 
of time and may have some financial and time implications. However, it is important 
to understand that these decisions are subjective in nature and have perceived value. 
Therefore some decisions which may be viewed as minor to some people, may be 
more important and life changing to others, particularly for those who are facing a 
negative life event such as suffering from a chronic condition.
Major life changing decisions
The diagnosis of a chronic disease is a life changing event in physical, psychological 
and social terms (Nussbaum et al. 2003; Bamack and Chrisler 2007; Sawka et al. 
2009) and the initial news of a life threatening condition is often devastating for 
patients (Stevens and Hildebrandt 2006). Very little information is available over 
what constitutes a major life changing decision or how chronic disease can influence 
life changing decisions. King et al (2000, p. 509-10) suggested that “Major life 
changes, by definition, require individuals to come to terms with a new set of life 
circumstances. Some life changes involve irrevocable alterations in our lives, 
requiring us to redefine the very meaning of our existence, to seek out new sources of 
purpose, and to reassess our priorities”. From the perspective of life events, life stage, 
life course, life transition and life goals, a general idea can be formulated about the 
importance of major life changing decisions.
Life is about choices where decisions play an important role. Life choices may 
become limited and undesirable due to negative stressful life events, and in this 
situation any decision could be life changing. In their daily routine people might flip a 
coin to make some decisions because in both cases (head or tail) the impact of the
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decision may not alter their life significantly. However, this may not be an option for 
people who are suffering from chronic illnesses for a very long period of time. People 
do not make major life decisions on a daily basis. Major life decisions are directly 
connected with life events, life stages, life goals and priorities and are so important 
that they affect the whole course of a person’s life. For example, decisions to move 
abroad or which career to select would have life long consequences and normally 
determine an individuals’ future life. Therefore, people usually give thoughtful 
consideration to every aspect of a life change which may have major implications, 
because their choice, right or wrong, may potentially change their life forever. 
Patients’ priorities in life change in different/difficult life situations, such as after 
important life events, after the onset of chronic disease or after life threatening illness 
(Heatherton and Nichols 1994; Carr and Higginson 2001). From a health perspective, 
an individual’s behaviour, personality and choices might be influenced by long term 
illness and illness may itself make it harder for patients to make appropriate life 
changing decisions. Long term poor health may even drag patients towards the 
ultimate life changing decision of suicide (Koivumaa-Honkanen et al. 2001). Making 
a major life changing decision in itself seems a major event in life because any wrong 
or right decision may change life for a considerable period of time and possibly the 
impacts of the decision may persist forever.
Some life changing decisions are age and gender related and timing is crucial for 
these decisions. For example, decisions at the right time about higher education and 
early career development or having children are important as part of the natural 
course of life and at different life stages, but the continuous long term impact of 
chronic disease on patients’ lives may influence these decisions. Patients might either 
decide differently or might delay their decision waiting for the right time or situation 
(complete cure or disease at a manageable level).
It is important to understand that major life change may occur in both negative and 
positive life events and/or as a result of decisions we make in important life situations. 
However, the influence of negative impact may remain for a long time and may affect 
the nature of subsequent life changing decisions. The diagnosis of a chronic disease or 
of a long term health condition, such as physical or mental disability due to a traffic 
accident, is a negative life event. The impact of a particular negative life event may
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remain with individuals for the rest of their lives and may change their life goals, 
priorities amd role/identity at different life stages. Moreover, one negative life event, 
such as onset of a chronic disease, limb amputation, death of a family member, 
imprisonment, addiction or divorce may affect other forthcoming positive life events, 
part of an expected normal life course, such as education, career choice, employment, 
marriage, housing, having children and moving abroad. All of these positive events 
are sources of happiness in life and of well-being, all of which could be affected by a 
single previous negative life event.
Balias and Dorling (2007) used life event and happiness data from the British 
Household Survey. They identified that being married, having a new relationship, 
employment-related gains, being parents, educational achievement and buying a 
house were associated with individuals’ happiness. In contrast, the end of a 
relationship, death of parents, poor health of parents and employment loss have 
negative impacts on happiness. Younger people were concerned about education 
related events whereas older people were more concerned about health. Balias and 
Dorling also noted that the end of a relationship may become a positive life event 
(reason for celebration) for some people and “pregnancy and birth” are associated 
with both happiness and unhappiness. This emphasises the subjective nature of 
response to life events and supports the argument that the reactions to some life events 
are associated with people’s individual circumstances which could lead to different 
life decisions.
It appears obvious that negative and stressful life events may trigger unhappiness and 
depression. The resulting persistently dejected attitude may turn into severe 
depression and may adversely influence people’s thinking and behaviour towards life 
changing decision making. People may change their predefined life goals because of 
ill health and set new priorities for the future, such as not to have a child, to change 
career or retire. Decisions, taken at the time of any major life event should be 
regarded as major life changing decisions. There is no specific definition of what 
constitutes a major life changing decision particularly a health-related life changing 
decision. In general, a major life changing decision (MLCD) could be defined as an 
important decision which could change or alter life forever or an important decision 
which has a long-term consequence or implication in life. For the development of a
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preliminary carefully considered definition, an in-depth insight into and knowledge of 
patients’ lives is crucial.
What can be learnt from the available literature?
In a literature search, only two articles matched the term “major life changing 
decisions”. These were related to psychology (Bauer et al. 2005) and to 
neuroeconomics (Bems et al. 2007). Other articles were not specific to disease impact 
on life changing decisions but contained some information related to disease and its 
influence on patients’ lives and were useful for conceptualisation.
Bauer et al (2005) examined the personal stories of life changing decisions in relation 
to personality and well being and discussed the concepts of “crystallization of desire 
(approaching to a desired future) and crystallization of discontent (escaping an 
undesired past)”. People make major life changing decisions either in an unbearable 
situation (crystallisation of discontent) or when they experience positivity in life and 
are eager to make changes (crystallization of desire). These studies seem to be a 
continuation of Baumeister’s (1994) work, in which he identified a phenomenon 
called “crystallization of discontent”, a period of distress which leads to major life 
change. To this effect, Bauer et al (2005) carried out two studies. In the first study, the 
data came from a larger study of life stories. Adults were asked to write down one to 
two pages about life changing decisions that they had made in their lives and were 
asked to complete other measures related to well-being, striving and traits. They 
tested two hypotheses: “Hypothesis 1: that crystallization of desire would be part of a 
constellation of personality characteristics that corresponds to well-being. Hypothesis 
2: that crystallization of desire would continue to predict well-being when controlling 
for striving and traits”. In the second study adult participants who had recently 
changed their career or religion were recruited and asked to write about their 
decisions to change. They tested hypotheses one and two from the first study and 
tested two new hypotheses. “Hypothesis 3: that participant emphasizing a 
crystallization of desire rather than discontent would be more likely to report that their 
decisions turned out well. Hypothesis 4: that crystallization of desire would be 
independent of how well the decision turned out in predicting well-being”. In 
summary, participants reported a higher level of life satisfaction and better decision 
outcomes when they had made decisions based on desire. This study suggested that
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motivation for new ideas in life may bring better decisions and well being as an 
outcome. However, more research is required to analyse how people take life 
changing decisions in negative life events, particularly in health-related situations. 
How to become motivated (internal or external) during a stressful negative life event 
is another area of concern, particularly in health-related life situations.
The subject of neuroeconomics measures human behaviour and related brain 
functioning. A combination of approaches from psychology, economics and 
neurosciences are combined to study and evaluate the role of the brain when people 
make decisions, decide preferences, take risks, seek rewards, learn, use their memory 
and knowledge and make economic decisions. To aid this research, neuroscientific 
tools such as electromagnetic recordings including electroencephalography (EEG), 
magneto-encephalography (MEG) and methods measuring metabolic or 
hemodynamic responses to neural activity such as positron emission tomography 
(PET) and functional magnetic resonance tomography (fMRI) are used to compare 
localised brain activities in different situations. Experiments normally use the 
techniques of assessing response to different choices/preferences, risk, reward, 
gambling and may use utility trade off methods (Kenning and Plassmann 2005).
In the second article Bems et al (2007) explained life changing decisions as an 
example of intertemporal choice. Intertemporal choice is a study of preferences, value 
allocation and decisions with consequences that play out over time. Life changing 
decisions related to education, marriage, fertility and how much food to eat, spending, 
investment, relationships and crime are some examples of intertemporal choices 
which contain tradeoffs. Bems et al (2007) discussed these choices from the 
perspective of neuroeconomics (psychology, economics and neurosciences) and 
highlighted the Discounted Utility (DU) model which has been used in economics to 
evaluate how people make decisions (intertemporal choices) and as a tool for public 
policy (decisions related to spending, development, health and education in the public 
domain). The DU model is based on weighing the positive and negative aspects of 
decisions by means of a loss and gain ratio (Bems et al. 2007). This is another 
approach to documenting and understanding life changing decisions. Detailed 
knowledge is required to apply this concept in the context of stressful, undesirable
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negative life events and subsequent major life changing decisions making, particularly 
in long term health-related situations.
Concerning broader aspects of the subject of life decision making, it is worth 
mentioning here that neuroscientists have also studied brain chemicals and their 
relationship to human behaviour. It is considered that neuromodulators (dopamine, 
acetylcholine and noradrenaline) are not only involved in every mental function and 
several psychiatric problems but also have more specific functions in learning, the 
decision making process and in regulating the balance between exploitation and 
exploration (Cohen and Jones 2005).
The extensive literature review of health, illness and patient centred issues, has not 
revealed any specific research evaluating health-related life changing decisions. 
Several studies (Robinson-Smith 2002; Smith 2002; Cassidy et al. 2004; Fisher et al. 
2007a; Fisher et al. 2007b; Miller and Askew 2007) referred to disease as “life 
changing” or as a “major life changing event or experience” but remained focused on 
disease evaluation, treatment, patient education and QoL. Some level of 
understanding can be obtained from the few available studies that show how chronic 
disease might impact on important life decisions.
Breast cancer is a life threatening condition and deciding to have children after breast 
cancer is an important life changing decision for mothers. Dow (1994) carried out a 
study to identify the reasons why young women decided to become pregnant after 
breast cancer, to describe helpful behaviours in decision-making and to explore the 
meaning of having children after breast cancer. In this qualitative research, 16 women 
took part in semi-structured interviews. The participants were asked to share their 
experiences following an open ended question about breast cancer and subsequent 
pregnancy. Three main themes were identified influencing having children after 
breast cancer treatment: having children as a cherished goal; a desire for sense of 
normalcy; and reconnection with others. In this study, the participants were 
interviewed after breast cancer treatment. Even in this situation, participants did 
mention concerns about pregnancy (having a normal pregnancy, having a healthy 
infant, disease recurrence and concerns related to breast feeding) and having children 
(recurrence and death, being hypervigilant, restructured living one day at a time, 
maternal concern). This research also highlighted the point that a longstanding desire
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for having children was interrupted by the diagnosis of breast cancer. Before the 
diagnosis, breast cancer participants were in control; however, after breast cancer, 
they lost control of their lives. Experiences about specific behaviour of their spouse 
and family, healthcare providers and other breast cancer survivors were identified as 
critical factors in decision-making. Behaviours recorded resulting in the decision to 
have a subsequent pregnancy are given in Table 1.4 (Dow 1994).
Dow’s research findings, particularly those given in Table 1.4, suggest that a 
patient’s personal efforts, professional help and the process of sharing experiences 
could be helpful to the person in making important decisions in life. This area was 
also discussed in another study, where patients with HIV chose not to become 
pregnant following learning about their diagnosis (Craft et al. 2007).
Anderson and Martin (2003) presented as a single case study the narratives of one 
couple (a cancer survivor and her husband), who lived through the life-changing 
events following a cancer diagnosis. The narratives are very moving and give insight 
into how a chronic life threatening condition can change a patients’ life. It is also 
evident that after the diagnosis, all of a sudden the patient’s priorities changed and the 
patient was preparing herself for the future. It is not clear whether the patient took any 
life changing decision, but words used by the patient in her story, such as, “I thought I 
was dying”, “I had no control over what was happening to me”, “I was still worried 
about my future” and “It was dehumanizing and very lonely” indicate that the disease 
and its treatment have a physical impact and result in emotional fluctuation, fear and 
uncertainty which may influence a patient’s priorities in life and may also change 
their family and social role and identity.
Physical health and marital dissatisfaction have a direct effect on each other (Ganong 
and Coleman 1991). Ill health, mental well-being and its associations with marriage, 
relationships and family have been widely discussed in the literature, and any change 
in circumstances due to health may impact on the QoL of family members and 
relationships. For example, if poor health causes a breakup in a relationship then 
divorce (as a stressful life event) may lead to poor health (Renne 1977; Albrecht et al. 
1983; Gove et al. 1983; Ross et al. 1990). Wilson and Waddoups (2002) carried out a 
study to investigate how poor health impacts on the breakup of marriages. The data
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were used from the four waves of the Health and Retirement Study (1992, 1994, 1996 
and 1998).
Table 1.4: Behavioural pattern in decision making to have a subsequent 
pregnancy (Adopted from Dow 1994)
The individual and 
spouse
Developing a realistic view on disease and decisions 
about one’s future
Learning to live with uncertainty over time
Needing the love and support of one’s spouse
Finding an obstetrician who is sensitive to their cancer 
history
The individual and the 
healthcare team
Having frank discussion about the “worst case scenario”
Having an oncology team available to answer questions 
about survivorship
Learning practical information on physiologic late effects 
(e.g. infertility, breastfeeding, fatigue)
Delineating personal versus medical decision making
The individual and the 
family
Knowing that family and friends may express 
apprehension and be less supportive
Individual and other 
cancer survivors
Meeting other women or learning about others who made 
similar decisions
In 1992 4,241 couples aged 51-61 entered into this study. The health mismatch 
hypothesis was tested by using different spousal health combinations and separation 
used as an indicator of marital dissolution. They did not observe marital dissolution 
from a life course perspective or from the perspective of influence of poor health on 
separation. However, the study still suggests that the poor health of a spouse at a 
young age may cause marriage dissolution over time. There is information concerning 
the impact of disease on marriage, marital adjustment and marital quality (Burman 
and Margolin 1992; Roth-Roemer and Kurpius 1996; Goodwin 1997; Cannon et al. 
1998); however, it is not clear whether chronic disease influences patient’s decisions 
to get married or prevents them becoming involved in any relationship.
Seidler and Kimball (2009) suggest that patients with chronic skin disease may learn 
to cope over time but their important decisions early in life may have long-lasting 
impact on their QoL. They used the Research Patient Data Repository (RPDR) 
database and cross-sectional analysis to determine any link between key ages or age
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ranges and social disconnection. Religious non-affiliation (for loss of social network), 
divorce (for loss of interpersonal connection) and use of Medicaid (for disconnection 
in the work place) were used as surrogate evaluative measures for the assessment of 
social connectivity among psoriasis patients. They found that divorce rates in 
psoriasis patients compared to the general population were higher in the age groups 
29-31 years (1.3% vs. 1.7; p < 0.05) and 32-34 years (2.3 vs. 1.1; p < 0.001). Seidler 
and Kimball (2009) highlighted the importance of the association of disease and age 
groups with the important life decision to divorce, but it is not clear whether psoriasis 
specifically had an influence on the patients’ decision to get divorced or whether 
psoriasis contributed to the partners’ decision to get divorced.
Chronic disease can also influence the major life changing decisions of other family 
members. In a cross-sectional study Fine et al (2005) asked a series of questions to 
parents of children suffering from inherited Epidermolysis Bullosa (EB) about the 
long term impact of their child’s illness on their marital life. A total of 54-64% 
parents of children with Dominant Dystrophic EB (DDEB) and Recessive Dystrophic 
EB (RDEB) reported that they had decided not to have additional children. Eighty- 
eight percent of divorced couples with children affected by Junctional EB (JEB), 50% 
of divorced couples with children affected by DDEB and 67% of divorced couples 
with children affected by RDEB reported that their child’s disease was a 
major/primary factor leading to their decision to divorce.
In a 1 -year follow-up study, Cvetkovski et al (2006) concluded that occupational hand 
eczema in later life is associated with poor QoL and lower socioeconomic status and 
results in patients taking prolonged sick leave, becoming unemployed or changing 
their job. One year is a relatively short period for follow up to assess these changes, 
but in this study 50% of patients had changed their jobs during the 12 months, which 
suggests how chronic illness can change life significantly. The frequency of job 
change in their study due to hand eczema was higher than when previously assessed 
by Meding et al (2005) in their 15 year follow-up study (1983-1998). They found that 
20 (3%) out of 706 patients from different employment backgrounds (medical and 
nursing work, cleaners, hairdressers, kitchen workers, painters and mechanics) 
reported change in their occupations because of their hand eczema, and 15 patients 
reported improvement after change in occupation. Eight percent of patients had
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reported change in their occupation before the initial 1983 examination. In terms of 
job change, both studies focused on occupational risk and did not discuss the nature or 
the consequences of the decision involved in relation to change in employment. It is 
obvious from both studies that chronic disease can influence a patient’s decision 
related to selection of jobs or to change in occupation. Long term illness can make it 
difficult for patients to remain in the same employment if their occupation is one of 
the major reasons for health deterioration. Choices seem very limited for patients and 
in some cases change of job might result in financial loss. Patients might remain in the 
same employment and suffer because of socioeconomic reasons (family, better 
housing and children’s education). Therefore, a change of occupation or the selection 
of job taking into account a health perspective are clearly major life changing 
decisions.
In another study, Malcomson et al (2008) conducted two qualitative focus group 
discussions to explore the impact of multiple sclerosis (MS) (n=13, age=40-67 years, 
mean disease duration=17 years) on patients’ lives. Several patients reported changes 
to their employment circumstances along with other disease related impacts 
(interpersonal and social life, stress, unpredictability, fear and impact on daily living). 
Despite the resulting loss in socioeconomic status, one patient made a decision to 
change from full time to part time employment and two patients gave up their paid 
jobs because of the impact (fatigue, lack of energy, decreased mobility and stress) of 
MS on their lives. The patients indicated that MS influenced their important decisions 
regarding employment and made them compromise (an undesirable objective) in the 
best way possible to accommodate their health needs and to take control of their 
resulting life style changes.
Arnold et al (2008) conducted six focus group (n=48) discussions with women 
suffering from fibromyalgia to assess its impact on their lives. Participants raised a 
variety of disease related (cognitive impairment, emotional, functional and QoL 
impact) and symptoms related (pain, fatigue and sleep) issues. Socially, fibromyalgia 
patients feel that due to the unpredictable nature of the disease, they are unable to plan 
any event and are judged by co-workers and friends as unreliable, resulting in loss of 
friendship and their withdrawal from social engagements. The participants also 
reported that they failed to properly look after their own children and families. For
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example, not being able to go for family trips was reported as life changing by 
patients and lack of participation in household activities and decreased sexual 
intimacy had caused great strain on their personal relationships. This indicates that not 
to take part in simple things, such as social activities, could be a life changing 
decision. Some people might still take part in different activities but embarrassment 
and humiliation and the long term nature of the disease might drag them towards 
complete isolation. Similarly, the constant strain of disease on personal relationships 
may lead to taking more serious life decisions, such as separation or divorce. The 
participants also reported that their disease not only made them change their job 
frequently but also reduced their working hours. Half of the patients left their jobs 
because of their illness, which ultimately resulted in financial instability. Some 
patients reported that their conditions stopped them from pursuing higher education; 
this seems to be a very tough life changing decision with resulting consequences of 
low paid menial hard work and further health deterioration (Arnold et al. 2008). This 
raised the question whether such patients need more support and appropriate advice at 
those life stages when they have to take important life decisions regarding 
employment and education. Indeed, this is another important area of concern and 
increased patient understanding seems necessary to reduce disease impact on 
decisions which determine the future course of life.
Choices concerning reproduction are also very important life decisions and disease 
may influence an individuals’ choice to have children. Kadir et al (2000) suggested 
that the decision to have children is a complex one, even in the absence of disease. 
They conducted a survey to assess haemophilia women’s experiences in pregnancy 
and their attitudes towards their reproductive choices. They found that age, emotional, 
social and financial factors were the main influences in planning pregnancy. Twenty- 
two percent of 160 women reported that their decision about their first pregnancy and 
13 of 132 women reported that their decisions about subsequent pregnancies were 
influenced by counselling and the results of parental diagnostic tests. The following 
question was also asked to all women, whether they had “ever made a conscious 
decision not to have children/any more children”. Fifty-four percent of the women 
reported that having haemophilia was a major factor in this decision. Forty-four 
percent did not want to transfer haemophilia to their child, 6% had previous 
experience of haemophilia in the family and 27% reported personal, social, financial
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and medical reasons for this decision (Kadir et al. 2000). This survey indicated an 
individual’s priorities in different life situations, such as the prime example of disease 
influence on having children. Various studies suggest that the decision to have genetic 
testing could be a life changing decision and may impact on family planning, 
interpersonal relationships, social, financial and employment aspects (Lim et al. 2004; 
Smith et al. 2004; Cameron and Muller 2009). Even the decision of parents about how 
to proceed after the antenatal diagnosis of congenital problems seems to be important 
and difficult to make, as the decision may change their lives forever (Rempel et al. 
2004). Similarly, other health-related decisions such as the decision over choice of 
treatment (whether surgery or medication) could be life changing for a patient 
(Mastaglia and Kristjanson 2001; Warren and Griffiths 2008; McHugh and Luker 
2009).
According to the Foreign and Commonwealth Office (FCO), around half of British 
people (age >55) said they were thinking of moving to another country and to start a 
new life. It has been emphasised that weather should not be the sole factor influencing 
the decision to relocate and people should consider the practical aspects of relocating, 
such as learning a new language, the political situation, currency fluctuations, the 
availability of long term healthcare and pension issues (Foreign and Commonwealth 
Office 2010). This FCO survey suggests that moving abroad seems a popular choice 
later in life among the British population, but their advice clearly indicates that 
relocating to another country is a life changing decision and any wrong or 
uncalculated move could be disastrous for individuals and for their families. If this is 
a big decision for healthy people, then it could be a daunting task for people suffering 
with chronic conditions.
Life decisions are subjective in nature and have perceived value. Some decisions 
seem very minor and more related to day to day activities/choices, but individuals’ 
circumstances such as onset of chronic disease could make these daily decisions and 
choices more important for that individual and life changing. Huggins et al (2009) 
surveyed young patients suffering from hydroa vacciniforme (HV) and suggested that 
type of chronic condition and duration of disease (median age at onset 7 years) can 
influence the quality of life impact. Concerning the Children’s Dermatology Life 
Quality Index (CDLQI) responses: 63.6% patients (n=ll, age range=9-17 years)
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reported impact on going out, playing and hobbies; 54.5% reported impact on choice 
of clothing; and 36.4% reported impact on swimming and sports activities. On their 
Dermatology Life Quality Index (DLQI) responses, 75% adult patients (n=4, age =18 
and over) reported that their skin condition influenced their choice of clothing. It is 
understandable that disease related aesthetic reasons and embarrassment (50%) could 
play an important part in viewing simple decisions such as choice of clothing or 
swimming as major decisions as they concern change of life style and image, which 
they feel to be wrongly perceived by others. In another study Hon et al (2008) found 
that young girls with atopic dermatitis had more problems concerning clothes or shoes 
than boys, indicating the importance of the relationship between gender and disease 
influence on specific aspects of patients’ lives. Similarly, decisions about life style 
may have serious consequences on health. For example, smoking, drinking and over 
eating can cause serious health problems (Wright et al. 2004). Any decision to alter 
these habits may determine individuals’ future health, indicating the significance of 
life style related decisions.
Conclusion
The nature of subjective directions, life events, life transitions, life course, life stages, 
life goals and life changing decisions are very complex. Their meaning might be 
different and hence confusing in sociology, philosophy, psychology and the realm of 
health. Despite separate descriptors, these concepts seem inter-connected. For 
example, in one complete course of life, individuals go through different life stages 
and have to face different life events (negative/positive). They subsequently have to 
make important life decisions which may change a person’s goals and life for ever. In 
other words, these concepts direct our thoughts towards change in life stages 
(childhood, adolescent, middle age and old age), identifying social roles/identities 
(son, daughter, student, employer, employee, husband, wife, parents, grand-parents), 
facing life events/circumstances (e.g. birth, marriage, separation, divorce, disease, 
education, career choice, retirement, death) and defining life goals/priorities e.g. to 
become an engineer, doctor, lawyer, artist, sports professional, traveller or politician). 
Life priorities and goals may differ from one individual to another due to their 
personal life circumstances, situations and the nature of the life event they face. 
Individuals’ priorities and goals may influence their attitude, perception of life, their
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behaviour and the important life decisions they make. The sequence of these concepts 
encompasses the chronology of one complete course of life.
Important life events, circumstances, or other factors, such as poor health, death, birth, 
divorce, and marriage can alter people’s lives for ever and subsequently may affect 
their QoL in psychological, social, physical and emotional domain. Therefore, the 
inclusion of the term “life changing events” and “life changing decisions” in the 
definition of QoL might to help improve and better reflect the ambiguous broad 
concept of QoL.
The medical and health sciences literature is replete with information predominantly 
related to the current impact of different diseases on patients’ QoL and mainly 
focused on traditional HRQoL domains (physical, social and psychological), therapy 
evaluation, treatment decision-making, utility preferences, impact on families, 
spirituality, and the implication of health economics, financial burden and healthcare 
facilities. In contrast, very little is known about the long-term impact of chronic 
disease on patients’ lives, for example the concept of influence of chronic diseases on 
major life changing decisions has never been studied before. Answers to some 
important specific questions need proper investigation, such as, what is the definition 
of life changing decisions from a HRQoL perspective? How do or should patients 
take their life changing decisions while suffering from long-term health problems? To 
what extent do chronic diseases influence major life changing decisions? What sorts 
of influential factors are involved in life changing decision? How capable are patients 
to take appropriate life changing decisions in life? Are there any guidelines or 
strategies available for patients and for healthcare providers to assist patients to take 
appropriate decisions allowing them to maximise their control over their lives? Lastly, 
does the exploration of major life changing decisions really matter to patients, their 
families or health providers? Thus, how people take life changing decisions and what 
factors influence their particular decisions, requires proper understanding.
The lack of knowledge in this area suggests a new research possibility. Along with 
both follow up and prospective research techniques, exploratory retrospective 
research methodology is essential to understand the magnitude of the influence of 
chronic diseases on life changing decisions. This critical analysis of the literature 
points to a completely new dimension to health-related outcome research and
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encompassing this concept might change the way researchers evaluate HRQoL. There 
is clearly a need for a new multidisciplinary comprehensive research and measuring 
techniques to capture fundamental information for further conceptualisation, to 
determine the definition of health-related major life changing decisions, to assess the 
feasibility of its measurement as a new dimension and to determine its possible 
implications on patients’ lives and the healthcare resources.
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AIMS AND OBJECTIVES OF THE STUDY
Aims
•  To identify the influence of chronic diseases on major life changing decisions.
•  To develop a standardised questionnaire to capture information related to 
health-related major life changing decisions.
Objectives
• To create a standard definition of health-related “Major Life Changing 
Decisions” for future research.
• To investigate the level and the type of affected MLCDs between different 
chronic disease areas.
• To identify key factors influencing major life changing decisions and its 
correlation with the disease.
• To determine the link between gender and type of influenced MLCDs
• To identify correlation between patients’ age and the number of MLCDs 
affected.
• To evaluate the psychometric properties of the newly developed instrument 
such as content validity, factor analysis and practicality.
• To define the possible use of this newly developed tool.
• To develop strategies for patients to facilitate better life decision-making.
• To record patients’ feedback about the study
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CHAPTER 2
Study rationale and methodological
framework
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INTRODUCTION
This was a cross-sectional prospective study and was carried out to investigate the 
influence of chronic diseases on major life changing decisions. Data was generated by 
asking patients to record the impact of their disease over the course of their life. This 
chapter provides detailed information related to study rationale, objectives, ethical 
considerations, inclusion and exclusion criteria, study design and data processing 
techniques, and analysis.
STUDY RATIONALE
Chronic diseases such as psoriasis, eczema, heart failure, rheumatoid arthritis, chronic 
obstructive pulmonary disease (COPD), chronic kidney disease (CKD), cystic fibrosis 
(CF) and diabetes are very common chronic conditions which may affect patients 
over many years and cause serious impacts on their HRQoL. Chronic skin conditions 
not only affect a considerable portion of the population but also have strong financial 
implications (Phillips and Dover 1991; Finlay 1992; Poon et al. 1999; Parsad et al. 
2003; Stem et al. 2004; Schafer 2006). Psychologically, physically and socially, skin 
disorders are very debilitating and may cause serious QoL impairment, disability and 
handicap. Similarly, other common chronic diseases, such as rheumatoid arthritis 
(Katz 1995), osteoarthritis (de-Bock et al. 1995), hypertension (Wei et al. 2005), 
congestive heart failure (Carels 2004), angina (Melsop et al. 2003), asthma (Meszaros 
et al. 2003) and COPD (Garrido et al. 2006), CKD (Perlman et al. 2005), CF (de-Jong 
et al. 1997) and diabetes (Rubin 2000) also have a severe impact on patients’ lives. 
The severity of impact related to different QoL domains may vary from disease to 
disease. For example, in patients with arthritis physical functioning is the most 
obviously affected area. Several research surveys have been carried out to assess the 
impacts of chronic diseases on QoL. However, these studies have not addressed the 
long term impact of chronic disorders on critical life decisions taken by patients.
The concept of life changing decisions has been discussed in the field of psychology 
as “crystallisation of desire and crystallisation of discontent” (Bauer et al. 2005) and 
in neuroeconomics as intertemporal choices (Bems et al. 2007). However, this 
concept has never been studied from the perspective of health, illness and patients. 
Despite the current impact of disease on patients’ lives being assessed in details, from
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several studies it is only possible to form a vague idea of how the resulting impaired 
QoL might influence major life changing decisions.
Decisions about the most important issues in life, particularly, marriage or 
relationships, divorce or separation, having a child, higher education, job and career, 
change of profession or early retirement, relocating to another city or country, are not 
easy. Even for a completely healthy person, such decisions are often difficult to make 
and people often seek advice from relatives, friends and professionals. This common 
human behaviour generates another important question: how do people with chronic 
disease take such decisions? One could easily imagine that the nature and duration of 
chronic disease may influence patients’ life changing decisions and prevent them 
from achieving their desired objectives and goals. For example, occupational 
limitations resulting from psoriasis may have a negative influence on choice of career 
or profession; genetic concern about psoriasis may change a patient’s approach 
towards having a child in the future. The visibility of psoriasis, acne and vitiligo may 
prevent younger patients’ from pursuing higher education, relationships and the type 
of work they might have wanted to select as a career. Rheumatoid arthritis and 
osteoarthritis have severe impacts on patients’ physical activities. Patients might take 
early retirement and some possibilities such as moving house or shifting to another 
country may no longer be an option because of the disease. Asthma, chronic 
obstructive pulmonary disease, hypertension and renal disease could restrict patients’ 
options of job opportunities. The effects of the disease on daily living and the need 
for constant care might disturb a patient’s marriage or a patient might decide not to 
engage in any relationship. Therefore, the long-term nature of debilitating disorders 
and resulting psychological, physical, social and financial impacts may change 
patients’ thinking and approach towards life and force them to adjust their life 
objectives according to their health and resulting circumstances.
It is clear from the above that making decisions about important issues in life, while at 
the same time living with chronic disorders, is a very difficult task. However, this 
aspect of the lives of patients and the magnitude of the impact of chronic diseases on 
life decisions has not yet been studied. But, from the practical experience in the 
routine clinics, it has been observed on many occasions that patients had taken 
different life decisions only because of their chronic skin condition. Based on
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observation a question posed: “can chronic diseases influence major life changing 
decisions?” Following an in-depth critical review of the literature, we have concluded 
that there is an evident gap in research in this area. A comprehensive study will 
therefore be carried out in order to identify the health-related life decisions issues that 
affect patients over time to inform the development of a questionnaire for assessment 
of such phenomenon. In addition, to develop strategies to meet patients’ decision 
support needs and to contribute to a better health outcome.
METHODOLOGICAL FRAMEWORK 
Study population
This study was a cross-sectional prospective study of patients who were treated at the 
University Hospital of Wales (UHW), Cardiff and University Hospital Llandough, 
Llandough (Cardiff and Vale NHS Trust) with chronic diseases (dermatology, 
cardiology, rheumatology, nephrology, diabetes and respiratory disorders) aged 16 
years or above for >1 year. Young patients (16 to 20 years) were specifically 
recruited because at this age, young people normally try to set their life goals and 
objectives for the future. For example, they might set their education targets and work 
hard to achieve professional qualifications to enter into a specific career.
Inclusion criteria
• Patients suffering from chronic disease (dermatological, cardio-vascular, 
rheumatologic, renal, diabetes or respiratory) for more than one year
• Patients aged 16 years or above
• Male or female
• Belong to any ethnic group
• Patients who can read and write in English
• Agree to protect the confidentiality of other focus group participants
• Are willing to share personal experiences in a tape recorded interview or
group discussion
Exclusion criteria
• Patients with comorbidity
• Patients under 16 years of age
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• Patients who have been suffering from chronic disease (dermatological, 
cardio-vascular, rheumatologic, renal, diabetes or respiratory) for less than 
one year
• Patients unable to read and/or write in English or who have special 
communication needs
• Patients who have disability from any other cause (physical or mental)
Ethical considerations
Due to the large scale of this project, to optimise the study results, to aid the smooth 
running of the project, to ensure good coordination among participating specialties 
and to minimise the cost and time, long and thoughtful consideration were given to 
the research plan before seeking ethical approval. Only one application for ethical 
permission was filed covering all study stages in order to increase the efficiency of 
the study and to aid its smooth running. Ethical permission to conduct this study was 
obtained from the South East Wales Research Ethics Committee in 2 June 2008 
(Appendix 1). Permission was also obtained from UHW Research and Development 
(R&D) department on 18 June 2008 (Appendix 2). Appropriate information about the 
study and patients rights was given to all identified patients using a “Patient 
Information Sheet”. Approved consent forms were used to record participants’ 
consent. Participants who took part in focus group discussions were specifically asked 
to agree to protect the confidentiality of other focus group participants. Every patient 
was allotted a “code number” for identification. Records of the digital recording of 
individual interviews/focus groups and written postal replies were kept in a secure 
place in the Department of Dermatology, University Hospital of Wales. Data were 
transferred to a Cardiff University secured computer without any personal details for 
analysis. Access to the Cardiff University computer is protected and only the 
participating researchers have the access to the data collected from study participants.
Study Design
This cross-sectional prospective study was carefully designed before its 
commencement in order to capture the most appropriate information to its maximum 
capacity in the allocated time frame. This study was carried out in the following five 
stages (Figure 2.1).
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Figure 2.1: Study Flow Chart
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Version 2 of a new tool ready for further 
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new measuring tool first version
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N=100
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Life in future
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Stage 1: Conceptualisation and item generation
Stage 2: Item reduction and development of the first version of a new tool 
Stage 3: Content validity and development of a revised version of the tool 
Stage 4: Factor analysis and development of the final version 
Stage 5: Formation of strategies for appropriate decision taking
Stage 1: Conceptualisation and item generation
Initial data was collected through (a) a postal questionnaire survey (b) individual 
interviews and (c) focus groups discussion to identify the influence of chronic 
diseases on major life changing decisions. A working definition of “Health-Related 
Major Life Changing Decisions” (HRMLCDs) was formulated during this stage. 
After collection of all the data from the postal survey, the individual interviews and 
the focus group meetings, main themes and categories were identified using 
qualitative analysis. This information was used for the development of a generic 
major life changing decision questionnaire “Major Life Changing Decisions Profile” 
(MLCDP).
Stage 2: Item reduction and development of the first version of a new tool
The items generated in Stage 1 were analysed using qualitative techniques to reduce 
them to the core items identified by the participants and yet retain population and 
gender specific items. After qualitative analysis, in three lengthy brain storming 
sessions, appropriate taxonomy and rephrasing of items were used to fit categories or 
domains. Standard scientific techniques in terms of language, reading age and item 
length were applied for the developmental version of the new tool MLCDP (version 
1).
Stage 3: Content validity and development of revised version of the tool
This stage was important to examine the new measure for its focus and emphasis for 
the intended population using a panel of judges consisting of consultant physicians 
and nurses from different disciplines. The panel rated each item for its language 
clarity, completeness, relevance and scaling. Agreement among the panel members 
was statistically measured using interclass correlation and kappa coefficient. The 
suggested changes by the panel were implemented to produce the revised version of 
the new tool MLCDP (version la).
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Stage 4: Factor analysis and development of the final version
The purpose of this exercise was further validation of the new tool seeking 
confirmation of the breadth and depth of the allocated domains through the 
application of the statistical technique of factor analysis. 210 patients (30 from each 
of the 7 medical specialities) were recruited and were asked to complete the revised 
(MLCDP- version la) tool. Internal consistency reliability of items within a factor 
were also tested using the reliability coefficient, namely Cronbach’s coefficient alpha. 
Face value and practicality of the new tool was also measured by using a separate 
questions sheet, mainly recording patients’ views on different aspects of the new tool. 
The end result of this phase was the final version of the new tool MLCDP (version 2) 
which will be examined for its other psychometric properties such as clinical validity, 
reliability and responsiveness in future work.
Stage 5: Formation of strategies for appropriate decision taking
Data collected from patients at stage 1 and stage 4 were meticulously scrutinized in 
detail for the creation of strategies to help patients develop more appropriate long­
term decision taking, hopefully allowing patients to develop their full and appropriate 
potentials in life. The information gathered through the newly developed tool may 
further inform clinicians, care teams and policy makers in their planning over how to 
deliver care, how to plan resources and how to develop strategies for patients to 
minimise the impact of chronic disease on major life changing decisions. Correct 
strategies would enable patients to make optimal decisions. Data collected during the 
stage 4 was used to create a more universally acceptable definition of “Health-Related 
Major Life Changing Decisions” (HRMLCDs).
Data collection techniques
At the study design stage, in addition to dermatology six other major specialities 
(nephrology, cardiology, cystic fibrosis services, respiratory medicine, diabetes clinic 
and rheumatology) were selected in order to capture a broad range of information 
from patients who were suffering from different types of the most prevalent chronic 
conditions. Specialities such as dermatology, cardiology and rheumatology cover a
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number of different chronic conditions. A consultant physician in each speciality was 
contacted and invited to take part in this study.
The study protocol with speciality specific sections was presented to all collaborators 
for their consideration and to seek their cooperation. After ethical approval was given 
by the South East Wales Research Ethics Committee, participating consultant 
physicians were invited for detailed briefing about the methods of each stage of the 
study and the step by step role of each member. The name “MLCD-study group” was 
given to this research collaboration. Several MLCD-study group meetings were 
carried out for research updates, particularly about patient recruitment, publications, 
study time frame and the smooth running of this large project in general.
Initial data was collected through (a) postal survey (b) individual interviews and (c) 
focus group discussions.
Postal survey
A total of 600 patients suffering from chronic diseases (i.e. cardio-vascular, 
rheumatology, cystic fibrosis, chronic obstructive pulmonary disease, diabetes and 
chronic kidney disease) for more than one year and who fulfilled the study 
inclusion/exclusion criteria, were invited to complete the postal survey (100 patients 
from each medical speciality). Patients suffering from chronic obstructive pulmonary 
disease (COPD), cystic fibrosis (CF) and diabetes were recruited from University 
Hospital Llandough, Llandough (Cardiff and Vale NHS Trust). Patient selection for 
each disease area was carried out by the responsible consultant physician and then a 
list of eligible patients was compiled for assigning identification code. A proforma 
was used (Appendix 3) to keep a record tracking all the posted survey packs and 
reminder responses. For example, the date of posting, date of response received and 
date of first reminder to non-responders. Survey packs were posted to patients who 
fulfilled the study inclusion/exclusion criteria with a covering letter signed by the 
responsible consultant physician caring for the patient. Patients were asked to read 
and try to understand the participant information sheet, sign the consent form, 
complete the requested sections and return them in the enclosed pre-paid self 
addressed envelope (Appendix A). One follow up request (Appendix B) was carried 
out to improve the response rate.
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The postal questionnaire survey pack consisted of four sections, and this was sent to 
all identified patients accompanied by a covering letter from respective consultant 
physician (Appendix C): each pack consisted of four sections: Section 1 consisted of 
the general “Participant Information Sheet” (Appendix D), which provided 
information about the purpose and the procedure of the study, recording, storage of 
data, data protection and anonymity of personal information. Patients were informed 
about their rights in this information sheet, emphasising that they had no obligation to 
take part, and could withdraw at any stage. Contact details with a several telephone 
numbers were specified in the participant’s information sheet for any queries. Section 
2 consisted of the “Participant Consent Form” (for postal survey) (Appendix E). 
Section 3 consisted of the “Participant Personal Details” sheet and was used for 
demographic data collection (Appendix F), such as age, gender, education, 
occupation, marital status and disease duration, Section 4 consisted of an 
“Exploratory Qualitative Assessment Sheet” (Appendix G). In this section, patients 
were asked to write down their experiences in response to one exploratory question 
“Please write down any ways in which your long-term disease has had a major 
influence on major life decisions”. In this section, examples of important life 
decisions were given to participant’s such as marriage or relationship, divorce or 
separation, having a child, higher education, job and career, change of profession or 
early retirement, relocating to another city or country. Common themes were 
identified from the returned responses and later were used for qualitative analysis.
Individual interviews
Fifty-five patients under the care of the Department of Dermatology, University 
Hospital of Wales, were contacted for individual interviews. They all had been 
suffering from chronic skin disease for more than one year and fulfilled the study 
inclusion criteria. For individual interviews, patients were identified through the 
hospital clinical record system (Patient Management System). The patients’ medical 
records were thoroughly searched to ensure the eligibility of the selected patients. 
Identified patients were contacted by the respective consultant physician directly in 
the dermatology out-patient department or via post.
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Patients approached in the out-patient clinic were given an interview information 
pack. Sufficient time was given to patients to read and understand the different 
sections of the individual interview pack. A choice was given to patients who were 
still interested in possibly participating either to take part in this study on the same 
day or to later inform the researchers using the dedicated telephone numbers whether 
or not they wished to participate.
For patients contacted by post, invitation letters with an information pack were sent 
out to eligible patients two weeks prior to their expected out-patient appointment so 
they would carefully read and understand the participant information sheet. The 
patients were asked to inform the researchers using the dedicated telephone numbers 
if they were willing to take part in the study or, alternatively, participants were asked 
to complete and tear off the bottom part of the clinician’s invitation letter and send it 
to the Department of Dermatology using a pre-paid self addressed envelope within 
four working days.
Interviews were carried out in the Welsh Institute of Dermatology, in a dedicated 
room either in the academic department or in the dermatology out-patient department. 
Those who indicated their interest by telephone or post were later contacted to 
schedule an interview at a convenient time for the patient.
Along with the clinicians’ invitation letter (Appendix H) each individual interview 
pack consisted of 3 sections; Section 1, general “Participant Information Sheet” 
(Appendix I), Section 2, “Patient Consent Form” (For individual interviews) 
(Appendix J), Section 3, “Participant Personal Details” sheet (Appendix K). In-depth 
one-to-one semi-structured interviews were carried out by Z U B and were recorded 
using a digital recorder. A semi-structured checklist was designed for conducting the 
individual interviews. After a brief introduction and obtaining informed written 
consent, the same open ended exploratory question which was used for the postal 
survey was asked to the patients (i.e. Could you please share your experiences about 
any ways in which your long-term disease has had a major influence on major life 
decisions). Patients were given sufficient time to think about the life and reflect on 
the ways they think their disease had influenced life decisions. Later, patients were 
asked to consider more specific aspects of life such as marriage or relationship, 
divorce or separation, having a child, higher education, job and career, change of
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profession or early retirement, relocating to another city or country and encouraged 
by the interviewer to speak freely about their experiences. Patients were asked to give 
examples in this more detailed discussion. Any new area reported by patients during 
interview was later included in the remaining interviews. The same guideline was 
used for all interviews. Digitally recorded interviews were downloaded later that day 
to a secure dedicated computer. Verbatim word by word transcriptions of all the 
interviews were carried out for in-depth qualitative analysis and to reduce interviewer 
bias. At the end of the each interview two additional questions were asked in relation 
to secondary objectives of this study: 1) How can we help patients to take appropriate 
MLCDs in a similar situation to you? 2) What do you think about this study?
Focus Groups
Twenty patients suffering from chronic skin disease for more than one year and 
fulfilled the study inclusion/exclusion criteria were invited from the Department of 
Dermatology, University Hospital of Wales to contribute to focus group discussions. 
The patients were contacted by their respective consultant physician and the same 
method for recruiting patients for individual interviews (described above) was used 
for the focus groups. Patients were invited to attend focus group discussions in the 
dermatology out-patient department either by post or at their visit to the dermatology 
out-patient department. After confirmation, participants were informed at least two 
weeks before about the venue (a specific allocated room in the Dermatology 
Department, University Hospital of Wales), time and duration of a particular focus 
group discussion. Dedicated telephone numbers were established so that participants 
could inform the researchers directly if they were unable to attend a focus group 
meeting.
Each focus group was organised in the same way and consisted of participants who 
were unknown to each other. A semi-structured checklist was used for each 
discussion, which was developed from information revealed by the postal survey and 
individual interviews experiences. Along with the clinicians’ invitation letter 
(Appendix L) the patients’ focus group information pack consisted of four sections. 
Section 1 consisted of the general “Participant Information Sheet” (Appendix M), 
Section 2 consisted of a separate “Additional Information Sheet for Focus Groups” 
(Appendix N). This section was completely different from the general participant
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information sheet and was created to provide more specific information about the 
formation of focus groups and to explain the systematic procedure of conducting the 
discussion. Section 3 consisted of “Participant Consent Form” (for focus group) 
(Appendix P). Section 4 consisted of “Participant Personal Details” sheet (Appendix 
Q). All focus groups discussions were moderated by Z U B and were recorded using a 
digital recorder.
The initial plan was to contact 50 patients to form five focus groups with 10 patients 
in each group. However, after completing two focus groups, it was clear that no new 
information was being obtained and so further recruitment for the remaining three 
focus groups was discontinued.
Researcher role as a moderator: The moderator’s role is crucial to the success of a 
focus group meeting. It is important to understand that participants generate the data 
and the moderator collects it. This basic understanding sets the tone of the role of a 
moderator. During each focus group discussion, the moderator’s main role was 
defined as follows (Krueger 1997):
• To create a relaxed environment
• To facilitate free and open discussion
• To maintain a focus on the topic areas (by skipping areas which have already 
been covered and directing participants to new areas)
• To make sure all participants take part in the discussion
• To move things forward and provide a smooth transition from one topic area 
to another
• To discourage direct conversation
• To demonstrate respect to every participant regardless of their social and 
educational background
Discussion formation guide: The focus group discussions were structured (Morgan 
1997). Participants were asked one question at a time, specific to the topic area 
selected by the moderator. As part of a structured plan, the moderator directed 
participants from general to more specific areas of the selected subject to facilitate 
more appropriate and specific discussion. A similar structured plan was used for both 
group discussions. During the discussion, participants were seated, facing each other
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around a round table to encourage all to freely take part in the discussion and respond 
more easily to any comments from other participants. The “Funnelling question 
technique” was used to direct discussion from general to more specific topics (Khan 
and Manderson 1992; Morgan 1997). The following pattern suggested by Krueger 
(1997) was used for opening the discussion: Welcome remarks; Overview of topic; 
Guidelines or ground rules; and Opening question.
After a brief welcome and the moderator-participant’s self-introduction (Morgan 
1997), the moderator opened the discussion by introducing a topic and by asking the 
same open ended question used for the postal survey and for individual interviews. 
The participants were asked “Could you please share your experiences about any 
ways in which your long-term disease has had a major influence on major life 
decisions”. After an initial response from all the participants, they were 
systematically directed towards more specific aspects of life such as marriage or 
relationship, divorce or separation, having a child, higher education, job and career, 
change of profession or early retirement, relocating to another city or country. The 
moderator did not ask any specific question to any participants. The moderator helped 
participants to freely share their views, experiences, attitude, behaviour and any 
influence of their skin condition on their lives. The patients were asked to share their 
views one by one for recording purposes. All conversation was digitally recorded. 
The moderator thanked all participants for their time and participation.
Setting: Focus group meetings were carried out in the Department of Dermatology, 
University Hospital of Wales. The participants were reimbursed for their travel 
expenses incurred attending a focus group meeting.
The complete lists of documents used in three qualitative methods are listed in Table 
2 .1.
Data processing and analysis
Verbatim transcriptions of the individual interviews and focus group meeting were 
carried out from the digital recordings. These transcripts and those of the written 
responses from the postal survey were saved on to a secure computer. NVivo 8 
qualitative software was used for analysis. Data was examined line by line and 
sentence by sentence.
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Table 2.1: List of sections related to each method used in this study
Method List of sections
Postal questionnaire 
survey pack
Section 1: Participant Information Sheet
Section 2: Participant Consent Form
Section 3: Participant Personal Details
Section 4: Exploratory Qualitative Assessment Sheet
Individual interview 
invitation pack
Section 1: Participant Information Sheet 
Section 2: Participant Consent Form 
Section 3: Participant Personal Details
Focus group 
invitation pack
Section 1: Participant Information Sheet 
Section 2: Additional Information for Focus Groups 
Section 3: Participant Consent Form 
Section 4: Participant Personal Details
The common themes were identified from the text, grouped into major life decisions 
and later used to develop the first version of the new questionnaire MLCDP (version 
1). Further confirmation of content validity of the initial version of MLCDP was 
carried out by a group of experts (consultant physicians and nurses from different 
disciplines). Agreement among the panel members was tested statistically using the 
ICC and kappa coefficient technique. On the basis of this analysis and suggestions 
from experts, changes were made to the MLCDP creating version la. Finally, 
exploratory factor analysis was carried out. Internal consistency reliability of items 
within a factor was also measured, using the Cronbach’s coefficient alpha to show the 
relationship of each item within a factor. The applicability and practicality of the use 
of this new tool was also assessed using a short 4-item questionnaire. The end result 
of this phase was the creation of version 2 of the new tool MLCDP. SPSS 12 and 16 
statistical software was used for all analysis.
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CHAPTER 3
Development of a new instrument for 
measuring the impact of chronic 
diseases on major life changing 
decisions: Conceptualisation and 
item generation
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INTRODUCTION
Conceptualisation of MLCDs and item generation was the first stage of the study. 
Due to lack of related information in the literature, detailed consideration was given 
at this stage for better understanding. Several meetings of the research team were 
carried out. The study question, methods, sample size, patient recruitment and data 
processing were discussed with research collaborators in order to obtain maximum 
information from patients. The detailed content analysis produced vital information 
for the conceptualisation of a novel concept of health and MLCDs. On the basis of the 
initial information, a working definition of “HRMLCDs” was formulated. Identified 
themes from patients comments were later used for items generation in a way that 
each item should represent each affected MLCD area reported by patients.
METHODS
Initial data collection
Initial data was gathered through (1) a postal questionnaire survey (2) individual 
interviews and (3) focus groups discussion to identify the influence of chronic 
diseases on major life changing decisions. The information obtained by these three 
main qualitative techniques was qualitatively coded into nodes, major categories and 
domains. Thereafter, it was analysed, summarised and quantified in the form of 
numbers and percentages to provide statistical meaning to the data.
Data processing and analysis
After collecting the initial data using the above mentioned three main qualitative 
techniques, the data were meticulously and systematically analysed word by word and 
line by line using NVivo 8 qualitative software. Main emerging themes and categories 
were carefully identified and grouped into main areas of patients’ reported and 
affected life changing decisions. This information was later used for the development 
of the initial version of a generic measure the “Major Life Changing Decisions 
Profile” (MLCDP). At first, postal survey data were qualitatively analysed using 
NVivo 8 qualitative software (described later in this chapter). In this “content 
analysis” 38 affected “MLCDs themes” were identified and grouped into 14 “core 
MLCDs categories”. These themes and core decision categories were later quantified 
in terms of frequencies and percentages using SPSS 16 statistical software to ascertain
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the magnitude of the impact of chronic diseases on MLCDs. Initially, in-depth data 
analysis was carried out separately for each individual speciality. The results were 
then combined to produce overall collective survey results.
All interviews were recorded using a digital recorder (interviews (n=50) total 
recording time=30 hours 52 min and 36 seconds, mean interviews duration=37.7 
minutes, range=6.4 to 118.4 minutes). Word by word verbatim transcripts of the 
individual interviews were carried out by Z U B. Data was qualitatively analysed 
using the specific technique known as “content analysis” employing Nvivio8 
qualitative software. Thirty-three affected “MLCDs themes” were identified and 
grouped into 13 “core MLCD categories”. All identified themes and core categories 
were quantified as frequencies and percentages using SPSS 16 statistical software to 
determine the level of influence of chronic skin diseases on patients MLCDs. The 
correlation between the patients’ age and the total number of influenced MLCDs 
reported by patients was calculated using the Spearman correlation coefficient.
Both focus group discussions were recorded using a digital recorder (FG1=57 
minutes, FG2=60 minutes. Word by word verbatim transcripts of the focus groups 
were made from the digital recordings. Data were analysed using the specific 
technique known as “content analysis” using NVivo 8 qualitative software. Nine 
affected “MLCDs themes” were identified and grouped into 6 “core MLCD 
categories”.
PROCEDURE
Postal survey: Participants were identified by the healthcare providers who were 
taking part in this study as collaborating researchers (consultant physicians). A total 
of 600 survey packs were posted or given to patients in the outpatient departments at 
the University Hospital of Wales and the University Hospital Llandough, Cardiff. 
These patients were adult (age 16 and over) from six medical specialities (cardiology, 
diabetes clinic, cystic fibrosis (CF) services, rheumatology, respiratory medicine and 
nephrology) who had been suffering from a chronic disease for more than one year 
(Table 3.1).
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Individual interviews: fifty-five patients suffering from chronic skin diseases were 
identified through the hospital clinical record via the “Patient Management System 
(PMS). Patients’ medical records were thoroughly searched to ensure that the strict 
inclusion/exclusion criteria were met. Identified patients were contacted by the 
clinician (dermatologist) either directly in the dermatology out-patient department or 
via post. After obtaining informed written consent, one to one in-depth interviews 
were carried out in the Welsh Institute o f Dermatology, University Hospital o f Wales, 
Cardiff.
Table 3.1: Total number of survey packs (total=600) posted to patients from
each speciality
Participating medical speciality Number of survey 
packs posted
Cardiovascular diseases 100
Rheumatology 100
Nephrology: Chronic Kidney Disease (CKD) 100
Diabetes 100
Cystic Fibrosis Services 100
Respiratory Medicine: Chronic Obstructive Pulmonary 
Disease (COPD)
100
Focus groups: Twenty patients suffering from chronic skin diseases were identified 
from the hospital clinical records via the “Patient Management System (PMS)”. 
Patient’s medical records were thoroughly searched to ensure that the strict 
inclusion/exclusion criteria were met. Identified patients were contacted either 
directly in the dermatology out-patient department or via post. After obtaining 
informed written consent, focus group discussions were carried out in the Welsh 
Institute of Dermatology, University Hospital of Wales, Cardiff.
Sample size and response rate consideration: Postal surveys are normally received 
as “cold” mail and because there has been no previous contact with the research team 
people may not respond. This may ultimately result in a response rate as low as 20% 
(Kelley et al. 2003). Similarly, the length, type and the nature of the survey may also 
influence the response rate (Zelnio 1980). In this study, the response rate was >50 % 
(n=310) (mean response rate= 51.6%, range= 36% to 61%), indicating a satisfactory 
level of response from six participating medical specialities (n=600) (Table 3.2).
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Reminders were sent out to non respondents with a personalised covering letter, 
which also increased the response rate.
The general rule on sample size for interviews, for ensuring that all relevant 
information is revealed, is that when no additional information is emerging from 
subsequent interviews, then a sufficient sample size has been reached. Glaser and 
Strauss (1967) discussed the concept of “data saturation point” in detail and refer 
saturation as a point in data collection in which
“no additional data are being found whereby the (researcher) can develop 
properties o f the category. As he sees similar instances over and over again, the 
researcher becomes empirically confident that a category is saturated...when one 
category is saturated, nothing remains but to go on to new groups for data on other 
categories, and attempt to saturate these categories also (p. 65)
This saturation point was reached at 28th interview when no new information was 
emerging. Another 22 interviews were carried out which yielded no new information; 
hence a satisfactory level of confidence had been achieved for initial data collection.
RESULTS
For the purpose of clarity the results will be presented in five parts: Part I, postal 
survey; Part II, individual interviews; Part III, focus groups; Part IV, content analysis 
and Part V, formation of definition of MLCD.
Part I. Postal Survey
Demographic characteristics of the study participants
A total of 258 (83.2%) responses were evaluable. There were 145 (56.2%) male and 
113 (43.8%) female participants with the mean age of 53.7 years (median=58 years; 
range=18-92 years) (Table 3.3). of these 129 (50%) only had school education, 81 
(31.4%) patients had college level and 48 (18.6%) had university education. More 
than a half of the participants (n=145, 56.2%) were married, 53 (20.5%) were single 
and 29 (11%) were divorced. In terms of employment status, 64 (24.8%) were 
employed, 29 (11.2%) were unemployed, 50 (19.4 %) were retired and 105 (40.7%) 
patients had retired early due to long term disease (Table 3.3).
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Patients had been suffering from one of 20 different chronic conditions. The overall 
mean disease duration was 17 years (range 2 to 58 years). Participants from 
cardiology had been suffering from heart failure (13), coronary artery diseases (11), 
congenital heart problems (7), atrial fibrillation (3), cardiomyopathy (2), aortic 
stenosis (2) and myocardial infarction (2). Participants from nephrology had been 
suffering from chronic kidney diseases (CKD) (CKD Stage IV: 19, CKD Stage V: 3). 
Participants from respiratory medicine had been suffering from COPD (38) and CF 
(53). Forty participants were suffering from diabetes (diabetes type I: 12, diabetes 
type 2: 38). In rheumatology there were 20 patients with rheumatoid arthritis, 15 with 
ankylosing spondylitis, 7 with psoriatic arthritis, 4 with osteoarthritis, 3 with 
polymaylgia rheumatica, 2 with systemic lupus erythematosus, 2 with Sjorgen's 
syndrome, 1 with reflex sympathetic dystrophy and 1 with myositis (Table 3.4). The 
mean age and mean disease duration of participants are listed by speciality in Table 
3.5.
Results: 310 (51.6%) of 600 patients returned their survey packs. 46 (7.6%) patients 
declined to take part and 6 (1%) patients had died (informed by relatives). 258 
(83.2%) patients (male=145, female=113; mean age=53.7 years, range= 18-92 years; 
mean disease duration=17 years, range=2-58 years; Rheumatology=55, CF=53, 
Diabetes=50, Cardiology=40, COPD=38, Chronic Kidney Disease=22) reported 
whether their chronic disease had had any influence on MLCDs or not. 207 (80.2%) 
patients reported their chronic disease had influenced at least one MLCD (core life 
decisions areas affected=14; mean MLCDs affected=2.1, range=l-9) and 51 (19.7%) 
patients reported no influence (Table 3.2).
The total numbers of affected core life decision areas with mean MLCDs are listed in 
table 3.6 by individual medical specialty. The mean number (4.3) of affected MLCDs 
was higher in CF patients then patients from any other speciality. As compared to 
other specialities, nephrology patients reported influence on less core life decisions 
areas (10) with a low mean (1.1) and a lower range of affected MLCDs (1-4). 
Whereas, diabetes patients reported more affected core life decisions areas (13) than 
patients from other specialities. A total of 119 patients reported influence on 1 to 2 
MLCDs, 57 patients reported 3 to 4 and 13 patients reported influence on 6 MLCDs 
(Figure 3.1). One patient reported influence on 9 MLCDs with an overall median of 2.
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Table 3.2: Postal survey response (%) by speciality
Participating 
medical speciality
Total survey 
packs posted or 
given to patients
(N=600)
Survey
response
rate
Declined 
(N=46,7.6%)
Patients had 
died 
(informed by 
relatives)
(N=6,1 %)
Nature of responses and level of disease 
influence on MLCDs
(N=310, 
51.6%)
Evaluable
responses
(N=258,
83.2%)
Influence on 
MLCDs 
(N=207, 
80.2%)
No Influence 
on MLCDs 
(N=51, 
19.7%)
Rheumatology 100 58 (58%) 3 (5%) - 55 (94.8%) 45 (82%) 10(18%)
Cystic Fibrosis 
Services (CF)
100 61 (61%) 8(13.1% ) - 53 (86.8%) 50 (94.4%) 3 (5.6%)
Diabetes Clinic 100 60 (60%) 10(16.6%) - 50 (83.3%) 37 (74%) 13 (26%)
Cardiology 100 46 (46%) 4 (8.6%) 2 (4.3%) 40 (86.9%) 28 (70%) 12 (30%)
Respiratory
Medicine
(COPD)
100 49 (49%) 9(18.3% ) 2 (4%) 38 (77.5%) 31 (81.5%) 7(18.4%)
Nephrology
(CKD)
100 36 (36%) 12(33.3%) 2 (5.5%) 22 (61.1%) 16(72.7%) 6 (27.3%)
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The MLCDs affected by chronic disease were related to early retirement (105, 
40.6%), job (76, 29.4%), having children (64, 24.8%), career choice (58, 22.4%), 
relationships (divorce, marriage, separation) (40, 15.5%), moving abroad (35, 13.5%), 
education (32, 12.4%), housing (30, 11.6%), moving to another city (11, 4.2%), to 
step down from professional body (3. 1.1%), to quit professional sports (3, 1.1%) and 
major treatment decisions (dialysis, transplant, surgery) (3, 1.1%). Decisions related 
to holidays and travelling abroad (39, 15.1%) and life style change (18, 6.9%) were 
also regarded as life changing decisions by a considerable number of patients (Figure
Table 3.3: Demographic characteristics of the study participants (n=258)
Variables Number (%)
Age (years)
Range 18-92
Median 58
Mean 53.7
Gender
Female 113(43.8)
Male 145 (56.2)
Education
School 129 (50)
College 81 (31.4)
University 48(18.6)
Marital status
Single 53 (20.5)
Married 145 (56.2)
Divorced 29(11.2)
Separated 1 (0.4)
Living with partner 8(3.1)
Widowed 22 (8.5)
Employment status
Employed 64 (24.8)
Unemployed 29(11.2)
Retired 50(19.4)
Early retirement 105 (40.7)
Part time employment 7 (2.7)
Student 3(1.2)
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Table 3.4: Frequencies of disease states for the six study groups
Specialities/diseases N Percent
1. Cardiology
Heart Failure 13 5.0
Coronary Artery Disease (CAD) 11 4.3
Congenital Heart Problems 7 2.7
Atrial Fibrillation (AF) 3 1.2
Cardiomyopathy 2 .8
Aortic Stenosis (AS) 2 .8
Myocardial Infarction (MI) 2 .8
2. Nephrology
CKD IV 19 7.4
CKD V 3 1.2
3. Respiratory Medicine
COPD 38 14.7
4. Cystic Fibrosis (CF) 53 20.5
5. Diabetes
Diabetes Type 2 38 14.7
Diabetes Type 1 12 4.7
6. Rheumatology
Rheumatoid Arthritis 20 7.8
Ankylosing Spondylitis 15 5.8
Psoriatic Arthritis 7 2.7
Osteoarthritis 4 1.6
Polymyalgia Rheumatica 3 1.2
Systemic Lupus Erythematosus 2 .8
Sjorgen's Syndrome 2 .8
Reflex Sympathetic Dystrophy 1 .4
Myositis 1 .4
Total 258 100.0
Table 3.5: Patients’ mean age and disease duration by medical speciality
Medical Speciality Number
of
patients
Patient Age 
(years)
Disease Duration 
(years)
Mean Range Mean Range
Rheumatology 55 55.1 28-82 17.0 2-47
Diabetes Clinic 50 59.4 27-84 17.1 2-56
Cardiology 40 59.5 19-81 15.5 2-58
Respiratory
Medicine
CF 53 27.7 18-53 25.6 7-53
COPD 38 65.8 53-84 9.1 2-50
Nephrology 22 68.3 46-92 12.4 2-33
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T able  3.6: Total m ajor life changing  decisions areas with mean M L C D s affected
by the six m edical specialities
M edical
speciality
N u m b er o f  
patients
Total n um ber o f  
m ajor  life changing  
decision areas  
affected
A ffected M L (  
per patien
: ds
Mean Median Range
Rheumatology 55 12 1.9 2.0 1-6
Diabetes clinic 50 13 1.8 2.0 1-7
Cardiology 40 12 1.6 1.0 1-8
CF 53 12 4.3 4.0 1-9
COPD 38 11 1.3 1.0 1-6
Nephrology 22 10 1.1 1.0 1-4
F igure 3.1: Distr ibution  o f  affected M L C D s am on g postal survey patients
(n=258)
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Figure 3.2: M L C D s influenced by chronic diseases for the postal survey
participants
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Impact on other important life issues: Many patients reported an impact of their 
chronic disease on other important aspects of their lives such as leisure and social 
activities, particularly not to socialise (53, 20.5%), impact on family (24, 9.3%), 
choice of holidays (17, 6.5%), driving (14, 5.4%) and influence on future plans (12, 
4.6%). These decisions were considered by the patients to be, for them major life 
changing decisions.
M L C D s reported by individual patient groups
The reported MLCDs relating to each participating speciality were examined in order 
to determine their link with the type of chronic disease.
R heum atic  disorders: Fifty-eight (58%) patients returned the questionnaire of whom 
3 (5%) declined to take part in the study. Fifty-five (95%) patients (male=18, 
female=37; mean age=55, age range=28-82 years; mean disease duration=17 years,
40.6
>9.4
24.1
2 2 -
15.5
15.1
4.2
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range=2-47 years; Rheumatoid arthritis=20, Ankylosing spondylitis=15, Psoriatic 
arthritis=7, Osteoarthritis=4, Polymyalgia rheumatica=3, Systemic lupus 
erythematosus=2, Sjogren’s syndrome=2, Myositis=l, Reflex sympathetic 
dystrophy=l) completed the study. 10 (18%) patients reported no influence while 45 
(82%) patients reported influence on at least one MLCD (core life decisions areas 
affected=12; mean MLCDs affected= 1.9, range=l-6). The reported MLCDs affected 
by rheumatic disorders concerned early retirement (28, 50.9%), job (16, 29%), having 
children (13, 23.6%), relationships (10, 18.1%), moving abroad (8, 14.5%), housing 
(7, 12.7%), career choice (6, 10.9%), education (3, 5.4%), holidays and travelling 
abroad (3, 5.4%), moving to another city (2, 3.6%) and life style change (1, 1.8). One 
patient also described the decision to have surgery as a MLCD (Table 3.7).
Cystic Fibrosis (CF): Sixty-one (61%) patients returned the questionnaire of whom 
53 (86.8%) (male=34, female=19) with mean age of 27.7 years (range= 18-53 years) 
and mean disease duration of 25.6 years (range= 7-53 years) reported influence of 
their CF on MLCDs. Fifty (94.3%) patients reported influence on at least one MLCD 
(core life decisions areas affected=12; mean MLCDs affected=4.3, range=l-9). Three 
(5.6%) patients reported no influence and eight (13.1%) patients declined to take part 
in the study. MLCDs affected by CF were having children (35, 66%), career choice 
(31, 58.4%), job (31, 58.4%), education (24, 45.2%), relationships (19, 35.8%), 
moving abroad (13, 24.5%), early retirement (12, 22.6%), housing (9,16.9%), moving 
to another city (3, 5.6%) and major treatment decisions (1, 1.8%) (Table 3.7). 
Decisions related to holidays and travel abroad (12, 22.6%), and life style change (2, 
3.7%) were also regarded as life changing.
Chronic Obstructive Pulmonary Disease (COPD): Forty-nine (49%) questionnaire 
were returned of which 9 (18.3%) were not completed and 2 had deceased (informed 
by relatives). The remaining 38 (77.5%) patients (male= 23, female= 15) with mean 
age of 65.8 years (range= 53-84 years) and mean disease duration 9.1 years (range=2- 
50 years) reported influence of their COPD on MLCD. Thirty-one (81.5%) patients 
reported influence on at least one MLCD (core life decisions areas affected=l 1; mean 
MLCDs affected=1.3, range=l-6) and 7 (18.4%) patients reported no influence. The 
MLCDs affected by COPD were early retirement (20, 52.6%), job (8, 21%), housing 
(3, 7.8%), career choice (2, 5.2%), moving abroad (2, 5.2%), to quit professional sport
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(2, 5.2%), decision to change life style (2, 5.2%), stand down from professional 
bodies (1, 2.6%), moving to another city (1, 2.6%) and having children (1, 2.6%) 
(Table 3.7). Nine (23.6%) patients reported decision about holidays and travelling 
abroad as MLCD and this was the second most frequently reported area reported by 
COPD patients.
Diabetes: Sixty (60%) patients returned their questionnaire of whom 10 (16.6%) 
declined to take part, and therefore there were 50 (type 1=12, type2=38; male=30, 
female=20) with mean age of 59.4 years (range=27-84 years) and mean disease 
duration of 17.1 years (range=2-56 years) evaluable patients. Thirty-seven (74%) 
patients reported influence on at least one MLCD (core life decisions areas 
affected=13; mean MLCDs affected=1.8, range=l-7) and 13 (26%) patients reported 
no influence. The MLCDs affected by diabetes were early retirement (20, 40%), 
career choice (13, 26%), job (12, 24%), decision to change life style (11, 22%), 
having children (7, 14%), relationships (7, 14%), moving abroad (6, 12%), housing 
(3, 6%), education (2, 4%), moving to another city (2, 4%), to stand down from 
professional bodies (1, 2%) and to quite professional sports (1, 2%) (Table 3.7). 
Decisions related to holidays and travelling abroad (7, 14%) were also regarded as life 
changing.
Cardiovascular disorders: Forty-six (46%) patients returned their questionnaire of 
whom 4 (8.6 %) declined to take part in the study and 2 (4.3%) had died as informed 
by the relatives. Forty patients (male=27, female=13) with mean age of 59.5 years 
(range= 19-81 years) and mean disease duration of 15.5 years (range=2-58 years) 
reported whether or not their disease had had any influence on MLCDs. Twenty-eight 
(70%) patients reported that their disease influenced at least one MLCD (core life 
decisions areas affected=12; mean MLCDs affected=1.6, range=l-8) and 12 (30%) 
reported no influence. The reported MLCDs concerned early retirement (15, 37.5%), 
having children (7, 17.5%), job (7, 17.5%), career choice (5, 12.5%), relationships (5, 
12.5%), housing (4, 10%), moving abroad (4, 10%), education (3, 7.5%), moving to 
another city (2, 5%), decision to change life style (2, 5%) and to stand down from a 
professional body (1, 2.5%) (Table 3.7). Decisions related to holidays and travelling 
abroad (6,15%) were also regarded as MLCDs.
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Chronic Kidney Disease (CKD): Thirty-six (36%) out of 100 patients returned their 
questionnaire of whom 12 (33%) declined to take part in the study. The remaining 22 
patients (male=13, female=9; mean age=68 years, range=46-92 years; CKD-IV=19, 
CKD-V=3; mean disease duration=12 years, range=2-33 years) were evaluable. 
Sixteen (78%) patients reported influence on at least one MLCD (core life decisions 
areas affected=10, mean MLCDs affected=l.l, range=l-4) and 6 (27%) reported no 
influence on MLCDs. The affected MLCDs were early retirement (10, 45.4%), 
housing (4, 18.1%), job (2, 9%), moving abroad (2, 9%), relationships (1, 4.5%), 
moving to another city (1, 4.5%), career choice (1, 4.5%), having children (1, 4.5%) 
and major treatment decisions (1, 4.5%) (Table 3.7). 2 (9%) patients reported the 
decisions to go for holiday and travelling abroad as MLCDs.
Table 3.7: Summary of MLCDs influenced by chronic diseases by the
six disease areas
MLCDs
n=207
Rheum*
n=45
CF*
n=50
COPD*
n=31
DM*
n=37
Cardio*
n=28
CKD*
n=16
Early retirement y y y y y y
Job y y y y y
Having children y y y y y y
Career choice y y y y y y
Relationships y y X y y y
Holidays and travelling 
abroad
y y y y y y
Moving abroad y y y y y y
Education y y X y y X
Housing y y y y y y
Lifestyle change y y y y y X
Moving to another city y y y y y y
To stand down from
professional
body
X X y y y X
To quit professional 
sports
X X y y X X
Major treatment decisions y y X X X y
*Rheum=Rheumatic disorders, CF=Cystic Fibrosis, COPD=Chronic Obstructive Pulmonary Disease, 
DM=Diabetes Mellitus, Cardio=Cardiovascular disorders, CKD=Chronic Kidney Disease
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P a rt II. Individual interview s
D em ographic ch aracteristics o f  the study participants
Fifty-five patients were invited for interviews of whom 5 (9%) declined to take part. 
Fifty (91%) patients, (male=25, female=25), mean age=42.3 years (median=44.5 
years; range=17-67 years), who were suffering from one of 8 chronic skin diseases 
(Figure 3.3) with mean disease duration of 29 years (range=2-61 years), participated 
in the study. Eighteen (36%) patients were single, 17 (34%) married and 7 (14%) 
divorced. Nineteen (38%) patients had school education, 16 (32%) college and 15 
(30%) patients had university education. More than half of the patients (27, 54%) 
were employed and 10 (20%) patients had taken early retirement. Patients’ detailed 
demographics are shown in Table 3.8.
Figure 3.3: D istribution  o f  skin d iseases in the study participants (n=50)
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Table 3.8: Demographic characteristics of the study participants (n=50)
Variables Number (%)
Age (years)
Range 17-67
Median 44.5
Mean 42.3
Gender
Female 25 (50)
Male 25 (50)
Education
School 19(38)
College 16 (32)
University 15(30)
Marital status
Single 18(36)
Married 17(34)
Divorced 7(14)
Separated 2(4)
Living with partner 5(10)
Widowed 1(2)
Employment status
Employed 27 (54)
Unemployed 5(10)
Retired 1(2)
Early retirement 10 (20)
Part time employment 1(2)
Student 3(6)
Housewife 3(6)
MLCDs influenced by skin disease
Of the 50, 45 (90%) patients reported the influence of their chronic skin disease on at 
least one MLCD (core life decisions areas affected=13; mean MLCDs affected=5.5, 
range=l-12) and 5 patients reported no influence. The affected MLCDs reported by 
patients were related to career choice (33, 66%), job (29, 58%), relationships (26, 
52%), education (22, 44%), moving abroad (16, 32%), having children (11, 22%), 
early retirement (10, 20%), housing (7, 14%), moving to another city (6, 12%), 
holidays and travelling abroad (5, 10%), decision to change life style (2, 4%) and to 
quit professional sports (2, 4%). Several “lifestyle related decisions” were also
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regarded as MLCDs by a large number of patients, such as choice of clothing (27, 
54%), stopped swimming (17, 34%), not to socialise (11, 22%) and wearing make up 
(11, 22%) (Figure 3.4). These were the only new themes that emerged during the 
interviews that had not been identified from the postal study. Decisions related to 
major treatment and to stand down from a professional body were reported in the 
postal surveys, but were not reported by patients during interviews.
The distribution of the number of affected MLCDs reported by 50 patients is shown 
in Figure 3.5. The distribution indicates the magnitude of affected MLCDs. More 
than half of the patients (n=26) reported that their disease influenced between 5 to 7 
MLCDs. Four patients reported influence on nine MLCDs, two patients on 10 
MLCDs and two patients reported influence on 11 and 12 types of MLCDs 
respectively.
F igure 3.4: M L C D s in flu en ced  by chron ic skin  d iseases identified  from
interview s
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Figure 3.5: N u m b er o f  affected  M L C D s reported  by patients w ith  skin d iseases
(n=50)
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Impact on other important life issues: 33 (66%) patients also reported impact of their 
chronic disease on other important aspects o f their lives such as choice of holidays, 
impact on family, leisure and social activities, driving and influence on future plans.
P a rt III. Focus g roup  discussions 
D em ograp h ic ch aracter istics o f  the study participants
Twenty patients were invited to take part in focus group (FG) discussions but 12 
(60%) declined. Eight (40%) patients contributed to 2 FG discussions; FG1, 
psoriasis=4, male=3, female=l, mean age= 48.7 years ( median=48 years; range=34 
to 65 years), mean disease duration 15.2 (range=ll to 23 years); FG2, eczema=4, 
male=3, female=l, mean age 40.7 years (median=41.5 years; range=26 to 54 years), 
mean disease duration=31 years (range=7 to 54 years). Patients’ demographic details 
are shown in Table 3.9.
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Table 3.9: Demographic characteristics of the study participants
Patient demographics FG1 (n=4) FG2 (n=4)
Disease Psoriasis Eczema
Age
Range 34-65 26-54
Median 48 41.5
Mean 48.7 40.7
Gender
Male 3 3
Female 1 1
Education
School 3 2
College 1 -
University - 2
Marital status
Single 1 2
Married 3 2
Employment status
Employed 1 3
Unemployed 1 1
Retired 2 -
MLCDs influenced by skin diseases
Initially, five FGs (n=50, 10 patients in each group) were planned but due to 
repetition and emergence of the same information, and difficulty in recruitment, 
further recruitment was stopped after two FG meetings. The information obtained was 
similar to the information gathered through the postal survey and the individual 
interviews, and no new information was gained. The MLCDs reported as being 
affected by patients during FG discussions were career choice, early retirement, job, 
housing, holidays and travelling abroad and life style related decisions such as choice 
of clothing, not to go swimming, and wearing make up. This provided reassurance 
that no major themes were being overlooked and confirmed the rigour of the earlier 
interview process.
Relationships between the patients’ age and their reported MLCDs
It was of interest to understand whether there was any link between the patients’ age 
and their number of affected MLCDs. There was a wide scatter, but showed a trend 
towards decreasing total number of influenced MLCDs with increasing age of the
79
patients (Figure 3.6) and this was statistically significant (rs = -0.46, p=<0.001, 
n=308). This suggests that younger patients need more help at an early stage of their 
disease to take control over their MLCDs and lives. It is clear that most of the 
MLCDs taken by patients are related to early life stages and many of these MLCDs 
may not be relevant at a later stage of life, such as having children, career and job. 
The total number of new MLCDs affected is therefore naturally less in older patients.
Figure 3.6: Scatter plot showing the relationship between patient age and the 
total number of MLCDs affected as reported by patients (n=308)
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Comparison of MLCDs for gender
Postal survey: The percentage of male participants (145, 56.2%) was slightly higher 
than females (113, 43.8%). Chronic disease influences on MLCDs related to career 
choice and early retirement were reported more frequently by male patients and 
influences on the decision to have children was reported more frequently by female
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participants. Otherwise, there were no significant differences between males and 
female regarding the type and the level of MLCDs affected (Figure 3.7).
Individual interviews (Dermatology): The numbers of male (n=25) and female 
(n=25) participants were equal and no significant difference was found between them 
in the way they reported the influence of their chronic disease on MLCDs and the 
number and the type of affected MLCDs. However, a higher number of male (n= 11) 
than female (n=5) patients reported an influence of their chronic disease on their 
decision to move abroad. Similarly, important decisions related to housing were 
affected in more female (n=7) than male (n=l) patients. In addition, the decision to 
wear make up because of their chronic disease was only reported by female patients 
(n=l 1) reflecting the gender specific nature of this MLCD (Figure 3.8).
F igure 3.7: C om parison  o f  M L C D s betw een m ales and fem ales (Postal survey)
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F igure 3.8: C om parison  o f  M L C D s betw een  m ales and fem ales (Ind iv idual
interviews)
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W hy ind ividual in terv iew s and focus group  d iscussions w ere conducted  in 
patien ts w ith  skin d iseases?
The question may arise here why only dermatology patients were recruited for the 
individual interviews and FG discussions and why the other six specialities were 
selected for the postal survey. Information can be obtained using a mixture of such 
qualitative techniques. When considered together, these techniques can complement 
each other to provide comprehensive information, but it is not always necessary to 
use all the possible techniques together. Each of these techniques has its pros and 
cons; for example postal surveys may yield less information, may be more expensive 
and time consuming than individual interviews and generate a low response rate. The 
technique for individual interviews seems quick, less expensive and has a good 
response rate. Individual interviews gathered detailed information but the possibility 
may exist of an interviewer’s bias. In focus groups, patients may avoid sharing 
sensitive issues due to the presence of other participants and due to time restrictions 
which may not allow detailed discussion by all participants. On the other hand, the 
time available, the cost of patients attending interviews, the potential major costs of 
group discussions for >500 patients and the availability of appropriate facilities are
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also important practical considerations for selecting a specific information gathering 
strategy. The reasons why only dermatology patients were recruited for individual 
interviews and focus group discussions were as follows:
• Dermatology was the leading medical speciality for this study. Also,
dermatology patients often have chronic disease, allowing recruitment of 
appropriate patients in whom MLCDs were likely to have been affected by 
disease.
• Ready access to dermatology patients and hence easier recruitment.
• Availability of appropriate facilities for conducting interviews and group
discussions in the Department of Dermatology.
• The Dermatology Department agreed to share patient expenses with the 
Centre for Socioeconomic Research, School of Pharmacy, as this study was 
jointly supervised between these two units.
It was decided at the protocol stage that only dermatology patients would be recruited 
for individual interviews and for focus group discussion.
Factors influencing MLCDs
Of the 258 evaluable replies, 207 (80.2%) patients reported an influence of their 
chronic disease on various MLCDs. The patients also reported various “factors” 
correlated to their chronic disease that had influenced their MLCDs and explained 
why they took MLCDs differently.
Twenty-five factors influencing MLCDs were identified. Ill health and severity of 
disease, reported by 71% of respondents, frequent hospital visits and treatment 
(30.4%), physical disability (30.4%) and stress, fear and anxiety (29.9%) were the 
most frequently reported factors (Figure 3.9). Life expectancy (1.4%), discrimination 
(1.4%) and job insecurity (0.9%) were the least frequently reported disease associated 
factors that influenced patients’ MLCDs. Details of all factors influencing MLCDs 
are shown in Table 3.10.
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Similar key factors were also indentified during individual interviews (n=45) (Figure 
3.10) and were also discussed during focus group sessions. These factors included ill 
health and severity of disease, appearance, public attitude and bullying, physical 
disability, lack of confidence, self esteem and self consciousness, embarrassment, 
working conditions and risk to health. These factors can be classed under “patient’s 
comments” which will be further described later in this chapter.
Figure 3.9: Key d isease  related  factors that in fluenced  M L C D s 
(P osta l survey, n=207)
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Table 3.10: Factors influencing MLCDs
Factors 
influencing 
MLCDs (n=207)
N CF*
N=50
Cardio*
N=28
COPD*
N=31
Rheum*
N=45
Nephro*
N=16
DM*
N=37
III health and 
severity of disease
147 (71%) 34 16 27 32 11 27
Frequent hospital 
visits/treatment
63 (30.4%) 17 10 7 17 1 11
Physical disability 63 (30.4%) 6 16 30 11
Stress, fear and 
anxiety
62 (29.9%) 18 5 12 12 2 13
Financial aspect 20 (9.6%) 6 2 - 8 - 4
Reliance on 
family members
20 (9.6%) 3 1 8 4 2 2
Proximity to
hospital,
home/family
19(9.1%) 15 - - - - 4
Genetic reasons/ 
counselling/advice
18(8.6%) 10 3 - 5 - -
Diet and habits 18(8.6%) - - - - - 18
Tiredness 16(7.7%) - 5 10 1
Depression 16(7.7%) - - 4 7 1 4
Health and social 
concerns to 
newborn child
14 (6.7%) 14 - - - - -
Insurance cost 14 (6.7%) 8 1 - 1 - 4
Weather 14 (6.7%) 3 1 5 3 - 2
Working
conditions
10(4.8%) 10 - - - -
Disease
explanation and 
embarrassment
10(4.8%) 8 - - 2 - 2
Medical care 
abroad
9 (4.3%) - 2 - 4 1 3
Risk to health 8 (3.8%) 8 - - - - -
Employers 
understanding 
of illness
7 (3.3%) 7 - - - - -
Infertility/IVF
treatment
6 (2.8%) 6 - - - - -
Long travelling 6 (2.8%) 6 - - - -
NHS and basic 
healthcare
4(1.9%) 4 - - - - -
Life expectancy 3 (1.4%) 3 - - - - -
Discrimination 3 (1.4%) - - - - - 3
Job insecurity 2 (0.9%) 2 - - - - -
* CF=Cystic Fibrosis, Cardio=Cardiology, COPD=Chronic Obstructive Pulmonary Disease, 
Rheum=Rheumatology, Nephro=Nephrology, DM=Diabetes Mellitus
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F igure 3.10: Key d isease related in fluentia l factors that influenced M L C D s
(In d iv id ual in terview s, n=45)
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P a rt IV. C onten t analysis
Content analysis is a systematic way of identifying and organising relevant segments 
of qualitative data into more meaningful information. Similar segments from the text 
were coded (thematic coding) and grouped into core categories for their meanings, 
easy identification, retrieval, comparison and quantification (frequencies). Strauss and 
Corbin (1990) described each core category as a “sun” and its associated themes as 
“planets”.
The detailed content analysis of qualitative data was carried out using NVivo 8 
“Qualitative Data Analysis Software” (QDAS) produced by QSR International Pt Ltd. 
This software provides a “tree branch”, a hierarchal coding system for emerging 
themes and links to their main category, or in other words, to their conceptual core 
domain. A colour coding system in this software makes a large amount of text data 
much easier to organise, aiding analysis. A “Memo” option allows researchers to note 
down their own thoughts while analysing data, which can later be linked to its original 
source.
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Initially, data obtained through three qualitative methods (postal survey, individual 
interviews and focus group discussions) were analysed separately in NVivo 8. 
Subsequently, all the data were combined in order to build a broader picture of 
different emerging aspects of MLCD themes. Data were meticulously analysed word 
by word and line by line from the large body of the verbatim transcription text. 
Various MLCD themes were identified coded and grouped into core MLCDs 
categories. As described earlier, during the analysis 38 affected MLCD themes were 
identified from postal survey and grouped into 14 core categories (Table 3.11), 33 
affected MLCD themes were identified from the individual interviews grouped into 
13 core categories (Table 3.12) and 9 affected MLCD themes were identified from 
focus group discussions grouped into 6 core categories (Table 3.13).
In total 41 themes were identified which will be described here with typical patients’ 
comments given as examples of “qualitative data quotations”, according to their 
prevalence and under the heading of 15 core MLCD categories.
Early retirement
The decision to take “early retirement” was the most prevalent affected MLCD 
reported by patients (postal survey: n=105, 40.6%; individual interviews: n=10, 20%; 
focus groups discussion=Yes). The unremitting nature of the impact of chronic 
diseases on patients’ lives was so immense that with time it had diminished some 
patients’ ability or desire to work. The majority of patients reported their desire to 
work until retirement age but the long-term nature of their illness prevented them 
from undertaking normal employment activities and eventually made it impossible for 
them to continue.
*7 retired from work in December 2004, much earlier then I had always planned as 
my illness caused me to be unreliable. My employer did not want me to retire but I 
felt unable to carry on as my input was essential for the running o f a small business ”
<Intemals\Rheumatology\RHEU-692>
“Due to bad health I can not carry on working and I have to take early retirement. It 
is all due to diabetes and related complications and I was classified as disabled”
<Intemals\Diabetes\DIAB-549>
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“As the direct result of this long term disease, I had no alternatives other then to take 
early retirement last May 2008, I should have continued to work for at least another 
five years ”
<Internals\NephrologyYNEPH-283>
Table 3.11: Main MLCD themes identified from the content analysis of the
postal survey (n=207)
Core MLCD categories MLCD themes
Career choice Abandoned career plan 
Career selection 
Change of profession
Decision to change life style Change in life style
Major treatment decision Decision to have dialysis 
Decision to have organ transplant 
Decision to have surgery
Early retirement Decision to take early retirement
Education Higher education 
Left education
Selection of an educational institute
Having children Delayed plans for having children 
Having children through IVF 
Not to have children 
Not to have more children
Holidays and travelling abroad Holidays abroad 
Travelling abroad
Housing Buying a house 
Moving to another house
Job Flexible working hours employment 
Gave up job 
Job selection
Not to mention illness on job application
Not to progress further in job
Not to seek employment
Part time employment
Self employment
To stay in same employment
Unemployed or remain unemployed
Moving abroad Decision to move to another country
Moving to another city Decision to move to another city
Relationships Divorce
Marriage
Not to become involved in relationships 
Separation
Stand down from professional 
bodies
Decision to leave professional body
To quit professional sports Decision to quit sports
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Table 3.12: Main MLCD themes identified from content analysis of individual
interviews (n=45)
Core MLCD categories MLCD themes
Career choice Abandoned career plan 
Career selection 
Change of profession
Decision to change life style Change in life style
Early retirement Decision to take early retirement
Education Higher education 
Left education
Selection of an educational institute
Having children Delayed plans for having children 
Not to have children 
Not to have more children
Holidays and travelling abroad Holidays abroad
Housing Buying a house 
Moving to another house
Job Flexible working hours employment 
Gave up job 
Job selection
Not to progress further in job 
Part time employment 
Self employment 
To stay in same employment 
Unemployed or remain unemployed
Life style decisions reported as 
MLCDs
Choice of clothing 
Not to go swimming 
Not to socialise 
Wearing make up
Moving abroad Decision to move to another country
Moving to another city Decision to move to another city
Relationships Divorce
Marriage
Not to become involved in relationships 
Separation
To quit professional sports Decision to quit sports
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Table 3.13: Main MLCD themes identified from content analysis of focus groups
(n=8)
Core MLCDs categories MLCD themes
Career choice Career selection
Early retirement Decision to take early retirement
Holidays and travelling abroad Holidays abroad
Housing Moving to another house
Job Gave up job
To stay in same employment
Life style decisions reported as 
MLCDs
Choice of clothing 
Not to go swimming 
Wearing make up
Retirement is generally regarded as one of the major life stages, when people 
officially stop working for a living. Retirement age is usually at a predefined time, 
defined by the state or employers (60 or 65 years of age) when people end their 
working life. It is normally organised with a state pension and other benefits related to 
pension contributions to allow people to live their remaining life within a reasonable 
economic standard. It is obvious that the decision to take early retirement for any 
reason has significant financial implications and in particular may not be an easy 
option for those who earn a limited income. Despite the huge financial implications of 
this MLCD, their chronic disease left no choice for many patients other than to take 
early retirement, in order to look after their health.
“Have had to seriously consider early retirement and subsequently the financial 
implications on pension options ”
<Intemals\Rheumatology\RHEU-695>
“My heart condition means that I had to finish my working life early. That caused a 
problem with a lack of finance ”
<Intemals\Cardiology\C ARD-109>
The financial implications of the decision to retire early should not be underestimated 
as retirement may lead to various interconnected impacts on patients’ health. For 
example, one diabetes patient reported:
“Early retirement: leading to a loss o f self worth resulting in depression leading to 
mental break down. Break down of family structure ”
<Intemals\Diabetes\DIAB-533>
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Looking after their health may become a full time job for some patients and it may not 
be possible for them to continue to take part in active employment. One dermatology 
patient reported:
“My eczema is a full time job apart from anything else. From the time you get up to 
the time you going to go to bed. Going to bed is not much fun because you are so 
restless. But it is actually a fulltime job looking after your skin ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-l 2>
Being unable to accept the condition and having specific beliefs may also play an 
important role in a patient’s psychological well being, leading to withdrawal from 
employment. One dermatology patient reported “psoriasis as a curse”:
“I  have tried but I  won 7. I  wasn 7 very well. I  couldn 7 stand up behind the till. I  
couldn 7 pick things up. I  couldn 7 get out from bed properly and then I  was diagnosed 
with psoriatic arthritis. Then, I  thought that I  have psoriasis, now I  have got this so it 
seems like i t’s not letting me go. It is going to be on my face until I  die and it is a 
curse. It is bad, it is horrible. It is like a curse on me ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-l 3>
The disease’s physical impact played a major role in the decision of some patients to 
take early retirement.
“I got arthritis from psoriasis and it just became impossible for me to get on and off 
the buses, walk to the school and stand in the yard so I  retired in 2003...I  suppose it 
was a physical part at this point. Because I  worked in school for 20 years and I  had 
gone to school with it most o f the time and they knew what I  had. I  think that was the 
only place where I  felt confident in that work but, as I  said, I  like paid in that summer 
because I  would be covered from head to toe and would have to suffer. It was only an 
hour and so which again is that the psoriasis. I  couldn't have worked any longer any 
where else. Because, I  couldn't have coped with the heat and everything else ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-21 >
On the other hand, working become a way of life for many people and taking 
retirement so early due to illness may also affect patients emotionally:
“That was the decision (early retirement) but it was an inevitable decision because o f  
the disease and that's influenced my life completely. The way the disease and that 
ability to work and hold down a job has influenced everything else both emotionally 
you know, that's a whole other story, how I  feel about not working for so long”
<Intemals\Interviews\Dermatology-Individual Interviews\II-28>
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“Because I had spent a lot o f time in the infirmary and the Heath... Yes definitely (it's 
a major life changing decision) and changed my life in a big way because it is nice to 
go out and meet people and talk to people. It is being locked away now ”
<Intemals\Interviews\Derrnatology-Individual Interviews\II-49>
Patients’ comments
“I stopped working at the age o f 52 due to health concerns. I  had to take this 
decision. It was preventing me to do normal life, so due to my ongoing health problem 
I  had to take this decision and not to engage in employment”
<Intemals\Cardiology\CARD-149>
“CF caused the premature end o f my career, forcing retirement at the age o f 37 
years ”
<Intemals\CF\Cystic Fibrosis\CF-404>
“Taking early retirement because I  could not continue looking after myself and 
working”
<Intemals\CF\Cystic Fibrosis\CF-431>
“Retired from work at 57 years due to tiredness as I  was a nursery nurse ”
<Intemals\Diabetes\DIAB-530>
“I  have had to finish work at 53. This has been hard as I  was developing a new 
career ”
<Intemals\Diabetes\DIAB-596>
“I  have to, I  had no options my health wouldn't take the pressure I  had health
problems, it was severe then and it was worse when I  finished and still worse now, so 
from the time I  left there to now its just gone down hill, it's up and then goes down but 
it got worse... o f course it had to be (major life changing decision), I  had no option... I  
left because my health wouldn't let me do anymore "
<Intemals\Interviews\Dermatology-Individual Interviews\II-47>
“Not being able to drive through lack o f confidence after many operations and not 
able to walk very far and having to rely on my family and friends to look after me. I  
had to take early retirement”
<Internals\Nephrology\NEPH-203>
“Unable to work for a very long period o f time. Then got the job in (employer name) 
but again due to my health I  have decided to take early retirement”
<Intemals\Respiratory Medicine\RESP-314>
“I  worked until 1994 but found that I  took early retirement on the grounds o f ill 
health because o f rheumatoid arthritis ...That decision was life changing for me as I  
loved my job, but I  realised that I  could no longer cope with trying to work and hold 
down a job ”
<Intemals\Rheumatology\RHEU-615>
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“ Unable to return to employment and my profession hairdressing due to joint pain 
and deformity o f my hands- took early retirement ”
<Internals\Rheumatology\RHEU-619>
“Have decided to give up work, have worked all my life, but have no quality o f life, so 
have taken ill health retirement ”
<Intemal s\Rheumatology\RH EU-660>
“I have also got psoriatic arthritis. I  had to finish work when I  was 47 and found that 
quiet hard to cope with at that time. Still do really because it makes you feel a bit 
useless. As you are not contributing, not doing anything, you know what I  mean...At 
the time, I  was too ill anyway, so I  was far too ill at that time to look for further 
employment” (FG1FP1)
“ Well the only thing that happened to me was when I  had this psoriatic arthritis and 
psoriasis, they offered me alternative employment such as office work and stuff like 
that, such as I  was on the safety committee. They wanted me to be the safety officer 
but at that time with all that was going on. I  just wanted to finish anyway. It was too 
much for me to do anyway... It was just getting to a stage where I  couldn't do the 
work. When I  actually stopped, before I  finished they employed another chap, right to 
work alongside me and I  was to tell him what to do. But in the end it is one o f those 
things that you can 7 work and say to a chap pick up that and lift that, in the end you 
try to do it yourself and it was just too much... I  had already served 33 years there and 
I  had to finish 10 years early. I  am sure at the end o f it I  could have more, I  wouldn *t 
say money, but more security i f  I  had done it another ten years ”
<Intemals\Interviews\Dermatology-Focus Group Discussion\FGlMP2>
Job
The major life changing decisions related to “Job” or employment was the second 
most prevalent affected MLCD reported by patients (postal survey: n=76, 29.4%; 
individual interviews: n=29, 58%; focus groups discussion=Yes). In this core MLCD 
domain, 10 major categories were identified: Gave up job, unemployment, part time 
employment, to stay in same employment and self employment were the most 
prevalent affected aspects of MLCDs. Less frequently reported MLCDs were related 
to: not to seek employment, not to progress, not to mention illness in job application 
and job selection.
Gave up job: Most patients reported that giving up an established job was not an easy 
decision but certainly was life changing in respect to their daily routine, finance, 
family, life style and future plans. Particular working environments also made it 
harder for patients to continue their chosen employment. Similarly, giving up such a 
job where patients might have opportunities to develop their career in the future made
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it more difficult for patients to take this important MLCD. The aesthetic nature of 
chronic skin diseases was the most obvious reason for several patients to take this 
decision, and to avoid continuous embarrassment. The physical nature of the 
employment had also contributed towards some patients’ decisions to give up their 
job.
Patients' comments
“I  was a long distance lorry driver. I  had to give up my job. For five years, I  didn ’t 
accept this; I  was the bread winner o f my family”
<Intemals\Diabetes\DIAB-572>
“ When going on to insulin I  was working in the Middle East and decided to give up 
my position there which was highly paid, 50+k per annum ”
<Intemals\Diabetes\DIAB-576>
“I was working in a soldering factory, developed asthma. Also missing a lot o f work 
and the boss complained I  was spending too much time off line in the toilet. Decided 
to leave the job, since then I  have not worked due to ill health ”
<Intemals\CF\Cystic Fibrosis\CF-499>
“Had to give up a job after becoming ill, a job I  enjoyed very much and hoped would 
move into a career”
<Intemals\CF\Cystic Fibrosis\CF-479>
“Initially after ventricular tachycardia in my early 20s had to resign my job and 
career as a field scientist (environmental) ”
<Intemals\Cardiology\CARD-l 16>
“The main thing that influences you i f  it's become apparent not to just yourself but for 
other people, and then you react the way the other people perceive you. Now in my 
particular case, I  used to work as a teacher and with that I  felt that I  was in the eyes 
o f my students throughout the day. Now with my particular skin condition with the 
sort o f dry skin, it is a very severe dryness which sometimes comes on even after I  put 
medication on. So I  found sometimes, teaching first thing in the morning after having 
prepared myself, you know like shower and then cream and then an hour later I  find  
that my skin was sort o f dry again and o f course the pupils then wouldn ’t waste any 
time pointing that out, sort o f laughing and saying “oh sir... this is happening, this is 
happening”...So therefore, as a reaction to that I  certainly felt very self-conscious 
about putting myself in that situation and it was certainly a factor in me deciding to 
leave the teaching profession...I didn 7 feel I  was able to give 100% sort o f with it i f  
the pupils were then going to be distracted through my appearance so that did cause 
me to think long and hard whether I  wanted to carry on in the classroom and perform 
in front o f children without my condition being under control, so that is the way i t ’s 
affected me regarding the sort o f work situation ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-07>
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“I was a shopkeeper and then I  got married. I  worked for a children’s school for eight 
years, I  looked after partially sighted children, which I  felt protected from them 
because they didn't judge me, in fact they couldn't see me properly which helped. 
They never judged me. I  worked for them for 8 years. That was the reason behind the 
change o f job. I  don't want to take it on my face again. People bring it to your face 
again when you've got psoriasis. I  used to scrub myself with the scrubbing brush 
because I grew up thinking because I  was dirty”
<Internals\Interviews\Dermatology-Individual Interviews\ll-13>
“Because I couldn't just physically couldn't do the job anymore. My hands were so 
cracked and bleeding all the time, my face was permanently purple and so itchy and 
so I  didn't have much hair left...yes because I  couldn't cope with the dirt on the shop 
floor and things like that and I  can't cope with paper, the dirt o f paper and things. So 
I can't touch a lot o f dust ”
<Intemals\Interviews\Dermatology-Individual InterviewsMI-l 9>
“Giving up work I  think was obviously a directly influenced decision really. We were 
living away from our home area, our home area is here, we were living away and we 
got to the point, I  was never really at work, so the decision was to leave work and 
return home. I  was with my partner then, I  wasn't single. We decided really because 
o f that to return home partly because o f the treatment available here and also you 
have support from family and things like that... I  was always on the waiting list for the 
surgery so that was always quite difficult. You are constantly sort o f in limbo, which 
explains why I  haven't worked for a long time. Once I  gave up work, never intended to 
stop working for good. I  moved back here and wanted to get another job but I  just 
never had that sort o f reliability I  can offer to an employer you know. I  could be o ff 
regularly. I  could never say when I  was going to have surgery... yea, that was my 
personal decision, they never asked me to leave or anything like that...I mean it was 
physical a lot o f it, the nature o f the condition mostly on my buttocks, I  had an office 
job and it's very difficult, just physically ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-28>
“So yes my illness then definitely made me make a choice to change my lifestyle 
which meant giving up my job because hidradenitis is triggered by many things 
including sweat, stress, friction...oh very big decision. I  mean you know it's your 
livelihood your career, I  mean the main reasons I  had to stop, I  had an operation, 
surgery around my bottom and everything. I  had a fistula which came out I  couldn ’t 
do the job, I  couldn't stand for anything, and I  am like sit upright... the decision to 
give up my job was because o f hidradenitis ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-30> 
“I went for catering because I  knew that you could wear long sleeves and ever thing. 
So I  did catering for two years, it wasn't a very good profession to go in, to be honest 
with you. It's really low paid and long hours, dreadful when you have a skin 
condition. When you are doing things like Dithro creams you have got to spend time 
and i f  you are working split shifts or steady shifts it didn’t suit, so I  gave up because it 
didn’t suit”
<Intemals\Interviews\Dermatology-Individual Interviews\II-41 >
“I  did mobile hairdressing at that time...I used to wear a wig, I  used to be conscious 
about it and then people used to think that they noticed and then (left this job) I  did 
eventually, I  was most embarrassed at one stage because I  was doing mobile hair
dressing I  went to this lady ’s house and she had a hanging basket when she opened 
the door. I  knocked my head on that hanging basket and it flew off and that was so 
embarrassing you know, but she was alright about it but that really I  thought what am 
I  doing with this job... I  left that job and went to work in an office for a conservatory 
company, (have to leave this job) it was just such hard work and my husband ”
<Internals\Interviews\Dermatology-Individual Interviews\II-46>
“/ joined the nursing home, /  was there for a good few years, and then I  left it because 
I was picking up quite a lot o f infections from people who had leg ulcers, different 
things and... it was very hard when you leave work, you know, stayed on for bit longer 
but my skin got out o f control so then I  went for something else, tried something else 
...yea, because I left the job... upsetting really because you go through all that much 
work and effort and you know and then you got to leave because o f your health ”.
<Intemals\Interviews\Dermatology-Individual Interviews\II-49>
“Finishedfire services as my health deteriorated”
<Intemals\Respiratory Medicine\RESP-314>
‘7  had just started my own dress-making business making bridal gowns when I  
developed rheumatoid arthritis so I  had to give it up straight away ”
<Intemals\Rheumatology\RHEU-686>
“The main one you know is been affected by is the ability to work at the 
moment ...well it is preventing me from working...at the moment it seems impossible. I  
just can’t. I  was working in a laboratory which obviously makes things even worse 
because you are wearing gloves and washing your hands all day long and it 
completely flares up ”
<Intemals\Interviews\Dermatology-Focus Group Discussion\FG-2MP3>
Unemployed or remain unemployed: Generally, long term unemployment refers to a 
situation where people want to work but are unable to find work either through lack of 
employment opportunities or lack of suitable work for the employee (health and 
disability). People cannot afford to be unemployed or remain unemployed for a very 
long period of time because of their financial commitments and because of the impact 
of unemployment on their family lifestyle. However, despite a delicate balance 
between employment and health, many patients decided to be unemployed in order to 
be in a position where they could look after their health properly. This important 
major life changing decision also had an emotional, psychological, financial and 
social bearing on their family and was mainly based on the patients’ previous 
unpleasant employment experiences associated with suffering from their chronic 
condition. The lack of understanding from employers, job suitability (unable to find a
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job suitable for their health) and unpredictability (remission and recurrence) of the 
chronic condition were also contributing factors.
On the other hand, if a patient had had chronic disease since childhood, then it made it 
more complicated and difficult for them to be in employment. Their chronic illness 
negatively contributed towards their lack of education and work skills and made it 
harder for them to find any suitable job. Because of the constant unpredictability of 
their chronic condition, patients preferred to remain unemployed as they didn’t know 
when and how long they would be in hospital. In some cases due to consultant 
intervention, patients stopped working and remained unemployed in order to get 
proper treatment and gain enough mental and physical strength to return later to 
suitable work. Some critics might argue that patients becoming unemployed or 
remaining unemployed may not be by choice but by need; they had to take this life 
changing decision. It is a genuine argument, but patients have to decide and the 
willingness of patients to work demonstrates their desire to take control over their 
chronic disease as part of their long term coping strategy.
Patients* comments
“Jobless at home, i f  there wasn't any eczema I  could have had a nicer better 
education and with a decent job...well not too happy, sort o f depressed you can 
imagine, my confidence is ok but I  still feel down because 1 am not working and living 
with parents ”
<Internals\Interviews\Dermatology-Individual Interviews\II-45>
“I  was suspendedfrom my job last year because I  was told I  was lazy and didn ’t work 
as hard as my colleagues. This has left me low and under confident and worried 
about further employment... Unemployed due to long term health problem ”
<Intemals\Cardiology\C ARD-103>
“Decided not to get employed because o f appointments, IV ’s, hospital 
admissions ...Always wanted to work but due to health decided not to ”
<Intemals\CF\Cystic Fibrosis\CF-460>
“Because I  left school early, I  was worried about being rebutted from work, as I  had 
no GCSE or working skills ”
<Intemals\CF\Cystic Fibrosis\CF-409>
“Yea because I  was, I  am still not dealing with it very well but Ijust couldn’t visualise 
myself in any work and dealing with it and dealing with my son and home and now
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obviously since July the other major situation (physical aspect/aesthetic reason)... 
confidence I think is my huge thing "
<Internals\Interviews\Dermatology-Individual Interviews\II-23>
“Unemployed because o f a long term health problem and decided to look after my 
health. Lack o f finances so living with parents "
<Intemals\CF\Cystic Fibrosis\CF-486>
“I have worked in every job, had until being stopped by my GP, because I  am down 
too much "
<Intemals\CF\Cystic Fibrosis\CF-489>
“A friend o f mine offered me a job. Stripping asbestos and when you strip asbestos 
from old buildings you got to have two full suits on. They call it double suiting. I  was 
struggling to pay my mortgage. I  still am. I  couldn 't take the job because when I ’m 
perspiring the itching is intense, it intensifies so much and I  knew that I  couldn't do a 
job so that's another way that it affected my life in a big way...from taking that 
employment yea, whereas 6 years ago I  would have taken it without a 
thought...definitely yea (major life changing decision), because I ’m still seeking 
employment. Now I  am in arrears with my mortgage it has really affected me in a big 
way"
<Intemals\Interviews\Dermatology-Individual Interviews\II-25>
“Over many years I  have made around 10 job applications and have not been offered 
ONE job"
<Intemals\CF\Cystic Fibrosis\CF-492>
“Following a redundancy situation I  felt that I  could not continue to my maximum in 
new employment, therefore long term employment becomes scary to me "
<Intemals\Respiratory Medicine\RESP-324>
“Because lam  not working it's affected my personal life, and not being independent, 
money and physically wise ”
<Intemals\Respiratory Medicine\RESP-399>
Part time employment: Part time employment refers to working for fewer working 
hours than normal full time working hours. Working fewer hours was part of some 
patients coping strategy to remain employed, and at the same time look after their 
health. However, financial worry was the prime concern for patients and made this 
decision crucial and life changing. Despite their chronic illness this way of working 
allowed patients to make themselves available for work with less responsibility and 
stress, to get out of isolation, to socialise, meet people and contribute to society 
without putting too much strain on their health. Sometimes the nature of treatment 
made it difficult for patients to work full time. However, changing to part time 
employment remains a critical decision that becomes necessary because of the nature
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and severity of their health condition. In other words, their health left no choice but to 
take this life changing decision to work part time.
Patients’ comments
“Had to cut hours in work due to bad health, resulting in less money ”
<Internals\CF\Cystic Fibrosis\CF-408>
“Job: after complications and operations I  now work only part time as a teacher”
<Internals\Cardiology\CARD-l 15>
“I do a part time job because it gives me time to do exercise to look after my heath ”
<Intemals\CF\Cystic Fibrosis\CF-434>
“Recently I  have had to go part time in work because o f my condition ”
<Intemals\CF\Cystic Fibrosis\CF-458>
“I  have had to decrease the hours that I  worked from full time to part time, because o f 
the effects from my diabetes ”
<Intemals\Diabetes\DIAB-554>
“Because o f the pills, potions and the creams and stuff I  did used to get very tired and 
very sore and my hands are very susceptible to being cracked and everything. So part 
time was better than doing the full time job and getting really really bad...financially 
yes, horrifically difficult because we needed the money, then you have to do what you 
can do ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-19>
“As a teacher o f French at secondary level, I  chose to work part time for 12 years for 
several reasons, one o f which was my reduced saliva/dry mouth which made it 
uncomfortable for me to teach classes (approximately 30 students) for 4/5/6 hours a 
day, five days a week”
<Intemals\Rheumatology\RHEU-636>
To stay in the same employment: This is one of the very interesting decisions patients 
made. Patients were comfortable where they were working with regard to their illness 
and job requirements. Other factors were: employers understanding of their illness, 
environment suitable for their health, less contact with the public, less work, less 
stress, fear of being unable to get another job, limited education or skills, and in some 
cases the aesthetic nature of their chronic illness. For example, if an employer 
understands their illness, then it is very easy for patients to explain why they are off 
from work today or why they need an urgent hospital visit or admission. At least this 
attitude gives patients a little freedom to think about their treatment rather then
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worrying about losing their job all the time, which itself may cause stress and further 
deterioration to their health. Having less promotion chances, less money, being afraid 
of not getting another job and the understanding of employers make this decision 
more life changing for patients.
Patients* comments
“Stay with current employers due to them being very understanding with regard to my 
health requirements ”
<Intemals\CF\Cystic Fibrosis\CF-410>
‘7  decided to stay in the same work place and never looked anywhere else as my 
employer understands my illness ”
<Intemals\CF\Cystic Fibrosis\CF-413>
“7 stayed at my last job for 11 years because I  felt safe there, the managers 
understand my illness and numerous hospital appointments, and not many places 
would be so understanding ”
<Intemals\CF\Cystic Fibrosis\CF-418>
‘7  am too worried about changing my job in case the place I  change to is not as 
understanding as my current employers ”
<Intemals\CF\Cystic F ibrosis\CF-440>
‘7  have had a lot o f support from my friends in work so the thought o f getting a new 
job was scary. It was very hard to go back to my current job. It scared me what may 
happen ”
<Intemals\Diabetes\DI AB-514>
'‘Yes it was definitely (major life changing decision) ...because I  lost my self esteem, 
my confidence and that I  was like my own boss in a way, so it give me the self 
confidence back, the independence ...oh, definitely yea, it helped me so much... it did 
change my life definitely and made me feel whole again as a person, brought my 
confidence back, my selfesteem and my trust in people... oh yea, major influence on 
my life, yea. I  mean it has been a hard climb up this road and falling back all the time 
and all o f a sudden it's falling a part ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-46>
“Oh, yes (kept me in the same job) I  couldn ’t get on because o f my health, it was only 
as I  said when I  finished I  might finish the driving. It just, it got the pressure that my 
body couldn't take it you see. It takes every time I  put pressure on it... deliberately 
took the decision to stay in the same job...because o f limited education which was 
one, and the skin, you see when you, how can I  explain, you see when you, you got to 
keep going back younger because that’s where the problem started you see, in a 
younger age right when you were smart you lost your education, so you going to lose 
it right the way through the years ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-47>
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“Being working with same employer (different department) since leaving school as I  
feel there have been limitations on career opportunities ”
<Intemals\Rheumatology\RHEU-645>
Self employment: The decision to be or remain self employed is a great example of a 
coping strategy to live with a long term health problem. Several patients took this life 
changing decision as a planned strategy in order to be in charge of their employment, 
treatment, health and better quality of life. Being self employed they could work 
whenever they wanted (flexible hours and shorter hours) and also look after their 
health.
Patients* comments
“At age 2 7 1 went into further education to allow me to be self-employed as I  become 
unemployed by companies due to my health ”
<Intemals\Cardiology\CARD-108>
“Had to leave full-time job due to health deterioration. Decided to go self-employed 
so I  can choose my own hours according to my health ”
<Intemals\CF\Cystic Fibrosis\CF-438>
“Because I  can work my own hours. The difference is now I  do not feel guilty. I  can 
work around it, i f  i t ’s bad, much more flexibility. I  can go home and shower whenever 
I  want. I  am not tied, you know just go and put some cream on and moisturise. 
Something I  wanted to do, which I  had to do really because the last two years is 
definitely a change in treatment”
<Intemals\Interviews\Dermatology-Individual Interviews\II-08>
“I  was self-employed. That did not affect my skin at all. Because when you are self 
employed you can do things that were fine. I  could accommodate them no 
problem...so I  could come, I  think it was like three days in a week, because I  was self 
employed and they were quite accommodating, they just say come in the morning and 
have your UV light...I could manage my time better, I  could manage my treatment, I  
had UV light and o f course when you are in employment you don’t want to be leaving 
a couple o f times a week, so I  did that. The first time it was very successful and it was 
quite clear and I  really appreciated it ”
<Intemals\Interviews\Dermatology-Individual Interviews\lI-41 >
“I  am currently self-employed. I  have found it more and more difficult to carry out 
this as it makes changes in my walking/shortness o f breath ”
<Intemals\Respiratory Medicine\RESP-316>
“Decision to become self-employed and worked flexible hours, difficult to manage 
financially. Wanted to be productive and work but not able to take on full time 
employment in demanding jobs as I  had in the past”
<Intemals\Rheumatology\RHEU-607>
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“It was a fact during my decision to go freelance because it was difficult doing the 
full time job that I  was doing. I  went through a particular difficult time and the 
amount o f time I needed to spend in a day sorting my skin out, it was difficult to 
actually be full time employed. So I  went self employed because I  had a bit more 
flexibility in my working day, which allowed me to sort o f do the regime I  needed to 
do with my skin at that particular time...you are asking whether I  am worse or better 
off. It ’s difficult initially but this is a few years ago. I  have built up my work now so 
actually it has ended up being a good decision for me, but at the time it was a difficult 
decision to make ”
<Intemals\Interviews\Dermatology-Focus Group Discussion\FG-2FPl>
Not to progress further in job: Not to progress further in a job appeared to be a big 
life changing decision as patients sacrifice their promotion, possible financial 
incentives and career development to make sure their health remains in control. It is 
not an easy decision to make, in terms of keeping a balance between new employment 
roles, level of stress, increasing responsibilities and looking after their health. Patients 
also reported fear of deterioration of their health which may have resulted in rapid 
demotion. In some cases several patients even redefined their duties to allow them to 
be in a stress free position and thereby deliberately ending their chances of promotion 
or progression to a higher position. In one case, due to his skin condition, a patient 
withdrew himself from promotion as he thought that the nature of his skin condition 
(psoriasis) would make it difficult for him to be in the new and demanding position.
Patients * comments
“Didn ’t apply for promotion, I  was accommodated with reduced working hours at the 
lower level ”
<Intemals\Cardiology\CARD-l 57>
“Decided not to progress further in my job as I  felt due to illness, I  am always in and 
out o f hospital”
<Intemals\CF\Cystic Fibrosis\CF-413> 
“HR post, changed to a more clerical role by request ”
<Intemals\Diabetes\DIAB-569>
“Let me think what sort o f jobs in the past I  have done, jobs I  haven’t gone for. There 
was one recently, there was a job vacancy where I  am working and a big part o f it 
was to do with promoting a pension scheme where we are and a big part o f it is 
standing up in front doing seminars, doing presentations in front o f lots ofpeople and 
that sort o f thing... could have been a good job, yea more money, yes, yea”
<Intemals\Interviews\Dermatology-Individual Interviews\II-03>
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“In my job I did have the opportunity to sort o f go into an aspect o f another job where 
I was working with chemicals, powders and things like this you know, but I  couldn’t 
because o f the psoriasis, because it would be major irritations the psoriasis so I  
couldn7 go there and also i f  I  were going into like what we call clean areas you know 
I wouldn’t because o f flakiness and things like this wouldn 7 be able to go in there...I 
choose to stay what I  was doing, I  mean what it was, it was a further thing on in the 
same business but an advancement, so you could say really promotion better job you 
know, a different side o f the business but ...well that is right (life changing) there,
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<Internals\Interviews\Dermatology-Individual Interviews\II-44>
Not to seek employment: This important life decision is similar to “unemployment” 
or to “remain unemployed”, but due to the nature of the emerging themes and reasons 
given by patients, it was justified as a separate category under the core MLCD domain 
“job”.
Patients * comments
“Have stopped applying for jobs as always rejected due to health history”
<Intemals\Rheumatology\RHEU-632>
“Difficulties finding work. I f  you told employers you had SLE because they had not 
heard o f it there was no longer any chance ”
<Intemals\Rheumatology\RHEU-673>
“Hard to find work because o f my illness (CF) not to seek job ”
<Intemals\CF\Cystic F ibrosis\CF-439>
“I  worked in radio but after missing time I  lost my weekly slot and I  have no intention 
o f trying to return ”.
<Intemals\CF\Cystic Fibrosis\CF-490>
“Inability to gain future employment”
<Intemals\Diabetes\DI AB-578>
“Alternative employment was considered but found to be impractical, physically, 
would not like to let down employer over that ...developed my health problems so took 
that decision not to seek further employment”
<Intemals\Diabetes\DI AB-5 82>
Flexible working hours employment: Instead of routine employment hours, many 
patients decided to work flexible working hours because of their chronic disease and 
as a part of their coping strategy. This is completely different from part time 
employment as it may involve a shift pattern. Although patients felt financially 
restrained and had poor chances of promotion and career development, this important
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decision resulting directly from them having chronic condition allowed patients a 
freedom to manage their health as appropriate (hospital visits, treatment, admissions). 
Most importantly, this also kept them in employment and earning reasonable money 
allowing them to get on with their daily lives.
Patients ’ comments
“I work close to home and on flexible hours to ease my life in terms o f commuting and 
time from home, and having the flexibility to do what I  want more or less when I  
want”
<Internals\CF\Cystic Fibrosis\CF-405>
“7 have had to change my role within the police service from an active authorised 
firearm officer to an office based role with hours to suit my needs i.e. later starts ”
<Intemals\Rheumatology\RHEU-677>
“I  have decided to stay with my dad’s company as I  think it’s a lot easier than having 
to explain to other employers with regard to why I  need time off for my illness ”
<Intemals\CF\Cystic Fibrosis\CF-470>
“Unable to work a “normal” shift patron as a nurse, I  work on a shift, 2 weeks ort/2 
weeks o ff to ensure I  have 2 weeks offfor rest plus catch up on sleep ”
<Interaals\Rheumatology\RHEU-606>
Job selection: Job selection is a very critical life changing decision. The decision 
(whether right or wrong for the individual) will determine what to expect in future in 
terms of health, stress, finance and family life. Decision taking may become more 
difficult and limited when suffering from a chronic disease. Many patients reported 
that this decision was certainly life changing and was a very tricky decision to make. 
Patients * comments
“Yes in a way (psoriasis), because I  suppose all through my life I ’ve been told that I  
can ’t do certain things. Then there were physical restrictions that prevented me doing 
other things. I  suppose I ’ve always done things differently. I ’ve never done things 
conventionally. I  decided to give it a go. I  applied for it. I f  I  got it I  got it i f  I  didn’t I  
didn ’t but I  at least I  put my name there...yes, it was a big decision because it meant 
that from I  suppose again the job I  was doing was in an environment where I  always 
lived, people I  always knew. Whereas doing that training officer’s job I  would be 
meeting complete strangers from different creeds, different cultures, different 
religions etc... yea and it was a lot o f travelling because I  was doing 1500 to 2000 
miles a week. So the travelling side o f it could potentially put a lot o f pressure on my 
treatment. And it did but I  just evolved the treatment regime to accommodate that”
<Intemals\Interviews\Dermatology-Individual Interviews\II-40>
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“I explained to them about my skin and obviously what happened and they gave me a 
selection o f jobs, not really physically touching anything, I  selected the sales advisor 
in a cycle department...it is really (life changing), because i f  I  didn’t have it I ’d 
probably be still doing music right now, but I  have a lot o f options open available to 
me whether I  can go with my family business, I  can actually do a bit more o f  
(company name) cars”
<Intemals\Interviews\Dermatology-Individual Interviews\II-42>
Not to mention illness on job application: This is an unexpected life decision which 
emerged during content analysis. It may not be important for many but was a life 
changing decision for one patient following which the patient managed to obtain a 
job. This honest account from a patient of how he gave false information on a job 
application indicates how chronic diseases can change a patient’s perception, 
behaviour and attitude to focus on their health and life.
Patient comment
“Decided not to mention CF on job application because o f several previous 
complications that had resulted in me taking the interview more about the CF than the 
job and my ability to do it, and people with less experience were then given the job. 
Had to omit information about having Cystic Fibrosis from job applications in order 
to get a job ”
<Intemals\CF\Cystic Fibrosis\CF-422>
Career Choice
Patients’ major decisions related to career choice were the third most important core 
MLCD category influenced by chronic diseases (Postal survey: n=58, 22.4%; 
individual interviews: n=33, 66%; focus group discussions: Yes). In this domain, 
identified themes were grouped into 3 main categories: abandoned career plans, career 
selection and change of profession.
Abandoned career plan: Patients had to take this difficult life changing decision in 
order to select different careers or jobs which would not affect their health. Several 
patients wrongly selected their careers at the beginning but later discovered that their 
chronic conditions were preventing them from carrying on doing what they wanted to 
do as a career in their lives. Several patients abandoned their career plan and left in 
the middle of their chosen career, indicating the need to highlight this important issue
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at an early stage of a disease. This would not only save patients’ time and money, but 
also potentially prolong their good state of health.
Patients’ comments
“I did not proceed in my career as I  thought my health situation would affect future 
career goals and a full time job ”
<Internals\CF\Cystic Fibrosis\CF-403>
“7 was due to take part in an IT course in Exeter University but due to my health at 
the time I  didn’t go on it. I  might be in a different profession ”
<Intemals\CF\Cystic Fibrosis\CF-424>
“I  am now finally qualified as a holistic therapist, I  want to be able to work but 
cannot as my health has seriously decreased which, I  have no choice about ”
<Intemals\Cardiology\CARD-108>
“Career: I  am trained as a lawyer but cannot pursue this fully as long hours, stress 
affects my illness too much and this prevents me from fulfilling my full potential”
<Intemals\Diabetes\DIAB-525>
“Influenced my decision not to pursue a high level career as a company director”
<Intemals\Diabetes\DIAB-555>
“For example, you know I  may have quite liked to, I  am not saying I  would have, but 
may have quite liked to have got away from the patient’s hospital, that sort o f thing, 
maybe then some rep work or something like that, but I  knew that I  wouldn’t be able 
to do anything like that i f  I  had eczema all over my face and I  was meeting people 
and...yes, yea, its stops things at a very early stage when you, when the idea comes in 
you know, you think oh yea that might be quite a nice job, I ’d quite like to do that”
<Intemals\Interviews\Dermatology-Individual Interviews\II-24>
“Have had to reconsider my commitment to future career development due to the 
extra mental and physical stress that would cause ”
<Intemals\Rheumatology\RHEU-695>
Career selection: Career selection is clearly a difficult task, even for healthy 
individuals. Initial career selection occurs at an early stage of life where young people 
select specific educational pathways to lead to their chosen career. Career choice is 
clearly an important major life changing decision. This is not an easy decision for 
patients who suffer from long standing illness and their decision (appropriate or not)
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to choose a specific career certainly changes their lives. Those who considered their 
health and made an informed choice at an early stage reported better outcome.
“Encouraged ” by parents to go to university so that I  would be able to get a “non- 
manual jo b ”. Chose to study archaeological conservation rather than straight 
archaeology because would not be required to work outdoors in the British climate, 
as more likely to work indoors than outdoors ”
<Internals\CF\Cystic Fibrosis\CF-422>
Some patients were not aware the possibility any career associated disease 
aggravating problems such as chemicals, dust, stress or working conditions. Due to 
lack of advice and awareness, some patients selected their career incorrectly more 
than once, which they abandoned later on and unfortunately wasted time at an early 
stage of their life and career development. This also severely impacted on their health, 
families and finance.
Patients9 comments
“I  feel Marfan’s, particularly the eye problem, influenced my career choice. I  
completed teacher training but never took a teaching job partly because o f the 
problems poor eyesight caused”
<Intemals\Cardiology\CARD-l 14>
“I left school straight into YTS to become a hairdresser, had to finish before I  was 
fully qualified as the chemicals was affecting my lungs ”
<Intemals\CF\Cystic Fibrosis\CF-403
“Wanted to be a car mechanic, but due to working conditions this was not a career 
suitable for my health ”
<Intemals\CF\Cystic Fibrosis\CF-410>
“Choose to do a business degree to have a career in a stable environment i.e. office 
work as opposed to working outside ”
<Intemals\CF\Cystic Fibrosis\CF-412>
“When I  was younger (age 12 approximately) I  thought about working with horses 
but was told I  could not work with horses because o f the germs it carries and CF, so I  
changed my career plan ”
<Intemals\CF\Cystic Fibrosis\CF-417>
“In terms o f career choice I  was to be an interpreter for the deaf community. I  
developed arthritis, that put a lot o f strain on joints and muscle ”
<Intemals\CF\Cystic Fibrosis\CF-499>
“As a child I  wanted to join the army (Action Man and trucks were my favourite toys). 
Unfortunately could not join the army as I  am a diabetic. I  wanted to join the
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ambulance services as a paramedic. Surprise, surprise, cannot join the 
paramedic/ambulance service because I  am diabetic! ”
<Intemals\Diabetes\DIAB-502> 
"I was a physical education teacher. Changed subject three years into teaching”
<Internals\Diabetes\DIAB-595>
“I would have liked to go on to do cooking and that but I  couldn’t because I  knew I  
would be discriminated against...I could have gone to medical things but I  feel 
discriminated with my skin...you got to make sure that you carry gloves all the time 
and that’s worse to me because the skin opens ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-09>
“I wanted to do a degree in English literature and I  had to take sort o f a completely 
different direction because o f treatment o f psoriasis and going in to the construction 
industry and train and got to be ultimately qualified as a quality surveyor. So that was 
one o f the major effects that disease had on my intentions for further education... well, 
the opportunity wasn ’t available to me so I  didn ’t decide not to, I  just, because I  felt 
that too much time would have been lost and it was inevitable that I  had to choose 
something else... well it was something that I  certainly would have much preferred to 
study English literature and working in construction was not my first choice. It was a 
matter o f having to earn a living and get a job which would pay you know, so that was 
the reason for doing it... and by the length o f time that I  have to spend in hospital”
<Intemals\Interviews\Dermatology-Individual Interviews\II-l 8>
“One o f the major decisions that I  made as a result o f my condition, I  had for a long 
time intended to join the Royal Air Force and having spoken to a number o f friends 
who were applying slightly earlier than I  did, fortunately, started to go down that 
road. They tell me that they leave the medical examination until last and then they tell 
you i f  you have a condition such as psoriasis you are not accepted. So I  thought, well, 
save everybody’s time, I  won’t even bother to apply, which I  think to a certain extent I  
can understand the military not wanting to take on people with a medical condition, 
but I  think that the severity and extent should be taken into consideration as well and 
also the type o f job available within the military, not all o f them are dependent on 
100% physical fitness”
<Intemals\Interviews\Dermatology-Individual Interviews\II-32>
“I  suppose the other one is my psoriasis that dictated my decisions, for example, I  
couldn’t pursue the career I  wanted because I  have got psoriasis because at that 
particular time we were not accepted in the armed forces with chronic disease 
regardless what it was. I  went to university nursing, but the style o f nursing I  was able 
to do because I  was a clinical risk, was to do psychiatric...so i t’s really my skin 
dictated which career I  have followed... I  had all the qualifications, had the necessary 
skills they were looking for but when I  came for a medical I  obviously I  had over 95% 
coverage when I  came to the medical so it was highlighted really, I  was a clinical risk 
to do general medicine which I  wanted to do... yes, I ’ve not done two years and that 
was a better choice for me ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-40>
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“When I  was thinking about my profession I didn’t know what to do, I  couldn’t 
decide... Yes, but I  will say when I  was 13 and you have to make choices o f what you 
intend to do, that’s when those consideration come in. Because I  decided when a lot 
o f my friends did at that time, it was a secretarial course and I  thought I  did not know 
whether I  wanted to go in to an office...Because you would be in a skirt and a shirt, 
and I  wanted to be covered up. When you think back about those days when you 
worked at (company name) they had a uniform, they wore short sleeves and pencil 
skirts. And I knew that I  did not want to be in a pencil skirt and short sleeves top 
because o f my psoriasis. So I  did a lot o f craft things, I  love art, textiles, cooking and I  
did a lot o f those things rather than going down the academic group, I did crafts 
things because I  thought that was what I  am going to do, something along those lines 
then... done secretarial route, with my friends, because all my friends did it, I  was the 
only one who did not...I’ve gone back to it, haven’t I  because I  went and did business 
finance later. When you are older you think oh this is all ridiculous ...when I  was 131 
should have done the secretarial course which then put me in further and I  should 
have done really, then probably I  would have done business and finance when I  was 
like 16”
<Intemals\Interviews\Dermatology-Individual Interviews\II-41 > 
“The health stopped me because i t ’s stopped me from my education and it’s stopped 
me doing what I  wanted to do, see, it reverses me into another field rather then going 
from the field that I  want, you know, you want to go it’s like a tree, you wanted to go 
straight but you end up you got to be branched off, see, you got to take the 
branches...my skin always had that, what can I  say, i t’s always taken the forefront, 
whatever the decision I  have made it’s been at the forefront”
<Intemals\Interviews\Dermatology-Individual Interviews\II-47>
“Yes that was basically my mom said “ What do you want to do? ” and I  said I  would 
like to go into beauty and hairdressing but I  can’t really because all the chemicals 
they use; and my friends would go to catering you mean cheffing and at that age you 
do tend to want to go where my mates are going but I  didn ’t...I suppose in a way it’s 
not right but I  wouldn’t have been comfortable with having to say to the teacher “I  
can’t touch that, I  can’t use that, I  can’t ”...definitely for the Army (career choice) 
because it was eczema and asthma comes together and I  was like never get in. I  knew 
I  wouldn’t be able to get in ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-48>
“Lookingfor different avenues o f possibly changing my career”
<Intemals\Nephrology\NEPH-300>
“Since leaving school, as I  feel there have been limitations on career 
opportunities ...Apprehensive o f applying for different jobs due to the consciousness o f  
having a disability ”
<Internals\Rheumatology\RHEU-645>
“I  always wanted to be a police officer and I  made my decision back in the days like I  
am going through at the moment. They wear dark uniforms and they wear short sleeve 
shirts, and I  did make a conscious decision not to go for the police force. Because that
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affects me...I knew it was a career thing, I  know that I  had a problem...It knocks your 
confidence again, once you have been knocked back like that then it is not just one 
job, everything it does ”
<Internals\Interviews\Dermatology-Focus Group Discussion\FGl MP1>
“ Yeah I  had a similar experience to that. I  went to train as a nurse when I first left 
school. The type o f nursing I wanted to do was people working with mental handicap. 
So it was not a sort o f nursing where I  would have been sort o f doing washing and 
things every day but they said because I  would be having to get my hands in soap 
solutions and things they automatically turned anyone down with eczema and at that 
point I  never had eczema on my hands. So I  felt it was really unfair that they just 
didn’t really listen to what I  said about my condition. They just said we do not take 
anyone for nurse training who has eczema in this area. And I  felt quiet stigmatised. It 
had a big effect on me at that point you know...yea that’s absolutely the eczema that 
has got me, I  passed the interview, I  passed everything and the final thing on the day 
was medical and it was because o f the medical that I  could not do it...well I  think the 
choice I  made was that I  was going to stick with the career but I  was not going to 
work in a place where they were going to judge me on that. As I  said before they were 
attaching a stigma to it and I  did not really want to work in a hospital that had an 
attitude ”
<Intemals\Interviews\Dermatology-FG Discussion\FG2FP 1 >
Change o f  profession: When patients realised that their current profession is not 
suitable for them, then they had to take another life changing decision to change their 
profession. It can be a brave decision as their career opportunities remained limited 
but their decision did change their lives in a more positive way. The lesson from this 
is that taking early informed decisions is not only better for their health, but also 
better for their finance, family and quality of life.
Patients’ comments
“Turned down for nursing course due to health despite academic 
achievements ...Leaving social work practice to lecture in order to prolong career”
<Intemals\CF\Cystic Fibrosis\CF-468>
“I  started as a carpenter and now I  work in an office ”
<Intemals\CF\Cystic F ibrosis\CF -470>
‘7  am a trained physiotherapist, but due to cross infection issues I  am undertaking 
another career ”
<Intemals\CF\Cystic F ibrosis\CF -471 >
‘7  was a builder working 18 hours a day, not eating much, not really looking after my 
self. Changed then to working in kebabs and pizza house just working evening times.
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Then I am working to become a driving instructor to work my own hours, the change 
o f career is to have a better and easier life for me and the family”
<Intemals\Diabetes\DIAB-542>
“7 used to work in (company name). I  worked there for 7 years then I  changed my 
profession to be a motor mechanic because o f my health condition ”
<Intemals\Diabetes\DIAB-549>
‘7  think what major bearing the psoriasis had on my working life is that I  was given 
the advice by one employer, because I  had to take so much time off, that he advised 
me to go into the public sector where there is more job security and that's what I  
did...I certainly think I  made the right decision to go into the public sector, but that 
was then when I  was, you know, 30 years ago or more...yes...I think the guy was 
being helpful ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-l 8>
“Also I  now do work by the internet. So that is a big major life changing thing. Now 
most o f my meetings done in virtual space rather than a real space because travelling 
is a problem...So my social life is over the internet as is my business life. So there was 
a big decision I  had to make...I am a professional artist by the way that's the work I  
do now. I  also write for 4 or 5 online magazines and publications. I  was a psychiatric 
nurse... I  was studying at university. 1 gave up my job as a nurse a year before. I  did 
15 years o f nursing, psychiatry nursing became too dangerous, so I  moved on...yes I  
studied and then got a degree and then got a teaching qualification because I  wanted 
to move from nursing to teaching”
<Intemals\Interviews\Dermatology-Individual Interviews\II-30>
‘7  wanted to work but later engineering work... but all the chemicals involved I  didn’t 
know at the time my skin and I  couldn ’t do the job so it sort o f fell through...I didn’t 
start the job I  went to college for... and there was no option for me so I  thought ...yea, 
and then I  started to go to the job centre for a few years looking for jobs signing on 
the dole ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-45>
‘7  really wanted to work at the (name o f hospital) with the babies unit but due to my 
chest problem I  have to go for other jobs ”
<Intemals\Respiratory Medicine\RESP-314>
“Cannot go back to my trade as a plasterer due to muscle damage and breathing 
problems in my chest, affected my everyday life ”
<Intemals\Respiratory Medicine\RESP-399>
‘7  have pursued a second career/hobby turned career as a horse riding instructor. As 
the arthritis may progress quickly I  have rescheduled various riding exams and riding 
objectives (I have brought the schedule forward) in case the arthritis affects my 
ability to ride at a later date ”
<Intemals\Rheumatology\RHEU-635>
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“Applied to train as a nurse but due to ill health I  was unable to take the opportunity”
<IntemaIs\RheumatoIogy\RHEU-645>
Having Children
The decision to have children or not to have children was a life changing decision for 
patients who had been suffering from a chronic condition for a very long period of 
time and who had gone through various treatment options over time (Postal survey: 
n=64, 24.8%; individual interview: n= ll, 22%; focus groups discussion: No). 
Patients’ decisions were directly influenced by their health-related circumstances, 
such as affordability, genetic reasons, their health and coping with their children’s 
health and the long term nature of the treatment. This was the fourth most frequently 
mentioned MLCD. Identified themes were grouped into 4 main categories of not to 
have children, delayed plans for having children, not to have more children and 
having children through IVF treatment.
Not to have children: Not to have children is basically a conscious decision to refuse 
or not to have a family. This decision changed patients’ lives significantly perhaps 
forever. Patients were clear in their decisions on genetic, social, financial, health and 
in many cases on moral grounds. For example, to avoid having a baby who may have 
or develop the same chronic condition and not to put them in the same situation for 
the rest of their lives.
Patients’ comments
“Having a family -  the risk ofpassing on the gene is high ”
<Intemals\Cardiology\C ARD-103>
“Don’t want to feel a burden to anyone, as could not have children due to 
medications and possible complications with children ”
<Intemals\Cardiology\CARD-108>
“Decided not have children and stay on the contraceptive as I ’m worried how it will 
affect my health in the long term and the baby’s health and life ”
<Intemals\CF\Cystic Fibrosis\CF-417>
“Went for genetic counselling but decided a child would be too much for me i f  my 
health deteriorated and it would not be fair on the child i f  something happened to 
me”
<Intemals\CF\Cy stic F ibrosis\CF -418>
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“Having a child: making decisions about the moral aspects o f the chance the child 
will have the same disease, then sharing medical issues around having children ”
<Intemals\CF\Cystic Fibrosis\CF-500>
“At the moment the thought o f having children is scary as many things can go wrong. 
I  am very paranoid about getting pregnant but hopefully I  will be able to cope one 
day”
<Intemals\Diabetes\DI AB-514>
“Children: I  would like to have children, however I  feel apprehensive about the effect 
this would have on my illness and also wonder i f  I  would have enough energy to look 
after them ”
<Intemals\Diabetes\DIAB-525>
“No, we have never actually intended for children. One o f the reasons, not one, i t ’s 
certainly isn't one o f the major reasons, but one o f the reasons being psoriasis, 
because I  didn't want children, any o f my children to go through what I  had 
particularly when I  was in school. I  am not saying that was a right decision or wrong 
decision but that has always been my decision. I  would not criticise anybody for 
saying that I  am wrong because I  am certainly not saying that I  am right but that is 
how I  see the situation”
<Intemals\Interviews\Dermatology-Individual Interviews\II-32>
“First one is about children. I  decided at the age o f 13 I  wouldn’t have children. 
Because I  didn’t want a child to experience what I  experienced in my childhood, i f  
they were bullied because o f psoriasis. Although society is a bit more accepting now it 
wasn’t 30 years ago. The same experience is still there so that’s the one decision I  
made and stuck by that. My childhood was horrendous. My parents did the best they 
could do with the information they had. I  got an older brother so they, i f  I  am honest, 
I  don’t know how the hell they did it. So it wasn't a fun experience. The actual 
physical element o f it was horrendous and I  made that decision at 12...At 121 was in 
hospital with a woman who had psoriasis and she was pregnant and she was there for 
9 months, her pregnancy flared her skin so badly ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-40>
“Thought hard prior to having children, I  am still not sure i f  I  have the ability to live 
up with my young son (but does anyone!!) ”
<Intemals\Rheumatology\RHEU-611> 
“Having a child, Can’t have a child whilst I  am on medication ”
<Intemals\Rheumatology\RHEU -624> 
“In early 20 ’s decided against having children as ankylosing spondylitis is genetic ”
<Intemals\Rheumatology\RHEU-632>
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“Not just being able to just try and start a family. Having to consider the 
consequences ”
<Internals\Rheumatology\RHEU-645>
Delayed plans fo r  having children: Several patients wanted to start their family but 
they were not sure about the genetic involvement or consequences of their chronic 
condition on a baby. They consulted their doctors, geneticists, health advisors, went 
through many tests and delayed their plans to have children for their own safety and 
for the health of a new bom child. In one case the doctor’s advice turned out to be 
wrong and the baby developed the same condition as the mother had.
Patients * comments
“Deciding to have children: took genetic advice on the matter. Throughout my late 
20s I  was unsure whether to start a family and found genetic counselling put my 
issues into perspective ”
<Intemals\Cardiology\CARD-l 14>
“Discuss genetic science with doctor before having baby ”
<Intemals\CF\Cystic Fibrosis\CF-461 >
“Having a child because o f genetics, it took eight and a half years for the test and 
then having a child, it's a long process. Was told I  was fit  and well enough to go 
ahead”
<Intemals\CF\Cystic Fibrosis\CF-495> 
“I  gave serious consideration before having a child. I  delayed making a decision 
about having a child due to diabetes ”
<Intemals\Diabetes\DIAB-598>
“What happened to us when I  was trying for a child before I  had Darier’s disease, 
when I  got married I  was 21 but it took five years. Before I  had her I  said to the 
doctor when they first saw my skin problem I  said to him i f  I  have children will they 
have it? he said “99% they wouldn’t ”. I f  they said to me fifty fifty I  wouldn't have... I  
mean its effects, my daughter is quite different but she is stronger and doesn 't need to 
see the doctor. She doesn 't take medication ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-05>
“I  made an appointment with my GP and I  told him the situation. There was a 
possibility that my children will get eczema. I  do not know the percentage; the wife 
went to the family clinic and told them the situation. We read up about it...oh yes, we 
had to give a big thought about it, big. My wife went to see the midwife ...there was a 
time we thought: well i f  we end up having a child and it 's a girl with eczema as bad 
as I  got we wouldn't cope with it... we are looking at in-between anything from one 
year to two years or perhaps longer. Because it was going to see different people, 
what about our chances and different things. We were concerned about coping with a 
young baby with eczema, severe eczema. My mother must have had a dreadful time. 
Without the medication ”
114
<Intemals\Interviews\Dermatology-Individual Interviews\II-l 2>
“Having children was a definite major decision, where the disease was considered we 
always sought advice from geneticist etc, looked into it directly because o f the 
disease. So it was really up to us and then more up to me in a way whether to take the 
risk. That's how it feels. Obviously, we have decided we would have children...yea 
that changed my life, well it was the decision whether to have children or not because 
o f this disease and the risk o f passing it on to them. Once you make that decision 
that’s it and you live with that but I  mean there is nothing you could do about it. I ’ve 
taken out health insurance for my children ”
<IntemaIs\Interviews\Dermatology-Individual Interviews\II-28>
“Yea for ages about having a baby and took me a while to get pregnant and ...I 
suppose, when it was very bad its about five or six years ago, I  think I  did because I  
thought I  can’t get pregnant not having the creams I  am using at the moment, 
specially in the first trimester I  can ’t take the amount o f steroid creams that I  am 
taking and have a baby because I  was worried that its going to have effects on the 
baby ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-50>
“Will have to plan to start a family if/when the time arrives. I.e. stop taking 
medication for three months ”
<Internals\Rheumatology\RHEU-606>
Not to have more children: The decision to not to have more children was based on 
patients’ experiences with their first pregnancy, the severity of their chronic disease, 
worries about complications, concerns about looking after their health and baby at the 
same time, their finances and the potential impact on family life.
Patients * comments
“Having a second child: due to complications after the birth o f my second child I  will 
not take the risk o f a second pregnancy”
<Intemals\Cardiology\CARD-l 15> 
“Restricted family to one child due to difficulties at birth ”
<Intemals\Diabetes\DIAB-530>
“Yes, I  wanted 4 children and I  stopped at 3 because I  could not cope with anymore. 
Having had 3 kids together, being so ill after the 3rd one. After the 3rd child a big 
influence was I  had to stop breast feeding. I  breast fed  my first two children 
exclusively for 6 months but with the third one my skin was so bad I  had to stop. I  
could only breast-feed her for 6 weeks...yes, I  always thought 4 children it was such a 
perfect number in a family. I  would like to have 4 children, after having 3 children I  
was exhausted I  couldn ’t face; you know we decided not to have another one ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-06>
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“The disease has affected me because it’s stopped me working... because you want to 
fetch your children up the best you can and it’s not been. You want to give everything 
i f  you can and because we had one child we can manage to give that child everything 
but i f  you have more boys you got less money to live on. At the time when I  finished 
work, my wife was part time so she could have gone back full time but there were no 
jobs around... but years ago we did think about it to have other children but because I  
was worse than I am now. It was a case o f managing a child but trying to pick him up 
and things like that because my arthritis was quite bad at that time, now we take 
different drugs and everything I t ’s helped, its managed my arthritis much better...I 
have decided because I have finished work as well, they finished me o ff and I  couldn’t 
afford to do different things so that has changed completely then, you tend to think 
more what you going to do, how to get things. When i t ’s two parents working it’s 
always easier then to afford different things, when there is a one wage coming in it’s 
different completely ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-20>
“Another life changing decision was made in relation to the number o f children my 
husband and I  were able to have. In view o f my renal failure my husband was advised 
to have a vasectomy as any further pregnancies would have an adverse effect upon my 
severely damaged kidneys ”
<Intemals\Nephrology\NEPH-283>
“Wanted to have more children but decided not to because o f ongoing health 
problems ”
<Intemals\Respiratory Medicine\RESP-314>
“I  had only one child, not being able to cope or wanting to pass on my illness to any 
o f my children ”
<Intemals\Rheumatology\RHEU-638>
“My long-term prognosis o f psoriatic arthritis and the medication I  have been 
prescribed has meant that having any further children may not be an option. I  have 
had to make a decision to not have any more children due to the fact I  have mobility 
difficulties and problems with my hands and wrists which on occasion makes it 
difficult for me to do things for myself and my children ”
<Intemals\Rheumatology\RHEU-675>
Having children through IVF (In Vitro Fertilisation): some patients, with cystic 
fibrosis or rheumatoid arthritis decided to have children through IVF. For some 
patients IVF wasn’t successful but had provided a potential opportunity to start their 
own family. Some patients found it difficult to explain about their illness, having 
children and IVF treatment.
Patients9 comments
“Decision to have children; due to health problems, children were born via IVF 
fertility”
<Intemals\CF\Cystic Fibrosis\CF-410>
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“I have spoken to my current girlfriend about having children. It was hard to explain 
because I am infertile, but my girlfriend understands everything and in the future I  am 
hoping to have a child”
<Internals\CF\Cystic Fibrosis\CF-427>
“ We went through IVF. My husband was afraid it would shorten my life span. I  was 
concerned about the possibility o f leaving a child without a mother”
<InternaIs\CF\Cystic Fibrosis\CF-494>
“Decided to have IVF as I  have a very supportive husband, now late 30’s ”
<Intemals\Rheumatology\RHEU-632>
“Have no children. Had IVF, it wasn’t successful ”
<Intemals\Rheumatology\RHEU-655>
Relationships
The area of relationships was the fifth most affected core MLCD (Postal survey: 
n=40, 15.5%; individual interviews: n=26, 52%; focus groups discussion: No). The 
most affected MLCDs reported by patients were related to: not to become involved in 
relationships, separation, marriage and divorce. The illness of patients and its 
associated physical, social and psychological trauma were the main factors to have a 
direct impact on patients taking MLCDs differently related to relationships.
Not to become involved in relationships: Patients thought that their treatment routine 
and hospital visits might put a strain on their relationship with their partner and were 
afraid that the relationship would end if the partner found out about the implication of 
their long term health problem. Fear of rejection and lack of self confidence were the 
other factors. Some patients had concerns over their life expectancy. Some patients 
had had more than one relationship but their health problems caused separation and 
due to these bad experiences they decided not to become involved in further 
relationships. Some patients didn’t want their partners to suffer with them. Patients 
also found it difficult to explain about their disease to their partners, and for that 
reason alone, they did not want to be judged by their disease. One patient described 
this approach as a “survival reflex” to exist, indicating that choosing not to become 
involved in relationships could be a major life changing decision.
Patients* comments
“Scared o f involvement in further relationships ”
<Intemals\CF\Cystic Fibrosis\CF-407>
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“Not really ready for a relationship right now because o f health, plus I  come in 
hospital often ”
<Internals\CF\Cystic Fibrosis\CF-409> 
“I decided not to be involved in a relationship due to further health problems”
<Internals\CF\Cystic Fibrosis\CF-424>
“I decided not to get close to anyone because I don ’t want them to see me suffer and 
have o f the same worries ”
<Intemals\CF\Cystic Fibrosis\CF-443>
‘7  found it difficult to start relationships. I  hated the thought o f explaining diabetes. I  
didn’t want to be judged”
<Internals\Diabetes\DIAB-514>
“ Will not or cannot form new relationships i.e. (no partner) by-product loneliness, 
resignation that it will be what it will be, not what it should be ”
<Intemals\Diabetes\DIAB-533>
“Only just started seeing someone when my skin cleared up and before that in 4 years 
being single for 4 years and haven’t had a date or any kind o f interaction with a man 
so that was a very tough time... oh o f course (difficult decision), everybody is human 
and everybody wants to be with somebody but 4 years is a long time, but you know it’s 
taken this time... now the last two weeks I  was talking to somebody for quite a long 
time... not being with someone (was a life changing decision) oh yea o f course, you 
feel very lonely, you know, just i t’s very hard”
<Intemals\Interviews\Dermatology-Individual Interviews\II-02>
‘7  did not at the beginning when I  was younger but then I  got older, like I  said as you 
get older you sort of... I  mean I  have sort o f boyfriends but I  wouldn ’t sort of, how can 
I  say, it was always at arms length. I  wouldn’t sort o f get too involved with...because 
you always think, they probably might find somebody prettier then m e...”
<Intemals\Interviews\Dermatology-Individual Interviews\II-03>
“Similarly with relationships, you know, I  do tend to hold back rather than, you know, 
sort o f willingly going out and looking for a partner... It is just how I  have to react, 
what I  have had to develop as a way o f managing the condition... I  have described my 
approach to that as taking a “survival reflex ” in a way doing what I  have to do to 
exist or to continue ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-07>
“It wasn’t a difficult decision because o f I  was so self-conscious o f my condition I  
thought right, ok, stay in don’t go out...I have been involved in a relationship but I  
noticed that the condition got worse. I  think, le t’s say in the last 10 years or so, I  
haven ’t had a proper relationship in about 7 or 8 years ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-14>
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“Mostly with relationships; I  have not been in any long term relationships all that 
much due to when they realise that I  am suffering from eczema they don ’t want to 
know ...they could see on the face and my hands”
<Intemals\Interviews\Dermatology-Individual Interviews\II-l 6>
“I would be extremely worried i f  I  even got the slightest bit involved with somebody 
because I don’t think I could cope with that, because that would take more 
involvement in somebody just getting to know somebody...yes, because it is not just 
when somebody you know you, commit to a relationship, you meet somebody else, it’s 
not that simple. Meeting with somebody else, getting to know them, there is another 
element involved here and because I  wanted to tell somebody straightaway but I  
would also be afraid o f putting them off because I  don’t feel feminine like this at all, 
not at all ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-23>
“It stopped me having any further relationship after my marriage had broken up... I t ’s 
a battle to deal with self-confidence. Massive battle to control your self-confidence... 
no, I  don ’t think it’s fear. I  just see it as a very unsettling thing ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-29>
“Yea in my life, no relationships previously, I  don’t get close because I  don’t feel 
comfortable getting close...yea it was my decision because o f my skin condition...yea, 
I  didn’t feel confident ...it was always, not a proper relationship, no I  didn’t feel 
confident...1 wouldn’t get close enough to people, even at school level, it was kind o f 
always a barrier between me and them ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-45>
“Relationships: whilst I  have no symptoms (thankfully), I  worry about getting into a 
relationship as they would have to know about the problems with my kidneys and may 
think about me differently”
<Intemals\Nephrology\NEPH-231>
“Not in a relationship as Ifind my arthritis stops me from going out to meet people as 
I  am usually in too much pain or too tired”
<Intemals\Rheumatology\RHEU-606>
“Relationships: from meeting with friends to intimate relationships, linked as above 
to some erosion in confidence (intimate relationships especially due to changing 
body, part deformity andfear o f pain) ”
<Internals\Rheumatology\RHEU-656>
Separation: Patients took this decision because their long term illness caused so much 
stress not only for them but also for their partners. For example, extra hard work 
related to treatment (creams and lotions), washing, and frequent hospital visits caused 
a rift in their relationships. In some cases partners were psychologically unable to 
accept the chronic disease. Patients also faced problems within their families as their
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chronic disease caused a series of impacts such as not working, less money, problems 
in the family and life style which than led to a break up in relationships.
Patients’ comments
“Relationships: separated due to stress o f illness ”
<Internals\CF\Cystic Fibrosis\CF-407>
“Separation: first partner was not interested in our relationship being long term 
because o f my illness. He wanted to know if  he could catch i t”
<IntemaIs\CF\Cystic Fibrosis\CF-429>
“Part o f my health was my decision also to end my relationship ”
<Intemals\CF\Cystic Fibrosis\CF-443>
“Financially was better working as my marriage broke up 8 years ago ”
<Intemals\CF\Cystic Fibrosis\CF-455> 
“Parted from my partner 5 years ago, very upset, deep depression, can 7 trust men ”
<Intemals\Diabetes\DIAB-529> 
“Reduced working hours, got less money, caused marriage problem (separation) ”
<Intemals\Diabetes\DIAB-542>
“Oh yes, because I  couldn 7 be natural, you know, couldn 7 just do the natural thing, 
it was always a restriction on everything we did, you know. We lived together as a 
couple but then you know, working around, I  can 7 even work around my bra, or you 
know, when it comes to physical attraction, you know...it was a breakdown because 
things just weren 7 nice and I  didn 7 feel confident and comfortable enough for myself 
so obviously we couldn 7 carry on our relationship ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-02>
“Those were short terms. Some was because o f skin, my skin condition you know. 
People look at you as i f  you are dirty, that sort o f thing. There is a bit o f stigma 
against it you know. I t ’s not you got a bad kidney, it does not show, everything is 
normal. But this is all outside and people just look. I t ’s first impression, people see 
you. I f  you go for a job interview and you have eczema ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-08>
“Some o f it was because o f eczema, she was getting fed  up having to help to do my 
treatment, the bed washing, the blood and our daughter had it as well”
<Intemals\Interviews\Dermatology-Individual Interviews\II-l 0>
“I  think it would be wrong to blame the condition for all o f it. I  would say there may 
be part o f it, you know, that affected the relationship; yes...my life is smaller and
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more insular. I  go to work, come home. I  don 't go out very much so that is how life 
changed. Whereas, when I  was younger; for example, hoping that the condition will 
clear up, I was just like everybody else. To go out, have relationships, but as the 
condition worsened it definitely affected me... it was a factor because at the time I had 
to use this topical lotion which is not very nice for a girl friend or wife... it was for me, 
you know, horrible stuff, smelly and it’s disgusting. How can anybody want to even 
come and give you a hug, let alone kiss you, that sort o f thing, you know, I  opted out 
for many years, you know, and after a while it begins to build up, so you become very 
conscious o f it ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-14>
"But it happened after, as I  said to you, when I was very upset, trying to deal with it 
in the early stages last year, he just sat there and totally ignored me or I  caught him 
just looking at me and I  felt I  could have been so emotional, but I  was thinking that he 
was looking at me in disgust but he never responded to me in any way, shape or 
form ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-23>
“Emm probably, to an extent because i f  you don't feel, i f  you are never satisfied with 
your lot because the condition is an inhibiting factor, then I  think that is an impact, 
that has an impact on your decision ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-33>
"I also think that it affects everything like relationships and how you perceive and 
how you think people are going to perceive you. I  think they are not to be trusted, I  
think, you think "oh waoo ”. You might meet somebody and when you tell them, you 
have got a skin condition; you do not know how they will react. But I  met my husband 
when I  was like 15. Because he accepted it I  married him when I  was 21. But don’t 
think it was the right thing to do because we ended up splitting 10 years later. We 
were together for 10 years and I've got a son from him but I  do not think he was the 
right person to be with...I think so yes. They wouldn’t say that was the reason but I  
believe it was...I mean one in particular commented on my skin and the fact at the 
time that problem with my hip and I  explained that I  could have arthritic psoriasis. As 
I  was getting older, i t’s a consideration. I  still have a problem with it and when I  sort 
o f mentioned this and 1 discussed it with his mother. I  could see this almost like this 
women had got a problem, you know. It wasn’t too long after that we split up and I  do 
think it had a bearing”
<Intemals\Interviews\Dermatology-Individual Interviews\II-41 >
"We had ups and downs, yea definitely, I  mean especially when the kiddies were at 
home. At one stage I  did walk out with my youngest daughter you know because there 
was an argument all the time, my husband was very loud and...yea I  had to go...I 
think it was (hair problem) because I  used to think, I  used to blame him for it you see 
and then he didn 7 used to help because he used to be worrying and get stressed a lot 
and have effects on me...yes he did have an attitude at first, yea, he did. He couldn't 
cope with it, he would say oh, you know, he was panicking over it and I  said don 7 
worry about it but it started to make me feel worse then, you know...yes, he was very
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embarrassed, yea, oh somebody is coming, put your wig on. What are you wearing 
that scarffor, it looks awful, I  said I  need to wear it to give me a break for a change ”
<Internals\Interviews\Dermatology-Individual Interviews\lI-46>
Marriage: Patients either delayed their plans to get married or decided not to get 
married because of their chronic condition. One patient raised his concern regarding 
the link between marriage, illness and the level of benefits he/she could get. Patients 
were also concerned about subsequent life changing decisions, such as having 
children after the marriage, would this place on extra financial burden on the families 
having to look after their children. To avoid this situation, or due to previous bad 
experiences, they simply decided not to get married and denied themselves their right 
to experience family life. On the other hand, two patients were deliberately married to 
persons who also had the same chronic disease and found it easier to cope with their 
health conditions. Patients stated:
“And looking at who I  married, I  married someone with severe eczema, whom I  didn’t 
meet through being in the clinic or anything but I  met him socially. It was just 
something I  don't like to talk about really, because we both were being seen in the 
clinic, perhaps that was, you know, one o f the reasons we got to know each other 
better. Why we have such a good relationship because we can under stand... i f  he 
scratches I  know how he feels, I  don 7 say something that's going to hurt, I  don't say 
just stop scratching and it is the same the other way around. You know occasionally I  
say oh you wouldn't believe how bad I  feel with the itching at the minute and he says 
yes I  do and then I  realise that he does, so it takes a lot o f pressure off and it really 
really helps. In the same way i f  I  bleed on something like a cushion or something I  get 
really embarrassed. He would do the same thing why you are getting embarrassed. 
Obviously, I  like him for who he is but it does help a little bit and it makes me feel a 
bit easier in myself ’
<Intemals\Interviews\Dermatology-Individual Interviews\II-27>
“Marriage: my chosen partner also had the same diagnosis. We had a lot in common. 
We both embarked on marriage fairly late on in life ”
<Intemals\Rheumatology\RHEU-607>
Patients * comments
“Because o f CF I  am not employed, I  am on high rate benefits and would lose my 
benefit i f  I  got married and my CF would get worse ”
<Internals \CF\Cystic Fibrosis\CF441 >
“Haven 7 got married due to health condition ”
<Intemals\Cardiology\C ARD-108>
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“Married at the age o f 37 after many years deliberately, had seen father die at 42 
after heart disease (including VT) worried about dying and leaving family and 
partner i f  the condition returned”
<Internals\Cardiology\CARD-l 16> 
“Marriage: decided against marriage due to long term health problem ”
<Internals\CF\Cystic Fibrosis\CF-429>
“I mean I  have no problem talking to people. But i f  it goes further and someone wants 
to get more personal, all these questions come up and its certainly has affected things 
like relationships, because I  am less likely to get involved. I  am not ashamed or 
anything or whatever, I  think it has to be someone very very close and then I  can 
describe what is going on and hopefully she would accept the situation. I  think, that’s 
what I  am hoping. I  could imagine a situation where someone may be put off by a 
situation because they don’t understand what is going on ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-07>
“My wish was that on my wedding day, I  would like to be able to walk down the aisle 
without limping. Since my diagnosis in 2002 a course o f sulphasalazine and physio 
improved my posture significantly. Once I  was back walking again, I  decided on the 
year I  got married”
<Internals\Rheumatology\RHEU-601 >
Divorce: long term chronic disease, inability to have children due to ill health, mood 
swing and disease impact on partner and family were some of the major factors 
influencing patients’ decision to divorce. In some cases patients’ partners had 
difficulty coping with their illness and the change in the partner/husband’s behaviour 
or attitude led to divorce. One patient reported that the treatment he had, had given 
him enough confidence to go out, meet people and socialise. Although this was a 
positive result, it caused an unexpected opposite adverse impact which lead to 
divorce. The patient stated:
“/  think what I  was saying, the medication for me it maybe gave me more confidence. 
The medicine gave me more confidence because the psoriasis is being suppressed by 
the medication. Whereas, i f  I  hadn't been on medication my personality was more 
conscious o f the fact that people were looking at me, were viewing and seeing the 
effects o f the psoriasis. After the medication I  then I  suppose I  was more confident to 
enter certain social areas and that then maybe affected that (relationship). What 
happened with my wife is that we sort o f drifted apart a little bit and there were all 
sorts o f background stuff going on. I  got involved with a number ofpeople which sort 
o f fuelled the separation... and that then in some respects was part o f a number o f 
things affected (created negative impact on my relationship) yes. Because when you 
have psoriasis and you become trusted by the person you are with and then you feel 
quite not vulnerable, I  suppose. But you know from a physical point o f view maybe 
you don't feel as attracted to people, you tend to stay in close social groups ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-39>
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Patients* comments
“Divorce, results o f illness, sterility and earning powers (1993) ”
<Internals\Cardiology\CARD-126>
“My ex-husband said I  have bad mood swings due to diabetes which resulted in 
divorce ”
<Internals\Diabetes\DIAB-507>
“We have been divorced for 12 years. I  waited until my children were grown up and 
starting their own life before I  allowed myself to have a life in a way, I  don 7 know in 
what way and how it would be and psoriasis will be all over me and everything...I 
wasn 7 perfect for him. He stated that he needed a wife with perfect skin and I  wasn 7 
like that ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-l 3>
“I  wouldn 7 say it is all to do with it but it was some part, yes it was. My wife was 
agitated with my problem. Although my wife was accepting but I  couldn 7 accept it 
and I  just felt, oh I  don 7 know, I  just didn 7 feel like it anymore. I  just didn 7 want to 
go to bed... embarrassed in front o f my own wife. I  just felt this. I  just wanted to be my 
own, you know what I  mean. I  just put things off. Put blazer on, so all bits on my 
blazer. I  didn 7 want to go to anything...It was (difficult decision) yea, you know I  had 
a beautiful home, yea, big decision. I  left the house. I  just said I  didn 7 want to be in 
the marriage anymore. Bad patch, we were in separate beds ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-22>
“Divorced: The worry about the outcome o f my kidney disease has caused me 
depression issues. Therapy has cost me 13K and I  have been unable to take anti­
depressants because o f the side-effects on my kidneys. This has impacted on my 
relationships ”
<Intemals\Nephrology\NEPH-231>
“Lack ofproper sleep due to pain at night leaves me feeling very weary and fatigued 
during the day. This continual lack o f sleep impacts in the way I  interact with people 
especially people close to me, this might have been a contributing factor to my first 
marriage breakdown ”
<Intemals\Rheumatology\RHEU-612>
“My marriage ended in divorce after only 5 years. My ex-husband stated my illness 
as a big strain on our family life ”
<Intemals\Rheumatology\RHEU-615> 
“My marriage failed (divorce) mostly due to this illness and how I  dealt with it ”
<Intemals\Rheumatology\RHEU-63 8>
Education
Education related MLCDs such as those related to higher education, to leaving 
education and to the selection of an educational institute were the sixth frequently
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reported aspects reported by patients (postal survey: n=32, 12.4 %, individual 
interviews: n=22, 44%, focus groups discussion: No).
Left education: The majority of patients left education (school, college, university) 
early in order to accommodate their health, or simply because they could not cope 
with the constant nature of their ill health and increasing educational demands. They 
felt that their health directly prevented them from continuing their education. Many 
patients were aware of the consequences of this major life changing decision; 
however their health problems left no option for them but to take this difficult 
decision. Several patients wanted to gain some level of education in order to avoid 
having to do a menial job, and to earn a reasonable income with less stress, which 
they thought would be helpful in coping with their ongoing health problems. Patients 
felt they had no choice but to leave further education due to regular hospital visits and 
admissions for several weeks to months. Because of their ongoing health concerns, 
some patients developed a negative attitude towards education which led them to 
withdraw from their educational interests and eventually they discontinued their 
education. One patient described combining education and coping with ill health as “it 
was too much”, which sums up the whole story. Some patients found it difficult to 
explain their illnesses to their teachers and class fellows, which directly impacted 
their life changing decision. Embarrassment, lack of self esteem and confidence also 
contributed towards this important life changing decision. One patient reported that at 
an early age he wasn’t able to think properly and reported his decision to leave 
education as the “easy way out” and stated:
“It wasn ’t wholly because o f that but there is a part o f it because o f your confidence 
at that age, because I  would have been sixteen, seventeen then and you really don’t 
think... well that’s how I  left school, with just GCSEs. I  only know that I  had 6 GCSEs 
and I  really didn ’t know what I  wanted to do anyway. I  had the GCSEs but I  didn’t 
have any sort o f A level or degrees or anything like that. I  mean had I  progressed, I  
could have done better; I  could have had a better career you know and decided what I  
wanted to do but i t ’s a bit late now...no (not a difficult decision), because it was an 
easy way out, you know ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-03>
In a similar situation another patient admitted the importance of education at an early 
stage and stated:
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“The overall experience you know o f school with the problem. I  wasn’t focused I  
suppose because I felt a certain way so I  didn’t go to school. I  should have. So I  didn’t 
finish my education, I left it at fifteen ”
<Internals\Interviews\Dermatology-Individual Interviews\II-02>
One patient claimed that psoriasis made him “dyslexic” which also suggested how 
vital early intervention is. The patient stated:
“Yes, because I was so wrapped up in psoriasis. When I  went to high school I  still got 
the bad treatment. Nobody wanted to sit by me. So it affected me so much I  couldn’t 
write nothing, I  couldn ’t think too hard, so therefore, I  have been dyslexic but I  know 
I  could do all these things ifpsoriasis didn ’t come first in my life. I  like to shut it away 
so I can get on with my life but it stops you, it really does... the decision I  took is that I  
am so bad with psoriasis I  am not allowed to have education. I  should know my place 
in society. So it was a waste o f time even learning because I  was no good to no one, 
so gave up with it all...at school (stopped education), I  loved to be a typist but I  left 
school and let the psoriasis overtake me and I  didn’t get the education at that level 
and that is why I  didn’t go there ”
<Intemals\Interviews\Dermatology-Individual InterviewsUI-l 3>
Patients’ experiences indicate the need of awareness in this area particularly among 
young patients and their carers. Parents, clinicians and health providers need to be 
able to advise patients at an early age, guide them towards better decisions, explore 
different routes for education and for their career, which will ultimately help patients 
to take control over their health and life.
Patients ’  comments
“Education: procedures and operations, tiredness has had an impact which has left 
me under-confident to begin again at FE or HE level. Started but not complete FE”
<Intemals\Cardiology\CARD-103>
“I  left school at 16 with no qualifications due to missing most o f the final year 
because o f health problems”
<Intemals\Cardiology\C ARD-108> 
“Left school early because o f chest problems, coughing a lot mainly, did not 
particularly like school and decided not to go to school or college ”
<Intemals\CF\Cystic Fibrosis\CF-409>
“Due to spending time in hospital, o ff sick from school, Ifelt I  wasn ’t able to carry on 
to further education ”
<Intemals\CF\Cystic Fibrosis\CF-424> 
“Decided not to carry on with school because o f CF, it was too much ”
<Intemals\CF\Cystic F ibrosis\CF441 >
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“Had planed to study fine art in Goldsmith School o f Art in London (scored the 
highest A-level art mark in the country) but stayed in Cardiff as I  had just had been 
diagnosed with CF and was ill in hospital. Had to give up studying at that time as I  
had a lot to cope with my newly diagnosed illness ”
<Intemals\CF\Cystic Fibrosis\CF-457>
“Did not do further education as I become more unwell and would not be able to do 
the work I  was applying for ”
<Internals\Diabetes\DIAB-507>
“ When I  was younger I  had to come out because my eczema affected my ability to 
study, so education in one way because eczema wasn’t under control when Ifirst went 
to university. Same reasons o f not being able to do studies because o f lack o f sleep or 
basically eczema out o f control, so last thing I  wanted to do was study, because I  
didn’t sleep very well. Maybe I  was taking anti-histamines so you got over tired...if 
say, my degree you know, 1 got at 22 I ’d have been well educated and probably got a 
better job by now ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-26>
“This is one o f the reasons that I  finished school at 16 rather then going on to further 
education, because mainly o f the reaction that I  had from my peers to the 
condition... that’s correct, because o f the reaction I  had, from particularly my peers, 
while I  was in school. To be very honest I  had enough o f it...at the time I  thought it 
was an easy decision but in hindsight I  think probably was a mistake but at the age o f  
161 thought I  knew best ”
<Internals\Interviews\Dermatology-Individual Interviews\II-32>
“I  was quite ill most o f time, bad when very young and an infant, sort o f cleared up in 
mid teens, early teens, then when I  got fifteen sort o f flared up again, I  was sort o f 
bed ridden almost. So started my last schooling, my exams... missed six months o f the 
school year by the time I  could go back. It was like pretty much exam ruined...just 
back and forth to the hospital trying to get treatment, after that I  was thinking ofjust 
retaking the exam but, I  was back and forth. I  decided to just completely forget it. I  
was looking at college later on but then there was nothing really I  could sort o f go to 
college for...basically it affected my education and my confidence during school as 
well...yes, definitely (changed my life)...just a general education, when I  was looking 
for a job, so I  didn’t have the qualification, the job I  could do was factory work but in 
factory work, you are dealing with chemicals and things that my skin cannot... ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-45>
Higher education: This area reflects patients’ major decisions whether or not to gain 
a higher education at college, university or at a professional level. Many patients 
chose and planned their specific career pathways and selected a specific line of 
education so that they could eventually be in a reasonable employment in a safe 
environment suitable to managing their health problems. One patient stated:
“Choose to do a business degree to have a career in a stable environment”
<Intemals\CF\Cystic F ibrosis\CF -412>
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The involvement of the parents is also important in advising children who suffer from 
chronic illness who are about to take important life changing decisions. In the 
following quote a patient clearly stated the importance of parental advice:
“Encouraged” by parents to go to university so that I  would be able to get a “non- 
manual job ”
<IntemaIs\CF\Cystic Fibrosis\CF-422>
On the other hand, the decision to embark on higher education as an adult was also 
sometimes tough and a life changing decision. These “late” but important adult 
decisions were based on patients trying to increase their chances of having a better job 
from the point of view of their health. One patient stated:
“As a diabetic child I  missed school often, which affected my education. I  have had to 
return and undertake education as an adult to seek career opportunities ”
<Intemals\Diabetes\DIAB-502>
Another patient stated:
“Probably education, I ’ve gone back to education now as I'm currently being on 
cyclosporine and my eczema improved so back to university, I  am pleased to get back 
to university ...Whereas, I  am going back to education now, so it's kind o f back to 
where I  should have been when I  was younger, perhaps”
<Intemals\Interviews\Dermatology-Individual Interviews\II-26>
However, it is evident that to start higher education is not a straight forward decision 
when a severe disease and a constant struggle with the illness are centre stage in 
someone’s life. For example, many patients did not pursue higher education in the 
first place or left while at university, due to a constant fear of missing lectures if they 
were to become seriously ill, fear of being at the university away from home, 
concerns about continuous problems caused by travelling and study related stress.
Patients * comments
“Education: Later in life thought about university but didn’t want to stay away from 
home ”
<Intemals\CF\Cystic Fibrosis\CF-407>
“My education and decisions on my future have been heavily based on my CF. Such 
as choosing not to go to university”
<Intemals\CF\Cystic F ibrosis\CF -428>
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‘'Left university due to problems travelling and being in university”
<Internals\CF\Cystic Fibrosis\CF-486>
“ With my application to my university course I was given advice by the disability 
adviser and the course leader advised me that the course would be too difficult to 
manage with my CF. I  ignored this and went ahead with the course. In hindsight I  
think that the advisors were correct as I  am having difficulty keeping up ”
<Intemals\CF\Cystic Fibrosis\CF-492>
“ Unfortunately, I  was doing well in my course. I  was in the top 10, I  think, in my 
course but it flared up and I  had to come to hospital for 3 months so I  missed the 
crucial part o f the common foundation part o f the course. Although I  arranged my 
placements so that I  would do that in my summer breaks, the college wouldn ’t let me 
at that time. So either I  re-sat the entire year, which I  wasn’t prepared to do to be
honest, that was the 2n^  year (bloody hard), so I  came out. I  suppose that my plight 
was highlighted after I  resigned because the principal from the college came to home 
to see me, to see why I  made that decision... Because I  couldn ’t physically re-do the 
entire year yet again. I f  Fd been struggling and failed it I  could have understood that 
decision but I  passed so well even though I  was in hospital. I  was only in Cl, then, my 
friends would take the lessons and I  was back in that environment that I  was in ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-40>
“Higher education: going to university was a decision made during a temporary 
remission. I  had a major flare up in my second year and was advised by my 
consultant to take a year out and rest, I  did not, very determined to finish and gained 
a degree ”
<Internals\Rheumatology\RHEU-607>
"It is difficult to get further education as you never know how you are from day to 
day”
<Intemals\Rheumatology\RHEU-621 >
Selection o f  an educational institute: Selection of an educational institute was also a 
major life changing decision for patients. Of course, their main concern was their long 
term health problem but they had to weigh their decision between getting a better 
education from a better university or to stay closer to home for family support and to 
be under the care of familiar hospital/staff they had known from childhood.
Patients * comments
"I originally decided to go to Gloucester University but had to think o f my health and 
choose Swansea as this was closer to home and closer in case if  I  got ill”
<Intemals\CF\Cystic Fibrosis\CF-434>
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“Higher education: no relation in terms o f course but looked for a university in 
proximity to CF Unit and family support structures ”
<Intemals\CF\Cystic Fibrosis\CF-451>
“Chose to move to Chester university from home to study, but decided to keep my 
hospital in Cardiff as Ifeel comfortable here ”
<Internals\CF\Cystic Fibrosis\CF-417>
“ When I  was applying for University I  wanted to go to Bath but changed my opinion 
to Cardiff because the hospital had better facilities then Bath/Bristol”
<Intemals\CF\Cystic Fibrosis\CF-492>
“Yes. I  wanted to be a nurse... no (other choice), I  could have gone, I  had the grades 
to wherever I  wanted but to be very honest with you UHW is home to me. I ’ve spent 
more time here than I  have in my parent’s home... and I  chose UHW...because o f my 
psoriasis, because it’s safe here. It is an environment I  know. Whereas, Swansea was 
my other option or Bristol...The other choices were Bristol, Swansea and 
Birmingham. I  think it was, it is quite a long time ago now...yes (UHW) and it wasn’t 
that far away from home, i t’s only 40 miles away from home ”
<Internals\Interviews\Dermatology-Individual Interviews\II-40>
Moving abroad
The decision by patients about moving abroad was the seventh most frequently 
mentioned major life changing decision which was directly influenced by their 
chronic illnesses (Postal survey: n=35, 13.5%; individual interviews: n=16, 32%; 
focus groups discussion: No). The decision whether to move or not to move abroad 
was a life changing decision for patients but they took this decision in a practical way, 
according to their health, their individual wishes and other circumstances including 
finance, health facilities, insurance and weather. The attitude of patients and the way 
they took this important life changing decision (weighing up the pros and cons) gives 
some insight into how patients develop strategies to help them deal appropriately with 
difficult but necessary life changing situations. The following comments from several 
patients indicate that their eyes were on the future consequences of their decision; 
hence they were very keen to take the right decision for them.
Patients * comments
“I wanted to go to Spain but decided not to go because I  was unsure o f the health 
facilities ”
<Intemals\Cardiology\C ARD-106>
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“I have always wanted to move to a warmer climate (France-Cyprus) but I feel I  
would be unable to afford the health insurance or potential medical bills, which has 
prevented me from doing so ”
<Internal s\Cardiology\C ARD-108>
“ We wanted to move to the USA but due to my CF I  decided against this. Firstly due 
to the NHS here and then having to pay for insurance abroad”
<Intemals\CF\Cystic Fibrosis\CF-405>
“Country: NHS, Not going for jobs in USA/Canada because I  would have to pay 
healthcare and drugs etc ”
<Intemals\CF\Cystic Fibrosis\CF-451>
“I wanted to move to Australia but there is no NHS and I  couldn’t afford the monthly 
drugs bill. Also I  was told I  may not get a visa due to diabetes ”
<Intemals\Diabetes\DIAB-507>
“Preparing to relocate to Florida in the winter months to avoid the cold weather”
<Intemals\Diabetes\DIAB-524>
“I have toyed with the idea o f emigrating. Even went as far as to look into the diabetic 
care but decided against it”
<Intemals\Diabetes\DIAB-553>
“First thing, in about two months time, I  am moving to Spain because I  know that’s 
the only place that my skin never causes me any problems. I  know because I  lived out 
there previously and worked out there previously and it’s always cleared up and 
never had any problem at all. And then as soon as you return home it starts up again, 
so it has been in the back o f my mind since I  was a child. Even when I  used to see my 
normal doctor he was saying “the best place is for you is abroad where the sun is ”, 
so from the age o f as a teenager I  always said to myself one day I  will go and we are 
eventually moving out now next month ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-48>
“I  was planning to live abroad for 6 months o f the year after retirement but now I  
don’t choose to do so. This has altered my life ”
<Intemals\Nephrology\NEPH-270>
“Moving: also considering moving to a more agreeable climate e.g. south o f France, 
Portugal ”
<Intemals\Respiratory Medicine\RESP-336>
“Was looking at a house in Spain but dropped the idea because o f health concerns 
and health facilities abroad and health insurance ”
<Intemals\Rheumatology\RHEU-659>
“Have twice considered emigrating abroad to Australia, N  Z or Canada, but access 
to health service here with my history decided against”
<Intemals\Rheumatology\RHEU-696>
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Holidays and travelling abroad
50 years ago this may not be have been a MLCD but in today’s society yearly 
holidays (sometimes three times a year) are important events in people’s lives and any 
change may become life changing for them. Many patients reported decisions about 
holiday plans as MLCDs (Postal survey: N=39, 15.1%; individual interviews: n=5 
10%; focus groups discussion: Yes). It is obvious that when holidays and travelling 
abroad becomes a part of a culture and a way of life in a particular society, then any 
divergence or hindrance in their cultural and life style behaviour and routine could 
become a life changing situation. In the UK, people normally take at least one holiday 
per year or travel abroad for various reasons such as to meet friends and family 
overseas, job, business and for study reasons. The majority of people take this 
cultural, social or leisure freedom for granted (even though it is a recent cultural 
phenomenon) which makes it very difficult to deal with when this freedom is taken 
away by any life event, such as chronic illness.
Holidays abroad: patients were keen to go on holidays abroad but sometimes did not 
due to the severity of their long standing illness, high insurance costs or inability to 
get health insurance, fear of deterioration of their illness during holidays, treatment, 
long flights, weather, appearance, embarrassment and limited holiday choice. Two 
patients categorised this decision as” life changing” and stated:
“No holidays: life changing because o f medication and travel sickness ”
<Intemals\Diabetes\DIAB-564>
“Not being able to go for holidays for eight years is life changing”
<Intemals\Rheumatology\RHEU-659>
Another patient reported inability to holiday abroad as “a sudden change in life” and 
stated:
A holiday abroad is not possible and was a sudden change in my life, but we had to 
take this decision because o f my insulin injections (5 times a day).
<Intemals\Diabetes\DIAB-572>
Patients’ comments
“Unable to have holidays andfly abroad”
<Intemals\Cardiology\CARD-l 86>
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“It also affected my holidays as I  could not fly, down to insurance costs. Airlines were 
not accepting me so it does affect me in a lot o f my outgoing activities with my family 
holidays ”
<Internals\CF\Cystic Fibrosis\CF-403>
“Choice o f holidays are only limited due to duration, can’t enjoy long holidays 
because offear o f getting ill ”
<Internals\CF\Cystic Fibrosis\CF-407> 
“Going on holidays as travel insurance will not cover me ”
<Intemals\Diabetes\DIAB-507>
“As soon as I  board a plane my ankles swell so much I can’t get shoes on. They 
remain this way in hot climates until I  arrive home again. Hence no more holidays 
abroad”
<Intemals\Diabetes\DIAB-557>
“Yes, I  feel happy to go on holidays in this country because I  don’t have to get 
undressed, it’s so cool. End o f it. I f  I  went to Spain or, I  don’t think I  could possibly 
do that...yea (major decision)...Oh, yes (influenced by disease), definitely. I t ’s ruined 
my life, yes. People say it could be worse, could be this and that. It doesn’t matter; I  
have got my own problems. I  accept people are going to have problems, but they can 
hide that problem, but I  get up in the morning and look at the bathroom, it reminds 
me every morning. It reminds me. I  try to cover up, bit o f makeup on your hands or 
whatever with moisturiser. That can only you have...yea (difficult decision)...yea, 
appearance, yes appearance (embarrassment)...yes, that’s right, yea, I  can’t explain 
it now. When I  first had it, i t ’s like psoriasis in different places but all the places 
joined up so my whole body is more or less one psoriasis ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-22>
“It probably is yea (life changing decision) because the only holidays we go now, 
then I  am happy, i f  is we hire a private villa with a private pool... (limitation in 
holidays choice) oh yes, yea... the only thing because o f then, you know, I  got private 
pool we can enjoy the holiday facilities, you know, with the grand children, and 
because people there know my skin problem so it’s no worries for me...well, it is yea 
(costly), you can go on cheap package holidays, you know, i f  I  wasn’t able to do that, 
I  would go on all the holidays but keep my vest on you know...oh yes definitely (life 
changing decision) you know because it sort o f your holiday thing and just sort o f 
closes right down you know all the opportunity or choices you have got and become 
more restricted”
<Intemals\Interviews\Dermatology-Individual Interviews\II-44>
“Being unable to plan holidays abroad has had a major effect”
<Intemals\Nephrology\NEPH-236>
“I  choose not to holiday abroad because I  am afraid in case I  am ill when I  am away. 
This has changed my life ”
<Intemals\Nephrology\NEPH-270>
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“About 8 years ago we wanted to do holidays abroad. Due to my health I  decided not 
to go as it was too much effort and I  am afraid to fly. It has changed my life ”
<IntemaIs\Respiratory Medicine\RESP-314>
“I have found it difficult to consider holidays as it would be complicated i f  I  had an 
attack while away ”
<Internals\Rheumatology\RHEU-629>
“Well I  used to go twice a year for holidays. My wife used to come with me twice a 
year. We are not going now, so that is how it has changed my life... especially abroad, 
you can’t walk around with a long sleeves shirt and trousers. You got to go down with 
shorts or maybe a vest on top that is it the maximum, and you will be showing 
whatever is wrong with you ”
<Intemals\Interviews\Dermatology-Focus Group Discussion\FGl-MP2>
Travelling abroad: The reasons stated by patients who had decided not to go abroad 
on holidays because of their disease were similar to those stated above. They included 
for example, fear of travelling with chronic illness, severity of illness, treatment 
options abroad, high insurance cost or inability to get insurance. The influence of 
disease on job related travelling had different impacts on patients, such as financial 
implications making this impact of high importance to patients.
“I cut down going abroad to a minimum when I  was working, I  travelled to many 
foreign countries in the periodfrom 1977-1997 with my work”
<Intemals\Cardiology\CARD-l 90>
The inability to visit family members and friends was described as a heart breaking 
and a difficult life changing decision for patients.
“Not being able to visit family in Australia ”
<Intemals\CF\Cystic Fibrosis\CF-440>
“Have been unable to visit my sister in South Africa due to high insurance and 
problems with long distance flights ”
<Intemals\CF\Cystic Fibrosis\CF-479>
“I would like to travel to visit my friends and family in other countries but cannot sit 
on a plane for long and would not like to be taken ill or go into hospital abroad”
<Intemals\Rheumatology\RHEU-638>
“Unable to visit family members in Malta due to severe pain in my bones”
<Intemals\Rheumatology\RHEU-659>
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Patients ’ comments
“Would not contemplate travelling abroad with my condition ”
<Internals\Cardiology\CARD-l 13>
“For many years our hobby has been caravanning and in particular crossing over to 
Europe several times a year and visiting various countries. This stopped as I  am 
unable to travel any great distance and also not having the strength to do what I  
wanted to do ’
<Internals\Cardiology\CARD-l 34>
“It has restricted our proposed travel plans - I  no longer do long haul flights ”
<Intemals\Cardiology\CARD-166>
“I wanted to go away travelling for 6 months to 1 year but felt that, being realistic, I  
couldn Y be away for this long for several health reasons. 1. I  couldn Y carry all the 
meds 2. I  think my health would suffer being away without checkups for that long a 
period”
<Intemals\CF\Cystic Fibrosis\CF-466>
“Location: although I  would like to see more o f the world, I  feel I  need to be close to 
my family in order to receive the support I  need. This makes me very resentful o f my 
illness ”
<Intemals\Diabetes\DIAB-525>
“A change in life style: I  developed diabetes 3 years ago and continued my usual life 
style o f travelling abroad for 2 to 3 months twice per year (which we had done for the 
last 30 years) but in January 20081 decided this had to stop for me... This change o f  
life style, obviously involves my husband -the real reason why we travelled, and who, 
until the end o f2008 has paid 2 to 3 trips to US but has now decided to give this up 
because I  will not accompany him anymore, though I  have not influenced him on this 
matter”
<Intemals\Diabetes\DIAB-581 >
“Travel implication: need oxygen supply when required. Additional cost o f portable 
oxygen supply during travel e.g. flight”
<Intemals\Respiratory Medicine\RESP-313>
“Unable to stay away from home for long periods due to nervousness o f never 
knowing how I  will be attacked by the condition day to day”
<Intemals\Respiratory Medicine\RESP-392>
Housing
Decisions related to housing (buying a house or moving to another house) generally 
related to individuals’ financial situation. However, the nature of the disease and 
patients’ long standing health-related needs influenced this decision significantly
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(Postal survey: n=30, 11.6%; individual interviews: n=7, 14%; focus groups 
discussion=Yes).
Buying a house: Buying a house was a very technical decision for patients. Health 
uncertainty was directly associated with their job, level of income, insurance and 
mortgage prospects. This health, job and financial link made house buying a very 
challenging life changing decision for patients, when they had to consider all the 
aspects before taking any final decision. Life expectancy was also a big issue for 
many patients as their prognosis made it hard to get a mortgage. Patients also feared 
that deterioration in their health or their death would be “unfair” and hard on their 
partner to deal with it. One patient lost his job due to illness and ultimately lost his 
mortgage. Patients had to consider their health needs in relation to their choice of size, 
design and location of the house. Patients also paid more money just to buy a suitable 
house to accommodate their health needs, such as not buying a house if the garden 
was overlooked, because of embarrassment related to their appearance, or choosing a 
bungalow because of difficulty with stairs.
Patients9 comments
“ When buying a house with my ex-partner I  bought a house. It did not stop me but I  
was unable to get the security because o f difficulties related to insurance because o f  
my illness ”
<Intemals\CF\Cystic Fibrosis\CF-413>
“Getting a house and mortgage is something that is affected by my health as I  am 
unsure about job security and being too ill to work someday, not being able to pay 
the mortgage o f f  ’
<Intemals\CF\Cystic Fibrosis\CF-428>
“Don’t feel as though I  can take out a mortgage. In case I  leave my partner in money 
troubles i f  anything did happen ”
<Intemals\CF\Cystic Fibrosis\CF-440> 
“Purchasing a house: as I  cannot get any life insurance to pay o ff the mortgage 
(should I  die before my mortgage is paid off) because I  am diabetic!! Although I  am 
currently fit  and healthy ”
<Intemals\Diabetes\DIAB-502>
“7 tell you what I  used to look at when I  had psoriasis was whether a house had a nice 
closed garden, so nobody could see me, so I  wouldn't buy a house i f  it was 
overlooked... would never pick a house with a garden overlooked. The house I  have 
got now I  paid more for that house ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-41 >
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“The loss o f my job by talking to my manager, this resulted in not only losing my job 
but I  had a mortgage with the company ”
<Internals\Rheumatology\RHEU-673>
Moving to another house: The majority of the patients had to downsize their housing 
because of their health and other health-related factors, such as lack of finance, 
physical aspects, pollution, dust, mould, carpet, long walk to shops and accessibility 
to hospital. In some cases, for example if patients had to carry oxygen all the time or 
suffered from a rheumatological disorder, patients moved to specially adapted houses 
so that they could move around. Patients also moved house nearer to their families in 
case there was any health deterioration and they needed immediate assistance. Some 
patents also wanted to move house because of their illnesses but they were unable to 
afford it.
Patients’ comments
“lam  considering selling my house. Downsizing to ensure financial stability”
<Intemals\Cardiology\CARD-102>
“The only real change has been moving house. The previous home was too big to 
manage, garden etc. Also I  now live in an apartment with a lift, so no stairs to 
negotiate. I  am reasonably stable now ”
<Intemals\Cardiology\CARD-l 17>
“Moved house because o f CF because I  need more space for my medication, 
wheelchair and oxygen ”
<Intemals\CF\Cystic Fibrosis\CF-419>
“Moved house due to living in a damp flat which affected my chest”
<Intemals\CF\Cystic Fibrosis\CF-438>
“When I  and my mum moved house my health played a big part in the choice o f  
house, location and surrounding area e.g. main road/air quality”
<Intemals\CF\Cystic Fibrosis\CF-490> 
“Moving house to be closer to my mother because lam  having frequent hypos”
<Intemals\Diabetes\DIAB-507>
“Moved into sheltered accommodation 10 years ago, I  had difficulty looking after my 
house and garden before moving”
<Intemals\Diabetes\DIAB-551 >
“Yes, in a round about way, yes (because o f psoriasis). We are in a bungalow now. 
The arthritis I  got from psoriasis. It went so bad I  had to move...I couldn't climb 
upstairs and o f course we didn’t have a mortgage and then pressure was on (name o f 
partner) to move again because we had another mortgage to buy the bungalow which
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I  could subsidise... 10 years ago (took decision)...oh definitely (right decision)... 
(improved life) yes ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-21>
“I used to live in an old house and I  did find that it just aggravated my skin more, so 
that my house I am in now, a new house which is only 10 years old, so I  suppose that 
was something and I suppose I  wanted to move. I  don’t know, maybe we had some 
carpets rather then wood flooring and even it stays more hygienic, I  just found my 
skin much better now in the house I am in. And o f course when I  was a student in the 
halls o f residence I  didn’t live there, something to do with my skin at the time being 
quite bad”
<Intemals\Interviews\Dermatology-Individual Interviews\II-50>
“I wanted to move house but the problem with my kidneys made me not move house, 
as I was warned that I  would not be able to get another mortgage ”
<Intemals\Nephrology\NEPH-231 >
“Because o f my illness I  had to retire early aged 58. This has caused major 
implications not just health wise but has also influenced my income. Because I  cannot 
earn a living, my spending capacity is greatly affected. We would like to move but 
cannot afford to ”
<Intemals\Respiratory Medicine\RESP-356>
“Relocating to an area where stronger network o f support i.e. friends. Shared home 
with my widowedfather, mutual support”
<Intemals\Rheumatology\RHEU-607>
“Home: need to move to smaller property, can no longer manage because o f 
cleaning, etc for the size o f house I  currently occupy. My garden has suffered greatly. 
Unable to do most o f the tasks I  used to do with ease. Even watering can be just too 
tiring. Linked to above need to move, but finding it difficult to summon the energy 
neededfor this major task”
<Intemals\Rheumatology\RHEU-656>
“I had to move house 6 years ago to a house that had been semi-adapted for the 
disabled, from a house I  owned to a housing association property. As I  couldn’t 
afford the adaptations...I am going to have to move to a bungalow in a different area 
as my condition is worsening and I  need to use a wheelchair more, the housing 
association is building it especially for me and my needs ”
<Intemals\Rheumatology\RHEU-672> 
“We moved house because I  used to do the gardening and I  couldn’t do the garden 
anymore. So we did move house and bought a flat, so it would be more compact and 
stuff like that... Oh, it was a big shock; you know my husband was already made 
redundant and I  was the only earner in the house anyway. So then we took the 
decision to sell the house and get a smaller flat you know. So it was like a downsize 
type o f thing. So that we knew we could afford, do you know what I  mean. Denise 
started to come down to money then ”
<Intemals\Interviews\Dermatology-Focus Group Discussion\FGlFPl>
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Decision to change life style
A decision to change life style usually results from a history of people developing life 
style habits (such as over eating, smoking, drinking alcohol) which later may develop 
into addiction and serious health hazards. It has always proved to be very hard for 
people to change lifetime habits and any change will change their lives forever. For 
some patients, their health left no choice but to take the tough decision to quit their 
habits and addictions in order to improve their health and prolong their life (Postal 
survey: n=18, 6.9%; individual interviews: n=2, 4%; focus group discussions: No). In 
some cases the advice of doctors led patients to take this crucial decision. For 
example, patients were either warned by their doctors or they were themselves aware 
of the demands of their health to do more physical exercise, to avoid junk food and to 
quit smoking and alcohol. One patient stated:
“Once they diagnosed my diabetes, I  decided that I  had to lose weight and cut down 
on smoking and change my diet. It was a fairly hard decision to make ”
<Intemals\Diabetes\DI AB-53 8>
In some cases, due to the nature of their illnesses, diet became a complicated issue. 
For example, patients had to take a certain amount of calories in order to keep at a 
desirable weight. One patient reported:
“I have had to change my diet and life style, eat lots o f high calorie snacks/main 
meals when naturally I  would want to eat a low calorie small diet. This is a daily 
struggle and frustrating ”
<IntemaIs\CF\Cystic F ibrosis\CF-457>
Patients found it even hard to shop when they had to go through every single product 
label to read the ingredients and calorie values in order to avoid risking any health 
deterioration;
“Always having to be concerned about how much carbs are in food when I  shop...Life 
style changes to me are important as in smoking, drinking etc ”
<Intemals\Diabetes\DIAB-507>
Patients 9 comments
“I live for today not for tomorrow. I  don’t worry about bills, I  just want to enjoy my 
life with my wife and get the most out o f it...I re-thought my life style and changed 
certain hobbies. I  no longer drink and try to stick with a healthy diet ’
<Intemals\Cardiology\CARD-142>
139
“Change o f life style: adapt to do things differently ...Gave up smoking when 
diagnosed (4 years) approx ”
<Internals\Cardiology\CARD-l 57>
“My lifestyle has changed. The older I  get the more exercise I  need to do to maintain 
my health. This will be good in the long term ”
<Internals\CF\Cystic Fibrosis\CF-434>
“When I  discovered that I  had diabetes I  realised I  had to change my lifestyle, eating 
and smoking. I  was determined to improve my health ”
<Internals\Diabetes\DIAB-534>
“Changed life style, social life, eating food, drinking, nights out, sexual life and 
family life, grand children...I would like to carry on my life style, but not being able to 
due to lack o f energy to change to a healthy life style, I  have to ”
<Intemals\Diabetes\DIAB-542>
“Diabetes has changed my life style. Which I  have to do anyway because o f the illness 
and i f  I  don ’t do that, I  will be in trouble. It was very hard to stop smoking, drinking, 
etc”
<Intemals\Diabetes\DIAB-549>
“Being diagnosed this is life changing as I  have to plan visits around diabetes instead 
o f travelling, food, medication. Previously I  could travel as and when I  
wanted...Domestic life style changed as diets etc have to change to accommodate the 
new eating habits o f diabetes and meal times are less flexible. Social life changed by 
the fact that habits have to change to allow me to accommodate the diabetes 
requirements...Life changing at home, any physical activities e.g. gardening, 
decorating even playing with grand children to an extent, have to be planned to take 
into account, the need to take more foodfor energy”
<Intemals\Diabetes\DIAB-560>
“Diabetes will cause anyone to have a change o f life style because there are rules to 
be considered...Life style needs to change because o f the illness...Most people when 
confronted with the reality that they have diabetes, try to deny the fact and try to 
continue with the regimen as was normal before. The time will come when the illness 
has to be recognised and life style has to change ”
<Intemals\Diabetes\DIAB-569>
“Alcohol is bad for eczema so I  gave up alcohol at very early age...well I  suppose it 
is (life changing decision) really yea because i f  I  were able to drink alcohol without 
waking up the next day with a red face and everything else that goes with it, heated 
the blood it does, it just causes you grie f’
<Intemals\Interviews\Dermatology-Individual Interviews\II-08>
“So it's changed me what I  wear. I  decided to lose weight to see i f  that would help so I  
changed my diet totally. I  am not quite a vegetarian but I  haven't eaten red meat for 5 
years. I  gave up sugar in just about everything, not just only in tea and coffee. I  don't 
have it in food stuffs... I  gave up smoking cigarettes...well, can I  be honest, sometimes 
I  see it as a blessing as much as a curse because I  feel that i f  I  had continued as I
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was I would probably be very ill, and the fact was that because o f hidradenitis, I  gave 
up alcohol. I was a heavy drinker, very heavy drinker, seven nights a week down the 
pub. Also I  was 22 stone, now I  am 17 stone because hidradenitis, when I  read about 
it, loosing weight may help, I  lost 5 stone over two years. I  am still going down 
slowly. So those were decisions, in a way maybe hidradenitis saved my life because I  
think that weight and drinking that amount and I  smoked. I  smoked 20 -30 cigs a day ”
<Internals\Interviews\Dermatology-Individual Interviews\II-30>
“Old age and advanced stage o f decline in my lungs has caused me to make major 
decisions on how I  live my life from day to day, as from 2009forwards ’
<Intemals\Respiratory Medicine\RESP-329>
“I started running and going to the gym to strengthen my body and help it to support 
my weight...I also had to reduce my intake o f salt to counter the side effect o f the 
prednisolone ”
<Intemals\Rheumatology\RHEU-646>
Moving to another city
The decision of patients to move or not to another city was also influenced by their 
long standing health problems. Decisions were taken both to accommodate health 
issues and to improve health and quality of life in general (Postal survey: n=l 1, 4.2%; 
individual interviews: n=6, 12%; focus groups discussion: No). For example, the 
following statement from a patient indicates the nature and importance of this MLCD:
“Once I  have had my transplant I  don’t know how many quality years I  will have left. 
Therefore I  would like to move out o f the city and to the sea /coast Cornwall/Devon ”
<Intemals\Cardiology\C ARD-103>
Several patients decided not to move to another city because of the fear of changing 
hospital and quality of treatment, so they were happy where they were. One patient 
reported:
“Moving away from home: will need to move to a new clinic and surgeon to allow the 
condition to be looked after ”
<Intemals\CF\Cystic Fibrosis\CF-402>
“Avoiding moving from my house to another city because o f the excellent GP and 
hospital and friends ”
<Intemals\Diabetes\DI AB-534>
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Some patients had the chance to move to another city to follow better prospects but 
decided against it because of their job, treatment, hospital, education, family and 
support of friends.
Patients’ comments
I have had the opportunity to move to England for a job but the hassle o f moving 
doctors and hospital has put me o ff  ’
<Internals\CF\Cystic Fibrosis\CF-428>
“Long term illness affected many life decisions, moving to the area where wife 
worked as the main earner. We have moved from Lancashire to Kent and to South 
Wales. I  had very little choice to move where her work was ”
<Internals\Diabetes\DIAB-567>
“Well it has been something that would block a move abroad. For instance, I  haven't 
seriously thought about it. I  think other factors have meant that we would stay here in 
Cardiff anyway, but we thought it would be nice to move to another part o f the 
country to retire, but then you always think o f healthcare and how effective it would 
be wherever I  move ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-l 8>
“My husband and I  had been planning to move from south to mid Wales to purchase a 
business. However, I  was advised by my renal physician to remain close to my family 
as I might require their support, particularly in respect to my two children. I  followed 
their advice ”
<Intemal s\N ephrology\NEPH-283>
“Reluctant to move away from Cardiff as treatment for my condition is nearby”
<Intemals\Rheumatology\RHEU-655>
“My progressive condition played a major part in deciding to move back to Wales 
after just 40 years living and working in London. Not only nearer to family but a 
larger more convenient central flat with lift with excellent transport on the doorstep 
and all aspects o f healthcare within reach and accessible ”
<Intemals\Rheumatology\RHEU-666>
To quit professional sports
Professional sportsmen have a career and a life time hobby following retirement. 
Several patients were involved in a particular sport that they loved, competed in, 
travelled for and from which they earned respect and money. They started their 
favourite sport as a career, but their plans didn’t work out, or were interrupted because 
of their ongoing chronic health problem and they chose to quit professional sports 
(Postal survey: n=3, 1.1%; individual interviews: n=2, 4%; focus group discussions:
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No). They had to decide whether to carry on with their sport and also put a strain on 
their health or to quit professional sports to look after their health first. Some patients 
wanted to carry on but they were unable to perform to their usual level of ability due 
to the severity, unpredictability and the nature of their illness, for example the 
embarrassment of having a chronic skin disease.
Patients ’ comments
“/  think what it is competition (karate career) then and, it was so much maintenance 
to get this skin down and keep your personal hygiene as well. It was too difficult 
because o f the training, that was more use o f your feet, so that is why, the smell would 
be more...yea and then I had to stop it, because then it was too extreme... I  just 
stopped it, it had, physical block, mental block is what I  mean, when you get older 
then you don’t feel it, people say something just won V say something but when you 
are younger you don’t feel that way, put on a lot o f weight, change my life style, 
mentally and physically ...I would have been training other people. I  can see myself, 
you know, training people and be into competition ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-09>
“/  used to swim for Cardiff when I  was seventeen but I  stopped after a while when the 
disease progressed and became very noticeable, so it is really embarrassing for me ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-l 5>
“I have always played golf to a high level but now I  am considering withdrawing 
from active play, with it would go the social interaction ”
<Intemals\Respiratory Medicine\RESP-324>
Stand down from professional bodies
Taking part in regular community or association activities is a life long social practice 
for many people. Patients’ chronic diseases prevented them from taking part in these 
activities or resulted in them surrendering their positions: these were reported as being 
major life changing decisions (Postal survey: n=3, 1.1%; individual interviews: n=0; 
focus group discussions: No).
Patients’comments
“Not stand for re-election as a trustee o f a charity as it involves meetings away from 
Cardiff’
<Intemals\Cardiology\CARD-194>
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“7 was a jazz band trainer. We qualified for the world championship, but because I  
don t have a driving licence I had to give up training. Using other means o f transport 
may deteriorate my condition so I had to give up and it was a life changing decision ”
<Internals\Diabetes\DIAB-549>
“/  had to stand down from various national committees and bodies on which I 
represented the local... The major one was acting as Chaplain. I have missed out so 
much during this last year... The main reason for standing down is not being in a 
position to plan ahead with a certainty that on a given date I will be well enough to 
fulfil the promise ”
<Internals\Respiratory Medicine\RESP-329>
Major treatment decisions
Some major treatment decisions were also reported as MLCDs by patients (Postal 
survey: n=3, 1.1%; individual interviews: n=0; focus group discussions: No). For 
example, the decision to have dialysis, organ transplant or surgery could easily change 
patients’ lives forever or may provide the opportunity and hope of having some better 
quality years. The fear of major treatment complications was also in the mind of some 
patients. The impact of their illness on families, and the consideration of treatment 
timing and its impact were the most interesting aspects of this life changing decision.
Patients' comments
“Going on dialysis is life changing. It will be time consuming and the decision will be 
made although I am not looking forward to it. I  will go whenever it is necessary”
<Intemals\Nephrology\NEPH-246>
“Lung transplant, because o f my son and husband I  would go for it without a 
thought ”
<Intemals\CF\Cystic Fibrosis\CF-495>
“Surgery: decision to have both knees replaced when still relatively young is one I  
don 7 regret. For me it was about quality o f  life and made bringing up a family far 
more manageable ”
<Intemals\Rheumatology\RHEU-607>
Life style decisions reported as MLCDs
Life style decisions are based on the activities that people do and choices that people 
make on a daily basis, such as what to wear, where to go and what leisure activities to 
do. People normally take these activities for granted, and so any change in 
circumstances, such as the onset of a chronic illness, may change their life style
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choices for ever. Patients’ choices will become limited; health concerns and 
limitations may make what would normally be an undesirable option a best 
alternative, which makes it life changing for patients. These life style decisions were 
reported as MLCDs only during individual interviews and during focus group 
discussions and were not reported by patients who took part in the postal survey. The 
life style decisions such as choice of clothing (n=23, 46%), not to go swimming 
(n=17, 34%), not to socialise (n= 11, 22%) and wearing make up (n=ll, 22%) 
appeared to some patients to be more important and life changing than some of the 
other more obvious MLCDs reported by patients, such as housing, moving abroad and 
major treatment decisions.
The patients’ main concerns over choice of clothing were about the changes in type of 
clothing (cotton or nylon), style (short sleeves, long sleeves, skirts, trousers) and 
colour (light colour or dark colour). Their decision concerning swimming was related 
to public attitudes and embarrassment: they were unable to enjoy swimming with their 
children and families and when on holiday. Patients who decided not to socialise 
stopped their regular visits to the pub or social clubs and decided to stay at home in 
isolation rather than going to parties and family gatherings. Wearing make up was a 
gender specific decision, depending on the nature of the patents’ condition. Patients 
either hid their chronic skin condition under make up or they were unable to wear 
make up because of their chronic skin disease. Being unable to wear makeup shattered 
their confidence and in their opinion made them psychologically different from other 
people.
The reason why lifestyle decisions are described at the end of this content analysis is 
because these decisions are normally perceived as routine daily decisions and not as 
MLCDs. The type and the magnitude of these reported impacts of chronic disease on 
patients’ lives provide a new insight into this area. The findings clearly suggest that 
any change in normal life routine due to chronic illness or being unable to perform or 
take part to their full potential (without restriction) in these activities for a long period 
of time becomes very important and life changing for patients. Patients who reported 
these decisions as MLCDs had been suffering from chronic skin disorders for many 
years. Skin diseases impact on a variety of factors, such as, obvious aesthetic 
perceptions, embarrassment, self confidence, self-esteem, public attitude, anxiety,
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depression and treatment. All of these factors contribute to life-style decisions being 
reported as MLCDs.
The following specific examples of patients’ comments grouped under each life style 
decision explain why these decisions were major life changing decisions for some 
patients, and how their quality of life and that of their families was subsequently 
affected.
Patients* comments (Choice o f clothing)
"Yes, yea that was quite a big part actually because the acne was on my shoulders, on 
my back and on front as well, it was quite difficult to buy clothes in summer. In the 
winter it was fine but in summer and i f  you 're going to a wedding or something like 
that, you always sort o f buy things that covered half way on your arms...I mean 
choosing clothes was terrible you know (why it is life changing?) because I  mean you 
go to a function, you know a Christmas party or something like that, and it is so hard 
to buy like a dress or anything, and you turn up and you feel everybody else will be 
lovely, little dresses, little straps and you be there covering up all your shoulders and 
everything and just felt again like you didn 7 f it  in, you know, that you are different to 
everybody else because you 're wearing different things, you know, trying to cover 
yourself...yea, yea definitely (changed my life) ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-03>
"It's got to be cotton. I  cannot wear anything synthetic. I f  you wear a nice suit, its got 
to go to the cleaner the following day because o f all the grease you carry on your 
body all the time. You just got to think so much ahead all o f the time... oh yes, i f  your 
skin is bad you wear long sleeves all the time, even in summer...yes, definitely (life 
changing decision), yea because I  still think there is a stigma attached to it. I f  you are 
driving a taxi and you get people in the cab and you have eczema all over your hands, 
i f  you are not showing it, people don't know, but i f  you got a short t-shirt...of course 
you are (hiding) you know, you just do not want people to know what is wrong with 
you. You just keep covering them because it is easier to cover them than explain... it 
is the second glance, it is the looks (public attitude). My kids are fine but when their 
friends come over and I  am wearing shorts and this lad says "oh your dad looks sort 
o f alien ”. It's all the explanations. You do not want to explain to people what it is. It 
is not catching and it is not dirty. You do think about yourself. It is just constant 
because you've had it all your life, that's the way, i t ’s built into you. It is like that's 
how it is...you do it all the time, you automatically buy long sleeves because you've 
always done it. Even now my skin is not bad; I  always wear long sleeves... (changed 
my life) 100%, I  would say what you wear... i f  you go to a restaurant, I f  you've got 
short sleeves shirt on and your skin is bad at the time and you just feel uncomfortable, 
you wouldn't enjoy yourself as much as i f  you covered up. It is psychological, it is 
really. Maybe no one is looking at you but you feel they are. What you do not see, it 
does not hurt you ”
<Intemals\lnterviews\Dermatology-Individual Interviews\II-08>
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"It ’s still major now. It is very big; I  will not go to the front door i f  somebody knocks 
at the door. I  have to get the cardigan because in the house I will wear short 
sleeves... I f  he wants to go out, sort my clothes I am going to wear and I have to make 
sure that it is long sleeves. The worst time is summer because, say you go to places 
you see all these women smartly dressed, I  have always got the trousers on and I've 
always got the long sleeves top and people, say you are working, they say what have 
you got on? And you can't explain to them why you have got it on. So it is big”
<Internals\Interviews\Dermatology-Individual Interviews\lI-21 >
"You prefer to hide it because you don 7 want people to say to you; "Oh what have 
you got, what is that? ” So yea you do try to hide it, or I try and hide it...yes, it is a big 
thing; it is horrible people saying "What is that? What is that rash you have got?”... 
at the moment I  would try to cover up as much as I  could...oh yea, definitely (major 
decision), yes it was. I  never could wear what I  wanted...I don’t think there is 
anything specific, it was just I  didn’t like to wear something where everyone could see 
my eczema ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-24>
"Big major decision. Depending on the state o f my arms. Some weeks my arms are ok 
and then I can, mostly I  can ’t...well it is (major decision), you should have a choice 
over what you want to wear. You shouldn 7 be governed, you know only work really 
governs you what you wear... well it can, I  really think, one individual thing changes 
your life. I t ’s everything put from one perspective. It is constant reminders that you’ve 
got this disease...yeah, you can’t wear long sleeved shirts, and you can’t wear dark 
tops, so you can't wear anything dark on top. It's all them things mixed in that have a 
psychological effect on you. What an individual thinks will not change your life. I t ’s 
everything that has a strain and a big effect on your life ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-25>
"Oh yes, that is something I  do all the time (hiding skin). I  have a habit o f  I  always 
pull down my cuffs...no actually it is because what you are doing here is you are 
making a decision everyday o f your life not revealing yourself ...yea and it becomes a 
habit now when it is less relevant but I  still do it, it becomes a feature o f my life... oh 
yea (major decision). I  have not worn t-shirts since I  was 11 ...how has it changed 
your life? It means you are obviously more guarded, you are more cautious; you are 
less open so it changes your personality because that sort o f wanting to hide yourself 
will have an impact generally. You have people who could, i f  I  put it bluntly who 
could be ugly as sin, fa t as lard and here they are wandering around with shorts and 
you think to yourself, bloody hell i f  I  looked like that I  wouldn't do that. They are 
prepared to not conform to the, you know you got to look beautiful or whatever 
somebody, with the skin condition because i f  lets say i f  you are huge, 20 stones that is 
normal. I  don 7 think 20 stones is normal. I  mean there are big people. I f  you are a fa t 
a person you are still normal. I f  you have a skin condition you are not normal. Now 
you make a decision, you lose weight, you put on weight, whatever it is but with the 
skin condition, it is imposed upon you (long-term and ongoing), that's abnormal. It is 
an ongoing thing; it's abnormal just like I  said losing a leg is abnormal. You’re 
supposed to have two and most people have got two. In that sense you are hiding 
something that is abnormal ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-33>
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“Yea, my choice o f clothes is because o f my psoriasis...it was my life changing 
decision on my clothes and what colour I  wear. I  wear trousers and I  always cover my 
arms when 1 go out ”
<Internals\Interviews\Dermatology-Individual Interviews\lI-35>
“I always did (for 20 years) because my psoriasis was quite bad... it didn 7 boost my 
confidence to keep wearing long sleeves, tops, no, because you are always conscious 
that people are thinking that she is always in long sleeves too, she never wears short 
sleeves ”
<Intemals\Interviews\Dermatology-Individual Interviews\Il-41 >
“Aaaa that is big one (choice o f clothing). Yea I have to, i f  I  am going to wear 
something, 1 can 7 wear anything i f  it itches, you know, when you are out for shopping 
you can 7 buy certain items o f clothing... long sleeves is good to hide eczema when its 
bad, and short sleeves is good for when it’s better, because the sun is out there and 
you want to get sun on your skin...yea (always wear) to cover my skin, i f  my skin is 
bad I cover...yea God (life changing) because its just automatic to you because you 
done it since I  was a child, I  don 7 know whether it ’,s like life changing, for me, it 
is... it would be because straight away you can 7 wear what you like to wear”
<Intemals\Interviews\Dermatology-Individual Interviews\II-48>
“Aa, colour is a major thing...it's everyday, these add up to a major decision, 
everyday you’ve got to make a choice o f colour, just this is everything, that is the 
colour o f carpet in your house, colour o f your car, down to the shirt you are wearing, 
down to long sleeves, short sleeves, every single thing...It goes on too long. I t ’s over 
the period o f time, i t ’s just so massive. Previously, one o f my big decisions was 
joining the police force where I  saw short sleeves, so I  deliberately avoided it ”
<Intemals\Interviews\Dermatology-Focus Group Discussion\FGlMPl>
“Another thing, on a bus they will sit behind you and they see ”
<Intemals\Interviews\Dermatology-Focus Group Discussion\FGlMP3>
Patients * comments (Stopped swimming)
“Don’t go swimming, decided not to go swimming because o f eczema and public 
attitude ...my children want to go swimming so I  have to rely on my wife to take then. I  
can 7 have fun in the pool with them... with arthritis you need to go in the pool. So I  
can 7 go in the pool (psoriasis), I  miss the enjoyment, and being with the family. It 
does make things hard that I  can 7 go with them ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-l 0>
“From the beginning...in school...yes (major life changing)...I can't swim because o f  
it and I never took games or PT or anything like that in my school years, that was 
because o f eczema, because o f embarrassment ”
<Intemals\Interviews\Dermatology-Individual InterviewsUI-l 6>
“I had psoriasis, I  wouldn't be seen with psoriasis (stopped at the age o f 16)...oh 
definitely (major life changing decision). It has spoilt a lot o f things like with children
148
or when we go out on holidays and we go away sometimes with friends and they go 
into the Jacuzzi and things. As I  said, this weekend was a classic example, we went 
away with grand children, they were in the water, my son, daughter and grand 
children and I sit at the balcony and watched them ”
<Internals\Interviews\Dermatology-Individual Interviews\II-21>
"I used to go to the swimming pool years and years ago when I was young and when 
the psoriasis was just on my hair then, and I  used to have long hair so it wasn ’t 
visible really, but for the past 20 odd years no, never...simply because you just see 
people staring at you and talking and you know it is just not worth it. People are not 
educated enough about it...oh yes, yea (major life changing decision), that I  wouldn’t 
do that. I mean the only thing that upset me as a major life changing thing by that way 
was when the grandchildren were younger, not going to pool with them...oh, it 
affected me that way, yes definitely ”
<Intemals\Interviews\Dermatology-Individual Interviews\Il-44>
‘7  used to go to swimming lessons and thought I  would like to go again but I  got this 
problem (skin condition) and it just stopped... oh yea, definitely (major life changing 
decision), the thing you stopped doing, something you want to do...because you can't 
do it, you can’t do what normal people do. The only way would be to wear a 
swimming hat which I  don’t like to. I  mean you can still go into the water but then 
you’ve got to tape it on ”
<Internals\Interviews\Dermatology-Individual Interviews\lI-46> 
Patients* comments (Not to socialise)
“ Very much so (major decision) because I  was very outgoing when I  was younger. I  
was always going out, very social and obviously the condition changed that... all kinds 
o f ways. When I was younger I  was never at home, always out all the time... my self 
consciousness about my condition (reason)...yes, I  wouldn’t say afraid but self 
conscious, embarrassment, bit o f fear ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-14>
‘7  suffered with nerves and yea, it is (major decision) I ’d rather not bother than feel 
embarrassed with it... I  feel that people are looking at you all the time. They don’t 
know it is eczema they might think it is something else and as people are people they 
don’t understand the situation, they can be nasty...calling names and they call you 
"spotty ”, things like that and I ’d rather not go ”
<lntemals\Interviews\Dermatology-Individual Interviews\II-l 6>
"Well, yes I wouldn't wear the clothes they wore then, you know, the short skirts or 
whatever it is they wore...: It was (difficult decision) but I  think it was just part o f  
growing up and that was it...never did (go out or socialise, clubbing, pub)...Isuppose 
it was (major decision) I  just sort o f did it. It was just that, that's the way I  was and 
that was the way i t ’s going to stay ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-l 9>
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"Oh definitely (major life changing), because I  was always, like, dancing and going 
out and between my arthritis and psoriasis... ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-21>
"I haven't got one (social life)... what it is I got everything, in the last 5-6 years. I ’ve 
locked myself crway (patient crying), because with everything I  just couldn’t cope with 
life. My psoriasis was worse and I wouldn ’t go out and meet people, I wouldn't go and 
sit in the park and I have a garden and sit in the sun...yes (life changing)...yea, 
because I find it hard to socialise ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-35>
“That's yea, that is life changing because I know that because I am going through 
that now because it's all on my face. The only place I keep getting eczema, it keeps 
coming up here on my face... I  won't go out...I won't go out. There has been a few  
because I am a dancer and I  won't go. There might be social events or something, i f  
my skin is really bad I won't go ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-48>
"Most o f the time I stayed in. I  don Y go out because people are cruel, very cruel and 
most o f the time I stay in now...my hands are bad and my face, I ’d rather stay at 
home. You are tired because o f treatment three times a day, the bandages for 8 
months, so you can't plan anything really because o f all the treatment and bandages 
and rest is most important...yea (major life changing decision) because I  like meeting 
people, you know, it is not nice to be on your own. When the children grow up they go 
and...yea, my eldest does the shopping for me and her husband”
<Intemals\Interviews\Dermatology-Individual Interviews\lI-49> 
Patients* comments (Wearing make up)
"It did, yea, because it changed the social group I  was in at school. Lot o f  people 
wouldn't talk to me because I didn't want to wear makeup and they said "she is 
weird”
<IntemaIs\Interviews\Dermatology-Individual Interviews\II-27>
"Spend so much money on make up, it is ridiculous, putting it on every day, couldn Y 
leave the house without it, wouldn Y open my front door without it on...yea (major life 
changing), It was a problem with my life, yea ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-02>
"Yes and also my skin is very sensitive so I  can’t wear any makeup...yes (major 
decision not to wear make up)...on a day to day basis it doesn’t worry me 
particularly. I ’m the sort o f person who are made up all the time but I  have not worn 
make up for so many years I ’ve forgotten how it is like. It would be nice to able to use 
make up on occasions, socially or whatever ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-06>
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“I can7 wear makeup at all, which is horrific. I f  I  could find  somebody that made a 
makeup that I could wear I would be there. I cannot wear makeup and I would love to 
wear makeup...yes (major life changing decision), (emotional-crying) especially 
being a woman you need to be able to do that... (Crying) a lot. Just, like, to be 
normal ”
<Internals\Interviews\Dermatology-Individual Interviews\ll-19>
‘7  do stop and think about things now. Even i f  I open a front door I  think about how it 
might be, can I go because I haven 't my wig on. I  don 7 like to wear it in the house. 
Who will it be and what, you know, and what will the impact be. I f  it is particularly 
my son's friends...yes, I  mean I will open the door, I  just don't like the reaction o f 
shock you know, but some time the postman, I haven 7 got the time to think about that 
too much but I will open it and here I  am again dealing with that, oh shock and you 
just think “oh god”. It is completely frustrating and when this first happened I  didn 7 
have wigs and walking around town and people I  know over the years just didn 7 
recognise me, walked pass and that was incredibly difficult... ”
<Intemals\Interviews\Dermatology-Individual Interviews\II-23>
“Yes (life changing), because people wear all these things and I've always been 
afraid to use it ”
<Intemals\Interviews\Dermatology-Individual lnterviews\II-35>
“Sometimes I  have gone to my job, I  just shove the wig on and I  haven 7 got, you 
know, because I have to put pencil in my eyebrows and everything and sometimes I  
haven 7 done it but I  don 7 worry about it now. I  used to...yea (always wear make up) 
because o f my eyebrows, eyelashes have gone. Before I  didn 7 have to, you can get up 
and “oh I  can go out today without makeup, I  am just going down the road, it won 7 
matter”...ohyea (life changing decision), definitely, you can 7 be normal, my husband 
would say “hurry up”, I  said “I  have got to put my eyebrows, my eyeliners on” ...that 
gives me confidence, i f  I've not got it on it's just like a, my husband asked me to take 
him to Barry, he goes out with his mate on Friday nights and we were picking up 
friends o f ours up the road and I didn 7 realise that I  didn 7 have enough make up on 
so (name) was talking to me and I  am sort o f holding my head down and I  can 7 look 
at him because I  realised I  didn't have any make up on, I  felt embarrassed... It just 
looks horrible, you know, not like normal... well, that is yea (life changing decision), 
definitely. I f  we didn 7 have make up, I  don 7 know what we would do, you know what 
I would do... but I  often think, I  was in a car accident and I was parked in the middle 
o f the road and a car came in to the back o f me and my wig fell o ff you know, and 
then a witness saw it and he picked it up and, I  am not worried about getting hurt at 
all, I  am worried about him seeing my head and he picked it up and I  felt so 
embarrassed, he was bald anyway, but you get so worried about things like that”
<Intemals\Interviews\Dermatology-Individual Interviews\II-46>
“Yes, it is an important one; I  think because i t ’s related to my job, i f  I  have got 
eczema on my face and I  often teach and I  do presentations. I  am not going to go and 
stand up in front o f people looking like I  have got eczema. So makeup is very useful 
to me but o f course there's a pay trade o ff which is that it's actually not good for the
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skin: as soon as I get out o f the situation I  need to take it o ff Again, I  have conflicts at 
times with the professionals who would say “do not use it”. And I  say I have to i f  I  am 
going to feel confident enough to get up in front o f people and to teach and to feel that 
sense o f confidence. I  do not want to think that people are just looking at my skin 
rather than hearing what I  say ”
<Internals\Interviews\Dermatology-Focus Group Discussion\FG-2FPl>
Non MLCD issues 
Driving
Deciding not to drive has a knock on effect on other aspects of life, especially on the 
family. It makes patients more dependent, and also creates a situation that other 
people cannot be dependent. For example, in a family situation if a wife or a husband 
decides not to drive, then the burden on lifting children or going shopping falls on one 
person, impinging on other aspects of life.
A considerable number of patients reported an impact of their chronic illness on 
driving. Although they didn’t mention this as an MLCD, during content analysis it 
appeared strongly that this could be a life changing decision. It was obvious from the 
views expressed by patients that their finance, leisure, visiting family and friends, 
daily activities and overall feeling of freedom was directly connected to driving. 
Patients had to choose between surrendering their driving licence on health grounds or 
keep driving and put their and the lives of others at risk. For those patients who 
decided not to drive again on health grounds, their lives were changed in a major way. 
Several patients’ jobs were related to driving; hence giving up driving had an impact 
on their finance and family life.
Patients * comments
“Learning to drive, my eyesight was badly affected due to Marfan’s syndrome and I  
thought I  would never drive. Due to advances in eye surgery I  had operations on both 
eyes and passed my driving test ”
<Intemals\Cardiology\CARD-l 14>
“I am unable to drive my car for any distance or to enjoy a day out with my family ”
<Intemals\Cardiology\CARD-128>
“ Coping with short-notice deterioration o f my health, affecting plans such as driving 
to a destination and unable to continue/complete it in the original planned method
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(e.g. self driving, then relying on others to finish the journey, or having to use 
alternative method) ”
<Internals\CF\Cystic Fibrosis\CF-500>
‘Driving: I  have a temporary driver’s licence now because o f my diabetes ”
<IntemaIs\Diabetes\DIAB-554>
“Diabetes has restricted my driving”
<InternaI s\D iabetes\D IA B-560>
“Driving, I  am more conscious o f my blood sugar level, what I have eaten etc because 
o f diabetes ”
<Internals\Diabetes\DIAB-598> 
"Not being able to drive through lack o f confidence after many operations ”
<Intemals\NephroIogyYNEPH-203>
"Do not drive to any different places ”
<Intemals\Rhuematology\RHEU-611>
“Should I  give up driving my car: I  keep asking myself this question because car 
driving is more stressful than usual as my neck is fused? At times driving is out o f the 
question, especially when I have a bout o f iritis ”
<Intemals\Rhuematology\RHEU-612>
The following patient’s comment sums up the entire approach of this content analysis:
“Like many branches on a tree, you know, that makes up that one disease. It's very 
hard to put on one thing that's what it is, everything is involved”
<Intemals\Interviews\Dermatology-Individual Interviews\II-25>
Patients9 comments in relation to study secondary objectives
During individual interviews, along with the main research question two subsidiary 
questions were asked in relation to the secondary objectives of this study: 1) How can 
we help patients in a similar situation to you to take appropriate MLCDs? 2) What do 
you think about the idea of this study? These questions were asked at the end of each 
interview in order to obtain the patients’ suggestions about MLCD strategies and their 
views on the idea of this study. Patients’ responses were scrutinised in detail and later 
used for the development of appropriate strategies for patients to consider before any 
MLCD. Patients’ comments were as follows;
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1) How can we help patients to take appropriate MLCDs in a similar situation to 
you?
"Give them the tablet I  am now on... tried all the other treatments from the doctors 
and they were not good enough ”
<Dermatology-lndividual Interviews\lI-02>
"I think it is very good actually because i f  I  had some kind o f support in my teenage 
years when it was so bad then I probably would have been a lot more confident and 
been out there and done lots o f things you know. It is not just cosmetics, it really is 
psychological and it really does affect you and, you know, i f  they can see this that 
somebody has so bad acne they got to think that, you know, they need help ”
<Dermatology-Individua1 Interviews\lI-03>
"Don't suffer, i f  there is any way that you can't suffer, by going to the doctors or 
changing your attitudes, then do it. Always find a sense o f humour; always find  a way 
o f laughing”
<Dermatology-Individual Interviews\II-04>
"I don't know. They (doctors) do their best. It is not going to go away, is it? "
<Dermatology-Individual Interviews\II-05>
"I think everyone's circumstances and situations are different. You just have to see an 
individual, whether they can cope with illness or not ”
<Dermatology-Individual Interviews\II-06>
"Only just one small thing. You brought up the point about life changing decisions 
and this is important. I  guess, I  have based a lot o f my decisions on the fact that I  may 
never get over this. I  mean never get rid o f this condition, so therefore, I  had to think 
i f  I  stop dancing (sorry dancing, another thing), i f  I  stop sports I  can live without it 
for the rest o f my life. With partners, could I  live the rest o f my life without a partner 
and job, you know, can I  do this job for the rest o f my life? I  had to be able to think is 
this the situation that I  can sustain, not just for tomorrow but after, to look as far  
forward as possible. It is not easy to get to do that at times but yes I  have had to 
consider very long-term, assuming the worst case scenario which is that you know the 
condition would not correct itself. So that has been a major factor in my thinking. Just 
regarding decision making, I  think it would be interesting to analyze not just the 
decisions that we have made but how the decisions have been made, what I  mean is 
make decisions for physical reasons or for emotional reasons or for logical reasons. 
It just strikes me, and again it depends on the type o f person you are, but some people 
may be very emotional and therefore i f  the appearance o f their skin is more important 
to them that would affect their decisions. Some people are more logical and they think 
it does not matter that my skin looks like this, but I  have to take this decision because 
this is the logical or the right decision but some may take a random decision. It just 
strikes me that we could look further at what is the main impulse which decides the 
decision, whether the emotional, the physical, the mental or the logical. This is what I  
wanted to add”
<Dermatology-Individual Interviews\II-07>
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"It is in you already. I f  you have that personality, you will get through it no matter 
what. There is a lot o f depression that goes with eczema. Suicide as well. However, I 
do not have that mind set. I  have been built differently ...Just have to be positive. At 
the end o f the day, it is not going to kill you; you have to work around it. You have to 
get through your life around it... There are different help groups but i f  no one goes 
there then they will not be able to help... I  think i f  you catch the kids early enough and 
you are good with your school there is a difference now, you have the internet and 
can get education at home, in the 70’s we were not even given a book. These days 
they have better options to complete their studies ”
<Dermatology-Individual Interviews\II-08>
"In a similar situation, is to plug your doctor, your doctor. Tell your doctor how you 
feel because that ’s the only way I  read it. Explain how you are feeling, I  wanted to 
know if  is there anything further we can look at, like today you can do a lot but it was 
never about when we were young. But you look at general things that you could 
improve in yourself because you can. It is a hereditary gene with us; I  can see what 
my father’s like... stay positive and everything, i f  you don't think that anybody is better 
then you. You are your own individual and i f  you want something you just got to go 
for it, you just really got to go for it because you shouldn 7 be discriminated against, 
and nobody should not be discriminated”
<Dermatology-Individual Interviews\II-09>
"Don 7 be afraid to ask for help because i f  you keep it to yourself it will cause more 
animosity to yourself and it will make you feel more depressed. This will aggravate 
your eczema because you are not talking about what you need to get o ff your 
chest...Make your own decisions within what you are comfortable to make and hope 
and try to influence people and society to be more open minded. Just because you 
have a skin condition, i t ’s supposed to be an equal society today ”
<Dermatology-Individual Interviews\II-l 0>
"Talk to people about it; don’t feel embarrassed about it, I  would say. You know, 
don 7 try to hide, that’s what I  did a lot you know and i t ’s for people to come to terms 
with... I  think i f  I  had had someone to talk to, i f  you give people someone to talk to 
about it as well you know how they would feel, I  think they get on better with life as 
well, you know what I  mean. Surprising the way we hide, you hide it and nothing is 
said about it, you just keep it to yourself you know, you talk to like I  talk to my sister. I  
wasn 7 embarrassed about this and that and when you are talking I can talk to you 
about it and its not too embarrassing, but i f  I  had been able to talk about it in my 
younger years I  think it would be a lot better and I  would have had more confidence ”
<Dermatology-Individual Interviews\II-l 1>
"I think everybody should know about psoriasis and that will encourage people not to 
hide, not to think this is some disease or burden on your life. You are part o f everyday 
society like other people. I f  you got psoriasis, you just put your head up and just take 
one step forward. I f  they don 7 like you with psoriasis, time to go away. You can get 
all the help from the hospital. They are the one. You can 7 wear anything, like you can
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put gel on your head, you can7 use any shampoo, you can’t use perfumes, you can 7 
use things in the hath. That is why it is so much about your life. It is with everything 
you do, with hygiene, with anything really ...I don't think, i t ’s made me feel that I am 
there. I should be down there still. I f  I  am on my own it is ok but when I am out, I  feel 
people looking at me because they can see psoriasis. I  change my opinion o f  
everybody because I don 7 think they would like to talk to me. I  think they just want to 
talk to me because they want to see what is the matter with you. When you just go, you 
look around, who said that joke about me? You think it is in their own mind, you know 
what I  mean. They look at you and they have already judged you and you ’re scabby 
and you are no good, you are dirty ”
<Dermatology-Individual InterviewsMI-13>
“Well, for the last 20 years it has had a huge effect on every decision just about I  
think... I am aware o f it, I am the one who had to make the decisions ”
<Dermatology-Individual lnterviews\II-14>
“/  don 7 know, I  think I talked about this with my mum but I haven 7 really had to face 
many major life changing decisions yet, so I  wouldn 7 really know how older people 
with the same condition are affected and I  only know one person with the same 
condition by chance so she kind o f helped me. Talked me through things and advises 
me when doctors recommended medication. I  think people just need to try network 
and find each other, so they can share stories ”
<Dermatology-Individual InterviewsMI-15>
“Better education for people. They can understand what eczema and skin complaints 
are about and haven 7 got the attitude that it is contagious or anything like that ”
<Dermatology-Individual InterviewsMI-16>
“I don 7 know, I  just want to say that people shouldn 7 worry about these things. I  
sometimes, when I  see like people with a really bad burn and scarring and they are ok 
so why should I  worry about this. I  mean like I  have two hands and two legs, one 
brain and everything. I  mean many people don 7 have this and shouldn 7 really worry 
about this. Life is just too short”
<Dermatology-Individual InterviewsMI-17>
“No, i t ’s always been at the back o f my mind I  couldn 7 do various things because o f  
it. Because o f its limitations ”
<Dermatology-Individual InterviewsMI-18>
“You have to turn around, this is my life not theirs. This is mine and I  have what I
have and that’s it and that’s the only way it goes ”
<Dermatology-Individual InterviewsMI-19>
“I think the doctors at the moment are doing a great job. What they have done for me 
over the years has helped me to make those decisions which are got to be made ”
<Dermatology-Individual InterviewsMI-20>
“I think people need to know that it is not contagious and what is the cause...I mean 
you have campaigns o f other things on television, like cancer and how it affects your
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life... I think skin diseases are sort o f shut to the back. It doesn’t seem to be a major 
factor to people ”
<DermatoIogy-Individual Interviews\II-21 >
“7 have never gone to the alopecia society, I  think for me that is a bit denial. I  don’t 
want to admit that I  am within that group, that’s probably totally the wrong attitude. I 
still can't do that, I  don’t know why... I  do anything you know, i f  you ask me to do 
anything to help, I  would do it. When I saw (name o f specialist nurse) about my 
camouflage makeup, I went to see her about putting camouflage makeup on my 
eyebrows but it is a hassle everyday, you don’t want to wake up and have to put, your 
eye brows on to give definition but between us we looked on the internet about fake 
eye brows because I said I have to have these done and these were three hundred 
pounds, so its expensive, but we looked and she said I might be able to get some 
funding for this so I  said i t ’s not going to be any help for me, but i f  its helps one other 
person get eyebrows on the NHS, its fantastic. They might not have three hundred 
pounds to have these done ”
<Dermatology-Individual Interviews\II-23>
“Nothing I  need to say but there should be more help, the help I  have had is from my 
GP. This clinic thing is fine though. You get to visit them in 3 months. Somewhere you 
can go as a person and get some general advice. Then group sessions are essential I  
think”
<Dermatology-Individual Interviews\II-25>
“There probably does need to be yea support, I  can imagine, specially for younger 
people, teenagers, maybe through school because obviously that’s the large part o f  
somebody’s life, decision making part o f life, and so best thing you need more support 
which is not just medical, perhaps the counselling support comes along with the 
medical support. As opposed to just “creams go, away”, you know there should be 
counselling support along with it. The counselling should be the advice other than the 
medical advice, should be there along with medical advice...it could be educational 
authority, primarily it has to be health authority because that is going to be the first 
point o f contact. The first point o f contact could be a consultant or a doctor so it 
starts from there because I  seen for example a doctor more than happy to help, ask 
for help in school, then going to see doctor regularly ...when you are younger and you 
just had little experience in terms o f disease it might affect you more and make it more 
difficult to take major life changing decisions ”
<Dermatology-Individual Interviews\lI-26>
“My parents, specially my mum, is brilliant ...didn’t know about the help available to 
me specially looking back on it as a teenager...a lot o f people used to think i t ’s a burn 
and asked me i f  you have been in a fire. My mobility was very limited a lot o f times as 
a teenager. Things like disabled badges etc. I  didn’t know about it. It would have 
made a big difference. So more information would have changed...probably 
workshops or funding schemes, specially transition between living at home as a 
teenager and then living away was a big change and all the questions you can ask 
your GP is a big thing you know... I  suppose i t ’s a difficult question. I f  you have a
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long term disease getting a treatment is paramount, that influences everything else. 
Long term means you will always have this ”
<Dermatology-Individual Interviews\lI-28>
“/  think it is difficult because everyone is different and their needs would be 
different ...how you deal with your illness psychologically has an impact on your 
physical disease and that why i t ’s important for people to understand how 
somebody ’s mentality is linked to their illness. People should treat the patient not the 
person, treat the people to understand the impact o f someone’s psychological state on 
physical illness ”
<Dermatology-Individual Interviews\lI-29>
“Information, find out as much as you can about your problem, get all the 
information you can, be that from hospitals, doctors, libraries, know your illness and 
then you can fight it. “I f  you know your enemy you know your illness ” you know how 
to deal with it but for that you have to have knowledge, gaining knowledge o f your 
illness will help you take control o f your life”
<Dermatology-Individual Interviews\II-30>
“On a number o f occasions I  did seek advice but not professional advice. Advice o f  
people either I  knew professionally through my work or contacts with the psoriasis 
support group and from their experiences I  found out that i f  they did not have an 
answer for something immediately then they knew somebody who could or did have 
an answer and I found it helpful. Occasionally the advice was that decision is up to 
me. At least there was always a shoulder to cry on. This thankfully is a great 
help...yes, I  would not want to jump out o f the frying pan into the fire. Therefore, I  
thought seeking advice is better rather than just making a decision. This could be 
worse...I think that there could be better public awareness. Even though these days it 
is much better than it was before. I  still feel there is some room for an 
improvement... One example that comes to mind is better media coverage. Which I  
can appreciate is extremely expensive, but better than newspaper, television, radio 
coverage. That would be a mighty advantage to people who are potentially going 
through what I  have been through and hopefully it will stop a lot o f things that have 
happened in the past from happening in the future because the public’s attitude in 
this kind o f area is essential ”
<Dermatology-Individual Interviews\II-32>
“It isn 7 there, I  would have thought honestly when you are young, especially as a 
teenager. The very first referral I  should have had was probably to a psychologist, i f  
they know them. I  think they look at the impact it has had it on your life at that stage. 
In a sense this conversation is the first conversation I  had in my life...yes, for example 
i f  you got cancer, you have a year to live, you will certainly get them...a nurse and get 
people to try to cope, what is the difference? ...yes I  know, you could argue i t ’s worse. 
At least with dying, six months and you are gone, yes i t’s a very serious situation but 
buddy it's a hell o f  a situation i f  you’ve got 40 years ahead o f you... absolutely. I  think 
you have to deal with people‘s perception what this condition is and how it affects 
them at an early age... the one thing you can do is counselling. Problem with it is that 
it also focuses on something you might not have focused on...yes, everything has 
mental element. That should go alongside ...if you think that a pimple can have a 
massive effect on someone’s self esteem, because all o f us look in the mirror and look
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at the pimple and many people decide, particularly a girl, that they will not go out at 
night because o f that pimple. And i f  you start taking that pimple, that I ’ve got many. 
That tells you the magnitude o f the effect”
<Dermatology-Individual Interviews\II-33>
“I f  I  knew from my early age that it can influence my decisions I  probably might have 
gone for specific help. Now, I  think I  realise how important it could be. I  think it is 
very important. In my point o f view, the big issue is inside not outside, therefore, the 
psychological aspect should be considered along with other treatment. It is not 
physical disability for me but I  think it is psychological disability ”
<Dermatology-Individual InterviewsMI-34>
“I  think talking to people, somehow let people know about these kind o f studies, 
targeting people in school perhaps because they are the most affected by this, 
teenagers, so going to school, talking to people in schools about these kind o f things 
and this kind o f study really and letting people know ”
<Dermatology-Individual Interviews\II-37>
“I  don’t know, education or media for more publicity for this...there was this TV 
series and there was a detective in it, he had psoriasis so people may relate to it. I  
mean there isn’t any coverage for this on TV, there is for all other kinds o f things but 
not for this. And there is a huge number ofpeople suffering from psoriasis. I  would be 
interested in a group session, I  wonder what I  might get out o f that...I don’t know i f  I  
am consciously or sub-consciously making decisions based on just about skin ”
<Dermatology-Individual Interviews\II-39>
“I  am registered with the association. I f  somebody wants to talk to somebody else 
about their skin they can phone another sufferer, so I  put my name for that and I  had 
a couple ofpeople call... i f  you said to me 2 years ago about counselling, I  would say 
you are barking mad....yes, I  think i f  I  had it at the very first, i f  my parents had had 
that sort o f family counselling sessions when I  was younger, they would not have felt 
so guilty about it, some o f the decisions they made, I  don ’t blame them. They did the 
best thing they could do with the information they had in front o f them, but they blame 
themselves a lot and I  think I  only know...I think having counselling, I  suppose, not a 
scary thing. Americans have made counselling something more dramatic. It wasn ’t a 
pleasant experience, it wasn’t something that I  enjoyed doing, but I  think it would 
have been less traumatic for me i f  I  done it earlier. Because some other things I  was 
dealing with came up when I  was 15 or 16, so we had to cover a lot o f ground to 
understand some o f my thought processes, because I  am learning how to make friends 
at 32 years o f age, that’s quite pathetic... i t’s only now that the psychological element 
has been taken seriously. So it’s long overdue but I  think it will definitely benefit, well 
it will benefit me”
<Dermatology-Individual Interviews\II-40>
“Help from doctors, I  had a lot o f help from doctors and, like, moral support from 
your parents and school teachers, that helps a lot as well....you can’t really change 
the public’s attitude really, because people are entitled to their own opinion really... I  
mean music could do it...yea, just to show them the person with eczema could be just
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as normal and want to do just the same things as themselves, not the most pleasant 
thing to look at but I  can do as many things, as possibly for far more ”
<DermatoIogy-Individual Interviews\II-42>
“I don 7 really know because I never really looked in to any o f these associations in- 
depth. I  really couldn 7 tell you what they offer now to be honest; I  mean that’s the 
problem. 1 have had this, probably a bit daft I  am, not, you know seeking contact to 
see what they can do with regard to supporting you or advising you or whatever. So 
i t ’s difficult for me to answer that, but, I  mean, i t ’s just for me i f  anybody, any 
association or any society is going to give you any advice, it has to come not only 
from you guys, the doctors who research it, i t’s got to come from people who suffer 
with it. Because, no disrespect to anybody you know, the dermatologists here have 
been fantastic...I think yea, but I  think it got to come from both sides (doctor and 
associations). I  will go home and have a look at the internet tonight, because we have 
been talking about it, but 1 never looked into it in-depth. I think any advice or any 
information has not only to come from the medical side but i t ’s also got to be 
somebody involved in these associations somewhere that does or has suffered with it 
and is able to give you a personal reassurance. Look, you know, I  know the doctors 
are helping medically, they are helping you, you know your drug, your treatment and 
everything and they support you as much as they can, but actually “I  know what you 
are going through ” that ’s the sort o f approach you know ”
<Dermatology-Individual Interviews\II-43>
“Yes, for acceptance, so they can, there should be something like a clinic where you 
can come and i f  you like to talk, to accept the disease, you have got to, and how to get 
on with it and carry forward in society... I  think counselling at the start would be good 
because, you know, i f  you learn to accept the situation and, right, don 7 wear long 
sleeves, wear short sleeves, you know, you got it just the way you got it, tell them. And 
you know i f  you go to counselling like that, and come to terms with your condition, 
then life changing decisions that you are making in the future are not so hard because 
i f  you accept it and you sort o f go into society, you are not going to be held back by 
yourself. This is what a lot o f major decisions are altered by, your imagine what’s 
going to happen when people find out... it would be good to be warned about this 
thing, because i f  you warned them about how this is going to affect you in life, life 
changing decisions you know, may be when one o f these life changing decisions 
comes up before you, because you have been warned it’s not going to hold you back 
so much. And you think, hang on, you know I  know this, and this is how I  want to do it 
and that’s it... that’s it, yea, you know for people initially to go where they are told but 
the disease, taught the disease, taught how to accept it and what sort o f influences on 
major decisions it could have throughout your life. That would be a good thing, I  
think “therapy” I  suppose you call it...I don 7 know whether the consultant should do 
it really, I  mean it is psychiatric I  suppose...well, you don’t realise, you know, until 
you sort o f sit down and talk about it and think about it, Oh, yea, it is like the 
holidays, I  think you don 7 realise this is a major decision and o f course affects other 
people like my wife and things, my wife might want to go staying in a nice hotel and 
things like that ”
<Dermatology-Individual Interviews\II-44>
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"It is, definitely, don7 be embarrassed, its nothing to ashamed of, its not like people 
can catch it, they are scared and shy away from you, its nothing...just improve their 
(young patients) confidence, just tell them its nothing to be embarrassed of, especially 
i f  there is bullying at school, people looking at you... it would be good to advise them 
about the long term treatment plan ”
<Dermatology-Individual Interviews\II-45>
"I say “don7 isolate yourself go out there, speak to your doctor and find  out what 
help is available”, even, you know, like come here to dermatology get the help 
yourself and talk about your problems to people, family and friends, you know who 
you can trust, because its surprising who will support you out there and you won't be 
on your own, specially i f  you join Hair Line. You get these news letters coming 
through, for other people writing in their own experiences and they were cured, some 
o f them are cured... well, I  am amazed you know, because when you talk, all these 
things come out and you can7 believe over the years how many decisions you have 
made which have influenced your life, and talking about it you feel better... oh yea, it's 
self healing, talking really (very important part o f rehabilitation), heals from within, 
because you are getting rid o f your negatives and your worries and it makes you 
positive. Well a problem shared is a problem halved that's what I  say, so anybody you 
know, and don't hesitate to get in touch with anybody whose got the same problem 
and meet up with them and become friends and support each other, you know ”
<Dermatology-Individual Interviews\II-46>
‘7 would definitely recommend it (specialist school) because when I was going to 
school, you walked in a pathway like a subway and I  sat under there scratching my 
legs so badly, it was so bad. And the doctor literally had to come up from the surgery 
and pick me up. I was crying, my legs were hurting so much and I  didn’t want to go to 
the school. You know, I  really didn 7 want to go because they were so spiteful to me, 
you know. I  did not have much hair with it because my hair was quite thin on my head 
as well, so when I  did go to the school I  done really well...trying to be a bit more 
confident. I  have lost mine you know, because there is a lot going on in my life but I'm  
trying to be more confident with it”
<Dermatology-Individual Interviews\II-49>
“/  suppose to make sure that you have the best advice, medical advice you can and to 
try be referred from the GP to a dermatologist. Sometimes it takes a while because 
again they are more expert in that field and even my GP said to (name) she is not an 
expert, because o f  his age he had to be referred, which was fine, that was really 
good... I  suppose, I  would say to people trying to do what they feel to be happy and as 
long as they can get the care they need, in terms o f moving to a different city or going 
to university, getting married, as long as they got care in terms o f knowing which 
cream to use, and fo r instance, I  had a short course o f steroids when I  was getting 
married. That helped me to think, well I am not going to be left on my wedding day 
whether it is a bad flare up o f eczema, I've always got a back up plan I  suppose in 
place ”
<Dermatology-Individual Interviews\II-50>
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Identification o f key words and phrases
Various key words and phrases from the patients’ comments were also identified 
during content analysis to understand their attitude for developing strategies for 
patients in a similar situation. These are as follows:
“I was classified as disabled”, “I had no alternatives”, “I should have been working 
for another five years”, “your disease is a full time job”, “it is like a curse on me”, 
“would have to suffer”, “it was an inevitable decision”, “it is being locked away 
now”, “I had to take this decision”, “I could not look after myself’, “this has been 
hard”, “I had no option”, “my health wouldn’t let me do”, “I realised I could not 
cope”, “have no quality of life”, “I didn’t accept this”, “you react to the way other 
people perceive you”, “people bring to your face”, “I grew up thinking I was dirty”, 
“made me make a choice”, “it seems impossible”, “I could have had a nicer better 
education and decent job”, “I am still not dealing with it very well”, “I just couldn’t 
visualise”, “you have to do what you can do”, “it scared me what may happen”, “all 
of a sudden you get and its falling apart”, “I can work around it”, “it has ended up 
being a good decision for me but at the time it was a difficult decision to make”, 
“having flexibility”, “I have always done things differently”, “I might be in different 
profession”, “prevents me from fulfilling my full potential”, “had to reconsider my 
commitment”, “encouraged by parents”, “suitable for my health”, “was told”, “I knew 
I would be discriminated against”, “I wanted to do”, “I had to take”, “the opportunity 
wasn’t available for me”, “was not my first choice”, “I didn’t know what to do, I 
couldn’t decide”, “he advised me”, “thought hard”, “I gave serious consideration”, 
“once you make a decision that’s it, you have to live with that”, “It was hard to 
explain”, “it is just how I have to react”, “survival reflex”, “it was a breakdown”, 
“how you perceive and how you think people are going to perceive you”, “I couldn’t 
accept it”, “how I dealt with it”, “I could have done better”, “it was an easy way out”, 
“I couldn’t think too hard”, “it was a waste of time”, “I had enough of it”, “choose to 
do”, “so it is kind of back to where I should have been when I was younger”, “the 
course leader advised me”, “you never know how you are from day to day”, “a 
sudden change in life”, “this has changed my life”, “it was a fairly hard decision to 
make”, “This is a daily struggle and frustrating”, “I live for today not for tomorrow”.
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2) What do you think about the idea of this study?
“I think i t ’s probably a very good study, I am surprised, that there has not been more 
research. I  can imagine that the way people look is quite a major factor in their 
decision making ”
<DermatoIogy-Individual Interviews\II-04>
‘7 think it is a good idea. It is very difficult to quantify the effect on something like 
this. I t ’s probably easier to quantify the effect on somebody who suddenly gets a 
disability because you can see a before and after sort o f thing”
<Dermatology-Individual Interviews\II-06>
‘7  think it is really good; it could help people, mentally and physically because i f  you 
could see somebody else having (the same problem) too then you (could) really help 
him”
<Dermatology-Individual Interviews\II-09>
“I f  you can help people over a problem we have had by understanding how we have 
dealt with it, it would make it easier for them, and help doctors and nurses to help 
people get through a traumatic time with their eczema. There is a light at the end o f  
the tunnel and it is all for good not for bad, these are the things we tried and dealt 
with ”
<Dermatology-Individual Interviews\II-10>
“This is about getting across the message to other people, how somebody’s life is and 
has been and possibly will be in the future, hopefully ”
<Dermatology-Individual Interviews'll-16>
“I  think it will help other people, hopefully that other people will realise what you 
have gone through and they think, well you have got to take these decisions and help 
other people take them. So I  think it is a good research study. This could help other 
people who got this disease to help them realise what they can do and what they can’t 
do”
<Dermatology-Individual Interviews\II-20>
“Think i t ’s very good. I  think this study needs to be done to see how it exactly affects 
the lives o f people. As I  said, I  never realised how i t ’s affected until we spoke now ”
<Dermatology-Individual Interviews\II-21 >
“I think it is excellent. Anything, anything will do to help raise awareness and help 
people get confidence back”
<Dermatology-lndividual lnterviewsMI-23>
“It is quite interesting to see what the outcome o f it is. What you discover and what 
other people’s experiences are, you know, because I  can imagine i f  I  was in school
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with it that probably would have influenced my choice o f career more than it did 
because I was already going down that route ”
<Dermatology-Individual Interviews\ll-24>
‘7  think it is a good thing. You can develop a good reaction from it as not many 
people are involved in it, but different people comment about their lives. It can only 
be good though there is lot to learn ”
<Dermatology-Individual Interviews\II-25>
“I think it is a good study. Like I  said a normal healthy person has difficulty making 
decisions, so yea it is another aspect just another aspect o f decision making, process 
o f thinking, well can I afford to do that? Shall I move there? Or you know, i t ’s, I  have 
got to think o f my eczema as well ”
<Dermatology-Individual Interviews\II-26>
‘7  think it s a really good idea because personally I  didn 7 realise how much my 
eczema has impacted on my major life changing decisions and it really has and i f  
people can be more aware and can get more support when making life changing 
decisions then it would be brilliant ”
<Dermatology-Individual Interviews\II-27>
‘7/ ’s a great study, particularly for medical people/community. I f  there could be some 
empathy. I t ’s understanding I  suppose. I t’s important that people listen to the patient. 
This department is fine, the problem I had with management etc, was because o f a 
misunderstanding. I  was viewed as a young guy with a boil on your bum. That ’s it. 
Anything that helps decision makers. It would be good as far as I  am concerned. 
Understand why I  would have complained when I  complained etc. It was important 
for me to push for the treatment or whatever and i f  somebody could have understand 
that better that ’s going to be good thing”
<Dermatology-Individual Interviews\II-28>
“I think i ts  very important that these studies continue because the more you learn 
about what people need the better it is ”
<Dermatology-Individual Interviews\II-29>
‘7  think i t ’s very good and will be very helpful to people ”
<Dermatology-Individual Interviews\II-30>
‘7  think it is an incredible idea, it is shame really it has not happened years ago. I  
took part in it because i f  my experiences could be o f any help to anyone I ’m thankful 
for it. They may not suffer like I  have in the past. I  fully support it ”
<Dermatology-Individual Interviews\II-32>
"Anything that raises the profile o f the consequence ofpeople having a skin condition 
and for it to be taken seriously. I  think for a serious condition, like Parkinson ’s i t ’s 
more obvious and more easier for people to understand the impact, I  don 7 think 
people understand this, even though i f  you tell them what it feels like to be sore or 
itchy, all day ugly etc. They are not going to think like that. But people would imagine 
what is like with cancer because they are afraid o f it themselves ”
<Dermatology-Individual Interviews\II-33>
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“I think it is very good idea, it can widen the area which will help understand treating 
people with very long illnesses. I  think it is necessary to understand. As I said I  never 
thought about how psoriasis can impact on my life decisions. Now, I  think it is 
important because ultimately it affects other things and your life style. I f  you know 
how to deal with that sort o f things then you can do better. Yea, I know it is different 
for different people but at least it can give some idea through other's experiences in 
life ”
<Dermatology-Individual Interviews\II-34>
“It is quite good actually, it does make you really think back the things, maybe at the 
time you didn 7 think it was influenced by your skin, but deep down you know they 
were ”
<Dermatology-Individual Interviews\II-41 >
‘7  think it would be a good thing obviously for a study and I  think it would be nice for 
people to understand what it ’s like to have eczema and live with it so long”
<Dermatology-Individual Interviews\Il-42> 
“It should be sort o f warn people, anything like this ”
<Dermatology-Individual Interviews\II-44>
“For younger people i t ’s definitely a good idea ”
<Dermatology-Individual Interviews\II-45>
“Well, I  think its brilliant, because it will help you in your research and it is a 
teaching hospital and it will help the new ones coming in and the patients, so this is 
all part o f  research which can help this problem with hair loss in the long-term and 
hopefully for good”
<Dermatology-Individual Interviews\II-46>
“I think it ’s fantastic, I  was really interested in it when I  had the information in the 
post, that is why I  agreed to it. I  thought it is amazing and I  think i t’s really good”
<Dermatology-Individual Interviews\II-50>
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Part V. Development of a definition for MLCDs
One of the most fundamental aspects of the aims of this study was to understand and 
formulate a basic definition of health-related major life changing decision 
(HRMLCD). As far as it is evident from the literature there was no previous scientific 
definition available of HRMLCDs. It was necessary to develop a definition before the 
development of any measuring tool in order to ensure that items in the tool meet the 
definition of HRMLCD. Information was gathered from a total of 316 patients 
through individual interviews (n=50), postal surveys (n= 258) and focus group 
discussions (n=8), in order to be able to conceptualise and define HRMLCDs. After 
the initial data collection and its statistical and content analysis, the data was 
thoroughly reviewed again. The main conceptual points, emerging themes, influential 
factors and individual patients’ circumstances were re-examined and meticulously 
discussed in several meetings of the participating researchers (ZU Bhatti, AY Finlay 
and S Salek). Finally, the following working definition of “Health-Related-Major Life 
Changing Decision” (HRMLCD) was formulated;
“We define a “Health-Related Major Life Changing Decision” (HRMLCD) as a 
person’s decision, that is influenced by having a chronic disease, that has a 
profound long-term impact on the course of the person’s life, in the context of 
the person’s circumstances and expectations”
The term person ’s decision refers to the concept of various important decisions people 
take at different life stages and at different life events such as major decisions related 
to education, career, marriage and having a family. These are some examples of 
decisions taken at an early stage of life. The phrase influenced by having a chronic 
disease refers to the life situation where a person is suffering from a long-term health 
problem and a person has to take their illness into account when taking any decision. 
In other words their illness influenced their decisions in that the person has to 
consider their health and future consequences before taking any MLCDs. The term 
profound long term impact refers to the magnitude of the decision impact over time. 
The term course o f the person’s life encompasses the various stages of life where 
people normally face various life events and take MLCDs, such as the stages of youth,
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middle age and old age. For example, generally people take life changing decisions 
related to education and career at a young age. In middle age people normally take 
decisions related to job or marriage and in old age people take decisions related to 
retirement. Many MLCDs can occur at any stage, such as those related to 
relationships, moving abroad, travelling and housing. The phrase in the context o f the 
person’s circumstances and expectations refers to an individual’s personal situation 
(level of health, income, available medical care, family support, physical and 
psychological wellbeing, living conditions and available opportunities). The word 
expectations refer to the persons perception, beliefs and attitude towards life and their 
approach (realistic or unrealistic) to important issues in life. The phrase in the context 
o f the person’s circumstances and expectations refers to the highly subjective nature 
of these decisions as circumstances and expectations may vary from one person to 
another, and what is a minor decision to one person, may be perceived by another 
person to be a major decision.
This is the first attempt of its kind to define MLCDs. This definition was actually 
firmly derived from patients’ comments and emerged during detailed content analysis. 
The research team reviewed patients’ comments, their expectations, perception and 
reported circumstances and formulated this robust definition. It was considered 
whether or not to mention disease “negative or positive impact” in the definition. The 
researchers were agreed that this was not the prime purpose of this definition. 
Presumably mostly the impact of disease would be negative because of the onset of 
chronic disease (negative life event). It was acknowledged though that there might be 
circumstances where disease influence on a MLCD might be positive. It was also 
considered that people could make MLCDs as a result of different life events in their 
lives, not necessarily because of the co-existing chronic condition, and this could 
result in the description of a different set of MLCDs. Therefore, the position was 
adopted in making the definition, to make it clear that this definition was formulated 
only in the context of MLCD potentially influenced as a result of suffering from 
chronic disease. No examples of MLCDs were given within the definition in order to 
make it simple and more flexible.
The QoL of patients was also discussed at this stage, as it became clear that the new 
domain and definition of MLCD could substantially add to our understanding of the
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intricate subject of QoL. The acknowledgment of the impact of disease on MLCDs 
within the wider definition of HRQoL could contribute towards a closer match 
between HRQoL description and the broader life-long reality experienced by patients.
Summary
• This chapter provides information about how initial data that was collected for 
conceptualisation and development of the new scale.
• NVivo 8 qualitative software was used for managing large quantities of data 
and for content analysis.
• Three main qualitative techniques (postal survey, individual interviews and 
postal survey) were used for data collection.
• It is clear from the initial data that chronic disease can influence MLCDs.
• The initial results were presented according to specialities to provide a snap 
shot of the results, which indicate that the magnitude of the influence of 
disease on MLCDs may vary between different medical specialities due to the 
nature of the disease and particular patients’ circumstances.
• The MLCDs related to wearing make up and having children were reported 
more frequently by female patients than by male patients.
• MLCDs related to choice of clothing, stopped swimming, not to socialise and 
wearing make up were only reported by dermatology patients.
• There was a significant negative correlation between patient age and the 
number of influenced MLCDs reported by patients.
• A variety of health-related influential factors have also been indentified.
• Patients’ responses were reviewed in detail and through content analysis, main 
themes were identified, grouped under main MLCD domains and later used 
for item generation and development of the new tool.
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• 41 themes were grouped under 15 MLCDs core categories.
• Information obtained at this stage was used for the development of the MLCD 
definition and MLCD Profile.
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CHAPTER 4
Item reduction and development of 
the Major Life Changing Decisions 
Profile (MLCDP)
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INTRODUCTION
The verbatim transcripts, information and strategies on questionnaire development 
(Streiner 2003) and the Quality of Life Questionnaire Compendium (Salek 1998, 
2007) were consulted at this stage.
All themes generated at Stage 1 were analysed using qualitative techniques to reduce 
the data identified by the participants to the core items and yet retain population and 
gender specific items. After qualitative analysis, three brain storming sessions were 
carried out to develop appropriate taxonomy, rephrase items and fit them into broad 
categories or domains. Standard techniques concerning language, reading age and 
item length were applied in the development of the new tool “Major Life Changing 
Decision Profile” MLCDP (version 1).
METHODS
The following 5 steps were used for the MLCDP developmental process:
1. General check list for profile development
2. Domain generation
3. Item/statement generation
4. Item reduction
5. Development of the draft profile 
RESULTS
General check list for profile development
The use of the check list initially allowed the research team to formally think about 
what kind of questionnaire or profile should be developed. This check list (Table 4.1) 
raised very basic fundamental developmental issues which were considered in detail 
(Streiner 2003). Its use was therefore constructive in order to make sure that no vital 
technical points were overlooked during the developmental phases of the new 
instrument. For example, detailed consideration was given to type, pattern, 
communication type, length, design, structure, layout, and scale options (Table 4.1). 
This list also ensured that items/statements in the new instrument would meet 
standard developmental criteria.
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Initially the qualitative data was reviewed and discussed by the research team in order 
to form a consensus on the fundamental structural points, as given in the check list. 
Because of the ordinal nature of the data and the retrospective nature of the initial 
research question asked, the researchers agreed to develop a self-administered general 
health profile with multi-dichotomous close-ended simple statements. Agreements on 
fundamental points are identified with an asterisk (*) sign in Table 4.1. The type of 
the new instrument was kept “general” due to the nature of the data obtained from the 
patients who were from seven medical specialities and suffering from one of 28 
chronic conditions. The pattern was kept as a “profile” rather than a “questionnaire” 
because of the nature of the data. It was decided by the research team that the way 
patients responded to initial research question, each item should be constructed as a 
single statement rather than a question format in order to create spontaneity. It was 
considered important for patients to be able to demonstrate the extent to which 
different areas were affected. It was considered how the new tool would be 
administered. Consensus was reached on it to be self administered; this has the 
advantage that it could also be used for postal surveys. The length of the profile was 
not a major issue at this stage and there was no preconceived length requirement. 
General questionnaires or profiles are normally longer than disease specific ones but 
the researchers were aware that questionnaires or profiles may later go through a 
process of evolution to meet the need for a shorter format. More importance was 
given to ensuring appropriate length of the individual items/statements. Efforts were 
made to keep statements between 6 to 10 words in length so that respondents could 
easily understand and respond in the shortest possible time and thereby encourage 
spontaneity in responding. There was discussion concerning the time frame of 
statements. It was clear during these discussions that the time frame should be the life 
time of the respondent, due to the nature of the MLCD concept and the way the initial 
information had been obtained.
Domain generation
The main MLCD categories were reviewed according to the nature, type and 
percentages reported by patients. A flip chart was used for this phase to help 
understand the link between patients’ comments, the main categories and the new 
domain of MLCDs. After long discussions and deliberations among the research
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team, 15 main MLCD categories (Tables, 3.11, 3.12, and 3.13), and some individual 
items identified at stage 1, were grouped under the following six MLCD domains:
A. Education
B. Career/work
C. Family/relationships
D. Social
E. Physical
F. Major treatment decisions
Examples of the groupings of different items under these domains are given in Table 
4.2.
Table 4.1: General check list for profile development
Type
• General health measure*
• Disease specific health measure 
Pattern
• Questionnaire
• Profile*
• Index
• Inventory
Communication type
• Self-administered*
• Staff-administered
• Postal*
Length
Design/structure and lay out
• Question wording (relevant to study purpose, no ambiguity)*
• Time frame (last week, last month, last year, over a life time*)
Last week, last month, over a life time*, past* or present tense
• Question response format
Open-ended (unstructured)
Closed ended (structured)*
-Single close ended (asking age and sex etc)
-Dichotomous close-ended (Yes or No)
-Multi-dichotomous close-ended (4 or 5 choices under one 
question, it means 4 or 5 choice related questions under one 
category)*
• Ordering of question (sensitive and difficult should be put at the end)*
Type of scoring system
• Likert Scale (Bipolar), two extreme values on each end, agree or disagree
• Adjectival Scale (Unipolar), none or little at one end, maximum at the other*
• Face Scales (for under age and patients with cognitive disorders)
• VAS (Visual Analogue Scale)
Data category
• Ordinal* (required ranking) level of influence should be assigned to each item
• Nominal (Nominal doesn’t require ranking, such as eye colour etc)
♦Agreements on fundamental points
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Table 4.2: MLCD domains with relevant categories
A. Education
Education
B. Career/Work
Career choice 
Early retirement 
Job
Professional bodies 
Professional sports
C. Family/Relationships
Having children 
Relationships
D. Social
Lifestyle (smoking, drinking alcohol)
Holidays/travel abroad 
Housing 
Move abroad 
Move city 
Clothing 
Swimming 
Not socialise 
Make up
E. Physical
Sports
Driving
F. Major treatment decisions
Dialysis
Organ transplant
_______Surgery_________________________________________________________
Item/Statement generation
The verbatim transcription of the patient interviews and survey responses were 
consulted during each item generation. Patients’ comments were reviewed and 
discussed in the context of the main categories and MLCD domains to formulate 
appropriate and relevant statements. Core MLCD domains and statements were 
arranged in a logical way to reflect life stages or in the sequence of life activities. 
Items were kept as short as possible. The majority of the statements were constructed 
using between 6 to 10 words and there were only two statements with 11 words. Also, 
double barrelled questions were avoided; asking two things in one question is not 
only difficult for patients and for analysis but also may create confusion over to 
which aspect the response refers. For complex MLCDs, such as life style decisions, 
examples from patients’ quotations were used for guidance in order to avoid double 
barrelled statements. Statements were specifically phrased in the past tense (covering
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the whole life) to guide and instinctively remind patients to look back over their lives 
and answer whether or not their chronic disease had influenced any important and 
major life changing decisions.
Each item should correspond to its core MLCD domain and statements should be 
designed to be clear to respondents rather than to researchers. Therefore, “key words” 
related to MLCD themes such as career choice, job selection, early retirement, having 
children, marriage, divorce, separation, moving abroad were included in each 
statement to direct patients to think about more specific aspects of MLCDs, in order 
to encourage more accurate responses.
Two non MLCD “life style” issues, item number E2 “I decided to take part in other 
sports activities” and E3 “I decided to give up driving” were grouped under the 
“physical” domain. Another issue related to “community activities” emerged as a 
MLCD during the detailed review of the “leisure and social activity” themes. From 
patients’ comments, it appeared that patients’ life long commitments to community 
activities were influenced by their long term illness, making the decision to give up 
these commitments was life changing for them. Therefore item D13 “I decided not to 
be involved in community activities” was included under the “social” domain. The 
MLCD related to “wearing make up” was gender specific and after a further review 
of patients’ comments it was evident that it should have been addressed separately. 
Another separate item D16 “I decided to wear a wig/toupee” was also included under 
the “social” domain.
The profile was designed to be kept generic and items were formatted to allow its 
potential international use. For example, in item D8 “I decided to return to this 
country”, the word “country” was used instead of “UK” and in item number DIO “I 
decided to move back to my home area”, the phrase “home area” was used instead of 
the “city name”. Similarly, particular examples attached to each statement were 
avoided in order to make the profile more general and internationally acceptable.
Item reduction
Initially, 48 items/statements were generated in the development of the first draft 
profile. Another qualitative review of the draft profile was carried out and statements 
considered inappropriate, vague and conceptually ambiguous were deleted. Several
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items were rephrased and combined together (Items D2, D3 and FI), and 
comprehensively modified to make them more appropriate and to fit the intended 
purpose. The following basic criteria were used for item reduction and modification:
• Frequency: Themes reported by <5% of the sample population were not 
included. 5% was taken as the cut off point for item reduction.
• Appropriateness: Statements should be relevant and linked to the intended 
purpose.
• Universality: Statements should capture patients’ perceptions, feelings and 
attitude accurately across the observed population regardless of their age and 
gender.
• Wording: The wording of statements must be clear and understandable to lay 
people and make sense to any individual with a minimum intelligence of 12 
years old.
One theme under the job category “not to mention illness on job application” was 
removed due to the inappropriateness of this action. Another theme in the same 
category “not to seek employment” was removed because of its similarity with the 
theme of “unemployed or remain unemployed”. One independent main category “to 
quit from professional sports” was excluded; this theme was reported by <5% of the 
patients. However some gender and speciality specific categories were retained, such 
as “major treatment decisions” and “to wear make up”. The statement, “To leave a 
professional association/committee” was retained because of its generic nature. One 
life style MLCD related to “swimming” was put under the “physical” domain rather 
than the “social” domain. It was only reported by patients who were suffering from 
skin conditions which reflected the obvious aesthetic reasons rather than physical 
ability. It was felt therefore that it should not fall under the physical domain. 
However, if this item were included under the “physical” domain, this would also be 
of relevance to other medical specialities (rheumatology, cardiology and respiratory 
medicine) along with dermatology and thereby made it more general. It was also 
noted that “swimming” is a specific type of sport. To make the “physical” domain 
more generic, another item E2 “I decided not to take part in other sports activities” 
was included.
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Initially, statements were phrased using five different styles starting with; “I decided 
not to”, “I decided to”, “I wanted to”, “I have to” and “I had to”. All statements were 
again thoroughly reviewed in the context of patients’ comments as part of “item 
extraction validation”. One by one, quotes were read and discussed for item retention 
and item extraction. With the consensus of the research team, the majority of the 
statements (31 out of 45 statements) were modified into the format of “I decided to” 
in order to make them uniform and consistent for the respondent. Eleven statements 
were phrased as “I decided not to” and three statements (D6, D9 and D15) were 
phrased in the “I wanted to” style because of the patients’ comments, to create 
originality in the statements and to help respondents to relate to these statements 
better and hence respond more accurately.
At this stage it was noted that there was a very fine line between some types of 
MLCDs, such as “give up a job” and “completely change my work”. Giving up a job 
means patients may start the same job at a later date or a similar kind of work later 
but “completely change my work” means patients changed their type of employment 
because of their illness. There was a very subtle difference between various issues but 
it was not possible to address every subtlety because this would have made the items 
more complex. Due to the intricate nature of this subject, profile statements were 
carefully reviewed and modified. Separate new statements were created, if required to 
eliminate subtle differences, in the simplest way possible for patients to understand.
Development of the draft profile
The 45-item draft profile was finally designed by a consensuses of the research team, 
covering six MLCD domains related to education (4 items), career/work (13 items), 
family/relationships (8 items), social (16 items), physical (3 items) and major 
treatment decisions (1 item). It was discussed whether career and work might be 
included as two separate domains but the research team was of the view that both 
terms are interchangeable. However, as separate MLCD domains could create more 
confusion for lay people and for subsequent potential cross-cultural adaptation. 
Patients placed more emphasis on “social” and “career/work” domains and that is 
why these consists of a larger item pool.
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Before the selection of a response scale, the possible options were considered and 
discussed (Streiner 2003). The generated data was ordinal in nature and that generally 
requires ranking of level of response (level of influence) which should be assigned to 
each statement for its evaluation. Several patients reported that their chronic disease 
had no influence on MLCDs. Some patients reported that their disease impacted on 
their MLCDs and some reported that their chronic disease partly influenced MLCDs. 
Conceptually it was obvious that this newly developed profile (the MLCDP) required 
a scale option which could record the influence of chronic disease in a logical way. It 
was agreed that the new tool should measure the level of the intensity of the disease 
influence on MLCDs in order to record whether each MLCD is partially influenced, 
moderately influenced or strongly influenced by the chronic disease. Various scale 
options were discussed in detail and a 5 point (0 to 4) uni-polar “Adjectival scale” 
(No influence=0, Slight influenced, Moderate influenced, Strong influence=3 and 
A very strong influence=4) was chosen for the evaluation of the level of the influence 
of chronic disease on MLCDs (Streiner 2003). This response option provides 
“descriptors along a continuum” as a continuous series of options and is often used to 
rate “self-reported health” (Streiner 2003). The use of a bi-polar Likert scale (similar 
in nature to an adjectival scale but generally providing two ends of extreme values 
separated by a neutral option) was also discussed but rejected as in their responses 
patients might drift towards the central point, which normally represents either a 
neutral point, no option, neither agree nor disagree or undecided (Streiner 2003). A 7- 
option scale was also discussed in detail, but it was the balance between friendliness, 
ease of response and reliability which resulted in the consensus for a 5-point scale.
At the end of the developmental process, it was decided to write an introduction to the 
MLCDP and to provide instructions for the respondent taking into account the 
statements and the selection of the response scale. An instruction sentence was placed 
at the top of every page of the profile to remind patients and to keep them focused. 
Very concise and clear introductory sentences were formulated for each section and 
placed under the heading of each MLCD domain for the guidance of patients. Despite 
the design of a large and open format lay out, the profile was kept to a maximum 
three pages to give a friendly and professional look. The final 45-item draft 
instrument MLCDP (version 1) (Figure 4.1) was presented to the panel of experts for 
its “content validation”.
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Figure 4.1: MLCDP version 1 (Date: 29.01.2010)
PLEASE TICK THE BOX WHICH BEST DESCRIBES HOW YOUR CONDITION HAS 
INFLUENCED YOUR MAJOR DECISIONS IN YOUR LIFE.□ EDUCATIONThe following statements refer to the influence J  J  &
of your chronic condition on your decisions about ^  ^  £
your education. & j f  J? J°
<f . f  *
1. Idecided to leave school education early........................... □ □ □ □ □
2. Idecided to change my study subject................................. □ □ □ □ □
3. Idecided to study near home................................................ □ □ □ □ □
4. I decided to leave college/university education.................. □ □ □ □ □□CAREER/W ORKThe following statements refer to the influence 
of your chronic condition on your decisions about 
your career/work.
1. I decided to change my choice of career........................ □ □ □ □ □
2. I decided to abandon my chosen career after starting.. □ □ □ □ □
3. I decided to completely change my work/profession..... □ □ □ □ □
4. I decided to take early retirement...................................... □ □ □ □ □
5. I decided to work flexible working hours......................... □ □ □ □ □
6. I decided to give up a job................................................... □ □ □ □ □
7. I decided to select a job suitable to my health................ □ □ □ □ □
8. I decided not to take promotion......................................... □ □ □ □ □
9. I decided to work shorter hours........................................ □ □ □ □ □
10. I decided to become self-employed.................................. □ □ □ □ □
11. I decided to stay in the same employment...................... □ □ □ □ □
12. I decided to remain unemployed........................................ □ □ □ □ □
13. I decided to leave a professional association/committee. □ □ □ □ □
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PLEASE TICK THE BOX WHICH BEST DESCRIBES HOW YOUR CONDITION HAS
INFLUENCED YOUR MAJOR DECISIONS IN YOUR LIFE.
[ c l  FAMILY/RELATIONSHIPS
The following statements refer to the influence & ^  %
of your chronic condition on your decisions about ^  ^  ^  ^
your family/relationships. & £  i f
^  4 /  4 *4
1. I decided to delay my plans for having children  □  □  □  □  □
2. I decided not to have more children...............................  □  □  □  □  □
3. I decided not to have any children.................................  □  □  □  □  □
4. I decided to have IVF (In Vitro Fertilisation) treatment... □  □  □  □  □
5. I decided not to have an intimate relationship...............  □  □  □  □  □
6. I decided not to marry........................................................  □  □  □  □  □
7. I decided to separate from my partner................. □  □  □  □  □
8. I decided to get divorced....................................................  □  □  □  □  □
7 ]  SOCIAL
“  The following statements refer to the influence
of your chronic condition on your decisions about 
your social life.
1. I decided to change my eating habits............................ □ □ □ □ □
2. I decided to change my smoking/drinking alcohol habits. □ □ □ □ □
3. I decided not to travel abroad or go for holidays abroad. □ □ □ □
4. I decided not to purchase any property.......................... □ □ □ □ □
5. I decided to move my home............................................. □ □ □ □ □
6. I wanted to move abroad but decided not to.................. □ □ . □ □ □
7. I decided to move abroad..................................................... □ □ □ □ □
8. I decided to return to this country..................................... □ □ □ □ □
9. I wanted to move to another city but decided not to...... □ □ □ □ □
10. I decided to move back to my home area....................... □ □ □ □ □
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PLEASE TICK THE BOX WHICH BEST DESCRIBES HOW YOUR CONDITION
HAS INFLUENCED YOUR MAJOR DECISIONS IN YOUR LIFE.
/  / / / &
11. I decided to move to another part of the country  □  □  □  □  □
12. I decided to wear different types or colour of clothes  □  □  □  □  □
13. I decided not to be involved in community activities  □  □  □  □  □
14. I decided not to socialise.................................................... □  □  □  □  □
15. I wanted to wear make up but decided not to...................□  □  □  □  □
16. I decided to wear a wig/toupee............................................□  □  □  □  □
[ 7 |  PHYSICAL
The following statements refer to the influence 
of your chronic condition on your decisions about 
your physicai aspects of life.
1. I decided not to go swimming.............................................  □  □  □  □  □
2. I decided not to take part in other sports activities  □  □  □  □  □
3. I decided to give up driving.................................................  □  □  □  □  □
□ M AJOR TREATMENT DECISIONSThe following statement refers to the influence of your chronic condition on your decision about your major treatment
1. I decided to make a major treatment decision.................  □  □  □  □  □
(For example dialysis, organ transplant, surgery, biologies)
THANK YOU FOR YOUR HELP Date ...................................
T h is  q u e s t i o n n a i r e  i s  n o t  t o  b e  r e p r o d u c e d  o r  p h o t o c o p i e d  w i t h o u t  t h e  p e r m i s s i o n  o f  t h e  a u t h o r s
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Summary
At the stage of item reduction and design of the new instrument, a process was 
followed involving five steps. After several brain storming sessions, the main 
MLCD categories were grouped under six MLCD domains.
48 items were generated for the development of the first draft of the new scale.
In developing the wording and structure of the new scale, the basic criteria of 
frequency, appropriateness, universality and appropriate wording were used.
The 45-item draft instrument MLCDP (version 1) was developed and then 
presented to the panel of judges for “content validation”.
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CHAPTER 5
The Validation of the MLCDP: 
Content Validity
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INTRODUCTION
Content validation is a process of establishing validity of an instrument by using the 
judgment of experts to remove items from the instrument or modify unrelated or 
inappropriate items which may cause error in evaluation. The opinion of the experts is 
also sought as to whether the scale is appropriate for the intended purposes and has 
the right focus and emphasis for the content being measured in the targeted 
population (Streiner 2003). Haynes et al (1995) defined content validity as:
“Content validity is the degree to which elements of an assessment instrument are 
relevant to and representative of the targeted construct for a particular assessment 
purpose”
Instrument content validation is a process which may encompasses several methods 
and both “quantitative” and “qualitative” approaches are appropriate as part of this 
process. It has been recommended that items should be judged by multiple experts 
using a 5 or 7-point assessment scale covering item relevance, representativeness, 
specificity and clarity. If there are more than five judges this may help to eliminate 
early items which if left in might be “outliers” at a later stage of analysis (Haynes et 
al. 1995). It is hoped to establish the content validity of the MLCDP in this chapter.
METHODS
The 45-item MLCDP (version 1) profile was subjected to content validation by a 
team of experts (panel of judges). Their task was to review the profile and rate each 
item on 4-point scale (strongly agree to strongly disagree) for its language clarity, 
completeness, scaling and relevance and suggest appropriate changes as necessary in 
order to develop a profile which could accurately measure what it was intended to 
measure. Consultant physicians, specialist nurses and academic experts from different 
disciplines were invited to join the panel of judges and to take part in this process.
Procedure
Content validation is an important process whereby a new measuring instrument is 
examined for its focus and emphasis relating to the target population. The content 
validation of MLCDP (version 1) was carried out in the following two phases:
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Phase 1: Quantitative assessment 
Phase 2: Qualitative assessment
During both phases, members of the panel of judges raised various issues related to 
MLCDP items’ language clarity, completeness, relevance, scaling, structure and 
layout of the draft instrument. The suggestions were in the context of their clinical 
and academic experience which allowed the group to make necessary changes and 
ensure that items were sufficiently comprehensive for the intended use.
Phase 1: Quantitative assessment
The MLCDP (version 1) and the “questionnaire items rating sheets” (Appendix R) 
were sent out to the panel of judges to rate each item and for their expert opinion. A 
covering letter (Appendix S) explaining the task accompanied these documents. The 
members of the panel were asked to bring their items rating sheets for more detailed 
discussion at the subsequent meeting for qualitative assessment. Instruction was 
provided for rating of the MLCDP (version 1) on a four point Likert type ordinal 
scale (l=Strongly agree, 2=Agree, 3=Disagree and 4=Strongly disagree) for each of 
the following four criteria:
Language clarity: The sentence and wording should be clear, understandable, 
straightforward and simple. Make sure the phrases and wording are unambiguous and 
jargon free and should be understood by a person who has the mental aptitude of a 12 
year old child.
Completeness: The sentence structure should be complete, not broken and should 
end properly.
Relevance: Each item should be relevant to the subject area and target population.
Scaling: 5-point adjectival scale is used for the scaling system (No influence, Slight 
influence, Moderate influence, Strong influence, Very strong influence). Panel 
members should rate the scaling system as to whether or not the response options fit 
the statements/item.
Under each item, a separate section was provided for the panel of judges to write their 
suggestions for change.
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Phase 2: Qualitative assessment
This process of content validation was based on the discussion between the members 
of the panel of judges. Only six members (clinicians=4, academic experts=2) were 
able to attend the qualitative assessment (discussion phase). Those members who did 
not attend this validation phase (n=9), returned their item rating sheets in order to 
include their responses in the discussion phase. The discussion for qualitative 
assessment was organised in the Department of Dermatology, School of Medicine, 
Cardiff University on 25 February 2010. The meeting lasted two hours and was 
digitally recorded for later analysis.
A Power Point presentation and an introduction were given by Z U B at the start of 
the discussion to remind the panel members about the purpose of the discussion, the 
time frame and the planned further course of the resultant outcome. At the request of 
the panel members, patients’ comments which had been obtained at an early stage 
(conceptualisation stage 1) of this study were consulted again on various complex 
MLCD issues, in order to understand them better and to assist modification of items. 
Relevant patients’ comments were projected on a digital electronic board using 
NVivo 8 transcript files via a computer, so that the panel of judges could discuss their 
responses and view the patients’ comments at the same time. With the consensus of 
the panel of judges, the outcome of this discussion resulted in making changes (item 
inclusion, retraction, modification, and sequence) to remove further ambiguity and to 
make the new measuring tool more simple, user friendly and easy to understand for 
respondents.
Data processing and analysis
Data was processed using SPSS 16 statistical software for windows. Descriptive 
statistics were used to record the demographics of the panel of judges. Kappa 
coefficient and intraclass correlation coefficient (ICC) techniques were used to 
evaluate the agreement among the panel of judges for inter-rater reliability.
The responses of the panel of judges as recorded on item rating sheets were analysed. 
Agreement among the panel of judges concerning each item was analysed by 
calculating the mean values of their ratings for “language clarity”, “completeness”, 
“relevance”, and “scaling”.
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The detailed discussion, which took place during the second phase of the content 
validation process, was digitally recorded and transcribed verbatim. The level of 
agreement among the panel members for each item of the MLCDP was assessed 
statistically by using kappa coefficient. The SPSS software generally provide kappa 
statistics for only two judges. The Cohen Kappa macro syntax file was computed 
using SPSS 12 software to calculate the multiple inter-rater agreement (>2 raters).
Kappa versus ICC: There is much discussion in the literature about which technique 
is better for inter-rater reliability. For non-quantitative data (categorical/nominal), the 
kappa coefficient is the techniques of choice. The ICC is more appropriate and better 
than the kappa technique for analysing data obtained from ratings using any scale 
(e.g.l to 10) (Futrell 1995; Gwet 2008). Therefore, it was decided to use ICC for the 
quantitative and kappa technique for the qualitative phase to measure the level of 
agreement (inter-rater reliability) among the panel of judges.
RESULTS
Demographic characteristics of the panel members
Fourteen people were invited to form a “panel of judges” and to take part in the 
content validation processes for the MLCDP (version 1). The panel members 
included clinicians from seven participating medical specialities and 13 took part in 
the first (quantitative) phase of whom seven were clinicians (Male=5; Female=2) and 
six specialist nurses (Female=6). The panel members’ professional backgrounds are 
listed in Table 5.1. Only four members (clinicians=4: Male=2, Female=2) from the 
panel of judges and two academic experts (Male=2), who both had vast experience in 
developing QoL questionnaires took part in the next panel discussion phase 
(qualitative) of the content validation.
Panel of judges’ ratings of the MLCDP items (Quantitative assessment)
Thirteen members of the expert panel completed and returned their content validation 
item rating sheets. The mean scores of each item (total=45) for each of four criteria 
are shown in Table 5.2. The median values of the judges’ (n=13) ratings for the four 
criteria (Table 5.3) indicated good expert consistency (agreement) in overall four 
criteria of language clarity, relevance, completeness and scaling.
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Table 5.1: The panel members’ professional backgrounds
Department Number Position Initials
Cardiology 2 Clinician JH
Specialist nurse LE
Dermatology 3 Clinician MC
Specialist nurse AT
Academic expert AYF
Nephrology 2 Clinician SR
Specialist nurse JJ
Rheumatology 2 Clinician SJ
Specialist nurse GM
Respiratory medicine 1 Clinician CB
Cystic Fibrosis services 2 Clinician IK
Specialist nurse CD
Diabetes 2 Clinician LG
Specialist nurse JB
Pharmacoepidemiology 1 Academic expert SS
The overall percentages of their agreement (strongly agree, agree, disagree or 
strongly disagree) on the four criteria also indicate that the majority of judges either 
“strongly agreed” or “agreed” on the four criteria. Concerning language clarity of the 
items, 58% of judges strongly agreed, 28% agreed, 12% disagreed and only 2% 
strongly disagreed. In terms of the relevance of the items, 55% of the judges strongly 
agreed, 33% agreed, 9% disagreed and 3% strongly disagreed. Concerning 
completeness, 50% judges rated strongly agree and 33% rated agree. Only 13% of the 
judges viewed some items as incomplete and 2% of the judges strongly disagreed in 
this respect. The panel of judges also viewed the scaling criteria in a very similar way 
as to their rating of other criteria; 57% strongly agreed, 28% agreed, 13% disagreed 
and 2% strongly disagreed. The overall disagreement level between the judges was 
<15% overall criteria with <5% recording strong disagreement (Table 5.4).
Panel of judges’ disagreement with the four criteria
More specific analysis of each item revealed that several judges raised concern over 
language clarity and some judges were not sure about the relevance, completeness 
and scaling of some items. Only three (23%) experts (speciality nurses) disagreed on 
> 20% of the items across the four criteria. The experts (> 3 panel members) 
disagreement or strong disagreements concerning the four criteria for specific 
MLCDP items were as follows:
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Language clarity: In terms of language clarity, experts were asked to assess whether 
the wording of an item was clear, understandable, simple, unambiguous and jargon 
free. Several judges raised concern over 13 items. Panel members either disagreed or 
strongly disagreed on items A1 (n=3), A2 (n=4), A 4 (n=3), B1 (n=3), B6 (n=5), B8 
(n=3), B ll (n=10), B12 (n=3), B13 (n=6), C4 (n=3), D5 (n=3), D13 (n=3) and FI 
(n=10) (See Figure 4.1 for item detail).
Relevance: Relevance was the most important aspect of the rating criteria. Panel 
members were asked to assess whether or not items were relevant to the subject area 
and the target population. Some panel members either disagreed or strongly disagreed 
on the relevance of items B6 (n=6), B8 (n=3), B ll (n=7), B13 (n=7), C4 (n=3), D15 
(n=3) and FI (n=3) (See Figure 4.1 for item detail).
Completeness: 14 items were considered to be incomplete by some panel members: 
A2 (n=3), A4 (n=3), B1 (n=4), B6 (n=4), B8 (n=3), B11 (n=8), B13 (n=8), C4 (n=4), 
C8 (n=6), D7 (n=3), D12 (n=7), D15 (n=6), D16 (n=5), FI (n=l 1) (See Figure 4.1 for 
item detail).
Scaling: For 10 items, the proposed scaling option was considered to be inappropriate 
as reported by panel members. These were item B1 (n=3), B7 (n=3), B8 (n=3), B ll 
(n=3), B13 (n=4), C6 (n=3), D12 (n=3), D15 (n=4), D16 (n=3) and FI (n=3) (See 
Figure 4.1 for item detail).
The items which failed to gain agreement across all four criteria when judged by 
panel members were B8 (language clarity: n=3, relevance: n=3, completeness: n=3 
and scaling: n=3), B ll (language clarity: n=10, relevance: n=7, completeness: n=8 
and scaling: n=3), B13 (language clarity: n=6, relevance: n=7, completeness: n=8 and 
scaling: n=4), FI (language clarity: n=10, relevance: n=3, completeness: n= ll and 
scaling: n=3), and on three criteria were Bl, B6, C4, and D15 (See Figure 4.1 for item 
detail).
Panel of judges’ suggestions for change
The panel members also proposed various suggestions for the improvement of some 
items. These suggestions, opinions and comments are listed in detail in Table 5.5. 
During the next discussion phase (qualitative) of the content validation, all items were 
examined again in great detail by the panel of judges, all suggestions were discussed 
and decision made for their implementations.
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Table 5.2: Mean scores of each of the four criteria as rated by the panel of
judges (n=13)
Domain Variables Mean (n= 13)
Category (Items) Language
clarity
Completeness Relevance Scaling
Education l 1.53 1.46 1.69 1.61
2 2.00 1.92 2.00 1.79
A 3 1.46 1.38 1.76 1.61
4 1.76 1.69 1.76 1.61
Job / career 1 1.76 1.69 1.84 1.76
2 1.38 1.30 1.38 1.38
B 3 1.23 1.23 1.30 1.384 1.30 1.38 1.53 1.53
5 1.15 1.30 1.23 1.38
6 2.00 2.07 2.00 1.48
7 1.61 1.69 1.69 1.48
8 1.76 1.76 1.76 1.76
9 1.23 1.23 1.23 1.38
10 1.30 1.30 1.38 1.46
11 2.61 2.38 2.46 2.46
12 1.76 1.53 1.53 1.61
13 2.23 2.38 2.46 2.07
Family / 
relationships
1 1.30 1.53 1.61 1.38
2 1.30 1.30 1.53 1.38
3 1.30 1.30 1.46 1.38
C 4 1.92 1.92 2.00 1.615 1.53 1.53 1.61 1.53
6 1.53 1.76 1.61 1.61
7 1.30 1.46 1.38 1.38
8 1.38 1.61 2.46 2.46
Social 1 1.46 1.38 1.38 1.38
2 1.38 1.30 1.23 1.38
D 3 1.53 1.53 1.46 1.534 1.30 1.61 1.69 1.76
5 1.69 1.61 1.38 1.38
6 1.46 1.46 1.46 1.53
7 1.53 1.69 1.84 1.61
8 1.38 1.38 1.46 1.30
9 1.53 1.46 1.46 1.46
10 1.38 1.38 1.38 1.30
11 1.30 1.30 1.53 1.38
12 1.76 1.76 2.46 1.69
13 1.69 1.61 1.69 1.61
14 1.38 1.38 1.38 1.46
15 1.53 1.61 2.23 1.69
16 1.69 1.76 2.23 1.69
Physical 1 1.30 1.76 1.76 1.38
2 1.38 1.53 1.69 1.38
E 3 1.23 1.23 1.46 1.30
Major
treatment
1 2.76 3.07 3.15 2.69decisions
F
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Table 5.3: Median scores of ratings (range=0-4) by the panel of judges on four
criteria
Judges Language
clarity
Relevance Completeness Scaling
1 1.00 1.00 1.00 1.00
2 1.00 1.00 1.00 1.00
3 1.00 1.00 1.00 1.00
4 1.00 1.00 1.00 1.00
5 1.00 1.00 2.00 1.00
6 2.00 2.00 2.00 3.00
7 2.00 2.00 2.00 2.00
8 2.00 2.00 2.00 2.00
9 1.00 1.00 1.00 1.00
10 1.00 2.00 2.00 2.00
11 1.00 1.00 1.00 1.00
12 1.00 1.00 1.00 1.00
13 2.00 2.00 2.00 2.00
Table 5.4: Agreement level in the ratings of the panel of judges (n=13) on the
four criteria
Response
option
Judges ratings across four criteria of the 45 items (%)
Language clarity Relevance Completeness Scaling
Strongly agree 58 55 50 57
Agree 28 33 33 28
Disagree 12 9 13 13
Strongly
disagree
2 3 4 2
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Table 5.5: Comments and suggestions proposed by the panel of judges
Panel members Item Expert opinion/suggestions
1. Consultant A1 “Early” is not defined. Do you mean<18? Or between
(Cardiology) GCSE or others
A2 Study subject is suggesting why / subject being studied. 
Recommended “....study subject (s)”
A4 Possibly split into two questions.
I.1 decided not to go into higher education 
(college/university)
II. I decided to leave college/university education early
B3 This overlaps somewhat with B1 and B6
B6 Some overlaps between B1 and B3
B9 Place adjacent to B5 (more logical order)
B ll Not sure where this is heading. Are you trying to see 
whether they stayed in the same employment rather than 
looked to develop their career?
C8 Some overlaps with C7
D9 “city” region, area?
DIO Some people may feel “home area” hard to define
D15 Less relevant for some diseases, more than others
D16 Less relevant for some diseases
E2 Perhaps add further statement or two here, to show 
difference, sports from high intensity to low intensity
FI It will be hard to make objective judgment for this 
question, which will be so dependent on the nature of 
the condition, the specific treatment proposed by their 
physician (s) and patient’s understanding of what major 
treatment decision is.
Other 1. Not applicable should be included in response option
2. Specialist nurse 
(Cardiology)
D12 Interesting, not sure on relevance. Are you trying to see 
if mood/attitude will change colour of clothes?
3. Consultant A2 “subject studies”? what do you mean in school or
(Dermatology) university
B2 “abandon” is this same as B1
B6 “a job”? any job
4. Specialist nurse A4 Early (word addition). Not to complete
(Dermatology) B7 I decided to select a suitable job for my health
C4 Word “seek” instead of “have”. Word “fertility” instead 
of “IVF”
C6 Or have long term partner
D4 Buy own home
D5 I decided to move back
5. Consultant B13 May leave because of too busy rather than ill health etc.
(Cystic Fibrosis) C l Delay? (change my plans)
C4 “Fertility” instead of “IVF”
C5 “Sexual” instead of “intimate”
C6 Or have a long term partner
D4 Explain property? Own home
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D7 Not CF specific. OK if general
D ll As already asked in D5
D15 Make up? “cosmetics”
El Why swimming highlighted
FI What’s biologies? But ok for general question
6. Specialist nurse A1 Before or after 16? ambiguous
(Cystic Fibrosis) A2 Not clear what is meant by this
B1 Not everyone would feel that they had a career-just a job
B2 “Career” implies something professional
B4 At what age should the decision to stop work due to ill 
health be termed early retirement
B6 Bit ambiguous
B9 Shorter than what?
B ll What is the purpose of this statement?
B13 What is the relevance of this statements
C4 To have IVF is not a decision that can be made by the 
patient “I decided to explore the possibility of referral 
for IVF”
D5 I decided to move house
D8 Ambiguous -which country?
DIO If you would move away in the first place
D ll Which country?
D12 Relevance?
D15 Relevance?
D16 Relevance?
El Relevance?
E2 What sports activities?
FI What is biologies? Patients may not understand this. Are 
dialysis and organ transplant really in the same league? 
With regard to question this question may cause anxiety
Other 1. All questions should have a N/A option
2. This questionnaire is far too long
7. Consultant B8 ?
(Rheumatology) B ll Out
Cl Delay to word change
C4 Change “IVF” to “fertility”
C5 Change “intimate” to “sexual”
D4 Change “purchase” to “buy” and “property” to “own 
home”
FI Ambiguous
8. Specialist nurse 
(Rheumatology)
No comments
9. Consultant A2 May be positive or negative influence
(Diabetes) A4 Early?
B3 But why?
B5 Why?
B6 Same as changing career/abandoned career/retirement
B7 Why? Physical / psychological
B9 Similar to flexible hours
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B ll Why? Weak
B13 ? more likely to join one
Cl Change “delay” to “change timing”
C4 Only CF? change to seek fertility
C6 Or long term partner
D2 Add “or” before word “drinking”
D4 Own house
D6 -ve
D7 +ve
D ll Overlap with above
FI X sign on the statement as not agree
10. Specialist nurse A2 I felt restricted on my choice of study subject
(Diabetes) B1 I was forced to change
C4 Cross sign (strongly disagree)
D1 Decided?
D5 Post code lottery
D9 Post code lottery
11. Consultant A1 In renal I would say majority will not have had
(Nephrology) condition until late in life. Whether or not applicable?
A2 See A1
A4 See A1
B2 Abandon?
B3 Is this the same as part 1
Cl May need a “not applicable” but I guess covered by no 
influence
C4 to
C7
I think these 4 questions are very difficult but you have 
more experience than I in that area
C8 Is “decided” the right word? Maybe they were decided 
but not their idea?
D7 Seems unlikely they will be answering this. They have 
moved abroad
D ll I feel there is some repetition here but may be cannot get 
around this
FI I don’t think this question is clear, as to what you want 
from patients
12. Specialist nurse B6 My job
(Nephrology) B13 Why is this relevant?
C2 For some patients they do not have any choice due to 
illness leading to fertility problems
C3 As above
C4 Accessibility of IVF may present problems
C5 These decisions may be out of the patients’ control due 
to individual circumstances
C6 See above
D1 I decided to change my diet. 
Word or instead of (/)
D2 Is this two questions not one?
D5 I decided to move house
D12 Is colour relevant?
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El Decisions may be made for partners due to 
circumstances not choices
E2 As above
E3 As above
FI Patients may not have choice in the decisions but may 
be forced by circumstances to make a decision. This 
question may need to be re-phrased
Other ? Need “not applicable” option for onset of disease 
rather than “no influence”
13. Consultant A1 to Not relevant to COPD
(Respiratory A4
Medicine) B1 Clarify before start. Career not relevant to COPD
B2 Job/Career
B6 Career/Job
B7 “for” my health
B ll ?
B13 Relevance?
Cl to 
C4
Not relevant to COPD
C5 “sexual” big decision in COPD
C6 Long term partner 
Could be relevant?
D2 Word “or” instead of (/)
D3 Modem trend
DIO Seems overlaps in these questions D8 to D9
D12 Colour relevance to COPD. Loose clothes
D15 Not really relevant to COPD
D16 Not relevant to COPD
El Need not applicable. Change? Many take it up
E2 Separate out? Group/exertion/give up dog/activities
FI I don’t like this question. Not really relevant at all to 
COPD patients and could be awkward to raise transplant
Test of agreement: Interclass Correlation Coefficient (ICC)
For the quantitative assessment part of content validity, the items of MLCDP (version 
1) were rated by the panel of judges on a four point ordinal scale (strongly agree, 
agree, disagree and strongly disagree). Due to the type of rating method/scale used 
(ordinal scale) for the assessment, the quantitative nature of the data and in order to 
be statistically relevant (Futrell 1995), the ICC technique was used to measure the 
inter-rater reliability among the panel of judges.
The Interclass Correlation Coefficient (ICC) analysis of absolute agreement showed 
an ICC of 0.707 (p=<0.0001; CI=0.606 to 0.782) indicating a good level of agreement
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among the thirteen members of the panel and supporting the content validation of the 
instrument (Table 5.6).
Table 5.6: Level of absolute agreement among the panel members using ICC
statistics
Intraclass
Correlation
95% Confidence Interval P value
Lower Bound Upper Bound
0.707 0.606 0.782 <0.0001
Panel discussion and the resultant improved MLCDP (Qualitative assessment)
Each item of the new profile was reviewed and discussed by the panel members. The 
ratings of the panel of judges and their suggestions about each item (results of phase 
1) were discussed until consensus was reached and members agreed on the retraction 
of items, addition and modifications of the final version of the MLCDP (versionla).
During the discussion it was noted that some items were more disease specific than 
others, but panel members were agreed over the broader concept and the general 
nature of the instrument.
In the light of the panel members’ suggestions and comments item B2 (I decided to 
abandon my chosen career after starting) was merged with item B6 (I decided to give 
up a job) due to the similar nature of both items. Item C7 (I decided to separate from 
my partner) was merged with C8 (I decided to get divorced), and D7 (I decided to 
move abroad) merged with D8 (I decided to return to this country) to make more 
comprehensive statements. Items B ll (I decided to stay in the same employment), 
B13 (I decided to leave a professional association/committee) and FI (I decided to 
make a major treatment decision) were removed because panel members considered 
these items as being unrelated to the topic area. The items E3 (I decided to change to 
different sporting activities) and E4 (I decided to be more physically active) were 
included as new items to broaden the physical domain (Table 5.7).
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Table 5.7: List of items merged, removed and added 
(See Figure 4.1 for item detail)
Items merged Items removed Items added
B2 with B6 B ll E3
C7 and C8 B13 E4
D7 and D8 FI
By consensus the response option of “No influence” was changed to “No influence 
OR Not applicable”. This change was necessary because some items may not be 
applicable to respondents. The domain B (Career/Work) name was changed to 
“Job/Career” in order to reflect the items included under this domain. The phrase 
“career and work” was also changed in the relevant introductory statements to 
“job/career”. The domain F “major treatment decisions” consisted of only one item 
“F I” and removal of this item reduced the profile to only five domains. Various 
changes to several items were also suggested by panel members and implemented to 
make the profile more unified, simple and easy to understand for respondents. Further 
changes to the structure and layout were also made. The general instruction was 
removed from the top of every page and one simple introduction and instruction was 
placed at the beginning of the first page. The sentence “For each statement please tick 
one box” was placed at the top of page 2 and page 3 of the profile to remind the 
respondent about the scale response options. The words “Name/Code number” 
“Date” and “Confidential” were added at the top of the first page of the profile to 
enhance its professional use. The profile development date and the version number 
were also placed at the end of the profile to avoid any confusion with previous or 
subsequent versions.
All of the changes suggested by panel members at the qualitative discussion phase of 
the content validation highlighted in bold are shown in Table 5.8.
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Table 5.8: Changes proposed by the panel members which received group
consensus (identified in bold)
MLCDP version 1 MLCDP version la
(consensus changes after meeting of panel 
members)
A1 to A3 Unchanged
A4.1 decided to leave college/university 
education
A4.1 decided to leave college/university 
education early
B. Career/Work
The following statements refer to the 
influence of your chronic condition on your 
decisions about your career/work
B. Job/Career
The following statements refer to the 
influence of your chronic condition on your 
decisions about your job/career
B1. 1 decided to change my choice of career B1. 1 decided to change my choice of 
job/career
B2.1 decide to abandon my chosen career 
after starting
B2.1 decided to give up my job/career after 
starting
B 3.1 decided to completely change my 
work/profession
B3.1 decided to completely change my 
job/career
B4 to B5 Unchanged
B6.1 decided to give up job Merged with Item B2
B7.1 decided to select a job suitable to my 
health
Moved to B6.1 decided to select a job/career 
suitable for my health
B8 to BIO Unchanged and moved to B7 to B9
B11 .1 decided to stay in the same 
employment
Removed
B12 Unchanged and moved to BIO
B13.1 decided to leave a professional 
association/committee
Removed
C1 .1 decided to delay my plans for having 
children
C1 .1 decided to change my plans for when to 
have children
C2 and C3 Unchanged
C4.1 decided to have IVF (In Vitro 
Fertilisation) treatment
C4.1 decided to seek fertility treatment
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C5.1 decided not to have an intimate 
relationship
C6.1 decided not to marry
Cl. I decided to separate from my partner 
and
C8.1 decided to get divorced 
D1 and D2
D3.1 decided not to travel abroad or go for 
holidays abroad
D4.1 decided not to purchase any property 
D5 and D6
D7.1 decided to move abroad
D8.1 decided to return to this country
D9.1 wanted to move to another city but 
decided not to
DIO. I decided to move back to my home 
area
D11 .1 decided to move to another part of 
the country
D12.1 decided to wear different types or 
colour of clothes
D13.1 decided not to be involved in 
community activities
D14.1 decided not to socialise
D15.1 wanted to wear make up but decided 
not to
D16.1 decided to wear a wig/toupee 
El
C5.1 decided not to have a sexual 
relationship
C6.1 decided not to marry or have a long 
term partner
Cl. I decided to get divorced or separate 
from my partner (C7 and C8 merged 
together to make one comprehensive 
statement)
Unchanged
D3.1 decided not to travel or go for holidays 
abroad (word abroad removed after travel)
D4.1 decided not to buy my own home
Unchanged
D7.1 decided to move from one country to
another. (D7 was merged with D8 to make it 
one comprehensive statement to cover the 
meaning of both statements)
This statement moved to D8
This statement moved to D9
This statement moved to DIO
I decided to wear different types/colour of 
clothes/shoes (moved to D ll)
moved to D12
moved to D13 
moved to D14
moved to D15
Unchanged
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E2.1 decided not to take part in other sports E2.1 decided not to take part in any sports
activities activities
E3.1 decided to give up driving moved to E5
Item E3 and E4 were included as new items
FI Removed
Test of agreement: Kappa coefficient
The Cohen’s kappa ( k ) statistics have been used to determine the level of agreement 
between two raters (Cohen 1960) but Fleiss (1971) incorporated multiple (>2) raters 
statistics to obtain a generalised kappa value for any number of raters. Kappa is 
defined as “the proportion of agreement between raters after agreement by chance has 
been removed” (Futrell 1995). The following ranges of kappa values is normally used 
to measure the level of agreement between raters (Norusis 2005): values below 0.40 
indicate poor agreement above chance; values in the range of 0.40 to 0.75 indicate 
fair level of agreement above chance; and values exceeding 0.75 indicate strong 
agreement above chance.
Landis & Koch (1977) assigned the following interpretation bands to kappa values:
Kappa Interpretation
< 0 Poor agreement
0.0 -  0.20 Slight agreement
0.21-0.40 Fair agreement
0.41 -  0.60 Moderate agreement
0.61 -  0.80 Substantial agreement
0.81-1 .00 Almost perfect agreement
The kappa coefficient is an appropriate technique for analysing non-quantitative 
(categorical/nominal) data (Futrell 1995). Therefore, in order to measure the level of 
agreement among the panel members who took part in the discussion (qualitative 
assessment phase), their responses were coded and analysed using SPSS 12 statistical 
software. As there were multiple raters (>2), a SPSS macro syntax file was computed 
with the actual data file to obtain the Kappa value.
2 0 0
The value of Cohen's Kappa for multiple raters (n=6) was 0.81, (p=<.0001, 
Cl=0.6946 to 0.9292). This value of kappa is “almost perfect agreement” (Landis and 
Koch 1977) and is highly significant, indicating substantial agreement among the 
panel of judges on the 45 items and supporting the content validity of the new 
instrument, MLCDP (version 1).
The final changes proposed by the panel of judges were implemented to produce the 
new 41-item version (version la) of the new MLCDP instrument (Figure 5.1). The six 
initial domains were reduced to five MLCD domains: education (4 items), job/career 
(10 items), family/relationships (7 items), social (15 items) and physical (5 items). 
This revised version of the new instrument was then taken forward for the next stage 
of the validation factor analysis.
DISCUSSION
The content validation of the MLCDP was the essential process in order to render it 
fit for purpose. Therefore, as recommended both quantitative and qualitative 
assessment techniques were applied (Haynes et al. 1995). Other general prerequisite 
criterion were met, such as the use of more than five experts (panel of judges), and 
assessment of each MLCDP item using a 4-point scale for its language clarity, 
completeness, relevance and scaling. The appropriate composition of the panel of 
judges (clinicians, specialist nurses and academic experts) was very effective at both 
the quantitative and qualitative (discussion phase) stages and their suggestions 
resulted in appropriate changes being made to several items. In subsequent qualitative 
panel discussion each item was discussed in the light of panel members’ proposed 
suggestions and the transcribed patients’ responses to ensure their relevance, coverage 
and potential responsiveness.
The guidelines for panel members were simple and no issues were raised concerning 
these. There was a varying degree of agreement among the panel members when they 
rated each item on the 4-point scale. However, when the results (rating of each item 
by panel members and suggestions) of this quantitative stage were considered at the 
panel discussion phase then the two academic experts played a vital role, particularly 
answering technical questions from other panel members in relation to questionnaire 
development. It was noted that some panel members were not sure about the inclusion
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of some disease specific items, but after review of the patients’ comments and hearing 
the expert opinion of the members from the relevant medical speciality, some disease 
and gender specific items were retained. This detailed discussion also resulted in a 
consensus among panel members on various other issues. For example, the natural 
grouping of items under specific MLCD domains, the removal of three items, the 
merger of six items to form three comprehensive items, the inclusion of two more 
items under the physical domain and the structure of the MLCD profile.
The most important concern among the panel members was the language clarity of 
several items. This was resolved with consensus by application of appropriate 
phraseology. The majority of the experts agreed that the content of the MLCDP was 
straight forward, the content seems appropriate in relation to the specific MLCD 
concepts and the profile was relevant to the target population. This agreement among 
the panel members was measured and found to be highly significant, giving 
confidence that the outcome of this stage is satisfactory in terms of establishing proof 
of concept for the MLCDP.
Summary
• Both qualitative and qualitative methods were used for content analysis.
• A panel of judges was brought together for the content validation process. 
Thirteen members (clinicians=7, specialist nurses=6) took part at the 
quantitative stage and 6 members (clinicians=4; academic experts=2) took part 
at the qualitative stage.
• At the quantitative stage, panel members judged and rated each item using a 4- 
point Likert scale on four criteria: language clarity, completeness, relevance 
and scaling.
• More than 50% judges strongly agreed on these criteria for the majority of 
items.
• The response and comments of each panel members was recorded in a 
structured way to inform the detailed discussion and final decisions.
2 0 2
• Decisions at the qualitative stage were based on the panel’s discussion 
concerning each item and the way the judges rated each item at the 
quantitative stage of content validity.
• Various changes were implemented, based on the consensus of the panel of 
judges and on the basis of the quantitative stage results.
• Six items were merged together, three items were removed and two new items 
were included.
• Agreement among the panel of the judges was measured by using ICC and 
kappa techniques. The value of ICC, 0.707 (p=<0.0001; CI=0.606 to 0.782) 
and kappa 0.8119, (p=<.0001, CI=.6946 to .9292) were highly significant.
• After the final changes, as suggested by the panel of judges, the six initial 
domains were reduced to five domains and a new 41-item MLCDP (version 
la) was formulated ready for the next stage of psychometric evaluation, factor 
analysis.
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Figure 5.1: MLCDP version la  (Date: 10.05.2010)
N a m e /C o d e  N u m b e r :  C o n f id e n t ia l
D a te :
Major Life Changing Decisions Profile 
MLCDP
Instructions: The aim of this profile is to measure how your health condition has 
influenced major life decisions in your life. For each statement please tick one box.
□ EDUCATIONThe following statements refer to the influence #of your chronic condition on your decisions aboutyour education. ^ / ,  / V
1. I decided to leave school education early □ □ □ □ □
2. I decided to change my study subject □ □ □ □ □
3. I decided to study near home □ □ □ □ □
4. I decided to leave college/university education early □ □ □ □ □
[ b ]  j o b / c a r e e r
The following statements refer to the influence 
of your chronic condition on your decisions about 
your job / career.
1. I decided to change my choice of job/career □ □ □ □ □
2. I decided to give up my job/career after starting □ □ □ □ □
3. I decided to completely change my job/career □ □ □ □ □
4. I decided to take early retirement □ □ □ □ □
5. I decided to work flexible working hours □ □ □ □ □
6. I decided to select a job/career suitable for my health □ □ □ □ □
7. I decided not to take promotion □ □ □ □ □
8. I decided to work shorter hours □ □ □ □ □
9. I decided to become self-employed □ □ □ □ □
10. I decided to remain unemployed □ □ □ □ □
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For each statement please tick one box 
[ 7 |  FAMILY / RELATIONSHIPS
The following statements refer to the influence &  # ^  ^
of your chronic condition on your decisions about 4? &
your family /relationships. ^  ^
1. I decided to change my plans for when to have children □ □ □ □ □
2. I decided not to have more children □ □ □ □ □
3. I decided not to have any children □ □ □ □ □
4. I decided to seek fertility treatment □ □ □ □ □
.5. I decided not to have a sexual relationship □ □ □ □ □
6. I decided not to marry or have a long term partner □ □ □ □ □
7. I decided to get divorced or separate from my partner □ □ □ □ □
H SOCIALThe following statements refer to the influence 
of your chronic condition on your decisions about 
your social life.
1. I decided to change my eating habits □ □ □ □ □
2. I decided to change my smoking/drinking alcohol habits □ □ □ □ □
3. I decided not to travel or go for holidays abroad □ □ □ □ □
4. I decided not to buy my own home □ □ □ □ □
5. I decided to move my home □ □ □ □ □
6. I wanted to move abroad but decided not to □ □ □ □ □
7. I decided to move from one country to another □ □ .□ □ □
8. I wanted to move to another city but decided not to □  , □ □ □ □
9. Idecided to move back to my home area □ □ □ □ □
10. I decided to move to another part of the country □ □ □ □ □
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For each statement please tick one box /  &
12. I decided not to be involved in community activities
13. I decided not to socialise
14. I wanted to wear make up but decided not to
15. I decided to wear a wig/toupee
□ □ □ □ □
□ □ □ □ □
□ □ □ □ □
□ □ □ □ □
□ □ □ □ □
□ PHYSICALThe following statements refer to the influence 
of your chronic condition on your decisions about 
your physical aspects of life.
1. I decided not to go swimming □ □ □ □ □
2. I decided not to take part in any sports activities □ □ □ □ □
3. I decided to change to different sporting activities □ □ □ □ □
4. I decided to be more physically active □ □ □ □ □
5. I decided to give up driving □ □ □ □ □
Please check you have answered all the statements
Thank you for your help
This questionnaire is not to be reproduced or photocopied without the permission of the authors
© Z U Bhatti, M S Salek, A Y Finlay, May 2010 
Date: 10.05.2010 
Version 1a
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CHAPTER 6
The Validation of the MLCDP: 
Factor Analysis
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INTRODUCTION
The next stage, after content validation of the revised version of the new tool 
(MLCDP, version la) was the confirmation of the breadth and depth of the allocated 
domains through the application of the statistical technique of factor analysis.
Factor analysis is a statistical technique to analyse, explore and identify the 
relationships between a set of variables (items) measured or observed, particularly 
between those with similar concepts. Factor analysis is widely used to reduce a large 
number of correlated variables to a more manageable number, and therefore can be 
used to reduce the number of items in a questionnaire (Pallant 2005).
In a nutshell, Norusis (2005) explained that “the goal of factor analysis is to 
reproduce observed correlations among variables by identifying a smaller number of 
shared factors that account for the observed correlations”. Thus, factor analysis was 
employed in this chapter to refine the MLCDP prior to its full scale psychometric 
evaluation which should include predictive validity, responsiveness and 
interpretability.
METHODS
Norusis (2005) and Pallant (2005) have recommended three key steps that should be 
considered for conducting factor analysis namely, assessment of the suitability of the 
data for factor analysis, factor extraction and factor rotation and interpretation. 
Furthermore, there are two types of factor analysis; exploratory factor analysis (EFA) 
and confirmatory factor analysis (CFA) which will be briefly described here.
Exploratory factor analysis (EFA)
EFA is the technique, often used early on as the first step to explore whether there is 
any correlation among a set of items (Tabachnick and Fidell 2001; Pallant 2005). This 
type of factor analysis has two exploratory uses, to identify the underlying 
dimensions, and to reduce data (Floyd and Widaman 1995). EFA groups together 
creates clusters of correlated variables (items) which allow researchers to explore and 
confirm the appropriateness of the structure of an instrument and help to identify 
items which may not contribute to underlying factors and which therefore may be
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deleted. Also, EFA is widely used to determine the “construct validity” of newly 
developed QoL instruments (Fayers and Hand 1997).
Confirmatory factor analysis (CFA)
CFA allows researchers to examine the “goodness-of-fit” of a prespecified factor 
model. CFA is considered by some researchers to be an appropriate method on 
theoretical grounds of testing an instrument’s underlying structure (construct 
validation), but its potential value in QoL research appears to be very limited (Fayers 
and Hand 1997). CFA’s complex techniques are normally used later in the analysis 
than EFA in order to test a hypothesis or theory and to confirm the structure 
underlying a set of variables (Pallant 2005).
Procedure
210 patients (30 patients from each of the seven participating medical specialities: 
dermatology, cardiology, respiratory medicine, cystic fibrosis services, rheumatology, 
diabetes clinic and nephrology) were recruited from the out-patients departments at 
the University Hospital of Wales, Cardiff and the University Hospital Llandough, 
Llandough and were asked to complete the revised MLCDP (version la). The 
MLCDP was printed on thick blue paper in order to give a professional look and to 
increase the response rate (Sharpe 1974; LaGarce and Khun 1995; Beebe et al. 2007). 
A patient information sheet was given to every patient (Appendix T) before they were 
asked to read and sign a consent form (Appendix U). A personal information sheet 
was used for the purpose of obtaining demographic data of patients (Appendix V). For 
the purpose of gaining information about “face validity and practicality” of the 
MLCDP, patients were asked to complete a separate questionnaire sheet (Appendix 
W). The result of this analysis is described later in this chapter.
Data processing and analysis
In this study, EFA was used and “principle component analysis” technique was 
applied using SPSS 16 statistical software. This was to explore the underlying 
structure of the MLCDP (version la), to confirm its appropriateness (construct 
validity) and to help further develop the instrument by reducing inappropriate items 
that may not contribute to underlying factors. A correlation and component matrix 
was created for the assessment of data suitability followed by application of the
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Kaiser-Meyer-Olkin (KMO) measure and Bartlett’s test of sphericity for adequate 
sampling. For factor extraction, Kaiser’s criterion and Cattell’s scree test were carried 
out and subsequently the Varimax technique was used for factor rotation and final 
interpretation. In addition, the statistics of Cronbach’s alpha were used to measure the 
internal consistency reliability of the instrument. This test was carried out along with 
factor analysis in order to generate more evidence for the retention and deletion of the 
items during subsequent analysis.
The following steps and rules were applied during the process of factor analysis:
1. Reliability test (Cronbach’s alpha) of 41 items was carried out before factor 
analysis. Items with “corrected items-total correlation” values <0.2 (not 
discriminating well) were removed.
2. Factor analysis of the remaining items was carried out.
3. Items which failed to load on any component were removed (well below the 
standard minimum recommended value of 0.3).
4. Items with a low loading (<0.4) were removed. As a rule of thumb 0.32 is 
considered to be a minimum loading for an item (Costello and Osborne 2005) but in 
this study due to the large number of variables >0.4 was considered to be the 
minimum loading to represent strong correlation.
5. Items loaded on multiple components with not much difference between values 
(weak complex variables) were removed. However, items with significantly higher 
loading were retained.
6. Further factor analysis was carried out to see whether or not the remaining items 
with a similar concept fitted together under the appropriate corresponding 
components.
7. Another separate factor analysis was carried out, without conducting the reliability 
test at the beginning in order to examine the difference (similarities, number of items 
removed and the types of items removed) between the results of two sets of factor 
analysis carried out in two different ways (with the reliability test at the beginning 
and without the reliability test at the beginning).
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8. An examination of the prevalence of items, displayed as a table showing the 
ranking of items according to patients’ response, was used to explore the prevalence 
ranking of deleted items. It was also used to assess the feasibility of reinstating any 
removed items, if considered necessary for conceptual reasons, and to assist decisions 
concerning whether or not removed items could be merged together. The lowest 
ranking items were compared with the items removed as a result of factor analysis to 
see the nature of both sets of items for further scale refinement. This was simply done 
by “eyeballing” the items’ prevalence (%)/ranking table to review the degree of 
corroboration between the two sets of data.
9. Remaining and deleted items were re-examined again by the research team as part 
of the scale refinement. Final decisions were made on the basis of the results of the 
initial factor analysis, the factor analysis carried out for comparative reasons and of 
the examination of item prevalence. Each item was discussed in detail. Items were 
deleted, retained, merged or rephrased on statistical, conceptual and philosophical 
grounds. Although the research team reviewed again all 41 items, more emphasis was 
given to those items with low prevalence and to those suggested for deletion by factor 
analysis.
10. Items that conceptually misfitted in the extracted components were moved to 
conceptually more appropriate and meaningful components in order to create a sense 
of logical order for respondents.
RESULTS
Demographic characteristics of the study participants
A total of 210 patients completed the MLCDP (version la) (female=108 (51.4%), 
male=102 (48.6%); mean age=50.8 years, median=52 years; range= 16-89 years) 
(Table 6.1). 122 (58%) of the participants only had school education, 52 (25%) 
patients had college level and 36 (17%) had university education. Half of the patients 
105 (50%) were married, 55 (26.2%) were single and 24 (11.4%) were divorced. In 
terms of employment status, 71 (33.8%) patients were employed, 42 (20%) were 
unemployed, 42 (20%) were retired and 46 (21.9%) patients had retired early due to 
the impact of chronic disease. Patients’ demographics are shown in detail in Table 
6 . 1.
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Patients had been suffering from one of 32 different chronic conditions. The overall 
mean disease duration was 19 years (range 2 to 74 years) (Table 6.2).
Table 6.1: Socio-demographic characteristics of the study participants (n=210)
Variables Number (%)
Age (years)
Range 16-89
Median 52
Mean 50.8
Gender
Female 108 (51.4)
Male 102 (48.6)
Education
School 122 (58.1)
College 52 (24.8)
University 36(17.1)
Marital status
Single 55 (26.2)
Married 105(50)
Divorced 24(11.4)
Living with partner 6 (2.9)
Widowed 19(9)
Civil partnership 1 (0.5%)
Employment status
Employed 71 (33.8)
Unemployed 42 (20)
Retired 42 (20)
Early retirement 46(21.9)
Self employed 6 (2.9)
Housewife 2(1)
Student 1 (0.5)
There were two cycles of factor analysis performed and will be reported in this 
chapter. However, for the purpose of clarity they will be labelled as “factor analysis 
I” and “factor analysis II”. Factor analysis II was carried out at scale refinement stage 
for comparison.
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Table 6.2: Prevalence o f different disease status in the study participants (n=210)
Specialities/diseases N Percent
1. Cardiology
Coronary artery disease (CAD) 7 3.3
Congenital heart disease 12 5.7
Atrial fibrillation (AF) 6 2.9
Myocardial infarction (MI) 3 1.4
Congestive pericarditis 1 0.5
Congestive heart failure 1 0.5
2. Nephrology
CKD IV 23 11.0
CKD V 7 3.3
3. Respiratory Medicine
COPD 30 14.3
4. Cystic Fibrosis (CF) 30 14.3
§. Diabetes
Diabetes Type 2 23 11.0
Diabetes Type 1 7 3.3
6. Rheumatology
Rheumatoid arthritis 12 5.7
Ankylosing spondylitis 1 0.5
Psoriatic arthritis 6 2.9
Osteoarthritis 1 0.5
Polymyalgia rheumatica 1 0.5
Systemic lupus erythematosus 1.0
Sjorgen's syndrome 1 0.5
Reflex sympathetic dystrophy 1 0.5
Connective tissue disorder 1 0.5
Sarcoidosis 1 0.5
Antiphospholipid syndrome 1 0.5
Fibromyalgia 1 0.5
Reflex sympathetic dystrophy 1 0.5
7. Dermatology
Psoriasis 16 7.6
Atopic eczema 8 3.8
Acne 2 1.0
Hidradenitis suppurativa 1 0.5
Alopecia areata 1 0.5
Pityriasis lichenoides chronica 1 0.5
Behcet’s syndrome 1 0.5
Total 210 100.0
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Factor Analysis I 
Reliability of the MLCDP
The reliability of the MLCDP (version la) was measured before factor analysis to 
determine whether or not items could be removed in order to increase the overall 
scale reliability. In the “items total statistics” table (generated by SPSS software), 
items are normally considered weak and less discriminative if their “items-total 
correlation” value is <0.2. Therefore, if the item is not discriminating well within the 
scale, removal of this item will increase the overall evaluative power of the scale. The 
cut-off value of item-total correlation varies in the literature from 0.2 to 0.4 (Nunnally 
and Bernstein 1994; Traub 1994; Lounsbury et al. 2006). The higher the value the 
more discriminating the item will be. Due to the unique conceptual basis of each item, 
the cut-off value of items-total correlation was kept to <0.2. The “items total statistic” 
also forecasts the level of Cronbach’s alpha if a particular item/items are deleted. An 
item should be considered for removal if it improves the reliability of a scale. 
Otherwise, in the case of small changes, it is better to retain the item (Pallant 2005).
The internal consistency reliability was measured by using Cronbach’s alpha 
coefficient (Cronbach 1951). The Cronbach’s alpha reliability of the 41 items was 
0.84 indicating that the scale has good reliability (Pallant 2005).
The “individual items statistics” indicated that for 7 items, the “corrected total-item 
correlation” values were <0.2 and therefore were removed. These items most likely 
would have not discriminated well within the scale. The removed items are 
highlighted in Table 6.3 in bold type. The full description of the removed items is 
given in Table 6.4. The removal of 7 items slightly increased the reliability of the 
scale (34 items) from Cronbach’s alpha of 0.84 to 0.85. No item was identified which, 
if it had been deleted, would have resulted in significantly better reliability.
Exploratory factor analysis
Exploratory factor analysis of the remaining 34 items of the MLCDP was carried out 
for the purpose of construct validity (Fayers and Hand 1997) and to determine the 
number of factors necessary to represent data using “principal component analysis” in 
SPSS 16 statistical software (Table 6.5).
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Table 6.3: Item-total statistics for the MLCDP (version la)
Scale 
mean if item 
deleted
Scale variance 
if item deleted
Corrected
item-total
correlation
Cronbach's 
alpha if item 
deleted
Leave school education early 23.9 293 .285 .843
Change study subject 23.9 292 .301 .842
Study near home 23.8 293 .231 .843
Leave college/university education early 23.9 291 .358 .841
Change choice of job/career 23.2 276 .453 .838
Give up job/career after starting 23.4 275 .529 .836
Completely change job/career 23.3 276 .467 .837
Take early retirement 23.2 281 .278 .844
Flexible working hours 23.5 283 .399 .840
Select a job/career suitable for health 23.2 282 .349 .841
Not to take promotion 23.8 289 .326 .841
Shorter working hours 23.3 282 .361 .840
Become self-employed 23.8 296 .092 .846
Remain unemployed 23.3 278 .404 .839
Change plans for having children 23.7 286 .353 .841
Not to have more children 23.8 291 .225 .843
Not to have any children 23.8 294 .161 .845
Seek fertility treatment 23.9 291 .392 .841
Not to have a sexual relationship 23.6 291 .230 .843
Not to marry or have a long term partner 23.9 292 .275 .843
Divorce or separation from partner 23.9 292 .281 .842
Change my eating habits 22.1 279 .364 .840
Change my smoking/drinking/alcohol habits 22.3 283 .241 .845
Travel or holidays abroad 22.8 279 .368 .840
Not to buy my own home 23.9 290 .349 .841
Move my home 23.5 286 .296 .842
Move abroad 23.5 295 .072 .847
Move from one country to another 24.0 298 .110 .845
Move to another city 23.8 289 .354 .841
Move back to home area 23.9 290 .440 .841
Move to another part of the country 23.9 295 .221 .844
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Wear different types/colour clothes/shoes 23.0 279 .332 .842
Involved in community activities 22.9 273 .507 .836
Not to socialise 23.0 274 .524 .836
Wear make up 23.9 292 .305 .842
Wear wig/toupee 24.0 298 .181 .844
Not to go swimming 22.9 274 .457 .837
Not to take part in sports activities 22.8 269 .544 .834
Change to different sports activities 23.3 286 .284 .842
More physically active 22.9 290 .156 .846
Give up driving 23.7 292 .182 .844
Table 6.4: Full description of 7 removed items
Item number Full description of the removed item
B9 I decided to become self-employed
C3 I decided not to have any children
D6 I wanted to move abroad but decided not to
D7 I decided to move from one country to another
D15 I decided to wear a wig/toupee
E4 I decided to be more physically active
E5 I decided to give up driving
All of the 34 items of the MLCDP (version la) were subjected to a “factor extraction” 
process. It has been recommended that analysis should ideally be based on 300 cases, 
however 150 cases should be sufficient to consider the data suitable for factor 
analysis (Pallant 2005). The sample size of 210 patients in this study was therefore 
considered sufficient for conducting factor analysis.
Correlation matrix
The data was statistically assessed for its appropriateness for factor analysis. A 
correlation matrix was generated as part of steps to be followed for factor analysis. A 
correlation matrix should show correlation coefficients of a magnitude at least r=0.3 
and above between variables (Pallant 2005). The correlation matrix for the 34 items
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of MLCDP demonstrated the presence of correlation coefficients r=0.3 and above 
between several variables, thereby providing evidence of the suitability of the data for 
carrying out factor analysis. (Appendix X)
Table 6.5: Remaining items (34) used for factor analysis
Item
numbers
Item numbers in 
MLCDP (version la)
Item short description
Item 1 A1 Leave school education early
Item 2 A2 Change study subject
Item 3 A3 Study near home
Item 4 A4 Leave college/university education early
Item 5 B1 Change choice of job/career
Item 6 B2 Give up job career after starting
Item 7 B3 Completely change job/career
Item 8 B4 Take early retirement
Item 9 B5 Flexible working hours
Item 10 B6 Select a job/career suitable for health
Item 11 B7 Not to take promotion
Item 12 B8 Shorter working hours
Item 13 BIO Remain unemployed
Item 14 Cl Change plans for having children
Item 15 C2 Not to have more children
Item 16 C4 Seek fertility treatment
Item 17 C5 Not to have a sexual relationship
Item 18 C6 Not to marry or have a long term partner
Item 19 C7 Divorce or separation from partner
Item 20 D1 Change my eating habits
Item 21 D2 Change my smoking/drinking/alcohol habits
Item 22 D3 Travel or holidays abroad
Item 23 D4 Not to buy my own home
Item 24 D5 Move my home
Item 25 D8 Move to another city
Item 26 D9 Move back to home area
Item 27 DIO Move to another part of the country
Item 28 D ll Wear different types/colour clothes/shoes
Item 29 D12 Involved in community activities
Item 30 D13 Not to socialise
Item 31 D14 Wear make up
Item 32 El Not to go swimming
Item 33 E2 Not to take part in sports activities
Item 34 E3 Change to different sports activities
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Test for sample adequacy
Along with the correlation and component matrix, two more statistical techniques 
“Bartlett’s test of sphericity” (Bartlett 1954) and “Kaiser-Meyer-Olkin (KMO) 
measure” (Kaiser 1970, 1974) were applied to check the adequacy of sampling. 
Bartlett’s test of sphericity should be statistically significant at p<0.05 and the KMO 
value should be 0.6 or above (Pallant 2005). The following KMO descriptors have 
been defined by Kaiser (1974) to allow their interpretation:
Measure in the 0.90’s = Marvellous 
Measure in the 0.80’s = Meritorious 
Measure in the 0.70’s = Middling 
Measure in the 0.60’s = Mediocre 
Measures below 0.50 = Unacceptable
In this study, the Kaiser-Meyer-Olkin (KMO) value was 0.73. This is greater than the 
recommended minimum of 0.6. Bartlett’s test of sphericity was significant at 
p=0.0001 confirming the sampling adequacy of the data and fulfilling the statistical 
criteria for carrying out factor analysis (Table 6.6).
Table 6.6: KMO and Bartlett's test: assessment of the suitability of the 34 items
of MLCDP for factor analysis
Kaiser-Meyer-Olkin Measure of Sampling Adequacy .736
Bartlett's Test of Sphericity Approx. Chi-Square
df
Sig.
2359.626
561
.0001
Factor extraction
To determine how many factors were able to be extracted, Kaiser’s criterion and 
Cattell’s scree test statistical techniques were applied:
Kaiser’s criterion
In Kaiser’s criterion rule, factors of Eigenvalue of one or more are retained for further 
analysis. Factor extraction using principle component analysis determines the
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numbers of factors (components) which represent the data. The components that are 
suitable should have an Eigenvalue of one or above (Pallant 2005). This principle 
component analysis for the initial factor extraction revealed 12 components with 
Eigenvalues >1, with percentages of variance 18.3, 8.0, 6.8, 5.2, 4.8, 4.3, 4.1, 3.7, 3.5, 
3.3, 3.2 and 2.9 respectively. These 12 components explained 68.6% of the variance. 
The Eigenvalues with the percentage of variance of all the factors is presented in 
Table 6.7 in detail. Kaiser’s criterion rule has been criticised because its use may 
retain too many factors in some cases (Pallant 2005). The default Eigenvalue is 1.0 in 
most statistical software packages, which therefore retain all factors with an 
Eigenvalue >1.0. This technique is therefore considered to be the least accurate 
method for factor extraction (Costello and Osborne 2005).
Component matrix
The component matrix for the 34 items of MLCDP was generated; this showed the 
loadings of 34 items on 12 components. It is obvious from the matrix that most of the 
items loaded strongly (0.3 and above) on the first six components. It is recommended 
by SPSS software that any loading above this value should be considered for future 
analysis. Of the 34, 20 items had values of >0.40 (Table 6.8).
CattelVs scree test
The use of a scree plot is another commonly used technique which allows retention of 
the exact numbers of factors for further analysis. The Cattell’s scree test (Catell 1966) 
depends on a visual analysis, and involves creating a graph by plotting the Eigenvalue 
of each factor, also known as “scree plot” resembling an “elbow” shape. The key part 
of this test is the identification of the position of any sharp variation or break point on 
the “elbow” of the graph. It is recommended that factors above this break point 
should be retained or be considered for further analysis (Catell 1966). In the scree 
plot shown in Figure 6.1, four components were retained for further analysis. The first 
factor has the highest Eigenvalue. There is a sharp drop after the first factor indicating 
that the first factor accounts for most of the variance (18%). Each successive factor 
indicates a smaller amount of total variance.
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Table 6.7: Principle component analysis describing the total variance
Component
Initial Eigenvalues Extraction Sums of Squared Loadings
Total % of Variance Cumulative % Total % of Variance Cumulative %
1 6.23 18.33 18.33 6.23 18.33 18.33
2 2.73 8.04 26.38 2.73 8.04 26.38
3 2.32 6.82 33.20 2.32 6.82 33.20
4 1.79 5.28 38.48 1.79 5.28 38.48
5 1.63 4.80 43.29 1.63 4.80 43.29
6 1.49 4.39 47.68 1.49 4.39 47.68
7 1.39 4.10 51.78 1.39 4.10 51.78
8 1.25 3.70 55.48 1.25 3.70 55.48
9 1.19 3.52 59.01 1.19 3.52 59.01
10 1.13 3.34 62.35 1.13 3.34 62.35
11 1.10 3.25 65.61 1.10 3.25 65.61
12 1.02 2.99 68.61 1.02 2.99 68.61
13 .93 2.74 71.35
14 .81 2.40 73.76
15 .80 2.37 76.12
16 .76 2.25 78.38
17 .70 2.06 80.44
18 .64 1.90 82.35
19 .59 1.73 84.08
20 .55 1.62 85.71
21 .53 1.57 87.28
22 .47 1.39 88.68
23 .46 1.36 90.04
24 .43 1.28 91.33
25 .41 1.22 92.55
26 .38 1.13 93.69
27 .35 1.04 94.74
28 .31 .92 95.67
29 .29 .85 96.52
30 .28 .83 97.35
31 .25 .73 98.09
32 .23 .70 98.79
33 .22 .65 99.44
34 .18 .55 100.00
Extraction Method: Principal Component Analysis.
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Table 6.8: Component matrix (twelve components extracted) of MLCDP
MLCDP
Items
Components
1 2 3 4 5 6 7 8 9 10 11 12
B2 .580 -.118 -.110 .503 -.126 -.112 .229 -.110 -.206
E2 .576 -.454 -.132 -.215 -.108 -.222 .139 -.183
D13 .564 -.449 .102 -.295 -.114 .140
D12 .562 -.447 .113 -.393 .129
B3 .545 -.363 .266 .101 -.244 .101 .369 -.169 .123
D9 .543 .289 .168 -.162 -.336 -.123 .267 -.190
B1 .540 -.300 .324 .251 -.173 -.253 .246 .114 .147
E1 .523 -.390 -.201 -.223 .114 -.172 -.234 -.205 -.170
C4 .497 .418 .178 -.112 -.173 .185 -.443
A4 .472 .388 -.164 -.397 .183 -.289 .175
B5 .457 .115 -.379 .125 -.223 .156 .224 -.111 -.206 -.273 -.113 -.125
B10 .448 -.168 .205 .367 .352 -.148 .125 -.138 -.137
D8 .438 .357 -.198 -.314 .170 .138 .186 .223
B8 .424 -.348 .392 -.405 -.185 -.158
D11 .422 -.365 -.175 -.218 -.112 -.179 .413 -.123 .162 .128
D3 .411 -.308 .171 -.304 -.203 .140 .251 -.188 .301
D1 .379 -.251 -.123 .372 .248 -.242 .294
D5 .354 .279 .351 -.261 -.197 -.216 -.329 .270
A3 .347 .534 -.245 .101 .191 .226 -.311 .199
A2 .402 .444 -.203 1 •A 00 CO .271 .106 -.283 -.270
B6 .432 .137 -.525 .153 .237 -.186 -.106 .247
C7 .363 .177 .514 .261 -.369 .134 .100 -.119
C6 .370 .272 .508 -.309 -.101 .230
B4 .301 -.257 .428 .398 -.118 .211 .345 -.125 -.165
C5 .259 -.213 .334 .196 -.168 .120 .291 .178 .199
C2 .269 .511 .497 .110 -.195 .334
A1 .346 .237 .294 -.132 .502 -.208 .286 .121 -.244
D10 .245 .124 -.127 -.476 .262 .134 -.141 -.102 .366 .303
C1 .431 .306 -.101 .124 .509 -.208 .128 .156
B7 .333 -.239 .237 -.171 .424 .199 .264 .383 .110
D4 .426 .208 .305 .168 .181 -.143 -.474 -.210 .104
D2 .229 -.318 .175 .191 -.156 .107 .300 -.308 .334 -.254
D14 .358 -.140 -.252 .283 .373 .175 -.279 .395
E3 .321 -.151 -.261 -.159 -.105 -.249 -.120 -.288 .188 .350 -.411
Extraction Method: Principle Component Analysis. 
12 components extracted.
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Figure 6.1: Scree plot showing the amount of variance (34 items)
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Component Number
Factor rotation and interpretation
Once the exact numbers of factors have been determined, the next step is to rotate 
factors either by “orthogonal” rotation (Varimax, Quartimax and Equamax) or by 
“oblique” rotation (Direct oblimin, Promax). The factor rotation technique reveals 
clearly the pattern o f loadings which assists their interpretation. The varimax 
technique is by far the most commonly used method for exploratory factor analysis 
and the direct oblimin method is the most commonly used for oblique rotation 
(Pallant 2005).
In this study, the orthogonal varimax rotation technique was applied. The varimax 
rotated component matrix revealed, that after rotation, thirty items loaded strongly 
(>0.40) (Table 6.9-highlighted in bold) on one o f the four components, indicating a
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strong correlation between the item and the corresponding components or factors. 
Most items strongly loaded on component 1 (11), component 2 (7) and component 3 
(7). Two items loaded weakly (<0.4) on component 2. Although these two items were 
above the standard minimum value of 0.3, it is likely that they may cause “noise” at a 
later stage of the analysis. It is up to the judgment of the researcher whether to retain 
or delete them. Only five items loaded on more than one component. It is normally 
advised that such items remain in the component associated with the higher loading 
value. It is also up to the researcher’s choice to place an item in the component which 
best fits with the concept of the particular item, if the variable has almost similar 
values on two components. If there is no significant difference between the items 
values associated with two different components, the item is normally considered for 
deletion. Only two items failed to load on any component (Table 6.9), and were 
therefore deleted.
Further analysis of “total variance explained” revealed that the four factors identified 
from the rotation accounted for 38.4% of the total variance, along with their 
percentage of variance explained (Table 6.10). The first two factors accounted for the 
highest proportion of variance, 10.5% and 10.2% respectively. The third factor 
accounted for 9.8% and the fourth factor accounted for 7.8% of the total variance 
explained. After rotation, the pattern of the percentage of variance of individual 
components and their cumulative percentage changed from the total variance 
explained earlier in Table 6.7. However, cumulative total variance explained (38.4%) 
does not change after rotation.
Further examination
In the rotated component matrix, two items which failed to load into any component 
(well below the standard minimum recommended value of 0.3) were removed from 
further analysis. There were two items with weak loading (<0.4) and one item loaded 
on multiple components with no significant difference in their values. Therefore, in 
total five items were removed from further analysis (Table 6.11).
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Table 6.9: Factor analysis of the MLCDP: Varimax rotated matrix with item loading
MLCDP Items Components
1 2 3 4
Seek fertility treatment .658 .146
Study near home .639 .149 -.185
Move back to home area .603 .196 .139 .109
Not to marry or have a long term partner .594 -.168 .303
Leave college/university education early .534 .292
Move to another city .519 .125 .255 -.122
Change study subject .514 .341 -.228
Change plans for having children .504 .175
Leave school education early .496 .147
Divorce or separation from partner .486 -.134 .417
Not to buy my own home .430 .107 .386
Not to have more children .177 - .137 .167
Involved in community activities .147 .800 .147
Not to socialise .113 .749 .205
Not to go swimming .663 .273
Not to take part in sports activities .645 .275 .243
Wear different types/colour clothes/shoes .588 .206
Travel or holidays abroad .156 .578 .143
Wear make up .168 .423
Change my eating habits .381 .247
Change to different sports activities .370 .270
Select a job/career suitable for health .691
Completely change job/career .121 .134 .671 .139
Change choice of job/career .137 .650 .206
Give up job career after starting .120 .585 .507
Flexible working hours .155 .126 .584
Shorter working hours .177 .195 .483
Not to take promotion .444 .146
Move to another part of the country .148 .275
Take early retirement .700
Remain unemployed .141 .223 .575
Move my home .198 .140 .517
Not to have a sexual relationship .154 .484
Change my smoking/drinking/alcohol habits .214 .406
Extraction Method: Principal Component Analysis. Rotation Method: Varimax with Kaiser Normalization.
Table 6.10: Four factors with total variance explained
Component Rotation Sums of Squared Loadings
Total %  of Variance Cumulative %
1 3.60 10.59 10.59
2 3.49 10.28 20.87
3 3.33 9.80 30.68
4 2.65 7.80 38.48
Extraction Method: Principle Component Analysis
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Table 6.11: Full description of the five removed items with reasons for their
removal
Reason Item Full description o f  removed item
Failed to load C2 I decided not to have more children
DIO I decided to move to another part 
o f  the country
Loaded weakly (<0.4) D1 I decided to change my eating habits
E3 I decided to change to different sporting 
activities
Loaded weakly on tw o  
components with not much 
difference b/w the two values
D4 I decided not to buy my own home
Further analysis can be performed if there is a large set of data to remove additional 
weak items and to maintain strong factors (Costello and Osborne 2005). A further 
factor analysis of the remaining 29 items of MLCDP was carried out to see whether 
or not the remaining items were fitting well together in their respective components. 
A similar step by step procedure as described earlier in “factor analysis I” was 
followed. KMO and Bartlett’s test of sphericity (Table 6.12), correlation matrix 
(Appendix Y) and component matrix (Table 6.13) were undertaken, fulfilling the 
basic criteria of carrying out factor analysis. The table of total variance explained 
(Table 6.14) extracted nine factors which explained 63.8% of the variance. From the 
scree plot examination (Figure 6.2), three factors were extracted for further analysis. 
This scree plot was relatively improved (smooth) compared to the previous scree plot 
where four factors were extracted. Again varimax rotation was applied to aid final 
interpretation.
Table 6.12: KMO and Bartlett's test: assessment of the suitability of 29-items of
MLCDP for factor analysis
Kaiser-Meyer-Olkin Measure of Sampling Adequacy. .756
Bartlett's Test of Sphericity Approx. Chi-Square
df
Sig.
1938.227
406
.0001
0
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Table 6.13: Component matrix (nine components extracted) of the MLCDP
MLCDP
Item
Component
1 2 3 4 5 6 7 8 9
B2 .589 -.129 -.143 .515 -.178 -.110 .168
E2 .574 -.449 -.113 -.149 -.123
D13 .566 -.448 -.317 .164 -.129
B3 .562 -.384 .258 -.253 -.260 .220
D12 .559 -.435 -.417 -.104 .108
B1 .549 -.333 .308 .165 -.299 -.285 .119 -.130
E1 .535 -.383 -.194 -.272 -.204 -.276 -.150
D9 .534 .291 .250 -.332 .262 -.121
C4 .505 .411 .240 -.120 .252 -.235 -.163 -.220
A4 .487 .376 .117 .191 -.479 -.115 -.102
B5 .450 .150 -.383 -.159 .302 .326 -.184
B10 .441 -.198 .138 .370 -.167 -.251 .254 -.196
D8 .440 .378 -.139 -.195 .200 .275 .331
B8 .430 .113 -.356 .113 .386 .357 -.293
D3 .422 -.298 .196 -.286 .140 .324 -.210
C1 .419 .308 .107 -.274 -.325 .168
A3 .353 .550 -.215 -.308 .294 .182
A2 .427 .476 -.108 -.148 .295 .220
B6 .437 .170 -.559 .136 -.138 -.162
C6 .359 .219 .539 -.182 -.220
C7 .366 .119 .526 .112 .508 -.108
B4 .309 -.325 .380 .433 .219 .101 .193 .219
D5 .341 .242 .353 -.125 .126 -.100 -.210 -.225
A1 .337 .203 .294 -.126 .642 -.163 .208
D14 .360 -.134 -.292 .372 .255 -.141 -.225 .260
B7 .314 -.259 .194 .363 .251 .431 .172
D2 .212 -.311 .141 .226 .326 .223 .414 -.302
D11 .447 -.350 -.151 -.238 -.200 -.118 .504
C5 .261 -.255 .312 .230 -.153 .371
Extraction Method: Principal Component Analysis. 
9 components extracted.
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Table 6.14: Principle component analysis describing the total variance explained
Component
Initial Eigenvalues Extraction Sums of Squared Loadings
Total % of Variance Cumulative % Total % of Variance Cumulative %
1 5.74 19.82 19.82 5.74 19.82 19.82
2 2.63 9.09 28.91 2.63 9.09 28.91
3 2.20 7.61 36.53 2.20 7.61 36.53
4 1.75 6.04 42.57 1.75 6.04 42.57
5 1.47 5.10 47.67 1.47 5.10 47.67
6 1.32 4.56 52.23 1.32 4.56 52.23
7 1.17 4.06 56.29 1.17 4.06 56.29
8 1.11 3.83 60.13 1.11 3.83 60.13
9 1.09 3.76 63.89 1.09 3.76 63.89
10 .97 3.35 67.24
11 .87 3.00 70.25
12 .82 2.85 73.10
13 .79 2.73 75.84
14 .74 2.58 78.43
15 .70 2.41 80.84
16 .60 2.07 82.92
17 .56 1.95 84.88
18 .54 1.88 86.76
19 .49 1.70 88.47
20 .47 1.62 90.09
21 .45 1.55 91.64
22 .40 1.41 93.05
23 .35 1.23 94.29
24 .32 1.13 95.42
25 .31 1.07 96.50
26 .28 .98 97.48
27 .26 .90 98.38
28 .24 .84 99.23
29 .22 .76 100.00
Extraction Method: Principal Component Analysis.
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Figure 6.2: Scree plot showing the amount o f  variance (29 items)
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Table 6 .15 confirms the initial structure of the scale after varimax rotation which 
reduces the number of MLCDP items and augments interpretation. All 29 items 
loaded to 3 extracted components. 26 items loaded highly (0.4 and above). 3 items 
loaded weakly (<0.4). Six items loaded on two components, and for 3 of these items, 
the values on two components were very close (weak complex variables). It is 
recommended that 5 or more strongly loading items (0.5 or above) are desirable to 
create a solid factor (Costello and Osborne 2005). Component 1 (factor) comprises of 
12 items in which only 2 items loaded weakly (range=0.31 to 0.69). Component 2 
comprises o f 10 items with factor loading ranging from 0.46 to 0.67, with no weak 
loading. Component 3 comprises of 7 items with loadings ranging from 0.38 to 0.72, 
with only one weak loading. Table 6.16 shows the total variance explained of the 
extracted component, demonstrating that the 3 factors accounted for 36.5 % of the 
total variance. Although there were 5 more items in the first rotation and four 
components were extracted, there was not much difference compared to the 
percentage of total variance explained after the first rotation (38.4%). The first factor 
accounted for the highest proportion of variance, 12.7%. The second and third factors 
accounted for an almost similar proportion of the variance; 11.9% and 11.8% 
respectively.
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Table 6.15: Varimax rotated matrix with items loading
MLCDP Items Components
1 2 3
Not to socialise .693 .215
Involved in community activities .683 .201
Not to take part in sports activities .632 .377
Take early retirement .548 .139 -.160
Travel or holidays abroad .535 .127
Not to go swimming .534 .426
Wear different types/colour clothes/shoes .471 .344
Remain unemployed .454 .176 .126
Not to have a sexual relationship .446 .126 -.125
Change my smoking/drinking/alcohol habits .400
Move my home .322 .272
Wear make up .311 .103 .201
Seek fertility treatment .672 .153
Not to marry or have a long term partner .235 .612 -.194
Move back to home area .190 .611 .148
Study near home -.167 .599 .214
Leave college/university education early .558 .268
Divorce or separation from partner .308 .542 -.191
Move to another city .510 .280
Change study subject -.129 .499 .393
Change plans for having children .489 .197
Leave school education early .151 .467
Select a job/career suitable for health .725
Completely change job/career .143 .174 .648
Change choice of job/career .155 .181 .599
Flexible working hours .156 .589
Shorter working hours .133 .551
Give up job career after starting .398 .163 .446
Not to take promotion .129 .387
Extraction Method: Principal Component Analysis. Rotation Method: 
Varimax with Kaiser Normalization.
Rotation converged in 7 iterations.
229
Table 6.16: Three factors with total variance explained
Component
Rotation Sums of Squared Loadings
Total % of Variance Cumulative %
1 3.69 12.74 12.74
2 3.45 11.91 24.66
3 3.44 11.86 36.53
Extraction Method: Principal Component Analysis.
From the above data it is apparent that the majority of items are close to each other in 
their corresponding components. For example, component 1 comprises of 12 items of 
which 9 items deal with MLCDs related to social and physical aspects of patients’ 
lives. Component 2 comprises of 10 items and 8 of these items deal with MLCDs 
related to family/relationships and education. The third component comprises of 7 
items and all the items are related to job/career MLCDs. The full description of each 
item in their corresponding components is shown in Table 6.17.
Table 6.17: Full description of 29 items loaded on three components with reasons
for removal of further six items
Extracted MLCDP Item full description Items deleted
component
number
(via)
number
B4 I decided to take early retirement
BIO I decided to remain unemployed
C5 I decided not to have a sexual 
relationship
D2 I decided to change my 
smoking/drinking alcohol habits
1 D3 I decided not to travel or go for 
holidays abroad
D5 I decided to move my home Weakly loaded 
(<0.4)
Dll I decided to wear different 
types/colour of clothes/shoes
Weakly loaded 
complex variable 
on component 1 
and 3
D12 I decided not to be involved in 
community activities
D13 I decided not to socialise
D14 I wanted to wear make up but decided 
not to
Weakly loaded 
(0.4)
El I decided not to go swimming Weakly loaded 
complex variable 
on component 1 
and 3
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E2 I decided not to take part in any 
sports activities
2
A1 I decided to leave school education 
early
A2 I decided to change my study subject Weakly loaded 
complex variable 
on component 2 
and 3
A3 I decided to study near home
A4 I decided to leave college/university 
education early
Cl I decided to change my plans for 
when to have children
C4 I decided to seek fertility treatment
C6 I decided not to marry or have a long 
term partner
C7 I decided to get divorced or separate 
from my partner
D9 I decided to move back to my home 
area
DIO I wanted to move to another city but 
decided not to
3
B1 I decided to change my choice of 
job/career
B2 I decided to give up my job/career 
after starting
B3 I decided to completely change my 
job/career
B5 I decided to work flexible working 
hours
B6 I decided to select a job/career 
suitable 
for my health
B7 I decided not to take promotion Weakly loaded 
(<0.4)
B8 I decided to work shorter hours
Weakly loaded and complex variables were considered for deletion (six more items) 
(Table 6.17). In total eighteen MLCDP items were deleted as a result of factor 
analysis I, and were considered at the next refinement stage of the scale. Items which 
did not conceptually fit in their extracted corresponding factors were also discussed at 
this stage and the total number of items were finalised. For example, item “B4: I 
decided to take early retirement” was grouped in component 1, along with most items 
related to the social aspects of peoples’ lives. This item could arguably fit in this 
component, as early retirement could be viewed as being a socially related MLCD. 
From an individuals’ perception and from a broader conceptual approach, this item 
could fit with social aspects. However, if we take a tighter specific approach, this item
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should be in the component where items are related to job and career. It is the 
responsibility of the researcher to judge whether an item conceptually fits with a 
component or not, and if it doesn’t belong there, either move it alongside other similar 
items or remove it all together.
Scale refinement
For the purpose of scale refinement and for selection of the final item, all the items 
that had been deleted as a result of factor analysis were compared with (a) the items 
deleted as a result of factor analysis of 41 items (Factor analysis II) carried out in 
different way (without any items being removed at the beginning through the 
reliability test) and (b) the prevalence of the items (items ranking).
(a) Factor Analysis II
An additional factor analysis of the 41 items of MLCDP (version la) was carried out 
in a different way. The purpose of this analysis was to compare the deleted items of 
this analysis with the deleted items of the initial analysis (factor analysis I) as 
described earlier in this chapter. In this analysis of 41 items, it was decided not to 
remove any item on the basis of any internal consistency reliability test at the 
beginning and so all 41 items of MLCDP (version la) were considered for factor 
analysis. In this analysis, items were deleted after the final varimax rotation based on 
the same criteria used for the previous analysis as described earlier in the 
methodology. The nature of the deleted items of this analysis were discussed by the 
research team and compared to the items deleted by the previous analysis, to inform 
the final decisions.
The same basic steps of factor analysis were applied. All the data values for 
suitability were in an acceptable range. Four factors were extracted after scree plot 
examination and varimax rotation was applied to assist final interpretation. As this 
analysis was carried out for comparative reasons to see whether any similar items 
were suggested for deletion by the two different factor analyses, only a brief 
description of this analysis is described here.
The final rotated component matrix (Table 6.18) revealed that four items failed to 
load (well below the standard minimum recommended value of 0.3) on any
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component, six items loaded weakly (<0.4) and one item loaded on two components 
with little difference between their values. Therefore, from this analysis 11 items 
were considered for removal (Table 6.19).
Table 6.18: Varimax rotated matrix with 41 items loading
MLCDP Items Component
1 2 3 4
Involved in community activities .761 .129
Not to socialise .745
Not to take part in sports activities .669 .284
Not to go swimming .576 .320
Travel or holidays abroad .545 .158
Wear different types/colour clothes/shoes .510 .259
Change my eating habits .418 .122
Change my smoking/drinking/alcohol habits .392
Give up driving .383
Wear make up .381 .201
Change to different sports activities .310 .158 .243 -.296
Seek fertility treatment .133 .661
Move back to home area .269 .617
Study near home .614 .101
Change study subject .570 .241 -.126
Move to another city .546 .260
Not to marry or have a long term partner .146 .488 -.166 .396
Change plans for having children .471 .207 .245
Leave college/university education early .452 .330 .207
Leave school education early .450 .357
Not to buy my own home .120 .437 .329
Move abroad .331
Move from one country to another -.148 .291 .108
Not to have more children .119 .250 .102
Become self-employed .143 -.107
Select a job/career suitable for health .177 .611 -.160
Wear a wig/toupee -.137 -.150 .583 .306
Completely change job/career .221 .192 .579
Flexible working hours .137 .206 .558
Change choice of job/career .200 .194 .550
Give up job career after starting .323 .517 .240
Move to another part of the country -.118 .503 .269
Not to take promotion .468
Shorter working hours .178 .250 .434 -.156
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More physically active .207 .251 -.245
Not to have any children -.204 .217 .148 .588
Take early retirement .341 .526
Move my home .121 .210 .493
Divorce or separation from partner .179 .368 -.149 .488
Not to have a sexual relationship .257 .456
Remain unemployed .364 .165 .384
Extraction Method: Principal Component Analysis.
Table 6.19: Reasons for the removal of 11 items
Reason for item 
removal
Item
number
Full description of removed item
Failed to load B9 I decided to become self-employed
C2 I decided not to have more children
D7 I decided to move from one country to another
E4 I decided to be more physically active
Loaded weakly 
(<0.4)
BIO I decided to remain unemployed
D6 I wanted to move abroad but decided not to
D14 I wanted to wear make up but decided not to
D2 I decided to change my smoking/drinking alcohol 
habits
E3 I decided to change to different sporting activities
E5 I decided to give up driving
Loaded weakly on 
two components 
with not much 
difference 
between the two 
values
D4 I decided not to buy my own home
These 11 deleted items were compared with the 18 items deleted as a result of the 
factor analysis I (Table 6.20). The comparison of the deleted items demonstrated that 
nine of the items were the same, which supported the initial approach of our factor
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analysis. In the next stage, the items deleted as a result of factor analyses were also 
compared with the prevalence (and their ranking) of these items.
Table 6.20: Comparison of the items deleted as a result of two different processes
of factor analysis
Comparison of two 
different EFA*
Item
number
Full description of the removed item
Common items deleted
B9 I decided to become self-employed
C2 I decided not to have more children
D7 I decided to move from one country to 
another
E4 I decided to be more physically active
D6 I wanted to move abroad but decided not to
E3 I decided to change to different sporting 
activities
E5 I decided to give up driving
D4 I decided not to buy my own home
D14 I wanted to wear make up but decided not to
Items only deleted after 
factor analysis I along 
with the above 9 
common items
C3 I decided not to have any children
D15 I decided to wear a wig/toupee
DIO I decided to move to another part of the 
country
D1 I decided to change my eating habits
D5 I decided to move my home
D ll I decided to wear different types/colour of 
clothes/shoes
El I decided not to go swimming
A2 I decided to change my study subject
B7 I decided not to take promotion
Items only deleted after 
factor analysis II along 
with the above 9 
common items
BIO I decided to remain unemployed
D2 I decided to change my smoking/drinking 
alcohol habits
* Exploratory Factor Analysis
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(b) The examination of prevalence of items
The item prevalence method is a simpler and possibly more appropriate way for 
considering which item to delete. This simple technique of comparison of items by 
eyeballing the table of item prevalence provides another insight into the 
appropriateness of the deletion of items as suggested by factor analysis. As the large 
sample is highly representative (n=210), examination of items prevalence is a 
powerful additional tool for selecting items.
An “examination of items’ prevalence” or items ranking table was used to compare 
the lowest ranked items (bottom of the ranking table) with the items deleted as a 
result of factor analyses. If an item conceptually did not belong to a specific 
component, then this examination also helped to inform the decision whether or not to 
retain that item, remove it or move it to a more conceptually relevant component.
A total of 210 (93.3%) of 225 patients completed the MLCDP (version la). Fifteen 
(6.6%) patients declined to take part. Patients answered all the items (41) in the 
profile. Each item in the profile represents one MLCD. The influence of chronic 
disease on the MLCDs of patients was measured on a 5-point scale (No influence or 
not applicable, slight influence, moderate influence, strong influence and very strong 
influence). The level of disease influence on MLCDs was evaluated according to the 
percentage of patients who reported this influence. Patients (n=210) answered all the 
items in the profile and no item was left unanswered. Items were ranked according to 
their prevalence (%) (Table 6.21). Only 16 items had a prevalence of <10%, as 
identified in bold text at the bottom of Table 6.21. The top three affected MLCD 
items reported by patients were related to life style and were placed in the social 
category (item Dl. I decided to change my eating habits: 71.4%, item D2. I decided 
to change my smoking/drinking alcohol habits: 58.5%, item D3. I decided not to 
travel or go for holidays abroad: 50.9%.
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Table 6.21: Prevalence of 41 MLCDP items, ranked according to the percentage 
of participating patients who reported them
MLCDP
items
Item full description %of
subjects
reported
Item
ranking
Dl I decided to change my eating habits 71.4 1
D2 I decided to change my smoking/drinking alcohol habits 58.5 2
D3 I decided not to travel or go for holidays abroad 50.9 3
E4 I decided to be more physically active 48.5 4
E2 I decided not to take part in any sports activities 46.1 5
D12 I decided not to be involved in community activities 45.7 6
D13 I decided not to socialise 42.3 7
El I decided not to go swimming 40 8
B8 I decided to work shorter hours 36.1 9
Dll I decided to wear different types/colour of clothes/shoes 34.7 10
B6 I decided to select a job/career suitable for my health 30.9 11
B1 I decided to change my choice of job/career 28.5 12
E3 I decided to change to different sporting activities 27.1 13
B3 I decided to completely change my job/career 26.6 14
B4 I decided to take early retirement 24.2 15
BIO I decided to remain unemployed 23.3 16
B2 I decided to give up my job/career after starting 23.3 17
C5 I decided not to have a sexual relationship 22.3 18
D6 I wanted to move abroad but decided not to 22.3 19
B5 I decided to work flexible working hours 21.9 20
D5 I decided to move my home 19 21
Cl I decided to change my plans for when to have children 14.2 22
E5 I decided to give up driving 12.8 23
B7 I decided not to take promotion 10.4 24
C3 I decided not to have any children 10 25
A3 I decided to study near home 9.5 26
D8 I wanted to move to another city but decided not to 9 27
C2 I decided not to have more children 8 28
C6 I decided not to marry or have a long term partner 8 29
B9 I decided to become self-employed 7.6 30
C7 I decided to get divorced or separate from my partner 7.1 31
D14 I wanted to wear make up but decided not to 7.1 32
A2 I decided to change my study subject 6.6 33
D9 I decided to move back to my home area 6.1 34
DIO I decided to move to another part of the country 6.1 35
D4 I decided not to buy my own home 6.1 36
A1 I decided to leave school education early 5.7 37
A4 I decided to leave college/university education early 5.7 38
C4 I decided to seek fertility treatment 4.2 39
D7 I decided to move from one country to another 2.8 40
D15 I decided to wear a wig/toupee 0.4 41
237
The comparison of ranked items with items deleted as a result of initial factor analysis 
demonstrated that of the 18, 8 deleted items (A2, B9, C2, D4, D7, DIO, D14 and 
D15) appeared in the lowest (<10%) section of the items prevalence ranking and 10 
deleted items appeared in the highest section of the prevalence ranking (>10%). 
Similarly, six deleted items as a result of factor analysis II, appeared highest in 
prevalence ranking. For example, item Dl (71.4%), D2 (58.5%) and item E4 (48.5%) 
appeared first, second and fourth in the prevalence ranking but these items were 
suggested by factor analyses to be removed. The complete details of this comparison 
are described in Table 6.22. This comparison was considered by the research team in 
their final selection of the items.
Table 6.22: Comparison of items deleted as a result of both factor analyses with
item prevalence/ranking
Item de 
result ol
leted as a 
FEFA*
% Items
ranking
Full description of item
1st
EFA
2nd
EFA
lowest in 
items
prevalence
ranking
D15 - 0.4 41 I decided to wear a wig/toupee
D7 D7 2.8 40 I decided to move from one country 
to another
D4 D4 6.1 36 I decided not to buy my own home
DIO - 6.1 35 I decided to move to another part of 
the country
A2 - 6.6 33 I decided to change my study subject
D14 D14 7.1 32 I wanted to wear make up but decided 
not to
B9 B9 7.6 34 I decided to become self-employed
C2 C2 8 28 I decided not to have more children
highest in 
items
prevalence
ranking
Dl - 71.4 1 I decided to change my eating habits
- D2 58.5 2 I decided to change my 
smoking/drinking alcohol habits
E4 E4 48.5 4 I decided to be more physically active
El - 40 8 I decided not to go swimming
Dll - 34.7 10 I decided to wear different 
types/colour of clothes/shoes
E3 E3 27.1 13 I decided to change to different 
sporting activities
- BIO 23.3 16 I decided to remain unemployed
D6 D6 22.3 19 I wanted to move abroad but decided 
not to
D5 - 19 21 I decided to move my home
E5 E5 12.8 23 I decided to give up driving
B7 - 10.4 24 I decided not to take promotion
C3 - 10 25 I decided not to have any children
* Exploratory Factor Analysis
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The conflict between the patients9 perception and scientific scrutiny
After factor analysis, some conceptually important items such as item C3 “I decided 
not to have any children”, item D6 “I wanted to move abroad but decided not to” and 
item E5 “I decided to give up driving” were deleted. However, these items were high 
in the items prevalence ranking (>10%); at 25th, 19th and 23rd respectively. The 
question was raised in discussion whether the factor analysis was “wrong” in 
identifying for rejection conceptually important and frequently reported items, or 
whether the patients were “wrong” in reporting or verbalising their perception. This 
conflict between the patient reality and scientific scrutiny was very evident. To 
resolve this in a way which accommodates both the concepts of the patients’ reality 
and the scientific approach appeared to be a difficult task. It would be ideal if the two 
coincided, but when these concepts don’t coincide, then researchers have to take some 
logical and informed but arbitrary decisions. It was felt that these decisions should be 
based on the side of the patient and the experience that patients shared during the 
detailed interviews and through the postal survey responses. Although it is difficult to 
justify this philosophical approach logically, in our view statistical analysis can be 
legitimately combined with clinical intuition and patients’ experiences. For example, 
there are National Institute for Health and Clinical Excellence (NICE) guidelines 
available to guide clinical decisions, but to maximise the quality of care of patients, 
clinician judgment can be based on a wide range of information about an individual 
patient combined with guideline information to make it more appropriate for patients.
Decisions related to the selection of items were not straight forward. For example, if 
we look at item Dl “I decided to change my eating habits”, 71.4 % of subjects 
reported this MLCD and it was top of the item prevalence ranking. However, one of 
the factor analyses suggested that this item should be deleted. Item E4 “I decided to 
be more physically active” was reported by 48.5% of the patients and appeared fourth 
in the item prevalence ranking, but both factor analyses suggested that this item 
should be removed. Similarly, item El “I decided not to go swimming” was reported 
by 40% of patients but again was suggested to be removed by one factor analysis. 
Another item D6 “I wanted to move abroad but decided not to” was reported by 
22.3% but suggested by both factor analyses to be removed. Statistical analyses 
suggested that these items should be removed, even though they were frequently
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reported by patients. On the other hand, items B9 “I decided to become self- 
employed”, C2 “I decided not to have more children” and D14 “I wanted to wear 
make up but decided not” appeared lowest in the items prevalence ranking and were 
also suggested by both factor analyses to be removed, but a close look at these items 
gives insight into the true nature of MLCDs. Therefore, this delicate situation was 
discussed in great detail; does removing items which genuinely represent MLCDs 
really make sense?
It was reassuring that nine identical items were removed by two different methods of 
factor analyses but in reality these items (41) are valid items by definition. All the 
items of the scale were generated by patients’ responses, after a long process of 
content analysis and lengthy discussions and it is possible to argue that in reality they 
should not be removed. The point of view was shared by the research team that if we 
end up creating a questionnaire which has excellent statistical validity but is less 
representative of the patient experience due to deletion of some very obvious MLCD 
items, then the whole processes might have to be repeated again in order to include a 
specific item if reported frequently again by patients. Therefore, it was decided to take 
a conservative approach to deleting items at the scale refinement stage.
Another question raised during discussion was whether three components, as 
extracted by EFA, are enough for a profile to be patient friendly. Initially, five 
domains were generated to reflect specific sets of items but as a result of factor 
analysis these five were squeezed to three tight components with lots of items in each 
component. So the concern was obvious: is this structure better for eliciting real 
information while possibly sacrificing vital information for the sake of “statistical 
correctness”. A useful profile should be user friendly and easy to understand by 
respondents, in order to get optimal responses. Taking this argument further, the 
factor analysis was of course very important in providing insight into the nature of the 
data but what 210 patients told about their real life experiences should be and were 
the key for the conceptualisation and generation of items. For example, factor analysis 
is helpful in identifying items to be considered for removal but the grouping of items 
created at the beginning of the process was based on patients’ responses concerning 
the nature of MLCDs. It was a logical grouping of items which reflected the way 
people live in the society and MLCDs were ordered relating to different life stages.
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After the process of statistical analysis the question was raised during the refinement 
stage that, “would it not be odd if we grouped two MLCDs of a different nature 
together in one component, such as “I decided not to have any children” and “I 
decided not to buy my own home”.
This obvious tension between patients’ reality and science could be reduced by 
accepting items for removal which may significantly “create noise” at a later stage in 
the validation process, some items can for example be merged and rephrased. The 
researchers’ judgment is vital. The combination of a statistical approach, a 
philosophical approach and a conceptual approach provides researchers with an 
overall broader picture of the construct. This combined approach assists the critical 
decisions concerning item selection, and allows the possibility of really representing 
the views of patients and their experiences without loosing any critical data in the 
process.
Synthesis of the factor analysis findings
Instead of removing conceptually important items, it was decided to apply appropriate 
“phraseology” and to collapse similar items into one compact item to remove any 
ambiguity which may have been created by having similar items. In particular there 
was a discussion concerning items related to “moving”. D9 “I decided to move back 
to my home area” and DIO “I decided to move to another part of the country” were 
merged and rephrased to encompass the broader concept of that particular MLCD 
theme. Similarly, the wordings of some other items were also reviewed by the 
research team as the particular wording used may have been the problem picked up by 
factor analysis and resulting in the implication for item removal. For example, the 
double phraseology of items such as item D6 “I wanted to move abroad but decided 
not to” and D14 “I wanted to wear make up but decided not to” may have resulted in 
confusion. The second part of the items “I decided not to” may have caused a problem 
and hence these items may be identified by both factor analyses as weak items.
The research team considered all the items deleted by both factor analyses and the 
items prevalence ranking in great detail and adopted a three-pronged strategy of item 
deletion, merger and application of appropriate phraseology for scale refinement. All 
41 items were reviewed and discussed again but more attention was given to those
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items which had an item prevalence of <10% (Table 6.21) and which were also 
suggested by one of the factor analyses to be removed (Table 6.20). The final results 
of scale refinement are as follows, which is presented according to the item number as 
it appeared in the profile and their prevalence/ranking (Table 6.21).
Low prevalence items suggested by factor analyses for deletion 
Item D1S: I decided to wear a wig/toupee
Item D15 was removed on the basis of its very low prevalence (0.4%). It was reported 
by only one subject and appeared last in the ranking (41st). One of the factor analyses 
also suggested that this item should be removed.
Item D7:1 decided to move from one country to another
Item D7 was removed because it was reported by only 2.8% of the subjects and came 
second from the bottom of the item prevalence ranking list. It was also suggested by 
both factor analyses to be deleted. The other reason for the removal of this item was 
there were several other items covering the MLCD theme related to “moving”. Item 
D7 was therefore removed because of the similar nature of three other items D5, D9 
and DIO.
Item D4:1 decided not to buy my own home
Item D4 was suggested to be removed by both factor analyses. It was also reported by 
only a few patients (6.1%) and came 36th in the items ranking list. Also, this item was 
only reported by cystic fibrosis patients. Therefore, it had narrow specificity, very low 
prevalence and its removal was suggested by both factor analyses. The item was 
therefore removed from the scale.
Item D5:1 decided to move my home,
Item D9:1 decided to move back to my home area and 
Item DIO: I  decided to move to another part o f the country
Item D5 was reported by 19% of the patients and was reasonably high in the item 
prevalence table (21st) but it was identified by the initial factor analysis for deletion. 
Item D9 was low in the ranking (34th) but it was not suggested by either factor 
analysis for removal. Item DIO also came low in the ranking (35th) but was suggested 
by one of the factor analyses to be removed. The research team discussed whether “I
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decided to move my home” also includes a move back to “my home area” and 
“another part of the country”, because when people move to another part of the 
country, they normally of course move their home. Similarly, if someone was going to 
move back to their original home area, this would also result in them moving home. It 
was suspected that because there were several items of a similar nature concerning 
this area, this may have caused problems for respondent and hence in factor loading. 
There was concern that retention of these items might cause strong “noise” at a later 
stage. On the basis of the above arguments, all three items D5, D9 and DIO were 
merged together into a single item “I decided to move”. This newly phrased item 
covers the general concept of “moving” regardless of the type of move.
Item A2:1 decided to change my study subject
Item A2 was not a straightforward item and was discussed in detail. Both factor 
analyses and its ranking in item prevalence (item ranking=33rd) highlighted it as a 
weak item and suggested that this item should be removed. However, the information 
obtained at the conceptualisation and item generation stages was reviewed and this 
item appeared to be a very important MLCD for young people. The concept of this 
item was not covered by any other item, and it was also reported by patients from 
several different specialities. On the basis of this information and particularly on the 
nature of the responses received at the conceptualisation stage, it was decided to retain 
this item.
Item D14:1 wanted to wear make up but decided not to
Item D14 was suggested by both factor analyses to be removed and also came lowest 
in ranking, reported by only 7.1% of the population. We argued earlier in this chapter 
that the wording of some of the items may have caused problems during factor 
analyses, such as the second part of this item “but decided not to”. Although this is a 
dermatology specific item, it was decided to retain the concept of this item on strong 
conceptual grounds. This item was rephrased to “I decided not to wear make up”
Item B9:1 decided to become self-employed
On reviewing the original patients’ comments, item B9 was a very big decision for 
patients who were taking positive control over their lives. However, both factor 
analyses suggested that this item should be removed. This item also appeared very
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low in the prevalence ranking (7.6%). It was discussed that this item is a positive 
item, a very important MLCD for patients, is related to a very major change in life 
and is not covered by any other item. Therefore, it was decided by the research team 
that on common sense and conceptual grounds this item should be retained.
Item C2:1 decided not to have more children and 
Item C3:1 decided not to have any children
Item C2 was suggested by both factor analyses for deletion and also emerged low in 
the item prevalence ranking 28th (8%). Item C3 was suggested by the initial factor 
analysis to be removed, but this item was reported by 10% of the patients. It was 
suspected by the research team that as these items are very similar in nature, with only 
a subtle difference, this might have made it difficult for patients to think clearly. They 
may therefore have responded to only one of the two statements, and answering only 
one statement would have resulted in serious problems when other psychometric tests 
were later carried out. The option of one compact single statement was discussed in 
order to try to capture the true response to the item, to enhance spontaneity in 
answering and to reduce ambiguity to respondents. It was decided to merge both items 
in a way that the concept of having children remained intact. Item C2 and C3 were 
merged together to form “I decided not to have children”.
Items suggested by factor analyses for deletion, but with high prevalence 
Item D l: I  decided to change my eating habits
Item Dl was suggested by the initial factor analysis for removal but appeared highest 
in the item prevalence ranking (71.4%). On the basis of its extremely high prevalence, 
item Dl was retained.
Item E4:1 decided to be more physically active
This item was identified by both factor analyses for consideration for deletion but it 
emerged fourth in the prevalence ranking, which made it one of the most highly 
prevalent items. Almost half of the population (48.5%) reported the influence of their 
chronic disease on this MLCD. It is a positive item and it appears from the interviews 
that physical activity is a very important issue to the patients. Item E4 was retained 
because of its high prevalence ranking.
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Item El: I  decided not to go swimming
Item El was suggested by initial factor analysis for removal, but reported by 40% of 
patients. Due to its high prevalence, this item was retained.
Item D ll:  I  decided to wear different types/colour of clothes/shoes
Item D ll was also suggested by initial factor analysis to be deleted but it was 
reported by 34.7% of patients. Due to its high prevalence, the research team decided 
to retain this item.
Item E3:1 decided to change to different sporting activities
Item E3 was suggested by both factor analyses to be removed, but came 13th (27.1%) 
in the item prevalence ranking. Due to its high prevalence, this item was retained.
Item D6:1 wanted to move abroad but decided not to
This item was reported by 22.3% of patients and ranked 19th in the items prevalence 
ranking. However, both factor analyses suggested that this item should be removed. It 
was suspected that this was because of the wording of this item. In particular the later 
part of the statement “but decided not to” may have caused problems during factor 
analysis. Due to its high prevalence it was decided to retain this item but it was 
rephrased to “I decided not to move abroad”.
Item D 5:1 decided to move my home
This item was merged with item D9 and DIO and discussed earlier in detail.
Item E5:1 decided to give up driving
Item E5 was suggested by both factor analyses to be removed but 12.8% of patients 
responded to this item, and it therefore ranked 23rd in the item prevalence ranking. 
Due to the high prevalence, the important nature of the MLCD, its major life-style 
implications and on simple common sense grounds, it was decided to retain this item.
Item B7:1 decided not to take promotion
Item B7 was reasonably high in prevalence (10.4%) but was suggested by initial 
factor analysis to be removed. Due to its prevalence, the important nature of this 
MLCD and on conceptual and common sense grounds this item was retained.
245
Item C3:1 decided not to have any children
This item was merged with item C2 and discussed earlier in detail.
Item D2:1 decided to change my smoking/drinking alcohol habits
Item D2 was suggested by the second factor analysis to be removed but appeared high 
in prevalence (58.5%) and second in the items ranking. Due to its high prevalence this 
item was retained.
Item BIO: I  decided to remain unemployed
Item BIO was also suggested by the second factor analysis for deletion but it appeared 
high in prevalence, being reported by 23.3% of the subjects, ranking 16th. Due to its 
high prevalence this item was retained.
Other items discussed
Item C4:1 decided to seek fertility treatment
Item C4 was not identified by the factor analyses for deletion as might have been 
expected, as it was only reported by 4.2% of patients and came third from the bottom 
of the items prevalence ranking. This item was very specific to male cystic fibrosis 
patients. The research team decided to review the patients’ comments obtained at the 
conceptualisation and item generation stages of the study. It appeared that the 
majority of the patients who reported this were from the same group of patients who 
decided not to have children. Item C4 therefore specifically belongs to that CF 
population, and even out of that CF population only 9 patients (30% of n=30) reported 
any influence. The “I decided to seek fertility treatment” concept was also discussed 
in relation to items such as “I decided not to have any children” and “I decided not to 
have more children”. It was suspected that the conflict of very similar concepts 
between these items may have confused respondents. Item C4 had a very low 
prevalence. It was entirely confined to one disease and it had limited applicability 
within a sub-group. Its possible conflict with other related items may have caused 
significant “noise” and error at later stages of the study. It was decided that on the 
basis of the above arguments item C4 should be removed from the profile.
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Item A l: I  decided to leave school education early and 
Item A4:1 decided to leave college/university education early
Items Al and A4 were 37th and 38th in the ranking of items prevalence; both items 
were reported by only 5.7% of the patients. Both items were not identified by any of 
the factor analyses for deletion. It was suspected by the research team that the lower 
response might have been due to the similarity between the items and it might be 
better if there was only single item covering this issue. It was decided that it would be 
better to merge the items and they were merged to “I decided to leave education 
early”.
Item C7:1 decided to get divorced or separate from my partner
This item was discussed by the research team because it emerged low in the item 
prevalence ranking (7.1%). Item C7 was not identified by any of the factor analyses 
for deletion and conceptually it was a very important MLCD for patients. Even 
though it was low in prevalence, the research team decided to keep this item on the 
grounds of common sense.
Item C6:1 decided not to marry or have a long term partner
This item was discussed because of its low prevalence in the prevalence ranking table 
(8%). It was not identified by any factor analysis for deletion. Like B9, this item was 
also considered as a very big change and important decision which was not covered 
by any other items. Due to the important nature of this MLCD, the research team was 
convinced that from every point of view, this item qualified as an MLCD item. 
Therefore, with consensus it was decided to retain this item.
Item D8:1 wanted to move to another city but decided not to
Item D8 was low in prevalence (9%) but it was not suggested by factor analyses for 
removal. As part of the refinement of the scale, it was important to review this item in 
the context of items D5, D9 and DIO. All of the three items were merged together and 
rephrased to a new statement “I decided to move” (see above). Item D8 however is 
completely the opposite or inverse of this concept, that the patient didn’t move 
because of their chronic condition. That is why the research team was of the view that 
this item is a very important MLCD and should not be removed. This item was 
rephrased to form “I decided not to move”.
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Item A 3:1 decided to study near home
This item is of course relevant to students who would otherwise have gone to another 
part of the country for their education, but they decided to study near home because of 
their chronic disease, availability of family support and to maintain nearness to the 
hospital and medical team that they had known for a very long time. This item was 
not identified by the factor analyses and it was reported by 9.5% of the respondents. 
This MLCD is crucial for any young student and may have long term consequences 
for their professional development in the future; this is why it is a life changing 
decision. For conceptual reasons, because of the patients’ comments and on the basis 
of common sense, it was decided to retain this item.
Item Cl: I  decided to change my plans for when to have children
Although this item was reasonably high in prevalence at 14.2% and was not suggested 
by any of the factor analyses for removal, the research team discussed its phrasing, 
particularly the latter part of the statement, “when to have children”. It was discussed 
whether the word “when” is relevant or not in this statement. The research team came 
to the conclusion that the word “when” reflects the specific nature of the item and its 
removal may result in the item being too similar to the newly phrased item “I decided 
not to have children”, which was developed as a result of merging item C2 and C3, 
thereby risking creating ambiguity among respondents. This item reflects that the 
concept of patients going to have children later or earlier than they otherwise would 
have chosen is different from the concept “not to have children”. It was decided to 
retain this item on the basis of it being a separate concept.
Item Bl: I  decided to change my choice o f job/career and 
Item B3:1 decided to completely change my job/career
Both items were high in prevalence (B 1=28.5%, B3=26.6%) and not suggested by the 
factor analyses for removal. As a part of the overall refinement stage of the scale these 
items were discussed again in detail. It is clear that patients may respond to both items 
because of their similarity. Although there is a subtle difference between the items it 
would be a difficult task for many patients to differentiate between the two. This 
would also create “noise” at a later stage when other psychometric properties are 
tested. It was decided that merger of Bl and B3 with appropriate phraseology would
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result in a stronger statement. Both items were merged to form “I decided to change 
my job/career”.
On the basis of both factor analyses and examination of items of low and of high 
prevalence (items ranking), 30 items were discussed in detail. Seventeen items were 
retained, of which three items were rephrased. Nine items were merged to create four 
new items and four items were completely removed. All the changes made after factor 
analysis and at the scale refinement stage are shown in Table 6.23. The list of the final 
32 items is shown in Table 6.24.
Table 6.23: The full detail of all the changes made after factor analysis and at the
scale refinement stage
Item
Number
Item full description 
MLCDP-versionl a
After factor analysis and scale 
refinement
Al I decided to leave school 
education early
Merged with A4 to form “ I decided to 
leave education early”
A2 I decided to change my study 
subject
Retained
A3 I decided to study near home Retained
A4 I decided to leave 
college/university education 
early
See Al
Bl I decided to change my choice of 
job/career
Merged with B3 to from “I decided to 
change my job/career”
B2 I decided to give up my 
job/career after starting
No change
B3 I decided to completely change 
my job/career
See Bl
B4 I decided to take early retirement No change
B5 I decided to work flexible 
working hours
No change
B6 I decided to select a job/career 
suitable for my health
No change
B7 I decided not to take promotion Retained
B8 I decided to work shorter hours No change
B9 I decided to become self- 
employed
Retained
BIO I decided to remain unemployed Retained
Cl I decided to change my plans for 
when to have children
No change
C2 I decided not to have more 
children C2 and C3 merged together to form “I 
decided not to have children”C3 I decided not to have any 
children
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C4 I decided to seek fertility 
treatment
Removed
C5 I decided not to have a sexual 
relationship
No change
C6 I decided not to marry or have a 
long term partner
Retained
Cl I decided to get divorced or 
separate from my partner
Retained
Dl I decided to change my eating 
habits
Retained
D2 I decided to change my 
smoking/drinking alcohol habits
Retained
D3 I decided not to travel or go for 
holidays abroad
No change
D4 I decided not to buy my own 
home
Removed
D5 I decided to move my home Merged with D9 and DIO to form “I 
decided to move”
D6 I wanted to move abroad but 
decided not to
Retained and rephrased to “I decided 
not to move abroad”
Dl I decided to move from one 
country to another
Removed
D8 I wanted to move to another city 
but decided not to
Retained and rephrased to “ I decided 
not to move”
D9 I decided to move back to my 
home area See D5
DIO I decided to move to another part 
of the country
D ll I decided to wear different 
types/colour of clothes/shoes
Retained
D12 I decided not to be involved in 
community activities
No change
D13 I decided not to socialise No change
D14 I wanted to wear make up but 
decided not to
Retained and rephrased to form “ I 
decided not to wear make up”
D15 I decided to wear a wig/toupee Removed
El I decided not to go swimming Retained
E2 I decided not to take part in any 
sports activities
No change
E3 I decided to change to different 
sporting activities
Retained
E4 I decided to be more physically 
active
Retained
E5 I decided to give up driving Retained
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Table 6.24: The MLCDP items retained for the final version
Serial
number
New item 
number
Item full description
1 Al I decided to leave education early
2 A2 I decided to change my study subject
3 A3 I decided to study near home
4 Bl I decided to change my job/career
5 B2 I decided to give up my job/career after starting
6 B3 I decided to take early retirement
7 B4 I decided to work flexible working hours
8 B5 I decided to select a job/career suitable for my health
9 B6 I decided not to take promotion
10 B7 I decided to work shorter hours
11 B8 I decided to become self-employed
12 B9 I decided to remain unemployed
13 Cl I decided to change my plans for when to have children
14 C2 I decided not to have children
15 C3 I decided not to have a sexual relationship
16 C4 I decided not to marry or have a long term partner
17 C5 I decided to get divorced or separate from my partner
18 Dl I decided to change my eating habits
19 D2 I decided to change my smoking/drinking alcohol habits
20 D3 I decided not to travel or go for holidays abroad
21 D4 I decided to move
22 D5 I decided not to move
23 D6 I decided not to move abroad
24 D7 I decided to wear different types/colour of clothes/shoes
25 D8 I decided not to be involved in community activities
26 D9 I decided not to socialise
27 DIO I decided not to wear make up
28 El I decided not to go swimming
19 E2 I decided not to take part in any sports activities
30 E3 I decided to change to different sporting activities
31 E4 I decided to be more physically active
32 E5 I decided to give up driving
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Final structure of the MLCDP
The factor analysis extracted three components for variables loading. Component 1 
comprised of 12 items and 9 items dealing with MLCDs related to social and physical 
aspects of patients’ lives. Component 2 comprised of 10 items and 8 items dealing 
with MLCDs related to family/relationships and education. Component 3 comprised 
of 7 items and all items are related to job/career MLCDs. However, after factor 
analysis and at the scale refinement stage the number of final items increased from 29 
items to 32 items.
In general, factor analysis suggested that the most of the items related to education, 
family and relationships should be in one component, items related to MLCDs 
covering social and physical aspects of patients’ lives should go together in another 
component and items related to job/career should be in another component. The final 
32 items were therefore placed in each conceptually relevant component as suggested 
by this factor analysis. Eight items were placed in the education/family/relationship 
section, nine items were placed in the job/career section and 15 items were grouped in 
the social/physical section (Table 6.25).
The majority of items correlated to each other and fitted well in their corresponding 
components. However, after factor analysis at the scale refinement stage, the research 
team decided to remove some items as suggested by factor analysis, retained some 
deleted items, merged various items and applied appropriate phraseology to make 
some items conceptually appropriate and user friendly. This scale refinement changed 
the final numbers and structure of some items, which made it inappropriate to keep 
the final 32 items in 3 extracted components as suggested by factor analysis. With the 
consensus of the research team, it was decided to keep the original format of the scale 
and present items according to life stages and life events under the original five 
MLCD domains in order to maximise patient understanding and acceptability (Table 
6.26). The final 32 items MLCDP (version 2) was thereby designed for further 
psychometric evaluation. (Figure 6.3).
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Table 6.25: MLCDP 32 items loading in three components
Component 1: Education/Family/Relationships
A ll  decided to leave education early 
A2 I decided to change my study subject 
A3 I decided to study near home
C1 I decided to change my plans for when to have children
C2 I decided not to have children
C3 I decided not to have a sexual relationship
C4 I decided not to marry or have a long term partner
C5 I decided to get divorced or separate from my partner
Component 2: Job/Career
Bl I decided to change my job/career
B2 I decided to give up my job/career after starting
B3 I decided to take early retirement
B4 I decided to work flexible working hours
B5 I decided to select a job/career suitable for my health
B6 I decided not to take promotion
B7 I decided to work shorter hours
B8 I decided to become self-employed
B9 I decided to remain unemployed
Component 3: Social/Physical
D l l  decided to change my eating habits
D2 I decided to change my smoking/drinking alcohol habits
D3 I decided not to travel or go for holidays abroad
D4 I decided to move
D5 I decided not to move
D6 I decided not to move abroad
D7 I decided to wear different types/colour of clothes/shoes
D8 I decided not to be involved in community activities
D9 I decided not to socialise
DIO I decided not to wear make up
El I decided not to go swimming
E2 I decided not to take part in any sports activities
E3 I decided to change to different sporting activities
E4 I decided to be more physically active
E5 I decided to give up driving
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Table 6.26: Final 32 MLCDP items distributed under the original conceptually
relevant five MLCD domains
A. Education
A ll  decided to leave education early 
A2 I decided to change my study subject 
A3 I decided to study near home
B. Job/Career
Bl I decided to change my job/career
B2 I decided to give up my job/career after starting
B3 I decided to take early retirement
B4 I decided to work flexible working hours
B5 I decided to select a job/career suitable for my health
B6 I decided not to take promotion
B7 I decided to work shorter hours
B8 I decided to become self-employed
B9 I decided to remain unemployed
C. Family /Relationships
C1 I decided to change my plans for when to have children
C2 I decided not to have children
C3 I decided not to have a sexual relationship
C4 I decided not to marry or have a long term partner
C5 I decided to get divorced or separate from my partner
D. Social
D l l  decided to change my eating habits
D2 I decided to change my smoking/drinking alcohol habits
D3 I decided not to travel or go for holidays abroad
D4 I decided to move
D5 I decided not to move
D6 I decided not to move abroad
D7 I decided to wear different types/colour of clothes/shoes 
D8 I decided not to be involved in community activities 
D9 I decided not to socialise 
DIO I decided not to wear make up
E. Physical
El I decided not to go swimming 
E2 I decided not to take part in any sports activities 
E3 I decided to change to different sporting activities 
E4 I decided to be more physically active 
E5 I decided to give up driving
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Figure 6.3: 32 Items MLCDP version 2 (Date: 04.04.2011), 
final structure and format
Name/Code Number: Confidential
Date:
Major Life Changing Decisions Profile 
MLCDP
Instructions: The aim of this profile is to measure how your health condition has 
influenced major life decisions in your life. For each statement please tick one box.
El EDUCATIONThe following statements refer to the influence #
of your chronic condition on your decisions about ^  ./ /  /  /  /  A
1. I decided to leave education early □ □ □ □ □
2. I decided to change my study subject □ □ □ □ □
3. I decided to study near home □ □ □ □ □
[ 7 |  JO B  I CAREER
1“  The following statements refer to the influence
of your chronic condition on your decisions about 
your job /  career.
1. I decided to change my job/career □ □ □ □ □
2. I decided to give up my job/career after starting □ □ □ □ □
3. I decided to take early retirement □ □ □ □ □
4. I decided to work flexible working hours □ □ □ □ □
5. I decided to select a job/career suitable for my health □ □ □ □ □
6. I decided not to take promotion □ □ □ □ □
7. I decided to work shorter hours □ □ □ □
8. I decided to become self-employed □  ' □ □ □ □
9. I decided to remain unemployed □ □ □ □ □
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For each statement please tick one box 
[ c l  FAMILY I RELATIONSHIPS
The following statements refer to the influence
of your chronic condition on your decisions about y  y  /  a
your family/relationships. ^  ^
1. I decided to change my plans for when to have children □ □ □ □ □
2. I decided not to have children □ □ □ □ □
3. I decided not to have a sexual relationship □ □ □ □ □
4. I decided not to marry or have a long term partner □ □ □ □ □
5. I decided to get divorced or separate from my partner □ □ □ □ □
3 SOCIALThe following statements refer to the influence 
of your chronic condition on your decisions about 
your social life.
1. I decided to change my eating habits □ □ □ □ □
2. I decided to change my smoking/drinking alcohol habits □ □ □ □ □
3. I decided not to travel or go for holidays abroad □ □ □ □ □
4. I decided to move □ □ □ □ □
5. I decided not to move □ □ □ □ □
6. I decided not to move abroad □ □ □ □ □
7. I decided to wear different types/colour of clothes/shoes □ □ □ □ □
8. I decided not to be involved in community activities □ □ □ □ □
9. Idecided not to socialise □ □ □ □ □
10. I decided not to wear make up □  ' □ □ □ □
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For each statement please tick one box
□ PHYSICALThe*The following statements refer to the influence &  ^  ^  of your chronic condition on your decisions about ^  ^  J  your physical aspects of life. ^
1. I decided not to go swimming
□□
□ □ □
2. I decided not to take part in any sports activities □  □ □ □ □
3. I decided to change to different sporting activities □  □ □ □ □
4. I decided to be more physically active □  □ □ □ □
5. I decided to give up driving □  □ □ □ □
Please check you have answered all the statements 
Thank you for your help
This questionnaire is not to be reproduced or photocopied without the permission of the authors
© Z U Bhatti, M S Salek, A Y Finlay, April 2011 
Date: 04.04.2011 
Version 2
257
The end result of this phase was the final version of the new tool MLCDP (version 2) 
which will be examined for its other psychometric properties such as clinical validity, 
reliability, responsiveness and interpretability in future work.
Face validity and practicality
When the data was collected for factor analysis, an additional separate sheet was 
handed to the 210 patients along with the 41-item MLCDP (version la) in order to 
assess its face validity and practicality. The “face validity and practicality 
questionnaire sheet” (Appendix W) consisted of six questions asking patients to 
record their views and comments about the newly developed profile.
210 patients returned their responses along with the completed MLCDP (version la). 
The results of their replies are presented here according to the sequence in which the 
questions were asked.
1. The mean time taken by the patients to complete the MLCDP was 5.7 minutes 
(range = 2-15 minutes) and median time was 5 minutes (Table 6.27).
Table 6.27: MLCDP completion time (n=210)
Time taken to complete 
by patients (in minutes)
Number of patients Percentage
2 5 2.4
3 10 4.8
4 29 13.8
5 65 31
6 43 20.5
7 27 12.9
8 15 7.1
9 7 3.3
10 8 3.8
15 1 0.5
2. When patients were asked whether the questionnaire was easy to complete, 204 
(97.1%) patients answered “yes” and only six (2.9%) patients answered “no”.
3. 198 (94.3%) patients answered that “the response options for the statements in the 
questionnaire” was straight forward. Only 12 (5.7%) patients disagreed.
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4. The next question was “How clear and understandable were the instructions and 
statements?” 131 (62.4%) patients answered “very clear”, 76 (36.2%) patients 
answered “clear” and only three (1.4%) patients answered “not clear”.
5. Question 5 aimed to understand from the patients’ point of view whether the 
statements in the MLCDP were comprehensive enough to measure the influence of 
disease on important life decisions. 181 (86.2%) patients answered “yes” and 29 
(13.8%) patients answered “no” to this question.
6. In this section patients who had answered “no” to question 5 were asked to write 
down the aspects of life they thought should be added to the questionnaire. No 
patients suggested any new life aspect which was not covered by the tool. However, 
some patients mentioned other points which are listed in Table 6.28 in detail.
Table 6.28: Comments reported by the patients on the face validity and 
practicality questionnaire sheet
Patient
ID
Patients’ comments
05 Maybe a box for explanation is required
09 Lots of question is not relevant to myself
10 • Change of job/job role taken was positive decision rather than negative
• My loss of hair trigger to start something new
14 The general activities and home life are severely affected by the condition 
(psoriasis) plus psoriatic arthritis which limits what one is able to or not able to 
do
16 An opportunity to explain reason
19 Impact on work i.e. psychological worry, emotional, stress, financial
23 Reasons for decisions to questions e.g. if a person decides not to take part 
in social activities, why is this?
24 Question about other people’s reactions
25 • Except no influence and not applicable should be two columns
• Emotional impact on decisions
27 Was the decision out of your hand e.g. not allowed to take work because 
of condition
29 Effects on other family members also relationships with friends
32 A question on whether or not you would consider taking any “life insurance” 
or financial protection products as a result of being diagnosed
67 Some not relevant to my life
71 • could include a box for extra interrogation
• Time scale; in the past 5 year or 10 year?
73 The statement “I decided to’ is misleading. I had no choice on many occasion 
due to my bad health
84 Allow comments to some answer as an option for example empty box to fill in
93 All the options were too broad
173 Can be use or more effective in follow up 5, 10, 15, 20 can see the adjustment
192 No provision for anticipated effects on life style
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DISCUSSION
Costello and Osborne (2005, p. 7) stated that “exploratory factor analysis is a complex 
procedure, exacerbated by the lack of inferential statistics and the imperfections of 
“real world” data”. Therefore, the researchers’ judgment concerning the deletion and 
retention of specific items is important and should be based on the patients’ responses 
and the research concept. For example, the researchers’ judgment is important when 
deciding whether cross loading items should be dropped or retained (Costello and 
Osborne 2005). It is also up to the judgment of the researcher to consider why an item 
was included at the first place. Indeed, the purpose of factor analysis was to see to 
what degree the mathematical approach confirms clinical intuition. This was 
demonstrated by the way that factor analysis was performed by various methods and 
at the same time we set the bar higher for the confirmation of appropriate results. For 
example, items with >0.4 loading were retained, factor analysis was carried out in two 
different ways and the examination of the prevalence of items generated enough 
evidence to take appropriate decisions for item deletion, retention, merger and 
application of new phraseology at the refinement stage.
These analyses were reviewed in detail in order to make decisions about removal or 
retention of items, or the possibilities of merging deleted items together to form one 
comprehensive item if required for conceptual reasons. Items deleted by both 
analyses were compared with the items prevalence table in order to allow an informed 
judgment for appropriate item selection. Statistical factor analyses suggested that 
some items should be removed, even though they were frequently reported by 
patients. This situation was discussed in detail in order to exercise some degree of 
judgment in making better sense of the data.
Having examined the exploratory factor analysis results and also after looking at the 
prevalence of the items responses it was decided to take a very conservative approach 
during the item selection process. Therefore, it was decided to keep in conceptually 
sound items at this stage, even though they may have been suggested by the factor 
analyses to be removed. It was decided to reserve those items for future work when 
other more sophisticated techniques, such as, Rasch analysis and items response 
theory, could be applied to the data for further scale refinement. The reasons for this 
conservative approach were very clear: all the items came directly from the patients
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and the patient origin had the paramount influence in our decisions concerning the 
development of the revised version (version 2) of the new scale. Another reason was 
to create a degree of spontaneity on the part of the respondent by ensuring that items 
were perceived as relevant.
Specific recommendations for further factor analysis
• Because of the deletion, merger and rephrasing of some items, it will be 
necessary to obtain a new set of data for another factor analysis in the future. 
This is necessary in order to see how the new set of modified items will 
behave. Following this an internal consistency reliability and test-retest 
relaiblity of the final remaining items needs to be carried out.
• The use of more sophisticated techniques, such as Rasch analysis and the 
application of item response theory is appropriate for further scale refinement. 
This could be carried out along with other classical test theory psychometric 
properties which are described later under “future recommendations”.
Uses of MLCD Profile (version 2) and response interpretation
The MLCDP (version 2) may be helpful in the following situations:
1. Broad epidemiological studies to identify which diseases have the biggest impact 
on patients’ lives in terms of their MLCDs and which disease is most important in 
terms of impacts on specific decisions. The MLCD Profile could be used as one 
measure of the disease burden.
2. In the clinic, to provide clinicians with a one-off insight into how a chronic disease 
has already impacted on a patient’s life decisions, in order to identify those at risk.
3. The profile could be useful for a general practitioner at a patient’s annual medical 
review to enable the clinician to discuss the highlighted issues.
4. To use it alongside a QoL questionnaire designed to measure current impact to 
obtain an overall picture of disease impact, encompassing both the long term and the 
current impact.
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After deciding on the final layout of the 32-item MLCDP (version 2), the research 
team discussed the possible scoring methods and interpretation of the profile in order 
to give meaning to a completed MLCD Profile. The discussion concerned the 
following fundamental points:
1. What would be the perceived “value” of a patient reporting only one MLCD 
influenced, if this one MLCD were to be compared with the 32 items of the profile or 
the total score of the profile, if such a scoring system were devised?
2. Does the MLCD Profile conceptually require any scoring system?
3. Would the total score be useful for meaningful interpretation of the data?
It was clear from the patients’ comments and the data obtained at the factor analysis 
stage that if a patient reported even only one MLCD influenced by their disease, that 
by definition is very important, particularly at one stage of their life. If a patient 
reported that two MLCDs had been influenced then that is even more critical and 
important for that patient. This study demonstrates that some patients reported that 
their disease had influenced >10 MLCDs, indicating an extraordinary level of long 
term impact on those patients’ lives. When we compare only one MLCD influenced to 
the 32 items listed in the MLCDP, it might at first glance appear that the patient has 
experienced minimal impact on their life, but in reality one MLCD influenced can 
change a patient’s life forever. After all, by definition each decision recorded by the 
profile as being influenced is a major decision which is life changing. There is a 
virtually no possibility that all 32 MLCDs would ever be affected in any one patient. 
This therefore, begs the question whether the profile should be scored in terms of a 
percentage or as an absolute value.
It would be totally inappropriate to express the number of MLCDs affected as a 
percentage of the total number of MLCDs in the profile because it is quite clear from 
this study that no patient would ever have experienced influence on all 32 MLCDs 
identified. The MLCDP is based on a unique concept, covering a patient’s whole life 
and is different from the traditional health questionnaires which normally have 
questions based on experience on the previous week or month’s duration of disease 
impact (current impact). The MLCDs in the profile were uncovered from across the
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population and therefore it would be inappropriate, unscientific and misleading to 
express the number of MLCDs affected in an individual as a percentage or proportion 
of a total score of the MLCDP. For an individual patient, even if the patient reported 
that only one MLCD had been influenced by the disease then this is, by definition 
affecting his life. It was decided on the basis of the nature of the concept, the 
accumulative nature of the impact of MLCDs and the mean number of reported 
MLCDs recorded in this study that the best way of presenting this type of data for an 
individual is the total number of MLCDs affected. Therefore, the fundamental unit for 
expressing data of MLCDP is the “total number of MLCDs that have been affected”.
Of course because this profile has 32 items, by definition, the maximum score that 
could be reached would be 32 items. In reality however, no patient would ever reach 
this score as our study (at conceptualisation stage) has shown that out of 308 patients 
only two reported more than 10 MLCDs affected. To allocate a “maximum value” to 
express this number of MLCDs in percentage terms would be meaningless. Thus, 
further research and hard data is required at the psychometric analysis stage in order 
to review whether for the final scoring model a single overall score, or a series of sub- 
domain scores is most appropriate. Also it remains to be determined whether 
individual item weighting is meaningful as compared to the unit of total number of 
MLCDs affected.
Summary
• The factor analysis of MLCDP (version la) was carried out on 210 subjects 
(30 patients from each of the seven participating specialties)
• Cronbach’s alpha of 0.84 showed a high internal consistency reliability of the 
41-items version, but 7 items with item total correlation value of <0.2 were 
removed before factor analysis.
• “Exploratory factor analysis” of 34 items was performed using the “principle 
component analysis” technique to measure the new scale construct validity.
• Statistical techniques such as Eigenvalue >1 and scree plot examination were 
applied for factor rotation.
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• Three factors were extracted for final interpretation.
• The standard was set at a high level for items loading and items scoring <0.4 
were removed.
• Complex items with low double loading were removed.
• After “varimax rotation”, 11 items were removed and in total, 18 items were
removed as a result of the initial factor analysis.
• Another factor analysis was carried out without the reliability test at the 
beginning. 11 items were removed and compared with 18 items removed as a 
result of initial factor analysis to see any similarity between the deleted items.
• Deleted items were reviewed through “examination of items’ prevalence” 
(lowest and highest ranking items).
• Conflict between scientific scrutiny and patients’ reality was observed during 
factor analysis as high prevalence items were suggested to be deleted by factor 
analysis.
• Final decisions were made on the basis of items deleted by both factor
analyses, examination of item prevalence, conceptual and common sense
grounds, detailed review of the patients’ comments and the judgment of the
research team.
• Thirty items were discussed in great detail and 17 were retained, in which 
three items were rephrased. Nine items were merged to create four new items 
(conceptually the same but new in construct) and four items were removed.
• The researchers’ judgment was used to design the final structure and lay out of 
the profile.
• Scale refinement changed the final number and structure of some items, which 
made it inappropriate to keep items in the three extracted components as 
suggested by factor analysis. The original format was considered by the
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research team to be more appropriate for better patient understanding and 
response. Items were presented in five MLCD domains.
• Finally, the 32-items MLCDP (version 2) was developed for further 
psychometric evaluation.
• Various potential uses of the MLCDP have been suggested in this section.
• The logical unit for expressing the data of the MLCD Profile is the “total 
number of MLCDs that have been affected”.
• The face validity and practicality of the initial version (la) (mean time taken 
by patients to complete the MLCDP=5.7 minutes; range = 2-15 minutes) was 
excellent but should be tested again, along with other psychometric properties, 
after development of the final version.
• It was decided by the research team that a new set of data is required for 
further factor analysis and more sophisticated techniques such as Rasch 
analysis and items response theory will help in further scale refinement.
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CHAPTER 7
General Discussion
Very little information is available in the literature about the influence of chronic 
disease on Major Life Changing Decisions (MLCDs), but there are some studies 
which give an indication about how chronic disease may influence MLCDs. These 
studies were not designed for the evaluation of the long-term impact of disease or the 
influence of disease on MLCDs, but are still crucial for the understanding of the novel 
concept of MLCD in a broader health perspective. Due to the lack of information in 
the literature, extra emphasis is given in this discussion to the conceptualisation of the 
MLCD concept from the experiences of respondents, the role of qualitative 
techniques, the issues raised by patients regarding health and MLCDs, the role of 
influential factors, the developmental and validation process of the MLCD Profile and 
the formation of strategies to support patients when taken MLCDs.
One of the aims of this study was to understand the magnitude of the influence of 
chronic diseases on MLCDs and the subsequent impact on patients’ lives. 
Conceptualisation of the notion of MLCDs was therefore one of the crucial parts of 
this study. A robust and comprehensive review of the literature was carried out to 
obtain all of the available information. All major health, social and psychological 
related databases were searched and thousands of articles were reviewed over a period 
of more than two years. It was surprising that only two articles were found that 
matched the search term “major life changing decisions” and more surprising that no 
relevant information was found about chronic diseases and their influence on MLCDs. 
Even if there was no obvious domain, indicator or descriptor concerning MLCDs, 
every questionnaire, profile and index was searched for this important aspect of 
patients’ lives. The lack of published information made the task of conducting this 
study more challenging but also more interesting because of the likelihood of 
obtaining some original and novel information directly from patients.
The significance of HRQoL is well established and has been widely studied from the 
perspective of patients. The evaluation of the current impact of disease on patients’ 
lives still remains the main focus of HRQoL research. Very few attempts have been 
made to evaluate the long term impact of chronic disease on patients’ lives. Life 
changing decisions have been studied in psychology as the “crystallization of desire 
and crystallization of discontent” (Bauer et al. 2005) and in neuroeconomics as 
“intertemporal choices” (Bems et al. 2007). These papers gave no information about
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the influence of disease on MLCDs. Although both studies used the term “life 
changing decision” their focus was not related to disease or its impact on patients’ 
lives. Similarly, there is very little information available about the long term impact of 
chronic diseases on patients’ lives. The literature review revealed information about 
life course (Ben-Shlomo and Kuh 2002; Kuh et al. 2003; Lynch and Smith 2005), life 
transition (Bridges 1980; Heatherton and Nichols 1994; Bauer and McAdams 2004b), 
life goals (Elliot and Sheldon 1998; Bauer and McAdams 2004a) and life events (Lief 
1948; Graham and Stevenson 1963; Rahe et al. 1964; Holmes and Rahe 1967; Kiecolt 
1994), and these concepts also helped in the conceptualisation of the notion of 
MLCD.
Some negative life events (e.g. chronic illness, accident, injury) may influence 
MLCDs such as marriage, divorce, job, education, having children, moving abroad, 
moving house, and retirement. For example, a diagnosis of chronic illness may 
influence an important life decision related to employment, such as whether to carry 
on in full time work or take a part time job or retire early, which might be a good 
option from the perspective of health. Such a decision might seem quite easy and 
simple but in fact may be very difficult to make because of the implications and 
consequences of the decisions which may result in financial instability, or may lead to 
other problems related to the patient’s mortgage, life style, family and relationships. 
This “knock on effect” may lead to further health deterioration.
Although studies identified in the literature review were not designed to capture the 
influence of chronic diseases on MLCDs, some of their findings aid our 
understanding of the concept of MLCDs. For example, Kimball et al (2010) reviewed 
the long term impact of psoriasis and proposed the concept of “Cumulative Life 
Course Impairment” (CLCI). This concept results from an interaction between “(a) 
the burden of stigmatization and physical and psychological co-morbidities and (b) 
coping strategies and external factors” (Kimball et al. 2010). The concept of CLCI as 
described (Kimball et al. 2010) does not specifically address the impact of psoriasis 
on MLCDs. However, if a MLCD is influenced by psoriasis, this is likely to 
contribute to CLCI and indeed it may be that influences on MLCD are of equal or 
greater importance than stigmatisation and coping strategies in contributing to CLCI. 
Although Kimball et al (2010) claimed this concept as their own, it has been
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suggested by others that cumulative life damage is an older concept, mainly studied in 
sociology and psychology (Ibler and Jemec 2011).
The decision to have children is a normal decision as part of a person’s life course. 
The desire to have children may be interrupted as a result of disease (Dow 1994). This 
issue was studied in relation to the experience of haemophilia patients in pregnancy 
and their reproductive choices (Kadir et al. 2000). However, our study, reported in 
this thesis, investigated this matter in more detail and demonstrated that the problem 
is far greater and more complex than previously reported. This aspect of patients’ 
lives has various dimensions. For example, chronic disease can influence patients’ 
decisions as to when to have children, whether or not to have any children or whether 
to have more children. This range of possible important decisions of patients may 
possibly not have emerged without the exploration of the MLCD concept.
Patients’ constant and long term struggle with their disease and other disease 
associated factors remains the key element contributing to the influence on MLCDs. It 
has been studied how poor health may impact on marriage (Wilson and Waddoups 
2002; Seidler and Kimball 2009) and these studies identified that chronic disease 
impacted patients’ relationships as a whole. As a result related MLCDs such as 
separation, divorce and not to marry or have a long term partner were influenced 
significantly by their chronic illness. Even a patient’s decision not to have a sexual 
relationship was reported as a MLCD by patients as part of their coping strategy to 
avoid embarrassment. The employment implications of disease and the resulting 
financial hardship is a very important issue for patients (Meding et al. 2005; 
Cvetkovski et al. 2006; Malcomson et al. 2008). The results of our study confirm our 
initial rationale that this problem is much deeper and wider than previously realised. 
During our study, a series of influenced MLCDs were reported by patients, such as 
their decision to take early retirement, change career, change job, select job only 
suitable for their health, work shorter and flexible working hours, self employment or 
remain unemployed. This whole range of impacts has never been studied before and 
this study not only explored the areas mentioned above but also identified disease 
associations in the form of “influential factors”.
One negative life event, such as onset of a chronic disease, limb amputation, death of 
a family member, imprisonment, addiction or divorce may negatively influence other
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subsequent life events, such as choice over education, career, employment, marriage, 
housing, having children or moving abroad. It is obvious that the life decisions that 
people make are normally intended to gain the desirable outcome of a better life. 
However, not every life decision turns out to be a positive or a correct decision. 
Clinicians are aware that after the diagnosis of a chronic or life threatening condition, 
acceptance is always a great challenge for patients. Patients search all available 
avenues for a cure and may take a considerable time to realise that they might have to 
live with the condition for the rest of their lives. Subsequently patients go through a 
process of denial, depression/anger, acceptance and adjustment (Lee 2005). A change 
in attitude to acceptance may give a patient motivation for the future but life changing 
decisions and related choices may remain very limited due to long term illness and 
other associated factors (severity, depression, treatment etc). Therefore, the ability to 
reach the desired future outcome may not be as successful as for disease free 
individuals.
Decisions at the right time about higher education and early career development or 
having children are important as part of the natural course of life and occur at 
different life stages. The continuous long term impact of chronic disease on patients’ 
lives may influence these decisions. Patients might either decide differently or might 
delay their decision. This is where health providers and clinicians may play a very 
important role in warning patients at an early stage about the long term consequences 
of chronic disease, which in turn might not only minimise the disease impact on 
patients’ lives, particularly on MLCDs, but also possibly reduce the burden on the 
healthcare system. It is possible that the specific individual circumstances and 
personality of an individual may influence the nature of and their approach to life 
changing decisions. This theory is supported by the factual observation of Baumeister 
et al (2001) that “bad is stronger than good”. They suggested that bad (negative) life 
events have a greater and more intense impact on individuals than good (positive) life 
events. People always react strongly to negative events. The intensity of response may 
differ due to the type of negative life events that people face. For example, response 
to imminent death will be immediate, whereas the reaction to the diagnosis of a 
chronic disease will be long term and the response may be reflected in much later 
subsequent life changing decisions. People may change their predefined life goals
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because of ill health and set new priorities for the future, such as not to have a child, 
to change career or to retire.
Understanding the possible long term impact of childhood disorders was an additional 
crucial part of MLCD conceptualisation. Through individual interviews and focus 
groups, it became clear that patients suffering from chronic skin conditions faced 
various health-related issues during their childhood that directly influenced them to 
take MLCDs differently. Bullying at school, lack of understanding from teachers and 
other pupils, constant treatment related distress, depression, and inability to take part 
in physical and social activities all had an influence. Similarly, the impact of disease 
on children could also influence important decisions of family members (Fine et al. 
2005), and possibly cause deterioration in normal family structure, parent-child 
relationships and impact on children’s personal growth and development and on their 
ability to perform to their full potential in later life.
Three qualitative methods, postal survey, individual interviews and focus group 
discussions were used to obtain the initial data for the conceptualisation of MLCDs. 
All three techniques were combined to produce rich data which allowed scrutiny of 
the information at a very detailed level. The postal survey was conducted in as 
systematic way as possible. A single open ended research question was asked that 
allowed participants to express themselves in a subjective and holistic way to obtain a 
broader picture of the concept. The simple instructions in the patient information 
sheet, the clinicians’ personal letter and reminders appeared to make a considerable 
impact on the response rate of participants. Despite an initial concern from the Cardiff 
and Vale NHS Trust and Research and Development Department (at the study ethical 
approval stage) about the very ambitious scope of this study in terms of large sample 
size (n=600) and the limited time frame, six medical specialities were invited to take 
part in the postal survey and the study was successfully completed. Limited resources, 
time and facilities did not allow recruitment of patients from all the medical 
specialities for individual interviews and focus group discussions. Much thought was 
given at the study protocol stage to obtain single ethical approval for all the stages of 
the study in order to avoid delays and allow smooth running of the project. This 
strategy was proved to be successful.
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The poor initial response rate to the postal survey was one big concern during this 
project, which caused considerable delay. However; assurance of strict 
confidentiality, the clinicians’ personal letter and reminders helped to obtain a 
desirable (51.6%) response rate for appropriate data analysis (Oppenheim 1992). Only 
dermatology patients were recruited for individual interviews and focus group 
discussions. The use of interviews and focus groups not only strengthened the study 
(Morgan 1997) but also confirmed and supported the information obtained from the 
postal survey. The only difference or new information obtained between the 
interviews/focus groups and the postal survey was related to “life style decisions” 
reported as MLCDs by the dermatology patients in the interviews.
The semi-structured individual interviews yielded more detailed information than the 
postal survey, as was expected. However, it was an emotional experience for the 
patients and the researcher (Z U Bhatti) alike to discuss their painful past experiences, 
particularly the undesirable outcome of their MLCDs. Similarly, during the focus 
group discussions it was noted that patients were nervous to discus this intimate 
aspect of their life in front of other participants. The MLCD concept appeared to be 
more sensitive than was initially anticipated; this may be one of the reasons why this 
area has not been studied before. Following guidelines (Krueger 1997; Morgan 1997) 
resulted in the smooth running of interviews and discussions and helped to create 
confidence between the patients and the moderator (Z U Bhatti). This great 
opportunity of having a direct conversation with patients was also of benefit to this 
study as it allowed the obtaining of patients’ personal views and their suggestions 
which contributed to the formulation of some strategies for other patients faced with 
similar situations, particularly for younger patients. This aspect will be discussed later 
in this chapter.
It was evident from the literature that the majority of studies concerning the impact of 
disease on quality of life have been based on evaluating the physical, social and 
psychological aspects of patients’ lives. This current study has produced completely 
new information which has never been explored before and which has introduced a 
completely new dimension in health outcome research. The obtained data highlight 
the intricate nature of health and the concept of MLCDs but have also revealed the
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type and the magnitude of MLCDs influenced by chronic illness and the subsequent 
impact on patients’ lives and on their family members.
The data presented in this study demonstrate that chronic diseases have a profound 
influence on MLCDs. The majority of patients reported that their chronic disease had 
influenced their decisions concerning early retirement, job, career choice or having 
children. These four MLCDs were the most frequently reported. Minor life style 
decisions, such as choice of clothing, stopped swimming, not to socialise and wearing 
make up were only reported as MLCDs by dermatology patients in the interviews and 
focus group discussions. This information was completely new and not reported in the 
postal survey. These MLCDs were discussed in detail with the patients during 
interviews and focus group discussions and clarification was sought for time and 
again. The reason for this approach was that these decisions are normally considered 
to be “routine” decisions, not major life changing ones. This information further 
enhanced the knowledge beyond the initial understanding, so it is now undersood that 
any decision perceived as routine by disease free individuals could be a MLCD for 
patients who had been suffering from a chronic condition for a long period of time. 
The persistent nature of their chronic condition and the resulting influential factors, 
such as embarrassment or the physical impact made patients think and act differently. 
Ultimately this change in behaviour becomes a permanent part of their lives and 
personality. When facing and coping with such constant difficulties, pain and anxiety 
on a daily basis, “small” decisions such as what colour and types of clothes to wear, 
appeared to change their life in a major way, and also had long term consequences on 
patients’ lives such as change in attitude and personality.
In certain situations, it was evident that patients did use “trade off’ scenarios. For 
example, whether to wear out of fashion clothes and hide their skin and have peace of 
mind or whether to wear fashionable clothes/colour and thereby expose their skin and 
health problem, risking facing an ignorant public attitude. To hide their skin with 
make up may have also made their skin condition worse but doing so the patients 
successfully avoided embarrassment. Due to the effects of make up on their skin 
condition some patients were unable to hide their skin and they experienced painful 
questioning and embarrassment. These situations are very difficult for patients and so 
the make up choice may be life changing for them. Several patients reported in their
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interviews that since childhood they had never worn short sleeves, skirts or dark 
colours or a swimsuit. Patients even kept themselves isolated for years from taking 
part in normal routine social activities such as clubbing, visiting the pub or beach 
activities. These activities would otherwise have been a normal part of their lives, 
particularly for adult patients and it was a very hard and difficult decision for them to 
stay at home and avoid public places. Similarly, it was very surprising to see that 
patients regarded decisions to change their life style habits as MLCDs. For example, a 
large number of patients changed their eating, drinking alcohol and smoking habits. 
For patients, it was difficult changing these life long habits which therefore made 
these decisions major and life changing for them. The decisions related to holidays 
and travelling and life style change were also regarded as MLCDs by patients, 
indicating the highly “subjective” and “perceived” nature of this concept. For 
example, a MLCD related to education might have been taken once or twice in a life 
time but life style decisions such as choice of clothing, swimming, holidays has a 
constant impact and remain with patients on a daily basis throughout their lives. The 
emotional concern attached to these decisions and the specific family and public 
nature of involvement can make these decisions MLCDs for patients. For example, 
people with psoriasis hardly ever wear short sleeves; this is clearly a QoL issue but it 
may become a MLCD because clothing is a part of one’s character and personality.
Holidays and travelling abroad was another area of life decisions regarded as MLCD 
by patients. People consider it a normal activity, a yearly family occasion, to relax and 
boost their energy for the coming year. In the modem world, particularly in the 
western world, it has become a very important part of their lives: whereas years ago 
nobody would have dreamt of such types of activities. Therefore, this activity would 
not have been a problem for patients in the past and it is to do with today’s society, 
culture and the attached expectations which people have. Now regular holidays have 
become so common that people take them for granted and any deviation due to 
change in circumstances makes it a major issue and life changing for them. Such an 
attitude in society is also related to the culture of a society. This emerging point of 
“expectation” is also incorporated with “patients’ circumstances” in our new 
definition of health influenced MLCD in order to make it more robust. It was evident 
throughout the study that some MLCDs are highly subjective in nature, as described 
earlier, and solely depend upon the nature of an individuals’ circumstances. In simple
274
words, some decisions might be minor to disease-free people but may be major and 
life changing for patients suffering from long term health problems. This change in 
circumstances, from a “disease free life” to a “disease affected life” and associated 
long-term complications also affected patients’ “life functionality”, “life 
development”, “functional behaviour” and “expectations”. This most detailed 
information related to the MLCD concept emerged during this study. This information 
was specifically discussed and highlighted during the formulation of our proposed 
“HRMLCD definition” and was included as a major conceptual part of the MLCD 
definition.
The formation of the definition of MLCD was a unique experience and making it a 
workable but robust definition was a difficult task. This is the first attempt of its kind 
and this study provides this fundamental basis of the MLCD concept, which in future 
will allow researchers to use it for further research. This definition was developed at 
the end of the conceptualisation of the notion of MLCD and also reviewed as planned 
in the light of data obtained at factor analysis. No new information had emerged from 
this data, and after long consideration, no change was made to the proposed MLCD 
definition.
This study allows researchers to understand the importance of taking the right 
decision in life at the right time. One wrong decision at an early age of a patients’ life 
or at an early stage of a chronic disease may change the subsequent course of life and 
may result in an undesirable outcome. For example, the decision to leave college or 
university education early, left patients with very limited career opportunities to 
develop professionally and earn a good income. Most of the patients had to take part 
in un-healthy menial employment to support their families. This not only resulted in 
further deterioration of their health, frequent hospital admissions, reduced working 
hours and less income, but also resulted in early retirement, which in turn influenced 
various MLCDs, such as break up of their relationships and their decision not to have 
more children due to financial difficulties. This outcome is in contrast to those 
patients’ experiences who planned their education and career path at an early stage 
with the advice and help of their parents and thereby gained a better health outcome 
and a more appropriate career.
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Usually, patients do not routinely seeks any advice from any health professional 
before taking any MLCD, apart from the genetic counselling situation where in some 
cases a decision is to be taken about having children. Some patients did report that 
they had consulted their family members before taking major decisions. Some patients 
thought that the constant nature of their illness had left no choice but to take certain 
MLCDs. Early retirement was one of the most frequently influenced MLCDs reported 
by the patients. This decision appeared to be one of the most difficult decision 
patients faced, due to its daunting repercussions at a later stage of their lives, 
including financial issues and change in status. This impact is viewed as a “MLCD- 
knock on effect”. The issue of early retirement was a major concern for patients but 
again they weighed their decision and it appeared that some patients traded off less 
money against better health in order to take control over their lives. Less income not 
only changed their life style but also impacted heavily on their social status and 
standing. This dramatic change also caused depression among many patients which 
ultimately led to further deterioration of their health. Therefore, it is not inevitable 
that the decision taken by a patient in the interests of better health always turns out to 
be a good decision. This situation raised the importance of developing strategies and 
tailoring help for patients at the right time. The patients’ first hand experiences 
highlighted in this study and the way they took their MLCDs, will help to inform the 
formulation of appropriate MLCD strategies for other patients.
By considering this aspect in more detail, then the difference between taking early 
retirement and not working will become obvious. Several patients reported that they 
wanted to work but there were not enough jobs suitable for their health. It was 
obvious from their comments that these patients did not want to retire early and if 
there had been enough jobs suitable for their health, these patients would have worked 
until their normal retirement age. This specific discussion, from the patients’ 
perspective, indicates that policies for better employment opportunities for patients 
suffering from chronic illnesses should be formulated with identification of this 
important area. This study and information arising from the use of the MLCD Profile 
could be used to highlight this issue at the highest government level. This could be of 
financial benefit to health providers, government and patients. Although the content 
analysis of this study provides enough information to strongly support the case for a 
review of health and employment policies, however, a detailed and more specific
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exploration in this area is needed for in-depth analysis and understanding. The new 
MLCD Profile could be used to assist in obtaining this information.
It was noted that some patients raised their concern over state benefits. They thought 
that there was not enough support from government and health providers and they 
were worried that they might not get proper benefits again if they had to take time off 
from work due to their constant battle with their long term illness. That was a risk that 
some patients did not want to take and so they decided to remain unemployed. It was 
difficult to understand how widespread this problem was and in view of personal 
financial reasons some patients may have not discussed this issue in detail. Further 
exploration of this area is needed to understand patients’ behaviour from a combined 
health and financial perspective and in terms of the resulting impact on MLCDs. This 
is another good example of how complex MLCD issues can be.
This study also indentified the issues relating to patients’ change in personality and 
changing attitude and approach to life. It was evident from patients’ comments that 
adversity can still allow personality to grow and develop and indeed be a spur to such 
a development. This aspect of some patients’ lives was very interesting. Patients were 
very enterprising and demonstrated resilience and improvisation, for example, 
becoming self employed or working shorter and flexible hours. The adversity of their 
disease appeared to be a blessing in disguise for some patients. It brought new 
opportunities for them and patients re-invented themselves to overcome their health 
problem in the best possible way. It was very interesting that one patient reported that 
“my disease saved my life”. This patient forcefully decided to change some life style 
habits; otherwise he may not have contemplated changing. Similarly, some patients 
decided to become self employed or decided to work flexible working hours, and this 
decision not only helped them to take control over their health, but also helped them 
to grow their personality and develop themselves.
The MLCD example of “career choice” in this study also provides evidence that 
wrong selection of a career at an early stage caused more problems at a later stage for 
some patients. For them, it was more difficult to live with the consequences of an 
inappropriate career choice than to face the difficulties earlier while still having their 
education. It was very hard and difficult for patients when they eventually found that 
their chosen career was not suitable for their health and they had not only wasted an
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important time of their lives but also their efforts and the money they had spent. They 
had no choice but to change their career to one suitable for their health. In some cases 
it was difficult to find a suitable job and patients even had to consider low paid, 
difficult and less attractive jobs with no growth opportunities in the future.
Divorce, marriage and separation were the obvious affected MLCDs concerning 
relationships. The decision “not to become involved in relationships” was also 
reported as a MLCD by some patients. This is another example of the highly 
subjective nature of the MLCD concept. The patients found relationships very 
difficult and embarrassing because of their illness and they did not want to be judged 
by their illness. The fear of deep involvement in relationships and possible rejection, 
had their partners found out about their illness, was one of the main reasons behind 
this particular decision. In fact some patients had experienced this problem several 
times while they were in relationships, and then they felt forced to take this important 
life changing decision. Patients felt that they became more isolated and appeared to be 
more emotional and psychologically unstable. Although one patient regarded this 
behaviour as a “survival reflex”, it was decided to describe this patient behaviour as a 
“MLCD psycho-reactionary reflex”. One could easily understand how difficult this 
could be for patients emotionally and psychologically; and this survival reflex or 
“patient survival instinct” to avoid this situation sums up the reason why this decision 
is categorised as a MLCD.
The majority of MLCDs affected as a consequence of their long term illness were 
reported in a negative sense by patients. However, some decisions were reported in a 
positive sense such as the decision related to “moving abroad”, which some patients 
thought had helped them to have a better health outcome because of more suitable 
weather conditions. One decision which was reported entirely in a positive sense was 
the decision to be “more physically active”. This created a sense of purpose in their 
lives and became a major life changing decision for them. For example to do more 
exercise and loose weight were major challenges for some patients. To change their 
eating habits and do exercise appeared to be life saving for many patients.
In terms of the relationship of gender to the type of MLCD affected, it was evident 
that the MLCDs related to early retirement, career choice and moving abroad was 
more prevalent in male patients. The MLCDs related to having children was more
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prevalent in female patients. The MLCDs related to wearing make up was only 
reported by female dermatology patients, indicating the gender and speciality specific 
nature of some MLCDs. It is important that more attention should be paid to specific 
MLCDs while dealing with particular gender group or speciality groups.
It was not possible to quantify the link between participants’ age and specific MLCDs 
reported, due to the retrospective nature of the research question asked. Patients were 
not asked at what age a specific MLCD was influenced by their chronic condition. 
The patients instead reported their entire past experiences covering their whole life 
while having the disease up to the time of the interview or survey and no attempt was 
made to link reported MLCDs encompassing the patients’ whole life with their age. 
Although examples can be obtained from the literature of creating arbitrary age 
groups for the purpose of descriptive analysis, the idea was rejected. This area could 
be explored at the next stage if this research is continued in order to ascertain whether 
at a certain age chronic disease may have influenced certain types of MLCDs. 
Although, the patients were not asked at what age they took a particular MLCD this 
study highlights the importance of this aspect. For example, the CF population 
consisted mostly of relatively young patients (mean age=27 years, range=18 to 53 
years) and the MLCDs reported by this group of patients were related to having 
children, job, career choice and education. In contrast, COPD patients were an older 
age group of participants (mean age= 66 years, range=53-84) who reported MLCDs 
were more related to early retirement, holidays and travelling abroad and job. It was 
clear that the types of MLCDs mostly taken by CF and COPD patients also reflect 
their respective age groups, which seems logical in terms of MLCDs, life course and 
from a life stage perspective. At this stage, the specific nature o f the MLCDs reported 
by CF and COPD patients cannot be linked with their respective age groups as we do 
not know at what age they took these decisions. Perhaps some COPD patients might 
have taken the MLCD of early retirement at a relatively young age because of the 
severity of their chronic disease or physical disability. This study also highlights 
therefore the importance of this interesting aspect for future research work.
The identification of influential factors in this study provides a crucial in-depth insight 
into patients’ lives. In total, twenty five types of influential factors have been 
identified. These influential factors were basically the main disease associated reasons
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why patients took MLCDs differently. It was noted that these influential factors were 
very important to the patients. The patients’ accounts of emotional turmoil (anger, 
depression and anxiety) raised the issue that health providers should consider the 
psychological stability or mental ability of patients to take MLCDs. It was no surprise 
to see that “ill health and severity of disease”, “frequent hospital visits and treatment”, 
“physical disability”, “stress, fear and anxiety” were the most prevalent influential 
factors reported by patients. However, the influential factors such as weather, 
insurance cost, discrimination and job insecurity were indicative of the importance of 
patients’ individual circumstances, and that is why it was very crucial to incorporate 
this aspect within the working MLCD definition.
Strategies for appropriate decision taking
This research clearly confirms that chronic diseases can significantly influence 
MLCDs. It also signifies the importance of the formation of life changing decision 
making strategies in order to guide patients to reach the most appropriate life 
changing decisions; with the best long term outcome.
We had an example in this study where the patients chose the wrong career because of 
confusion, lack of knowledge and because they did not consider seeking advice. After 
completion of their education when they started working, they realised that they were 
in the wrong career because of their health. Some patients then changed their career 
and some did not bother to try to do so, as they thought they were too late for further 
education or to follow another career path, perhaps due to their long term struggle 
with their illness. During the interviews some patients seemed confused on various 
occasions in their lives and there was a possibility that this confusion might have 
played a part in their taking the wrong MLCD which ultimately affected their health, 
family, and social life over a very long period of time. This study demonstrates that 
the impact of their chronic disease on their MLCDs could be minimised by seeking 
appropriate help and advice at an early stage.
The formation of appropriate MLCD strategies was the final stage of this study. Data 
collected from patients were meticulously scrutinized in detail and used for the 
development of possible strategies. These strategies may help patients to learn how to
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make appropriate long-term decisions which may in turn improve their Quality of 
Life.
Throughout this study it was noted that as a “preventative measure”, appropriate 
strategies would enable patients to make the correct decisions but that this approach 
could only be based on patients’ own experiences. During the individual interviews 
we had the opportunity to ask patients “how can we help patients to take appropriate 
MLCDs in a similar situation to you”. The responses from patients are reported in the 
content analysis section of this thesis. All responses were examined in detail and used 
for the development of appropriate strategies to help patients to take the most 
appropriate MLCDs in the future.
Patients’ personal efforts, professional help and sharing experiences could all be 
helpful in making important decisions in life (Dow 1994). Another important aspect 
that has resulted from this research is that now we have some understanding about 
what patients think when they have to make MLCDs. This information should enable 
us to formulate better strategies to support them. During the decision-making process 
a patient may ask themselves a series of simple questions such as, is it the right time? 
am I taking the right decision? what will happen in the future? what will happen to 
my family and children? can I do it? and what are my options? The influential factors 
identified provided additional insight for developing MLCD strategies. In addition 
various words and phrases from the patients’ comments, identified during content 
analysis also hold the key for developing strategies. For example, “I was classified as 
disabled”, “I had no alternatives”, “it is like a curse on me”, “I had no option”, “I 
didn’t accept this”, “you react to the way other people perceive you”, “I am still not 
dealing with it very well”, “I just could not visualise”, “you have to do what you can 
do”, “I can work around it”, “had to reconsider my commitment”, “encouraged by 
parents”, “I did not know what to do, I couldn’t decide”, “once you make a decision 
that’s it, you have to live with that”, “survival reflex”, “I could have done better”.
All the above selected words and phrases are from patients’ comments, indicating 
patients’ attitudes, personality, uncertainty, fear, psychological and mental pressures 
which have developed over the years in patients, and therefore, might benefit from 
structured systematic assistance, to help deal with MLCDs. Patients realised in later 
life that calculated and informed decisions can be made. It is true that patients have to
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take their decisions but strategies can provide various options to be looked at before 
any final decision is made. There is a possibility that strategies may not be successful 
in all cases, due to the subjective nature of MLCDs, individual circumstances and 
high level of expectations, but at least patients can look at all available options in 
order to find the best possible solution.
There is no doubt that to predict the exact (positive) outcome of every decision is 
very difficult. This study has demonstrated that decision-making is important for 
patients and their health depend a great deal upon the best possible outcome of their 
decisions. The diagnosis of chronic disease is part of the undesirable life transition 
from a disease free life stage to a disease life phase. This phase remains throughout 
their lives which makes it more difficult for patients to forget about their previous 
good life and to move forward. It is possible that mental rehabilitation may help 
patients to accept the reality of their current life status in order to plan their role for 
future life stages. Whether someone is suffering from chronic disease or not, a right 
frame of mind is always required to make appropriate decisions. This study has also 
demonstrated that this may be achieved successfully if the impact of disease- 
associated influential factors is minimised. The right frame of mind takes our 
thoughts through the decision-making process, where people create rationales and see 
the pros and cons of decisions and eventually make a judgement and expect best 
possible outcome.
The concept of living with a chronic condition for a long period of time, possibly for 
the rest of their lives, has a huge psychological impact on patients and their families 
and may harm their ability to think in a right frame of mind. This study has also 
indicated that the realization and acceptance of circumstances, personal limitations, 
ability to adjust and adopt an appropriate approach at the right time, along with 
frequent contact with a physician and other healthcare providers to ensure appropriate 
treatment and advice, may help patients to take control over their lives and guide them 
towards making the right decisions, resulting in better long-term outcomes.
The process of taking MLCDs is a battle between choices. This battle starts with the 
individuals’ thinking process; strategies which are currently available could assist 
making the decision process easier and better. Flipping a coin to make a decision, 
although such an attitude might not harm disease-free individuals, is not an option for
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patients suffering from chronic conditions. In everyday life, we face the dilemma of 
difficult choices. Taking chances in every difficult choice situation is not a common 
practice. People normally think carefully and judge their decisions carefully about 
what is best for them. Intuition also plays a role in this situation when an individuals’ 
understanding of the issues is very limited. However, if we were to leave all our 
decisions to our unconscious minds, then what is our conscious mind for? We should 
rationalise our choices using the best of our mental ability. A calculated approach 
may help patients make more appropriate decisions. MLCDs are subjective in nature 
and depend upon individuals’ circumstances and their expectations. Therefore, it is 
very difficult to formulate one unified strategy or guideline which can fit all patients 
and decisions. However, through the findings of this study it is possible that patients 
can adopt a strategy or strategies according to their circumstances and need. Before 
making any MLCDs, patients may consider the following strategies which have 
arisen from this study (Figure 7.1): these strategies are based upon the views of 
patients and their suggestions for strategies, obtained at the individual interview 
stage. These are summarised as follows:
1. Establish regular contact with a physician to maximise treatment options and long 
term management planning. This will help patients to plan better for the future and to 
make MLCDs. Patients should discuss current and possible future MLCDs with their 
consultant or healthcare providers in the light of their management plan and the 
possible future outcomes of their health, thereby enabling them to take better 
decisions.
2. Contact the relevant local authorities such as the health, education, work and 
pension departments to gain knowledge about their rights, available facilities, funds 
and support before taking a major decision. If possible patients should seek an 
individual appointment to discuss the nature of their health condition, their particular 
disease associated needs, and their ability and inability to do things in the light of 
possible future outcomes.
3. Keep in touch with relevant patient associations and support groups in order to gain 
knowledge from the real life experiences of others. This may be helpful not only to 
assist better decision taking, but also to keep updated on new research and treatment.
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Creation of possible real life scenarios, choices and options and comparison with 
positive and negative MLCDs outcomes should be considered by patient. Advice from 
other patients and their family members and organisations to assist patients is 
essential and can be obtained through patients’ welfare associations and from support 
groups suffering from a similar condition. Being aware of the experiences of others 
and how others have faced similar situations will help patients to take informed 
decisions.
4. Early realisation and acceptance of the chronic nature of an illness is crucial in 
order for a patient to move forward and look for better options for their health and for 
their current and future QoL. Understanding of personal circumstances (the situation 
that a patient is in when a decision has to be made), realisation of their likely 
limitations because of their illness (physical and financial) and understanding the 
difference between what they want to do and what they can do will help patients to 
make better MLCDs.
5. Adjustment approach: patients should consider their options to take control over 
their limitations caused by their chronic illness and try to adjust as soon as possible to 
minimise the disease long term impact, for example, adjustment to their physical and 
financial status.
Figure 7.1: MLCD strategies for patients
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Study implications
• The detailed robust literature review presented in this thesis has revealed that 
there is very little information available in terms of the long term impact of 
disease on patients, particularly the influence of disease on MLCDs. This 
study should help future researchers to understand the basic elements of the 
long term impact of chronic disease and its influence on MLCDs. This study 
has developed the initial understanding of this concept.
• To our knowledge this study is the first one of its kind. It will help researchers 
in the future to incorporate the concept of health and MLCD into the concept 
of life course and life events in the fields of psychology, sociology and 
epidemiological studies.
• As there is now a new understanding of Health-related MLCDs, the current 
definitions of the scope of QoL are incomplete. The incorporation of the 
MLCD concept into such definitions is now needed to make them reflect this 
wider understanding.
• This study demonstrates that MLCD is a missing dimension in HRQoL 
research and should be considered in future development of HRQoL 
questionnaires.
• This study identifies the need for evaluation of long term impact of chronic 
disease on patients’ lives, particularly the influence on MLCDs. This study 
will allow future researchers to use the domain of “MLCD” as a parameter in 
the assessment of disease long term impact and the overall assessment of 
HRQoL.
• The potential uses of the MLCD Profile, as defined earlier in the thesis, will be 
helpful for future researchers.
• The data from this study can be used to inform health, education and 
employment policies and will enable the creation of more patient friendly and 
patient centred policies. The new tool, the MLCDP, can play a potential role in
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achieving this goal, along with current QoL questionnaires, by quantifying this 
area.
• The information obtained from this study and the use of the MLCDP in the 
future will help educate health providers, particularly in the area of study 
related to possible long term consequences of chronic conditions. Healthcare 
providers will be better prepared to warn and help patients at an early stage of 
their disease, or immediately after the diagnosis, and offer a long term 
management plan.
• The MLCDP could be used for epidemiological surveys to find out which 
chronic conditions have the most influence on which type of MLCDs.
• Along with the development of the MLCD Profile, one of the major outcomes 
of this study is to devise strategies for chronic patients’ life cycle 
management. These strategies are based on the preliminary findings of this 
study and provide an initial structure. A more robust plan could be refined 
with further research.
Study limitations
• Due to the long process of recruiting a large number of patients (in total 900 
patients were contacted) for the two separate stages of the study (stage 1 and 
stage 4), time restrictions did not allow to carry out further validation or 
detailed psychometric testing of the MLCDP.
• For the individual interviews and the focus group discussions, patients were 
only recruited from the Department of Dermatology. This was because one of 
the supervisors was the head of the Department of Dermatology, hence 
making access to Dermatology patients much easier. Time restrictions and 
practical resources made it difficult to widen the interview base. There were 
some aspects of MLCDs that were only revealed in the Dermatology 
interviews, it is therefore possible that there might have been other MLCDs 
specific to patients from other specialities that might have been revealed if 
direct interviews had been carried out in other speciality groups.
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• Patient recruitment for focus group discussions was very difficult. This was 
perhaps because of the sensitivity of the MLCD topic. Patients did not want to 
discuses these life issues in front of other patients. More new information 
might have been obtained if more focus group sessions had been held. 
However, the information from the focus group sessions that were completed 
simply repeated information obtained through interviews.
• Initially, it was envisaged to include many different medical specialties in this 
project but due to time restrictions it was decided to include only a selection of 
major specialties. Our sample size from seven medical specialties was more 
than sufficient, but more specialities would have resulted in more diversity.
Future work
• Development of a “Patient experience and MLCDs database”: The results of 
this study and the MLCD Profile could be used for the formation of a “Patient 
experience and MLCD database”. This anonymised database could be 
developed to record all the MLCDs that patients have taken in their lives along 
with their reflection whether these MLCDs were right or wrong and what in 
retrospect they would have done differently. Patients could be referred to this 
database at any time in their life when they have to take a MLCD. The use of a 
database, with real life examples and scenarios narrated from patients’ actual 
experience, is an idea which could be realised without major resources. For 
example, this study has already gathered enough examples and scenarios from 
patients’ responses to form the basis of a database for the guidance of patients 
and to enhance public awareness about the lives and MLCDs of patients with 
chronic illness. The content analysis part of this thesis could be consulted for 
various examples.
The ethical, practical, administrative and financial issues are substantial for 
developing this kind of database. Therefore, a pilot study is needed to establish 
evidence for its viability and cost effectiveness. This proposed project 
therefore could be tested at a small level such as in one or two medical 
specialities (e.g. Dermatology or Rheumatology) of a local NHS Trust and
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could be extended further to other specialities for more observations, if it 
proved to be practical, cost effective and useful for patients.
• Introduction of psycho-social rehabilitation care: As a result of this study, it is 
clear that leaving patients alone without organised help may lead to 
depression, isolation and may cause further deterioration in their health, with 
increased hospital visits, less hours working, less income and ultimately an 
increased financial burden on the healthcare system. It is noted from the 
patients’ comments that psycho-social rehabilitation care would be helpful for 
some patients and this approach could be explored in future work. In this 
proposal for possible additional care for patients suffering form chronic 
disease over a very long time, consultants would work with specialist nurses, 
psychologists and psychiatrists to ensure optimised psycho-social 
rehabilitation care. Trained patient volunteers suffering from chronic disease 
would be available to provide first hand advice to patients. Professionals with 
expertise in career advice, education and social services would also contribute 
to the wider team.
After the diagnosis of chronic illness, this team could make a patient’s life 
journey more productive and healthy by means of offering a better long term 
management plan, regular counselling, genetic counselling and connecting 
with people suffering from same chronic condition. Patients could meet with 
education and employment professionals and discuss their specific issues. This 
would be particularly helpful for younger patients to guide them through their 
life and make their disease less burdensome and themselves more productive.
Initially, such a multidisciplinary care approach would need to be tested in a 
pilot study based on one medical speciality in a local NHS Trust to asses its 
applicability, practicality and usefulness before any further recommendations 
could be made. Currently, no hospital offers such a programme or similar 
facilities for patients suffering from chronic conditions. One programme, the 
“Expert Patients Programme” (EPP) has been developed and licensed by 
Stanford University, California, USA and is run by volunteers and some 
employees of local health boards in the UK (http://www.expertpatients.co.uk). 
EPP is a community based programme but none of our participants (>300)
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mentioned any knowledge of this programme. However, it is proposed that 
due to the magnitude of the disease influence on MLCDs, the nature of the 
disease associated influential factors, patients’ individual circumstances and 
the specific needs attached to various gender and age groups, the patients’ 
multidisciplinary psycho-social rehabilitation care concept should be explored 
in future studies.
• New data is required for further factor analysis and internal consistency 
reliability of the remaining items. In addition, full further psychometric 
evaluation of the MLCDP should be carried out using both classical test theory 
approach and novel techniques, such as items response theory.
• Further studies are required to create a tool similar to the MLCD Profile which 
would be sensitive to clinical change. The current profile is not designed to 
detect change over time (amenable to change) or to be used in follow up 
studies, such as before and after drug intervention.
• A degree of understanding about the relationship between patient age and the 
specific nature of MLCDs affected is important for the development of 
appropriate strategies, to help and advise patients. This area should be more 
precisely explored in future research, where patients could be asked about 
their age at the time when a disease influenced a specific MLCD. This might 
be helpful in targeting a particular age group for giving advice concerning 
specific MLCD.
• This study has demonstrated that the prevalence of specific MLCDs affected 
by the disease may be different among patients from different medical 
specialities. This area could be explored separately with a larger sample size to 
confirm the preliminary findings of this study.
• It has been learnt from the individual interviews and focus group discussions 
that some of the MLCDs might have been taken with the involvement of 
parents or family members, teachers and employers or even may have been 
imposed upon patients. In future work, patients could be asked specifically 
about each MLCD taken, whether or not it was their own MLCD or whether
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the MLCD, particularly at an early age, is in effect taken by parents, teachers 
or clinicians for them.
• The detailed accounts of patients in this study provide enough material to 
produce a book. Such a publication could act as a “reality novel” which could 
provide a learning curve for both patients and the general public. Such a book 
could enable unaffected people to have a better understanding about people 
who are suffering from a long term chronic disease.
• The development of strategies to influence government regulations and 
policies could be achieved in related future works. For example, it would be 
helpful to generate information to be incorporated by health, education and 
work and pension departments to give to patients and health providers. This 
would allow ready access to available help for patients suffering from long 
term health problems and for those who have developed physical and 
psychological disability as a result of their chronic illness.
• The next level of exploring this concept is the understanding of the influence 
of chronic disease on the MLCDs of family members. This secondary 
influence of disease could be incorporated into QoL questionnaires aimed at 
family members.
• The MLCD Profile could be used in long term follow up studies to identify the 
cumulative types of MLCDs affected over time.
• The issues surrounding MLCDs are very complex and highly subjective. Even 
for normal people this is a very important subject due to its long term 
consequences. There is a need to study a control group to see the difference in 
the approach between people with or without chronic disease and to confirm 
that MLCDs are, by nature, part of the normal course of life and of life stages 
in everyone.
Patients’ views about the study
At the end of each individual interview, when patients were asked about what they 
thought about the idea of this study, their replies were not surprising. The majority of
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patients were aware of the influence of their disease on MLCDs and this was the first 
time for them that anyone has asked question about this subject. Patients were very 
surprised to know about the lack of information in this area.
One patient stated:
“7 think it is an incredible idea, it is shame really it has not happened years ago. I 
took part in it because i f  my experiences could be o f any help to anyone I ’m thankful 
for it. They may not suffer like I  have in the past. Ifully support it”
<Dermatology-Individual Interviews\II-32>
Another patient stated:
“7 think it’s probably a very good study, I  am surprised, that there has not been more 
research. I can imagine that the way people look is quite a major factor in their 
decision making ”
<Dermatology-Individual Interviews\II-04>
The following comments from patients indicate that some patients did not realise that 
how much their disease has already impacted on their MLCDs.
“7 think i t ’s a really good idea because personally I  didn’t realise how much my 
eczema has impacted on my major life changing decisions and it really has and if  
people can be more aware and can get more support when making life changing 
decisions then it would be brilliant”
<Dermatology-Individual Interviews\II-27>
“Think i t ’s very good. I  think this study needs to be done to see how it exactly affects 
the lives o f people. As I  said, I  never realised how it’s affected until we spoke now ”
<Dermatology-Individual Interviews\II-21>
These findings were similar to the study conducted by Eghlileb et al (2007), in which 
they measured the attitudes of subjects to QoL enquiry. Patients’ comments are 
reported in detail in the content analysis section of this thesis.
Conclusion
This study provides a new insight into the magnitude of the long term impact of 
chronic disease on patients’ lives, most importantly the influence on MLCDs. 
Examining long term impact, life transition, life course and life events helps the 
understanding of the exceptional nature of life changing decisions in the context of 
health. Although the MLCDP requires further validation, it provides a means to
291
measure this impact on patients’ lives. It is easy to complete as a generic tool and 
covers most MLCDs. This novel concept requires further research to ensure all 
relevant aspects of patients’ lives are covered. The magnitude and the nature of this 
impact may be different in patients from different medical specialities due to the 
nature of the illness, its duration, the patients’ age and gender and individual 
circumstances. This study confirms that a holistic approach in treating patients is 
important. From the perspective of health and illness, any factor outside traditional 
dimensions (physical, social, psychological), which could improve a patients’ life, 
should also be considered for evaluation in the hope that better understanding may 
lead to improvement in the QoL of patients with long term disease. This also supports 
the concept of identifying “what things are important in people’s lives?” (Bowling 
1995).
The new HRQoL domain of “MLCD” appears to be a “missing link” in the QoL 
literature. This study highlights the importance of assessing long term impact and the 
MLCD Profile could be used as a parameter for the assessment of long term impact of 
chronic diseases on patients’ lives.
The most important outcomes of any study are those that are patient centred. The 
development of strategies for patients also highlights the need of awareness of this 
concept among health providers and among health, education and employment policy 
makers in order to consider patients’ long term illness, its impact and the MLCDs that 
patients take in life. Clinician understanding is vital in this area, so they can warn 
patients about the consequences of their chronic condition at an early stage and can 
offer better long term management plans. At the same time, patients can develop 
contact with patient associations, psychiatrists and psychologists. This approach will 
not only help patients to take better informed MLCDs but also help them develop 
their personality and maintain a positive attitude. This in turn gives patients more 
control over their lives and should result in fewer hospital visits and a reduced burden 
on the healthcare system. The knowledge of health providers and clinicians about 
MLCDs, particularly about the “knock on effects of MLCDs” is crucial. This 
approach would give patients the opportunity to make “well advised” MLCDs and 
increase their mental, physical and social strength for their personal development and 
personality growth.
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The results presented in this thesis will potentially add considerable knowledge to this 
relatively unknown area of health outcome research. Patients’ comments and quotes 
presented in this thesis provide a unique body of information and insight to patients’ 
lives which was previously unknown. In particular, knowledge has been gained about 
patients’ perceptions, attitudes, personalities, behaviour and the way they think in 
different life situations where they have to make important life changing decisions. 
Understanding patients’ health and its relationships with their life changing decisions 
opens the door for researchers to re-think the way long term impact of disease has 
been evaluated.
Finally, it would be fitting to bring this thesis to close with words from Dubos (1976, 
p. 9) which encapsulated the essence of this work: “Medicine cannot by itself 
determine the quality of life. It can only help people to achieve the state of health 
that enables them to cultivate the art of life but in their own way... It implies also the 
ability for each person to do what he wants to do and become what he wants to 
become, according to human values that transcend medical judgment”. This indicates 
that a patient’s own willingness to have control over life is absolutely essential. 
Therefore, along with medical interventions, the personality factor can impact on 
health (Kressin et al. 2000) and the way in which people approach life circumstances 
(Wrosch and Scheier 2003).
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S u m m a ry
The purpose of this review is to identify knowledge about the influence of 
chronic disease on major life changing decisions (MLCDs). This review was 
carried out in three stages: identification of key search terms; selection of 
databases and searching parameters; and evaluation of references. Only 
two articles matched the main search term 'major life changing decisions'.
No article reviewed or measured the influence of chronic disease on major 
life changing decisions. However, 76 articles and various sections of seven 
books were identified that provided insight into this area and these are 
reviewed in detail. This literature review has brought together previously 
scattered information on chronic disease impact on important patient life 
decisions. These include decisions related to having children, marriage and 
divorce, job and career choice, social life, holidays, travelling and education. 
Lifestyle decisions viewed by patients as major decisions are also 
documented. The influence of cancer on life decisions is discussed, as are 
affected life decisions of other family members. Very little information is 
available about the long-term impact of chronic disease on patients' lives 
and methodology to assess long-term impact is incomplete. This review 
points to a novel dimension to health-related outcome research, the impact 
of chronic disease on major life changing decisions, and its possible 
implication for patients' future health.
Introduction
The health sciences literature is replete with infor­
mation related to the current impact of different dis­
eases on patients' quality of life (QoL) and is mainly 
focused on the traditional health-related quality of 
life (HRQoL) domains (physical, social and psycho­
logical). In contrast, very little is known about the 
long-term impact of chronic diseases on patients' 
lives, for example the influence of chronic diseases 
on major life changing decisions (MLCDs) such as 
in relation to career choice, having children, mar­
riage, divorce, early retirement and moving abroad.
Through this literature review we introduce and 
explore this new concept and highlight its impor­
tance in a patient-centred healthcare system.
M ethods
The search strategy was carefully formulated to 
retrieve appropriate publications and to reduce 
the chances of missing important relevant infor­
mation. It involved three stages:
• Stage 1: Identification o f key search terms -  The key 
search terms were selected to gain a broad
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perspective and to ensure a wide coverage of 
the literature. The terms included life changing 
decision, long-term impact and QoL. The main 
key term 'life changing decisions' was com­
bined with: influence, chronic disease, family, 
decisions and over time (Table 1).
• Stage 2: Selection o f databases and searching par­
ameters -  OvidSP MEDLINE(R) database was 
selected for the initial comprehensive literature 
search. Searching limits were kept general in 
order to get more information from a broader 
perspective. The search was limited to original 
articles, and abstracts published in English. A 
separate questionnaire and item search was 
also carried out of the 'Compendium of 
Quality of Life instruments'.1,2 Data resources 
searched are listed in Table 2.
'T able 1 ^ ----------------------------------------------
Search results of different individual and 
combined terms
Single or combined terms Retrieved
used in searches references (n)
Life changing decisions 2
Patient decisions 93
Personal decisions 45
Family decisions 52
Change in lifestyle 115
Patient fear 95
Patient opinions 73
Patient suggestions 12
Patient views 133
Patient recommendations 39
Patient experiences 480
Patient account v 249
Patient perceptions 711
Patient feelings 19
Patient adaptations 1
Patient diary 93
Influence on Quality of Life 368
Long illness 44
Living with disease 95
Coping with disease 74
Quality of Life over time 70
Long-term impact 1255
Quality of Life, long-term 60
impact and disease: 
combined search /
Disease, influence, impact, 73
family and decisions: 
combined search
'Table 2 >---------------------------------------------
List of data resources searched
1. Ovid Medline
2. Google Scholar
3. Cardiff University electronic journals portal
4. Cardiff University Electronic Metalib resources: 
Cochrane Library (Wiley), Embase, Excerpta 
Medica (Ovid), PubMed, Web of Science, Zetoc
• Stage 3: Searching results and evaluation of 
references -  A review of published studies and 
articles was conducted. The aim and method­
ology of each study given in the abstract of 
the article identified was read to determine its 
relevance. Articles were then retrieved from 
the main database. A total of 4251 articles 
were retrieved from the OvidSP MEDLINE (R) 
database for close inspection to identify any 
study with potential relevance to our research 
concept. Articles were obtained with a 
number of combinations of different selected 
key terms such as 'life changing decisions' 
and 'patient decisions' (Table 1). A total of 
3397 articles were identified from a separate 
search using a combination of quality of life 
and different descriptors of studies such as pro­
spective study, long-term study, qualitative 
study, longitudinal study, cohort study and 
follow-up study. When the term 'life changing 
decisions' was entered in the Cardiff University 
Metalib resources (Figure 1) 1941 articles were 
retrieved. Only two articles matched the exact 
term 'major life changing decisions'.
Quality of Life instruments search
An extensive search was carried out in the 'Com­
pendium of Quality of Life instruments'.1,2 This 
compendium describes over 150 questionnaires, 
profiles and inventories and covers general, 
disease specific, group specific and economic 
specific instruments. The purpose of the compen­
dium search was to investigate in detail whether 
any questionnaire, profile or inventory has 
included the term 'life changing decision' for the 
assessment of disease impact on patients' lives. 
The search did not reveal any questionnaire, 
profile or inventory that has included any item,
  — .
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Figure 1 ^ -------------------------------------------
Metalib resources result for the term life chan­
ging decisions'
Cochrane Library 1521
Web of Science 251
1165Pub Med
Zetoc
Embase
0 500 1000 1500 2000
Number of references
domain, indicator or descriptor to cover the 
impact of illness on important life changing 
decisions.
Results
In the literature search, only two articles matched 
the term 'major life changing decisions'. These 
were related to psychology3 and to neuro­
economics.4 In the first article Bauer et al.3 exam­
ined the personal stories of life changing 
decisions in relation to personality and wellbeing 
and discussed the concepts of 'crystallization of 
desire (approaching to a desired future) and crys­
tallization of discontent (escaping an undesired 
past)'. In the second article Bems et al.4 explained 
life changing decisions as an example of intertem­
poral choice. Intertemporal choice is a study of 
preferences, value allocation and decisions with 
consequences that play out over time. Life chan­
ging decisions related to education, marriage, fer­
tility and how much food to eat, spending, 
investment, relationships and crime are some 
examples of intertemporal choices which contain 
trade-offs. Both studies were unrelated to the 
concept of health and life decisions.
Health and major life changing decisions
Life is about choices and decisions play an impor­
tant role. Life choices may become limited and 
undesirable due to negative stressful life events, 
and in this situation any decision could be life
changing. The diagnosis of a chronic disease is a 
negative life changing event in physical, psycho­
logical and social terms5' 6 and the initial news 
of a life-threatening condition is often 
devastating for patients7. King et al.8 suggested 
that 'Major life changes, by definition, require 
individuals to come to terms with a new set of life 
circumstances. Some life changes involve irrevoc­
able alterations in our lives, requiring us to redefine 
the very meaning of our existence, to seek out new 
sources of purpose, and to reassess our priorities.' 
The diagnosis or onset of disease, however, is not 
a decision that a patient takes. Very little infor­
mation is available about what constitutes a major 
life changing decision or how chronic disease can 
influence life changing decisions.
What can w e learn from the available 
literature?
Our extensive review has not revealed any specific 
research evaluating health-related life changing 
decisions. Several studies9-14 referred to disease 
as 'life changing' or as a 'major life changing 
event or experience' but remained focused on 
disease evaluation, treatment, patient education 
and quality of life. A few studies described how 
chronic disease might impact on important life 
decisions.
H a v in g  c h i ld r e n
Reproductive choices are very important life 
decisions and disease may influence an individ­
uals' choice to have children. Kadir et al.15 
suggested that the decision to have children is a 
complex one, even in the absence of disease. 
They conducted a survey of women with haemo­
philia to assess their experiences in pregnancy 
and their attitudes towards their reproductive 
choices. They found that age and emotional, 
social and financial factors were the main influ­
ences in planning pregnancy. Twenty-two of 160 
women reported that the decision about their 
first pregnancy, and 13 of 132 women reported 
that the decision about subsequent pregnancies 
was influenced by counselling and the results of 
prenatal diagnostic tests. The following question 
was also asked to all women, whether they had 
'ever made a conscious decision not to have 
children/any more children'. Fifty-four percent
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of women reported that having haemophilia was a 
major factor in this decision; 44% of women did 
not want to transfer haemophilia to their child, 
6% had previous experience of haemophilia in 
the family, and 27% reported personal, social, 
financial and medical reasons for this decision.15 
This questionnaire survey revealed individuals' 
priorities in different life situations, such as the 
prime example of disease influence on having 
children. Various studies suggest that the decision 
to have genetic testing could be a life changing 
decision and may impact on family planning, 
interpersonal relationships, social, financial and 
employment aspects.16-18 The decisions of 
parents about how to proceed after the antenatal 
diagnosis of congenital problems is important 
and difficult to make, as the decision may 
change their lives forever.19
Breast cancer is a life-threatening condition and 
deciding to have children after breast cancer is an 
important life changing decision for mothers. In 
1994, Dow20 carried out a study to identify the 
reasons why young women decided to become 
pregnant after breast cancer, to describe helpful 
behaviours in decision-making and to explore 
the meaning of having children after breast 
cancer. In this qualitative research, 16 women 
took part in semi-structured interviews. The par­
ticipants were interviewed after breast cancer 
treatment and were asked to share their experi­
ences following an open-ended question about 
breast cancer and subsequent pregnancy. Three 
main themes were identified that influenced 
having children after breast cancer treatment: 
having children as a cherished goal; a desire for 
sense of normalcy; and reconnection with others. 
Participants expressed a range of concerns about 
pregnancy (having a normal pregnancy, having a 
healthy infant, disease recurrence and concerns 
related to breastfeeding) and having children 
(recurrence and death, being hypervigilant, 
restructured living one day at a time, maternal 
concern). This research also highlighted in some 
patients that a longstanding desire for having chil­
dren was interrupted by the diagnosis of breast 
cancer. Before the diagnosis, breast cancer partici­
pants were in control; however, after breast cancer, 
they lost control of their lives. The behaviour of 
their spouse and family, healthcare providers 
and other breast cancer survivors were identified 
as critical factors in decision-making.20 These
findings suggest that a patient's personal efforts, 
professional help and the process of sharing 
experiences could be helpful to the person 
making life changing decisions influenced by a 
recent health event. This area was also discussed 
in another study, where newly diagnosed patients 
with HIV chose not to become pregnant.21
Anderson and Martin22 presented the narra­
tives of one couple (a cancer survivor and her 
husband), who lived through the life changing 
events following a cancer diagnosis. The narra­
tives are very moving and give insight into how 
a chronic life-threatening condition can change a 
patient's life. It is also evident that after the diag­
nosis, the patient's priorities changed and was 
preparing herself for the future. It is not clear 
whether the patient took any life changing 
decision, but words used by the patient in her 
story, such as 'I thought I was dying', 'I had no 
control over what was happening to me', 'I was 
still worried about my future' and 'It was de­
humanizing and very lonely' indicate that the 
disease and its treatment have a physical impact 
and result in emotional fluctuation, fear and 
uncertainty which may influence a patient's pri­
orities in life and may also change their family 
and social role and identity.
Marriage and divorce
Physical health and marital dissatisfaction have a 
direct effect on each other.23 Health, mental well­
being and its associations with marriage, relation­
ships and family have been widely discussed in 
the literature, and any change in circumstances 
due to health may impact on the quality of life of 
family members and relationships. For example, 
if poor health causes a break-up in a relationship 
then divorce (as a stressful life event) may lead 
to poor health.24- 27 Wilson and Waddoups28 
carried out a study to investigate how health 
impacts on the breakup of a marriage. Data were 
used from the four 2-year periods of the Health 
and Retirement Study (1992, 1994, 1996 and 
1998). In 1992, 4241 couples aged 51-61 years 
entered into this study. The health mismatch 
hypothesis was tested by using different spousal 
health combinations and separation was used as 
an indicator of marital dissolution. Marital dissol­
ution was not observed from a life course perspec­
tive or from the perspective of health influence on
■a*p.**---------------------------------- -----------------------------
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separation. However, the study still suggests that 
the poor health of a spouse at a young age may 
cause marriage break-up over time. There is infor­
mation concerning the impact of disease on 
marriage, marital adjustment and marital 
quality;29 -32 however, it is not clear whether 
chronic disease influenced patients' decisions to 
get married or prevented them becoming involved 
in any relationship.
Seidler and Kimball33 suggest that patients 
with chronic skin disease may learn to cope over 
time but their important decisions early in life 
may have long-lasting impact on their quality of 
life. Seidler and Kimball used the Research 
Patient Data Repository (RPDR) database and 
cross-sectional analysis to determine any link 
between key ages or age ranges and social discon­
nection. Religious non-affiliation (for loss of social 
network), divorce (for loss of interpersonal con­
nection) and use of Medicaid (for disconnection 
in the work place) were used as surrogate evalua­
tive measures for the assessment of social connec­
tivity among psoriasis patients. They found that 
divorce rates in psoriasis patients were higher in 
the age groups 29-31 years (1.3% vs. 1.7%; 
P < 0.05) and 32-34 years (2.3% vs. 1.1%; P < 
0.001) than corresponding rates in the general 
population. Seidler and Kimball33 highlighted 
the importance of the association of disease 
and age groups with the important life decision 
to divorce, but it is not clear whether 
psoriasis specifically had an influence on the 
patients' decision to get divorced or whether 
psoriasis contributed to the partners' decision to 
get divorced.
Chronic disease can also influence the major 
life changing decisions of other family members. 
In a cross-sectional study Fine et al.3* asked a 
series of questions to parents of children suffering 
from inherited epidermolysis bullosa (EB) about 
the long-term impact of their child's illness on 
their marital life; 54-64% parents of children 
with dominant dystrophic EB (DDEB) and reces­
sive dystrophic EB (RDEB) reported that they 
had decided not to have additional children; 
88% of divorced couples with children affected 
by junctional EB (JEB), 50% of divorced couples 
with children affected by DDEB and 67% of 
divorced couples with children affected by 
RDEB reported that their child's disease was a 
major factor leading to their decision to divorce.
Job and career choice  
In a 1-year follow-up study, Cvetkovski et al.35 
concluded that occupational hand eczema in 
later life is associated with poor quality of life 
and lower socioeconomic status and results in 
patients taking prolonged sick leave, becoming 
unemployed or changing their job. One year is a 
relatively short period for follow-up to assess 
these changes, but in this study 50% of patients 
had changed their jobs during the 12 months, 
which suggests how chronic illness can change 
life significantly. The frequency of reported 
change of job due to hand eczema was higher 
than when previously assessed by Meding 
et al.36 in their 15 year follow-up study (1983- 
1998). They had found that 20 (3%) out of 706 
patients from different employment backgrounds 
(medical and nursing work, cleaners, hairdressers, 
kitchen workers, painters and mechanics) 
reported change in their occupations because of 
their hand eczema, and 15 patients reported 
improvement after change in occupation. Eight 
percent of patients had reported change in their 
occupation before the initial 1983 examination. In 
terms of job change, both studies focused on occu­
pational risk and did not discuss the nature or the 
consequences of the decision involved in relation 
to change in employment. It is obvious from both 
studies that chronic disease can influence a 
patient's decision related to selection of jobs or to 
change in occupation. Long-term illness can make 
it difficult for patients to remain in the same 
employment if their occupation is one of the 
major reasons for health deterioration. Choices 
become limited for patients and in some cases a 
change of job might result in financial loss. Patients 
might remain in the same employment and suffer 
because of socioeconomic reasons (family, better 
housing and children's education).
The effects of eczema 'over the last few years' 
on patients' quality of life were assessed in 92 
eczema patients.37 Eighty percent of the patients 
reported effects on their family life. Working 
patients lost around £5000 (median estimated) 
over the previous year. Other impacts identified 
were effects on sexual relationships (57%), effects 
on choice of career (51%) and 52% reported 
effects on long-term personal friendships and 
relationships.37
In another study, Malcomson et a l 38 conducted 
two qualitative focus group discussions to explore
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the impact of multiple sclerosis (MS) (n = 13, age 
40-67 years, mean disease duration = 17 years) 
on patients' lives. Several patients reported 
changes to their employment circumstances 
along with other disease-related impacts (inter­
personal and social life, stress, unpredictability, 
fear and impact on daily living). Despite the 
resulting loss in socioeconomic status, one 
patient made a decision to change from full-time 
to part-time employment and two patients gave 
up their paid jobs because of the impact (fatigue, 
lack of energy, decreased mobility and stress) of 
MS on their lives. The patients indicated that MS 
influenced their important decisions regarding 
employment and made them compromise (an 
undesirable objective) in the best way possible to 
accommodate their health needs and also take 
control of their resulting lifestyle changes.
Social life, holidays, travelling and 
education
Arnold et a l.39 conducted six focus group (« = 48) 
discussions with women suffering from fibro­
myalgia to assess its impact on their lives. Partici­
pants raised a variety of disease-related (cognitive 
impairment, emotional, functional and quality of 
life impact) and symptom-related (pain, fatigue 
and sleep) issues. Socially, fibromyalgia patients 
feel that due to the unpredictable nature of the 
disease, they are unable to plan any event and 
are judged by co-workers and friends as unreli­
able, resulting in loss of friendship and their with­
drawal from social engagements. The participants 
also reported that they failed to properly look after 
their own children and families. Not being able to 
go for family trips was reported as life changing 
by patients and lack of participation in household 
activities and decreased sexual intimacy had 
caused great strain on their personal relationships. 
This study indicated that not to take part in simple 
things, such as social activities, is viewed by some 
people as a life changing decision. Those affected 
might still take part in different activities but 
embarrassment and humiliation and the long­
term nature of the disease might drag them 
towards complete isolation. Similarly, the constant 
strain of disease on personal relationships may 
lead to taking more serious life decisions, such 
as separation or divorce. The participants also 
reported that their disease not only made them
change their job frequently but made them 
reduce their working hours. Half of the patients 
left their jobs because of their illness, which ulti­
mately resulted in financial difficulties. Some 
patients reported that their conditions stopped 
them from pursuing higher education; this is a 
very difficult life decision to take with resulting 
consequences in some circumstances of low paid 
menial hard work and further health deterio­
ration.39 Such patients may need more support 
and appropriate advice at those life stages when 
they have to take important life decisions regard­
ing employment and education. Increased 
patient understanding seems necessary to reduce 
the inappropriate impact of the disease on 
decisions which determine the future course of 
life.
Lifestyle d ecisions as major life changing 
d ecisions
Life decisions and their perceived value are sub­
jective in nature. Some decisions perceived as 
major by some patients may seem very minor to 
an observer and more related to day-to-day activi­
ties/choices. However, individuals' specific cir­
cumstances, such as experiencing the onset of 
chronic disease, could make these daily decisions 
and choices more important for that individual 
and life changing. Huggins et al.40 surveyed 
young patients suffering from hydroa vaccini­
forme and suggested that both the type of 
chronic condition and the duration of disease 
(median age at onset 7 years) influenced the 
impact on quality of life. Concerning the Chil­
dren's Dermatology Life Quality Index (CDLQI) 
responses, 63.6% patients (n = 11, age 9-17 
years) reported impact on going out, playing and 
hobbies, 54.5% reported impact on choice of cloth­
ing, and 36.4% reported impact on swimming and 
sports activities. On their Dermatology Life 
Quality Index (DLQI) responses 75% adult 
patients (n = 4, age >18 years and over) reported 
that their skin condition influenced their choice 
of clothing. It is understandable that 
disease-related aesthetic reasons and embarrass­
ment (50%) could play an important part in influ­
encing patients to view simple decisions such as 
choice of clothing or swimming as 'major 
decisions' as they involve change in their lifestyle 
and image, which patients may feel to be wrongly
I*- -------------------------------------
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perceived by others. In another study Hon et al.41 
found that young girls with atopic dermatitis had 
more problems concerning clothes or shoes than 
boys, indicating the importance of gender on 
disease influence on specific aspects of patients' 
lives. Decisions about lifestyle, for example 
smoking, drinking and over-eating, may have 
serious consequences on health.42 Any decision 
to modify these habits may determine an individ­
ual's future health, reflecting the significance of 
lifestyle-related decisions. Similarly, other 
health-related decisions such as the decision over 
choice of treatment (whether surgery or medi­
cation) could be life changing for a patient.43-45
Are the long-term impacts of diseases 
being measured?
It is important to understand the long-term 
impacts of a chronic disease as these impacts 
may change over time. Understanding long-term 
impacts may assist clinicians in developing 
better management plans for patients.
Several studies have assessed the quality of life 
impact experienced by patients who had 
suffered from chronic diseases for a long period 
of time.46 -54 However, these studies predomi­
nantly assessed current experiences and were not 
specifically designed to assess the long-term 
impact. Similarly, in follow-up studies the assess­
ment of disease impact mainly compares current 
impacts, and the changes which have occurred 
in the level of current impact over a period of 
time.55 - 62 This may not reflect the different type 
of impacts that the patient has experienced over 
the intervening years. To record the true long-term 
impact, it would be necessary to ask patients how 
their illness has affected them over the full period 
of their illness. Such a holistic exploratory retro­
spective approach could provide a new insight 
into the nature of the long-term impacts faced by 
patients during different stages of their life includ­
ing newly affected domains, such as health-related 
major life changing decisions.
D iscussion
Some negative life events (e.g. chronic illness, acci­
dent, injury) may influence major life decisions 
such as marriage, divorce, job, education, having
children, moving abroad, moving house and 
retirement. For example, a diagnosis of chronic 
illness may influence an important life decision 
related to employment, such as whether to carry 
on in full-time work or take a part-time job or 
retire early, which might be a good option from 
the perspective of health. Such a decision might 
seem simple but in fact may be very difficult to 
make because the consequences of the decision 
may result in financial difficulties, which may 
lead to other problems related to the patient's 
mortgage, lifestyle, family and relationships. 
This knock-on effect may lead to further health 
deterioration. Although studies included in this 
review were not designed to capture the influence 
of chronic diseases on major life changing 
decisions, some of their findings aid our under­
standing of this novel aspect of health-outcome 
research.
Kimball et a l.63 reviewed the long-term impact 
of psoriasis and proposed the concept of 'Cumu­
lative Life Course Impairment' (CLCI). **This 
concept results from an interaction between '(a) 
the burden of stigmatization and physical and 
psychological co-morbidities and (b) coping strat­
egies and external factors'.63 The concept of CLCI 
as described63 does not specifically address the 
impact of psoriasis on major life changing 
decisions. However, if a major life changing 
decision is influenced by psoriasis, this is likely 
to contribute to CLCI,64 and indeed it may be 
that influences on major life changing decision 
are of equal or greater importance than stigmatiza­
tion and coping strategies in contributing to CLCI.
In other words, one negative life event, such as 
onset of a chronic disease, may influence decisions 
relating to several subsequent life events, such 
as choice over education, career, employment, 
marriage, housing, having children and moving 
abroad.
It is obvious that the life decisions that a patient 
makes are normally intended to gain the desirable 
outcome of a better life. However, not every life 
decision turns out to be a positive or a correct 
decision. After the diagnosis of a chronic or life- 
threatening condition, acceptance is usually a 
great challenge for patients. Patients search all 
available avenues for a cure and may take a con­
siderable time to realize that they might have to 
live with the condition for the rest of their lives. 
A change in attitude to acceptance may give a
J  Ft Soc M ed 2011: 104:241-250. DO110.1258/jrsm.2011.110010 247
Journal of the Royal Society of M edicine
patient motivation for the future but life changing 
decisions and related choices may remain very 
limited due to the ongoing illness and other 
health-related factors, such as severity, depression 
or treatment. Therefore, the desired future outcome 
may not be as successful as it would be in disease- 
free individuals. Decisions at the right time about 
higher education and early career development or 
having children are important as part of the 
natural course of life and occur at different life 
stages, but the continuous long-term impact of 
chronic disease on patients' lives may influence 
these decisions. Patients might either decide differ­
ently or might delay their decision. This is where 
health providers and clinicians may play a very 
important role to warn patients at an early stage 
about the long-term consequences of chronic 
disease, which in turn not only might minimize 
the disease impact on patients lives, particularly 
on major life changing decisions, but also reduce 
the burden on the health system.
Conclusion
There is little specific information in the literature 
about the impact of chronic diseases on major life 
changing decisions. There is no defined measure 
to capture this vital information. Up to now- the 
assessment of the long-term impacts of a disease 
has been based on the repeated evaluation of its 
current impacts on patients' lives, thereby, poten­
tially missing major aspects of the impact. Impor­
tant specific questions remain unanswered: what 
is the definition of a 'major life changing 
decision'? How do patients take their life changing 
decisions while suffering from long-term health 
problems? To what extent do chronic diseases 
influence major life changing decisions? What 
influential factors are involved in life changing 
decision-making? How capable are patients to 
take appropriate life changing decisions? There 
is a need for strategies for healthcare providers 
to assist patients to take appropriate decisions 
and allow them to maximize their control over 
their lives.
The lack of knowledge in this area revealed by 
this review suggests new areas for research. In 
addition to both follow-up and prospective 
research techniques, exploratory retrospective 
research methodology is essential to understand
the magnitude of the influence of chronic diseases 
on life changing decisions. This review has high­
lighted a novel dimension to health-related 
outcome research, the new domain of 'major life 
changing decisions'. Encompassing this concept 
may make health-related quality of life estimation 
closer to reality. There is a need for multidisciplin­
ary research to capture fundamental information 
for further conceptualization, to determine the 
definition of health-associated major life changing 
decisions, to create a suitable instrument for its 
measurement, to assess the feasibility of this new 
concept as a new measurable dimension and to 
assess its possible implications on patients' lives 
and on healthcare resources.
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Major life changing decisions 
and cumulative life course 
impairment
Editor
The proposal by Kimball et al. 1 o f  the concept o f  Cumulative Life 
Course Impairment (CLCI) is an important step forward in 
enhancing our appreciation o f  the wider burden o f psoriasis. The 
authors state that ‘CLCI results from an interaction between the 
burden o f stigmatization and physical and psychological co-mor­
bidities and coping strategies and external factors.’ However, an
additional critical potential influence on CLCI is the impact of 
psoriasis on Major Life Changing Decisions (MLCDs). We have 
been exploring this related, but separate concept both in dermatol­
ogy2,3 and across several medical specialties including cardiology,4 
respiratory medicine,5 cystic fibrosis,5 diabetes,6 nephrology7 and 
rheumatology.8
In 50 patients with chronic skin diseases, including 16 patients 
with psoriasis, the percentage of patients in whom MLCDs were 
affected by the skin diseases relating to career choice was 6 6 %, job 
58%, relationships 52%, education 44%, moving abroad 32%, 
having children 22%, early retirement 20%, housing 14% and 
moving to another city 12% ,3 It is clear therefore that chronic skin 
disease has a profound impact on these critical decisions in 
people’s lives.
Several key influential factors on MLCDs have been identified 
including ill health and severity o f disease, embarrassment, appear­
ance, stress, fear and anxiety, frequent hospital visits and treat­
ment, public attitude, risk to health, physical disability, working 
conditions and depression.2,5-8 Some o f these have also been noted 
by Kimball et aLx as being integral influences on CLCI, thereby 
emphasizing that CLCI and the impact on MLCDs are different 
aspects o f the wider reality experienced by the patient.
While not all MLCDs that are influenced by chronic skin 
disease are necessarily negative in their outcome, several MLCDs 
such as the decision not to have children or not to continue in a 
particular career may add to the cumulative impairment caused 
by the disease.
It is o f note that the types o f MLCDs influenced by skin disease 
are similar to those affected by other non-dermatological disease, 
emphasizing that these issues are o f importance across the whole 
o f medicine and not confined to psoriasis or skin disease.
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Re. major life-changing 
decisions and cumulative life 
course impairment
Editor
We wish to thank Drs. Bhatti, Salek and Finlay for their com­
ments, and also to recognize their substantial contributions to the 
field. We absolutely agree with their supposition that major life- 
changing decisions (MLCDs) can be substantially affected by skin 
disease and may add to the cumulative impairment o f  disease. We 
have three additional observations to make regarding the impor­
tance o f MLCDs:
1 First, many o f these decisions, such as marriage, career choice, 
education and child bearing, occur relatively early in most peo­
ple’s lives. We draw attention to the life-course models, and 
specifically the ‘critical period model’ proposed by Kuh and 
Ben-Shlomo. 1’2 The concept o f critical and sensitive periods is 
applicable, and we postulate that the onset o f psoriasis during 
critical or sensitive periods (e.g. adolescence and early adult­
hood), when a majority o f  these MLCDs are made, will have a 
greater impact on life course than later onset o f psoriasis. 
Given that one o f  the peaks o f psoriasis onset occurs in the late 
teens, this population may be particularly vulnerable to the 
effects of disease on MLCDs. In contrast, patients who are 
affected by psoriasis later in life in their 40s and 50s are likely 
to be more established in their career and relationships, having 
made many MLCDs earlier; thus, the effects o f  psoriasis may 
be less apparent. Data showing improved quality o f life in 
older patients with similar disease severity support this con­
cept.3,4 Treatment plans and the risk-benefit ratio may there­
fore be somewhat different in this younger population, but
further research is required to understand the impact of psori­
asis in this group.
2 Secondly, the effects o f  MLCDs may magnify each other 
and not simply be additive. For example, poor economic 
status may also affect education and social status.
3 Lastly, we agree that these concepts are likely applicable to 
other chronic diseases in non-dermatological areas.
We continue to develop the concept o f Cumulative Life Course 
Impairment (CLCI) in psoriasis. Specifically, we are investigating 
further the concept o f critical time periods to understand the 
relative impact o f various exposures on outcomes in CLCI. We 
look forward to seeing how this patient-centric concept and its 
attendant research will evolve.
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British Association of Dermatology calls for patient- 
centred disease treatment
Judith Leavy 10 9  Dec 2 0 x0  | o Comment(s)
Treatment of chronic skin diseases need to target physical, psychological, 
and social issues, Judith Leavy reports
Researchers from the British Association of Dermatologists say that recent 
findings on major life-changing decisions (MLCDs) among dermatology 
patients strongly suggest that the future of chronic skin disease treatment 
should be patient centred and should cover the patient’s physical, 
psychological, social and MLCDs domain.
Data presented at the British Association of Dermatologists’ conference in 
Manchester showed that 90 per cent of patients with a chronic skin 
condition said it had influenced a major life-changing decision, with 22 per 
cent saying that their disease had even influenced their decision on 
whether or not to have children.
Speaking to the Medical Independent, Dr Zaheer Bhatti, a consultant 
dermatologist in Bristol and research group leader said: “Being a 
dermatologist having a special interest in the impact of chronic skin 
diseases on patients’ QoL and in health outcome research, we were aware 
of long-term impacts and noticed that some patients had taken different 
life decisions only because of their chronic skin condition.
Tor example, MLCDs related to education, career choice, relationships, 
job and early retirement.
“At the start of our survey we were not sure about the magnitude of the 
impact on patients’ MLCDs and in what ways chronic skin diseases had 
influenced their MLCDs. “Our literature review yielded no information 
from health and MLCDs perspective studies which increased our curiosity 
and determination to gain insight knowledge in this new area.”
The research group focused on people with long-term skin diseases in both 
individual interviews and focus group discussions.
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“We were surprised to see not only the magnitude of the disease influence 
on MLCDs but also about how minor and routine life decisions can become 
MLCDs for patients; particularly decisions related to choice of clothing, 
wearing makeup, not to go swimming, and withdrawal from social 
activities,” Dr Batti said.
Similarly, decisions related to travelling and holidaying abroad were also 
reported as MLCDs by a considerable number of patients. Decisions to 
have children, moving abroad, moving to another city and decisions 
related to housing appeared to be more major and important than we 
initially anticipated.
Dr Bhatti and his team were also surprised at the way patients reported 
how the severity of their disease impacted hugely on their life decisions, 
with 82 per cent of patients reporting that these were affected by ill health 
and severity, embarrassment (78 per cent), appearance (74 per cent), lack 
of confidence/self consciousness (74 per cent), and stress and anxiety (64 
per cent).
“We designed our survey in order to evaluate the longterm impact of 
chronic diseases on patients’ lives, particularly on MLCDs. We asked our 
research questions retrospectively so that patients could look back on 
their lives and see whether their chronic skin disease had influenced any 
MLCDs over time.
'The majority of patients were suffering for very long periods of time 
(mean disease duration at individual interviews was 29 years, while among 
focus groups the average disease duration was 15.2 years) and was 
necessary to obtain the information from their life-time experience,” said 
Dr Bhatti.
With psoriasis affecting about 2 per cent of the population and eczema 
affecting at least one in six school children and about one in 20 adults, the 
survey was designed to evaluate the long-term impact of chronic diseases 
on patients’ lives.
Due to the fact that the impact of skin disease is so immense, the group 
stressed that patients should be advised about the consequences of 
chronic skin disease and should be supported by health professionals and 
new pharmacological advancements.
The authors added that public awareness and understanding should be 
included as part of a broader approach.
Dr Bhatti stressed the need for early patient education about the long-term 
effects of chronic skin diseases, saying: “Clinician understanding is vital so 
that patients can be warned early about the longterm consequences of the 
disease.
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“Timely advice to younger patients about their longterm management and 
future plans might minimise the disease impact on patients’ lives. Through 
this process, the disease’s impact on other associated aspects of life- 
changing decisions such as finance, career development, future plans and 
. quality of life can be minimised.
“For the assessment of the full impact of chronic skin diseases, influence 
on MLCDs should be measured for better health outcomes. Our study 
demonstrates that MLCDs can be used as a parameter for the assessment of 
long-term impact of chronic skin disease.
Systematic measurement of this impact on MLCDs would complement 
current measures of immediate impact of skin diseases on quality of life 
and potentially aid clinical decision taking and long-term management,” 
he said.
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R eporting from the British Association of Derm atologists (BAD) 
annual m eeting,M anchester
New research into a range of common skin diseases affecting hundreds 
of thousands of Britons will reveal the true impact of the conditions on the 
lives of patients A series of studies, presented attheBntish Association 
of Dermatologists' conference in Manchester, shows the influence that 
diseases such as acne, eczema and psoriasis, can have on people’s 
relationships work and everyday lives In total nine out often (90%) 
patients with a chronic skin condition said it had influenced a major life- 
changing decision-with one in five (22%) saying that their disease had 
even influenced their decision on whether or not to have children
One study 1 found:
•  Almost half (46%) said their skin disease had a bearing on their 
choice of clothing they wore
•  One in five said it influenced whether they wore make-up (22%)
•  The same proportion said that their condition prevented them from 
socialising and a third (34%) had stopped swimming.
•  Two thirds (66%) said their skin disease had influenced a major 
life-changing decision relating to theircareer. while decisions 
relating to education (44%) were also affected
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New Studies Reveal Impact of Most Common Diseases
flew research into a range of common skin diseases affecting hundreds of thousands of Bntons 
will this week reveal the t n e  impact of the conditions on the lives of patients.
A senes of studies, presented a t  the Bntish Association of D erm atologsts' conference in 
Manchester (6-8 July 2010), shows the influence that diseases such as acne, eczem a and 
psonasts, can have on people's relationships, work and everyday Ives.
ABOUT THE STUDY
P re ss  R elease  Supplied w ith th e  Kind 
Permission o f Nina Goad, a t  the  British 
A ssociation  o f  D erm ato log ists.
In total, nine out of ten (90 per cent) patients with a chronic skin condition said it had influenced 
a major life-changing decision -  with one in five (22  per cent) saying that their disease had even 
influenced their decision on whether or not to have children
One study found:
• Ahnost half (46 per cent) said their skin disease had a bearing on their choice of dothing 
they wore.
• One in five said it influenced whether they wore make-up (22 per cent).
• The sam e proportion said that their condition prevented them from socializing and a third 
(54 pet cent) had stopped swimming.
• Two thirds (66 per cent) said their skm disease had influenced a m ajor (fe-changng 
decision relating to th a t  career, while decisions relating to education (44 per cent) were 
also affected.
• One in five (20  per cent) said their disease had a beanng on whether they took earty 
retirement.
http://www.talknsoriasis.com/webdocs/featurcs/rescarch into range of commo 
n skin conditions.php 
(Accessed 12th October 2010)
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F ea tu res  - New S tud ies  R eveal Im pact o f Most Common Diseases
New research into a range o f com m on skin d iseases affecting hundreds of thousands of Britons 
wit this week reveal the true im pact of the conditions on the fives of patients.
A senes of studies, presented  a t  the British Association of Derm atologists' conference in 
M anchester (6 -8  July 2010), show s the influence tha t diseases such as  acne, eczem a and 
psoriasis, can have on people 's relationships, work and everyday lives.
In total, nine out of ten (90  per cent) patients with a chronic skin condition said it had influenced 
a m ajor life-changing decision -  with one in five (2 2  per cen t) saying th a t their disease had even 
influenced their decision on w hether o r n o t to  have children.
« Almost half (46  per cent) said their skin disease had a  bearing on their choice of dothing 
they w ore.
•  One in five said it influenced w hether they w ore m ake-up (22  per cent).
•  The sam e proportion said thar their condition prevented them from socialzing and a third 
(34 per cent) had stopped  swimming.
•  Two thirds (66  per cen t) said their skin disease had influenced a m ajor life-changing 
derision relating to  their career, while decisions relating to education (44 per cent) were 
also affected.
« One in five (20  per cent) said their d isease had a bearing on w hether they to o k  early 
retirem ent.
http://www.bmi.com/coiitent/341/bmi.c3842.fuH 
(Accessed 14th August 2010)
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Minerva
Scientists have successfully taken apart a rat lung and rebuilt it with newcells 
The new lung exchanged oxygen and carbon dioxide for a shorttime after being 
transplanted into a live rat The technique involved removal of the spongy 
epithelial cells and blood vessels of the lungs with detergent, leaving a scaffold 
of connective tissue that retained the mechanical properties of the original lung. 
The scaffold w as “marinated" in a mixture of lung epithelial and endothelial cells 
and within a few days the engineered lung contained alveoli, microvessels, and 
small airways that were repopulated with the appropriate celltypes 
{Saencexpress2010; published online 24 June. doi:10.1126/science.1189345)
What impact do common skin conditions have on the British public? Studies 
presented to the British Association ofDermatologists' conferencein Manchester 
about acne, eczem a, and psoriasis report that 90% of those afflicted say their 
skin has influenced a major life changing decision, and 20% say it affected their 
decision whetherto have children. Just under half said their skin condition 
affected their choice of clothing, one infive said it affected whetherthey wore 
make up; the sam e proportion said their condition prevented them from 
socialising, and a third said they had stopped swimming (www.bad .org.uk).
British Association of Dermatologists
PRESS RELEASE
7%skur^
New studies reveal impact of most common diseases on work, relationships and even 
decision to have children. For immediate release, Monday July 5th, 2010
New research into a range of common skin diseases affecting hundreds of thousands of Britons will 
this week reveal the true impact of the conditions on the lives of patients.
A series of studies, to be presented at the British Association of Dermatologists’ conference in 
Manchester, will show the influence that diseases such as acne, eczema and psoriasis, can have on 
people’s relationships, work and everyday lives.
In total, nine out of ten (90 per cent) patients with a chronic skin condition said it had influenced a 
major life-changing decision -  with one in five (22 per cent) saying that their disease had even 
influenced their decision on whether or not to have children.
One study* found:
• Almost half (46 per cent) said their skin disease had a bearing on their choice of clothing they 
wore.
• One in five said it influenced whether they wore make-up (22 per cent).
• The same proportion said that their condition prevented them from socializing and a third (34 
per cent) had stopped swimming.
• Two thirds (66 per cent) said their skin disease had influenced a major life-changing decision 
relating to their career, while decisions relating to education (44 per cent) were also affected.
• One in five (20 per cent) said their disease had a bearing on whether they took early
retirement.
Another study1 found that skin conditions are the most frequent reason for people to consult their GP 
with a new problem, more so than respiratory problems, musculoskeletal disorders and mental illness.
A third study2, relating just to psoriasis, found that:
• Two thirds of patients with severe symptoms said the disease has had a negative impact on 
their working life.
British Association of Dermatologists, 4 Fitzroy Square, London W 1T 5HQ
www.bad.org.uk, 0207 383 0266
[m/f]
• Four out of ten (42 per cent) said the disease had limited their income, or restricted their 
future employment or career choice.
• A third of such patients (32 per cent) reported discrimination in the workplace on the basis of 
their condition, while one in five (19 per cent) said that their disease had contributed to them resigning 
or being dismissed from a job.
• More than a third (37 per cent) felt that, owing to their disease, they have not performed as 
well in education as they could have done.
• Nine out of ten (87 per cent) felt that their mood, mental health and general enjoyment of life 
suffers, with three-quarters (73 per cent) saying they have reduced drive and 69 per cent saying they 
have reduced aspirations because they have psoriasis.
• Psoriasis was also found to influence patients’ personal relationships, with 67 per cent saying 
that their disease has prevented them pursuing intimate relationships. Three out of ten (29 per cent) 
have ended an intimate relationship because of their condition.
• Most patients (87 per cent) believed there to be a lack of understanding about psoriasis 
among the public.
Chief Executive of The Psoriasis Association, Helen McAteer said: “This is the largest UK web-based 
survey to assess quality of life issues in psoriasis. Our findings illustrate that severe psoriasis has a 
significant and long-lasting impact on people’s lives in the UK -  far greater than was previously 
appreciated.”
Nina Goad of the British Association of Dermatologists said: “I work with skin disease patients on a 
daily basis so I am aware of the profound effect that symptoms can have on people’s lives, but 
despite this I was still stopped in my tracks by some of the findings of this research.
“The fact that such a high number of people cite having a skin disease as a major consideration in the 
decision of whether to have children, or say that it has brought about the end of a relationship or 
caused them to stop socializing, is just so sad.
British Association of Dermatologists, 4 Fitzroy Square, London W 1T 5HQ
www.bad.org.uk, 0207 383 0266
“Add to this the statistics about job losses and discrimination in the workplace, and a clear picture 
begins to emerge of what so many people in the UK are having to endure. Of course not all patients 
will be influenced to this degree, but it is worrying that so many are. And we are not talking about one 
rare disease here, which would be bad enough. Skin conditions are incredibly common.” 
[m/f]
-Ends-
Notes to editors:
1. Background statistics -  prevalence of skin disease
• 24% of a GP’s case load is for skin conditions1
• 26% of people report having suffered from a skin rash/allergies/irritated skin, 13% from 
eczema and 12% from acne/spots, over the preceding 12 months. (‘A Picture of Health’; PAGB / 
Reader’s Digest 2005, http://www.pagb.co.uk/information/PDFs/Pictureofhealth.pdf)
• Acne affects 80 to 90% of adolescents in the UK, and for 30% of these, their acne will be 
severe enough to warrant medical attention. 14% of women in the UK aged between 26 and 44 suffer 
from facial acne.
• Psoriasis is a common skin problem affecting about 2% of the population. It occurs equally in 
men and women, at any age, and tends to come and go unpredictably. It is not infectious, and does 
not scar the skin.
• Eczema (atopic eczema) affects at least 1 in 6 school children and about 1 in 20 adults. 
(Patient UK - http://www.patient.co.uk/health/Atopic-Eczema.htm)
• For information on other skin diseases visit www.bad.org.uk
2. Study details
‘Patients with the following diseases were interviewed: psoriasis, eczema, acne, hidradenitis 
suppurativa, ichthyosis, palmoplantar genodermatosis, alopecia areata, Dariers disease. The 
influence of chronic skin diseases on major life-changing decisions as a parameter for the 
assessment of long-term impact.
Z.U. Bhatti, S. Salek* and A.Y. Finlay
Department of Dermatology, School of Medicine, Cardiff University, Cardiff, Wales, U.K. and ‘Centre 
for Socioeconomic Research, Welsh School of Pharmacy, Cardiff University, Cardiff, Wales, U.K.
1 Updated Dermatology Health Care Needs Assessment: Skin conditions are the commonest new 
reason people present to general practitioners in England and Wales: implications for education and 
training.
J. Schofield, D. Fleming,* D. Grindlayf and H. Williams!
United Lincolnshire Hospitals Trust, Lincoln, U.K.; ‘Royal College of General Practitioners Research 
and Surveillance Unit, Birmingham, U.K. and fCentre of Evidence Based Dermatology, University of 
Nottingham, Nottingham, U.K.
British Association of Dermatologists, 4 Fitzroy Square, London W 1T 5HQ
www.bad.org.uk, 0207 383 0266
2Survey of 1760 UK adults. 52% defined their disease severity as ‘very active’ or ‘extremely active’ 
and for the purpose of this study are therefore defined as having severe psoriasis. Severe psoriasis 
has a greater negative effect on quality of life than previously appreciated: a U.K. web-based patient 
survey.
A.V. Anstey, G. Edwards* and A. Lasst 
[m/f]
Aneurin Bevan Health Board, Gwent, U.K.; ‘Psoriasis Association, London, U.K. and tAbbott UK, 
Maidenhead, U.K.
Further information and contacts
If using this research, please mention that the study was released at the British Association of 
Dermatologists’ Annual Conference.
The conference will be held at Manchester Central conference centre, from July 6th to 8th 2010, and is 
attended by UK and worldwide dermatologists and dermatology nurses.
Case studies and interviews with the researchers available on request.
For more information please contact: Nina Goad, British Association of Dermatologists,
Communications Manager, Phone: 07825 567717, Email: nina@bad.ora.uk. Website: 
www.bad.ora.uk
The British Association of Dermatologists is the central association of practising UK dermatologists. Our aim is to continually 
improve the treatment and understanding of skin disease.
British Association of Dermatologists, 4 Fitzroy Square, London W 1T 5HQ
www.bad.org.uk, 0207 383 0266
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Diabetes influences life-changing 
decisions
£ TVtUObtrty y.
Diabetes influences decisions about life-changing 
events for three quarters of people who have the 
condition, a UK study has shown.
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a si'-ei t  ***3e3i% cxxca efteapH aviaj *rrfe
XHXZcr SR.
Cardiff Uwversity r e s e a r c h e s  believe that improved climctan awareness 
of this effect, and provision of appropriate support, may improve the future 
health and lives of people with diabetes.
The researchers surveyed 00 patients about the effect of diabetes or 
major bfe changing events Almost 74% of patents reported that dabetes 
influenced ther decisions regarding major life changing events.
Among the respondents, 40% sad that dabetes had influenced their 
decision to take early retirement and 22% sad  it had influenced a 
aeasion to change profession.
Respondents ateo sad that dabetes had influenced seasons to 
change lifestyle (22%) or have children (14%).
The findings were presented at the Dabetes UK Annual Professional 
Conference m Liverpool last week
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Canolfan Gwasanaethau Busnes 
Business Services Centre
S o uth  E a s t W ales Research Ethics C om m ittee Panel C
Direct Line: 02920 376823/376822
Telephone: 02920 376822/6823 
Facsimile: 02920 376835
02 June 2008
Professor A Y Finlay 
Professor of Dermatology,
Cardiff University and Head of the Dermatology Department,
University Hospital of Wales,
Heath Park,
Cardiff
Dear Professor Finlay
Full title of study: A  cross-sectional prospective study to investigate the
influence of chronic diseases on major life changing 
decisions.
REC reference number: 08/W SE03/16
Thank you for your letter of 15 May 2008, responding to the Committee’s request for further 
information on the above research and submitting revised documentation, subject to the 
conditions specified below.
The further information has been considered on behalf of the Committee by the Chair, Mrs J 
Jenkins.
Confirmation of ethical opinion
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the 
above research on the basis described in the application form, protocol and supporting 
documentation a s  revised.
Ethical review of research sites
The Committee has designated this study as exempt from site-specific assessm ent (SSA).
There is no requirement for [other] Local Research Ethics Committees to be informed or for 
site-specific a ssessm en t to be carried out at each  site.
Conditions of the favourable opinion
The favourable opinion is subject to the following conditions being met prior to the start of 
the study.
Management permission or approval must be obtained from each host organisation prior to 
the start of the study at the site concerned.
Appendix 1
Canolfan Gwasanaethau Busnes Business Services Centre
Ty Churchill Churchill House
17 Ffordd Churchill 17 Churchill Way
Caerdydd, CF10 2TW  Cardiff, CF10 27W
N H S  Ff6n: 029 20 376820 W HTN: 1809 Telephone: 029 20 376820 WHTN: 1809
*LA.l U  Ffacs: 029 20 376826 Fax: 029 20 376826Cj I C_i
cymru  rhan o Addysgu Bwrdd lechyd Lleol Powys /  part of Powys Teaching Local Health Board
Management permission at NHS sites (“R&D approval”) should be obtained from the 
relevant care organisation(s) in accordance with NHS research governance 
arrangements. Guidance on applying for NHS permission is available in the 
Integrated Research Application System  or at http://www.rdforum.nhs.uk.
Approved documents
The final list of docum ents reviewed and approved by the Committee is as follows:
Document Version Date
Application 5.5 01 April 2008
Investigator CV S Salek 04 February 2008
Investigator CV A Y Finlay 04 February 2008
Protocol 1.1 18 March 2008
Covering Letter S Salek 01 April 2008
Summary/Synopsis 1 25 January 2008
Letter from Sponsor Cardiff University 05 February 2008
Peer Review Joint Trust & University 
Peer & Risk Review 
Committee
20 March 2008
Compensation Arrangements UMAL 01 August 2007
Participant Information Sheet: Postal Questionnaire 1.2 15 May 2008
Participant Information Sheet: Focus Group 1.2 15 May 2008
Participant Information Sheet: Individual Interview 1.2 15 May 2008
Participant Information Sheet: Additional Information 
Sheet for Focus Groups
1.1 15 May 2008
Participant Consent Form: Individual Interviews 1.1 15 May 2008
Participant Consent Form: Focus Groups 1.1 15 May 2008
Participant Consent Form: Postal Questionnaire Survey 1.1 15 May 2008
Response to Request for Further Information A Y Finlay 15 May 2008
Response to Request for Further Information A Y Finlay 29 April 2008
Invitation for Individual Interviews 1.2 15 May 2008
Invitation for Postal Questionnaire Survey 1.1 15 May 2008
Exploratory Qualitative Assessment Sheet 1.1 15 May 2008
Participant Personal Details 1.1 15 May 2008
Flow Chart 1 25 January 2008
Invitation for Focus Group 1.2 15 May 2008
Statement of compliance
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The Committee is constituted in accordance with the Governance Arrangements for
Research Ethics Committees (July 2001) and complies fully with the Standard Operating
Procedures for Research Ethics Committees in the UK.
After ethical review
Now that you have completed the application process please visit the National Research 
Ethics W ebsite > After Review
You are invited to give your view of the service that you have received from the National 
Research Ethics Service and the application procedure. If you wish to make your views 
known p lease use the feedback form available on the website.
The attached document “After ethical review -  guidance for researchers” gives detailed 
guidance on reporting requirements for studies with a favourable opinion, including:
• Notifying substantial amendments
• Progress and safety reports
• Notifying the end of the study
The NRES w ebsite also provides guidance on these topics, which is updated in the light of 
changes in reporting requirements or procedures.
We would also like to inform you that w e consult regularly with stakeholders to improve our 
service. If you would like to join our Reference Group please email 
referencearoup@nres.npsa.nhs.uk.
08/WSE03/16 Please quote this number on all correspondence
With the Committee’s  best w ishes for the su c c e ss  of this project
Mrs JsJenkinsjp  
Chair
Email: jagit.sidhu@ bsc.wales.nhs.uk
Enclosures: After ethical review -  guidance for researchers” - SL- AR2
08/WSEO3/16 Page 4
Copy to: R&D Department for Cardiff & Vale NHS Trust
R&D Department for Cardiff University
/  Dr Z U Bhatti, Dept of Dermatology, Cardiff University, University Hospital of 
'  W ales, Heath Park, Cardiff, CF14 4XN
Professor S  Salek, W elsh School of Pharmacy, Cardiff University, Redwood 
Building, King Edward VII Avenue, Cardiff, CF10 3XF
i
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Eich cyf/Your ref 
Ein cyf/Our ref
Welsh Health Telephone Network 1872 
Direct line/Llinell uniongyrchol
Appendix 2 Cardiff and Vale NHS Trust Ymddiriedolaeth GIG 
Caerdydd a'r Fro
University Hospital of Wales 
Ysbyty Athrofaol Cymru
Heath Park,
Cardiff CF14 4XW 
Phone 029 2074 7747 
Minicom 029 2074 3632
Parc Y Mynydd Bychan, 
Caerdydd CF14 4XW 
Ff6n 029 2074 7747 
Minicom 029 2074 3632
Tel: 029 20743742
Fax: 029 20745311
Research.Development@cardiffandvale.wales.nhs.uk
From: Professor MF Scanlon
Trust R&D Director 
Radnor House 
University Hospital of Wales 
Cardiff 
CF14 4XW
18 June 2008
Professor Andrew Finlay 
Department Of Dermatology 
Cardiff University, Heath Park 
Cardiff
Dear Professor Finlay
Project ID : 08/CMC/4212 : A cross-sectional prospective study to investigate 
the influence of chronic diseases on major life 
changing decisions
REC Reference: 08/WSE03/16 
Amendment Number: 1 
Amendment Date: 02/06/08
The above amendment has been received by the Joint Trust/University Peer and 
Risk Review Committee.
The documents reviewed were:-
Document Version Date
Protocol 1.1 18/03/08
NHS REC Application Form 1.1 undated
Revised Consent Form For Individual Interviews 1.1 15/05/08
Revised Consent Form For Focus Groups 1.1 15/05/08
Revised Consent Form For Postal Questionnaire Survey 1.1 15/05/08
Revised additional I S for focus group 1.1 15/05/08
Revised Invitation Letter for Focus Group Discussion 1.2 15/05/08
Revised Invitation Letter for individual interview 1.2 15/05/08
Revised Invitation Letter for postal questionnaire survey 1.1 15/05/08
Revised participant personal details 1.1 15/05/08
Revised PIS(FG) 1.2 15/05/08
Revised PIS(I INT) 1.2 15/05/08
Revised PIS(PQS) 1.2 15/05/08
Revised qualitative assessment sheets 1.1 15/05/08
I can confirm that the above support documentation has been approved and that you 
may continue with this study accordingly.
Please ensure that the appropriate Research Ethics Committee have a copy of this 
letter.
May I take this opportunity to wish you success with the project and remind you that 
as Principal Investigator you are required to:
• Inform the Trust R&D Office if any external or additional funding is awarded for 
this project in the future.
• Inform the Trust R&D Office of any further amendments relating to the 
protocol, including personnel changes and amendments to the actual or 
anticipated start / end dates.
• Complete any documentation sent to you by the Trust R & D  Office or 
University Research & Commercial Division regarding this project.
• Adhere to the protocol as approved by the Research Ethics Committee.
• Ensure the research complies with the Data Protection Act 1998.
Yours sincerely, 
m  Professor MF Scanlon
’ » Chair of the Joint Trust/University Peer & Risk Review Committee
CC R&D Lead Dr Richard Motley
Chris Shaw, Research and Commercial Division, Cardiff University
C:\my documents\lisa\databases\study folders\4212\RD Letters\08-CMC-4212 Amendments After Approval 18- 
06-2008.doc
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Appendix 3
Patients* details for postal survey
Name of speciality:
Note: For patient recruitment, please stick patient addressograph in the 
“Addressograph” column and write “broader disease description” and “disease 
severity” in relevant column s. Code numbers are allocated for each patient for 
identification. Thank you
Code
No
Addressograph Broad disease 
description
Disease severity 
Mild/moderate 
/severe
Dr Bhatti to Com slete
Date Posted Date
2ndposting
Date
Response
Received
Freepost RRZA-ESKS-ATUE
Major L ife  Changing D ecis ion s-S tud y  Croup
Department o f  Dermatology
3rd Floor Glamorgan House
U n iv ers ity  H ospital o f  Wales
Heath Park
Cardi f f
CF14 4XN
III I III
Appendix 
A
A p p en d ix  B
Pennaeth Adran Yr Athro A Y Finlay
Departm ent of Dermatology
Head of D ep artm en t P rofessor A Y Finlay
Yr Adran Dermatoleg
Y ears  BLYNEp
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Date:
R em inder
Cardiff University 
3rd Floor
Welsh Institute of Dermatology 
Heath Park 
Cardiff CF14 4XN 
Wales UK
Tel Ff6n + 44(0)29  2074 4721 
Fax Ffacs + 44(0)29 2074  4312 
E-mail E-bost FmlayAY@cardiff.ac.uk 
www.dermatology.org.uk
Prifysgol Caerdydd 
3ydd  Uawr
Sefydliad D erm atoleg Cymru 
Mynydd Bychan  
Caerdydd CF14 4XN 
Cymru DU
Study Title: A cross-sectional prospective study to investigate the influence of 
Long-term diseases on Major Life Changing Decisions
A few weeks ago we sent you a request to take part in a research survey. So far we 
have not received a reply from you. We realise that there may be many reasons for 
this. We are sending this reminder because your taking part in this research would be 
very helpful to the success of the study.
We would be extremely grateful if you could complete and return this at your earliest 
convenience.
Thank you for considering this.
Yours sincerely
Professor Andrew Finlay
Professor of Dermatology
Chief Investigator MLCD-Study Group
Appendix C Cardiff and Vale NHS Trust Ymddiriedolaeth GIG
Caerdydd a'r Fro
University Hospital of Wales 
Ysbyty Athrofaol Cymru
Eich cyf/Your ref 
Ein cyf/Our ref
Welsh Health Telephone Network 1872 
Direct line/Llinell uniongyrchol
Heath Park,
Cardiff CF14 4XW 
Phone 029 2074 7747 
Minicom 029 2074 3632
Parc Y Mynydd Bychan, 
Caerdydd CF14 4XW 
Ffon 029 2074 7747 
Minicom 029 2074 3632
Date: 11/08/2008 
Version 1.2
Invitation for postal questionnaire survey
Dear Sir/Madam,
We would like to invite you to take part in a postal questionnaire survey as part of our 
research to understand the influence of long-term diseases on major life changing 
decisions. This postal survey would give you a chance to let us know about your 
experiences, especially about long-term diseases and whether they influence critical 
life changing decisions.
We enclose information about this survey to help you decide whether to take part in 
this research study.
Information sheet
Consent form (for postal questionnaire survey)
Personal details sheet 
Qualitative assessment sheet
Please take time and make sure that you have read and understood these before 
making a decision. I am one of the researchers involved in this study. However, this 
study involves several departments and is being co-ordinated by the Department of 
Dermatology; hence all replies are going to the Dermatology Department for analysis. 
If you are willing to take part in this research, please sign the consent forms, complete 
the other sections and send them to the “Major Life Changing Decisions-Study 
Group” (MLCD-Study Group), Department of Dermatology using the enclosed pre­
paid self addressed envelope. We would appreciate if you could send your reply 
within the next few weeks.
Your taking part in the study would help us to develop strategies for better healthcare 
in the future.
Thank you very much for considering taking part in this study.
Yours faithfully,
/
Name of researcher
A p p en d ix  D
Departm ent of Dermatology 
Head of D ep artm en t P ro fesso r A Y Finlay 
Yr Adran Dermatoleg 
Pennaeth Adran Yr Athro A Y Finlay
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Date: 11/08/2008 
V ersion: 1.3
P artic ipan t Inform ation Sheet 
(F o r Postal Q uestionnaire  Survey)
Cardiff University 
3rd Roor
Welsh Institute of Dermatology 
Heath Park 
Cardiff CF14 4XN 
Wales UK
Tel Ffdn + 44(0)29  2074  4721 
Fax Ffacs +44 (0 )29  2074  4312 
E-mail E-bost RnlayAY@cardiff.ac.uk 
www.dermatology.org.uk
Prifysgol Caerdydd 
3ydd Uawr
Sefydliad D erm atoleg Cymru 
Mynydd Bychan  
Caerdydd CF1A 4XN 
Cymru DU
Study Title: A cross-sectional prospective study to investigate the influence of long­
term diseases on major life changing decisions.
Dear Participant,
We would like to invite you to take part in this study to help us understand how long­
term diseases influence major life changing decisions. This “Participant Information 
Sheet” will provide you with in depth detailed knowledge about this research, such as 
aims and objectives, method, selection criteria, data protection and your rights. Please 
take your time to read and understand this information. Please do not hesitate to ask 
any question if you need further explanation of any aspect of this research.
W hat is the  P u rp o se  o f the  study?
Long-term diseases have enormous Quality of Life impact on patients’ lives and cause 
serious impact on day to day living. Decisions about the most important issues in life 
are often not easy. Long-term disorders may result in patients taking different 
decisions. Up to now, little is known about this. The main aim of this study is to 
identify the influences o f long-term disease on major life changing decisions and a 
questionnaire will be created for future research.
W hat is the s tu d y  p ro ce d u re?
No drugs are being tested and there is no blood or other laboratory tests.
This research study consists of
A. Individual interviews
B. Group discussions
C. Postal survey
Patients with skin diseases will be invited either for individual interview or for a 
group discussion. The postal questionnaire survey will be used for patients who suffer 
from heart, joint, kidney, diabetes or chest problems.
What will happen to me if I take part?
You are only invited to take part in the postal questionnaire survey. Patients suffering 
from heart, joint, kidney, diabetes or chest problems will receive this postal survey 
pack. You will be asked to write any ways in which these conditions have had an 
influence on major life decision taking. Responses will be returned by post using an 
enclosed prepaid envelope.
Why have I been invited?
You fulfil our “inclusion criteria” for this research and so we have selected you to 
receive an invitation to take part in this study. Points of our inclusion criteria are as 
follows:
■ Patients who have been suffering from long-term disease for more than one 
year
■ 16 years of age and over
■ Patients who can read and write in English
■ Agree to protect the confidentiality of other focus group participants (if taking 
part in focus group discussion)
■ Are willing to share personal experiences in a tape recorded focus group 
discussion (if taking part in focus group discussion)
Do I have to take part?
This research is absolutely voluntary. It is up to you to decide whether or not to take 
part. If you do decide to take part you will be given this information sheet to keep and 
be asked to sign a consent form. If you decide to take part you are still free to 
withdraw at any time and without giving a reason. A decision to withdraw at any 
time, or a decision not to take part, will not affect the standard of care you receive.
How will I be treated if I do not take part?
Not taking part will not affect the standard of care that you receive.
What are the possible risk and benefits of taking part?
There are no harmful aspects of this study. This research is based on 
interviews/discussion and written responses. There is no clinical or medical risk. Your 
participation will help to develop a new patients’ life changing decision taking 
questionnaire. This will enable health care providers to form appropriate strategies 
that would help patients with their long-term decision taking, resulting in improved 
Quality of Life.
Will my taking part in the study be kept confidential?
All the information gathered from you will be kept strictly confidential. Records of 
voice tape recording of individual interviews/focus groups and written postal replies 
will remain in a secure locked cabinet in the Department of Dermatology, University
W ill m y tak in g  p art in th e study_be kept co n fid en tia l?
All the information gathered from you will be kept strictly confidential. Records o f 
voice tape recording o f individual interviews/focus groups and written postal replies 
will remain in a secure locked cabinet in the Department of Dermatology, University 
Hospital of Wales. Every patient will be allotted a “code number” for identification. 
Responses will be transferred to a University computer without any personal details. 
Access to University Hospital computers is protected and only the researchers will 
have access to the participant’s records. Immediately after the completion o f this 
research, recorded material will be destroyed under the supervision o f supervisors and 
other staff members. Patients will be informed once the data is destroyed. The name 
and address of participants will not be disclosed. Published results will not reveal any 
personal information.
W hat if there  is a p roblem ?
If you have any complaint, you can contact any of the following;
1. Professor Andrew Finlay 029 20744721
2. Professor Sam Salek 029 20876017
3. University Hospital of Wales Patient Advice and Liaison Service (PALS)
029 2074 2233
W ho is o rganising  and fund ing  the research?
This research is funded and jointly organised by the School o f Pharmacy and 
Department of Dermatology, School of Medicine, Cardiff University.
W ho has reviewed the study?
This research has been examined and thoroughly reviewed by:
•  Cardiff University (Research and Commercial Division)
•  Cardiff and Vale NHS Trust Research and Development Office
•  South East Wales Local Research Ethics Committee
W hat if I do have any questions?
If you have any questions about this study, the following investigators will be pleased 
to answer your questions.
1. Professor Andrew Finlay 029 20744721
2. Professor Sam Salek 029 20876017
3. Dr Zaheer Uddin Bhatti 029 20745875
4. Sister Anne Thomas 029 20742672
A p p en d ix  E
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D epartm ent of Derm atology 
Head of D ep artm en t P ro fesso r A Y Finlay
Yr Adran Dermatoleg
Pennaeth Adran Yr Athro A Y Finlay
Cardiff University 
3rd Floor
Welsh Institute of Dermatology 
Heath Park 
Cardiff CF14 4XN 
Wales UK
Tel Ff6n + 4 4 (0 )29  2 0 7 4  4721 
Fax Ffacs + 44 (0 )29  2 074  4312 
E-mail E-bost RnlayAY@cardiff.ac.uk 
www.dermatology.org.uk
Prifysgol Caerdydd  
3ydd  Uawr
Sefydliad D erm atoleg Cymru 
M ynydd Bychan  
Caerdydd CF14 4XN 
Cymru DU
CONSENT FORM
(For Postal Questionnaire Survey)
Date: 11/08/2008 
Version 1.2
Centre: Cardiff and V a le  N H S  Trust 
Code Number:
I 8 8 3 - 2 0 0 8
|25
Y e a r s  BLYNErD
Study Title: A cross-sectional prospective study to investigate the influence of long-term  
diseases on major life changing decisions.
Nam e of Researcher: Professor A Y  Finlay
I confirm that I have read and understand the participant information sheet dated 11/08/2008  
(Version 1.3) for the above study. I hereby give written consent to participate in the study that 
involves me completing a postal questionnaire pack.
Nam e of Patient D ate Signature
A p p en d ix  F
Departm ent of Dermatology 
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Code Number:
Date: 15/05/2008 
Version 1.1
Cardiff University 
3rd Floor
Welsh Institute of Dermatology 
Heath Park 
Cardiff CF14 4XN 
Wales UK
Tel Ff6n + 44(0)29  2074  4721  
Fax Ffacs + 44(0)29  2074  4312 
E-mail E-bost FinlayAY@cardiff.ac.uk 
www.dermatology.org.uk
P a r tic ip a n t P ersonal D etails
Prifysgol Caerdydd 
3 ydd  Uawr
Sefydliad D erm atoleg Cymru 
M ynydd Bychan  
Caerdydd CF14 4XN 
Cymru DU
Study Title: A cross-sectional prospective study to investigate the influence of long­
term diseases on major life changing decisions.
Dear Participant,
Please complete the simple questionnaire and circle the appropriate answer. Thank 
you very much for your help.
Gender: Male/ Female
Marital Status: Single / Married / Divorced / Widowed
Education: School / College / University
Employment Status: Employed / Unemployed / Retired / Early retirement
If you are unemployed, retired or took early retirement, please state your reason
Long-term disease / other reasons
Age: Years
Diagnosis:
Duration of the disease: Years
A p p en d ix  G
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Date: 15/05/2008 
Version 1.1
Code Number:
Cardiff University 
3rd Floor
Welsh Institute of Dermatology 
Heath Park 
Cardiff CF14 4XN 
Wales UK
Tel Ffon + 44(0)29  2074  4721  
Fax Ffacs + 44(0)29  2074  4312 
E-mail E-bost FinlayAY@cardiff.ac.uk 
www.dermatology.org.uk
Prifysgol Caerdydd  
3 ydd  Uawr
E xplo ra to ry  Q ualita tive  Assessm ent Sheet
Study T itle: A cross-sectional prospective study to investigate the influence of 
long-term diseases on major life changing decisions.
Over a lifetime, people take many major life decisions. Examples of major life 
decisions include marriage or relationship, divorce or separation, having a child, 
higher education, job and career, change of profession or early retirement, relocating 
to another city or country. Please write down any ways in which your long-term 
disease has had a major influence on major life decisions.
Thank you very much for your help.
Caerdydd CF14 4XN 
Cymru DU
1
2
3
4.
Code Number: Exploratory Qualitative Assessment Sheet
5.
6.
7.
8.
9.
10.
Appendix H Cardiff and Vale NHS Trust Ymddiriedolaeth GIG
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University Hospital of Wales 
Ysbyty Athrofaol Cymru
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Parc Y M yn y d d  B ychan, 
C a e rd y d d  CF14 4XW  
Ffon  029  207 4  7747 
M in icom  029 207 4  3632
Date:
Invitation for individual interview
We would like to invite you for an interview as part of our research to understand the 
influence of long-term diseases on major life changing decisions. This interview will 
give you a chance to let us know about your experiences, especially about skin 
diseases and whether they influence critical life decisions. We enclose information to 
help you decide whether to take part in this research study.
Information sheet
Consent form (for individual interview)
Personal details sheet
Please take time and make sure that you have read and understood these before 
making a decision. If you are willing to take part in this research study, please inform 
us within four working days either on telephone number 029 2074 5875 or 
alternatively you can tear of the bottom part of this letter and send it to the 
Department of Dermatology using the enclosed pre-paid self addressed envelope. We 
will let you know when and where the interview will be held. We will try to fix a time 
convenient for you. Taking part in the study would help us to develop strategies for 
better health care in the future.
Thank you very much for considering this matter.
Yours sincerely,
Professor Andrew Finlay 
Professor of Dermatology
Note: Please do not send your consent form. We will ask you to sign it on the day of the 
interview.
Please state if you would like to take part in an individual interview. Yes / No 
Name:.................................................  Signature:..............................................
Address:
Telephone Number: (optional)
Date: 15/05/2008 
Version 1.2
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Cardiff University 
3rd Floor
Welsh Institute of Dermatology 
Heath Park 
Cardiff CF14 4XN 
Wales UK
Tel Ff6n + 4 4 (0 )2 9  20 7 4  4721  
Fax Ffacs + 4 4 (0 )2 9  20 7 4  4312  
E-mail E -bost FinlayAY@cardiff.ac.uk 
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Partic ipant Inform ation  Sheet 
(F o r Ind iv idual In terv iew )
Prifysgol Caerdydd  
3 yd d  U awr
Sefydliad D erm atoleg Cymru 
M ynydd Bychan  
Caerdydd CF14 4XN 
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Study Title: A cross-sectional prospective study to investigate the influence of long­
term diseases on major life changing decisions.
Dear Participant,
We would like to invite you to take part in this study to help us understand how long­
term diseases influence major life changing decisions. This “Participant Information 
Sheet” will provide you with in depth detailed knowledge about this research, such as 
aims and objectives, method, selection criteria, data protection and your rights. Please 
take your time to read and understand this information. Please do not hesitate to ask 
any question if you need further explanation of any aspect o f this research.
W hat is the Purpose  of the study?
Long-term diseases have enormous Quality of Life impact on patients’ lives and cause 
serious impact on day to day living. Decisions about the most important issues in life 
are often not easy. Long-term disorders may result in patients taking different 
decisions. Up to now, little is known about this. The main aim of this study is to 
identify the influences of long-term disease on major life changing decisions and a 
questionnaire will be created for future research.
W hat is the study  p rocedu re?
No drugs are being tested and there is no blood or other laboratory tests.
This research study consists of
A. Individual interviews
B. Group discussions
C. Postal survey
Patients with skin diseases will be invited either for individual interview or for a 
group discussion. The postal questionnaire survey will be used for patients who suffer 
from heart, joint, kidney, diabetes or chest problems.
What will happen to me if  I take part?
You are only invited to take part in a individual interview. This will be carried out in 
the dermatology out-patient department. You would be asked about the ways in which 
your skin condition has had a major influence on major life changing decision taking. 
The interview will be recorded using a tape recorder. The interview will not take more 
than 40 minutes.
Why have I been invited?
You fulfil our “inclusion criteria” for this research and so we have selected you to 
receive an invitation to take part in this study. Points of our inclusion criteria are as 
follows:
•  Patients who have been suffering from long-term disease for more than one 
year
•  16 years of age and over
•  Patients who can read and write in English
•  Agree to protect the confidentiality of other focus group participants (if taking 
part in focus group discussion)
•  Are willing to share personal experiences in a tape recorded focus group 
discussion (if taking part in focus group discussion)
Do I have to take part?
This research is absolutely voluntary. It is up to you to decide whether or not to take 
part. If you do decide to take part you will be given this information sheet to keep and 
be asked to sign a consent form. If you decide to take part you are still free to 
withdraw at any time and without giving a reason. A decision to withdraw at any 
time, or a decision not to take part, will not affect the standard of care you receive.
How will I be treated if I do not take part?
Not taking part will not affect the standard of care that you receive.
What are the possible risk and benefits of taking part?
There are no harmful aspects of this study. This research is based on 
interviews/discussion and written responses. There is no clinical or medical risk. Your 
participation will help to develop a new patients’ life changing decision taking 
questionnaire. This will enable health care providers to form appropriate strategies 
that would help patients with their long-term decision taking, resulting in improved 
Quality of Life.
Will my taking part in the study.be kept confidential?
All the information gathered from you will be kept strictly confidential. Records of 
voice tape recording o f individual interviews/focus groups and written postal replies 
will remain in a secure locked cabinet in the Department of Dermatology, University 
Hospital of Wales. Every patient will be allotted a “code number” for identification. 
Responses will be transferred to a University computer without any personal details. 
Access to University Hospital computers is protected and only the researchers will 
have access to the participant’s records. Immediately after the completion of this 
research, recorded material will be destroyed under the supervision of supervisors and 
other staff members. Patients will be informed once the data is destroyed. The name 
and address of participants will not be disclosed. Published results will not reveal any 
personal information.
What if there is a problem?
If you have any complaint, you can contact any o f the following;
1. Professor Andrew Finlay 029 20744721
2. Professor Sam Salek 029 20876017
3. University Hospital of Wales Patient Advice and Liaison Service (PALS)
029 2074 2233
Who is organising and funding the research?
This research is funded and jointly organised by the School o f Pharmacy and 
Department of Dermatology, School of Medicine, Cardiff University.
Who has reviewed the study?
This research has been examined and thoroughly reviewed by:
•  Cardiff University (Research and Commercial Division)
•  Cardiff and Vale NHS Trust Research and Development Office
•  South East Wales Local Research Ethics Committee
What if I do have any questions?
If you have any questions about this study, the following investigators will be pleased 
to answer your questions.
1. Professor Andrew Finlay
2. Professor Sam Salek
3. Dr Zaheer Uddin Bhatti
4. Sister Anne Thomas
029 20744721 
029 20876017 
029 20745875 
029 20742672
Ca r d i f f
UNIVERSITY
P R I F Y S G O L
CaeRDY[§>
D epartm ent of D erm atology 
Head of Department Professor A Y Finlay 
YrAdran Dermatoleg 
Pennaeth Adran Yr Athro A Y Finlay
Cardiff University 
3rd Floor
Welsh Institute of Dermatology 
Heath Park 
Cardiff CF14 4XN 
Wales UK
Tel Ff6n + 4 4 (0 )2 9  2 0 7 4  4721  
Fax Ffacs + 4 4 (0 )2 9  2 074  4312  
E-mail E -bost RnlayAY@cardiff.ac.uk 
www.dermatology.org. uk
Prifysgol Caerdydd  
3 yd d  Uawr
Sefydliad D erm atoleg Cymru 
M ynydd Bychan  
Caerdydd CF14 4XN  
Cymru DU
Date: 15/05/2008 
Version 1.1
Centre: Cardiff and Vale NHS Trust 
Code Number:
CONSENT FORM
(For Individual Interviews)
A p p en d ix  J
I 8 8 3 - 2 0 0 8
125
Y ea rs  b ly n e ,§>
Study Title: A cross-sectional prospective study to investigate the influence of long-term 
d iseases on major life changing decisions.
Name of R esearcher: P rofessor AY Finlay
Please initial box
1. I confirm that I have read and understand the participant information shee t dated 
15/05/2008 (Version 1.2) for the above study. I have had the opportunity to consider the 
information, ask  questions and have had th ese  answ ered satisfactorily.
2. I understand that my participation is voluntary and that I am free to withdraw at any time, 
without giving any reason , without my medical care or legal rights being affected.
3. I am  willing to take part in a  tape recorded interview.
4. I understand that relevant sections of my medical notes and data collected during the 
study may be looked at by individuals from regulatory authorities or from the Cardiff and 
Vale NHS Trust, w here it is relevant to my taking part in this research. I give permission for 
these  individuals to have a c c e ss  to my records.
5. I agree to take part in the above study.
Name of Patient Date Signature
□
□
□
□
□
Name of Person taking consent Date Signature
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S tu dy  T itle: A cross-sectional prospective study to investigate the influence of long­
term diseases on major life changing decisions.
Dear Participant,
Please complete the simple questionnaire and circle the appropriate answer. Thank 
you very much for your help.
G ender: Male/ Female
M arita l S ta tu s: Single / Married / Divorced / Widowed
E du cation : School / College / University
E m p lo y m en t S ta tu s: Employed / Unemployed / Retired / Early retirement
I f  you  are u n e m p lo y e d , re tired  o r  to o k  ear ly  re tirem en t, p lease  sta te  y o u r  reason
Long-term disease / other reasons
A ge: Y ears__________
D iagn osis:
D u ra tio n  o f  th e  d isea se: Years
fcv NHSt? G IG
CYMRU
Eich cyf/Your ref 
Bn cyf/Our ref
Welsh Health Telephone Network 1872 
Direct line/Llin^H uniongyrchol
Dear
A p p e n d i x  L  Cardiff and  Vale NHS Trust Ymddiriedolaeth GIG 
Caerdydd a'r Fro
University Hospital of Wales 
Ysbyty Athrofaol Cymru
Heath Park,
Cardiff CF14 4XW 
Phone 029 2074 7747 
Minicom 029 2074 3632
Parc Y Mynydd Bychan, 
Caerdydd CF14 4XW 
Ffon 029 2074 7747 
Minicom 029 2074 3632
Invitation for focus group discussion
We are organising an open “focus group” discussion as part of our research to 
understand the influence o f long-term diseases on major life changing decisions. This 
discussion meeting will give you and other participants a chance to talk about your 
experiences, especially about long-term skin diseases and whether they influence 
critical life decisions. We enclose information about the focus group discussion to 
help you decide whether to take part in this research study.
■ Information sheet ■ Additional information for focus groups ■ Consent Form (for 
focus group) ■ Personal details sheet
Please take time and make sure that you have read and understood these before 
making a decision. If you are willing to take part in this research study, please inform 
us within four working days either on telephone number 029 2074 5875 or 
alternatively you can tear off the bottom part of this letter and send it to the 
Department o f Dermatology using the enclosed pre-paid self addressed envelope. We 
will let you know when and where the focus group discussion will be held. We will 
try to fix a time convenient for you. Participants will be reimbursed travel expenses in 
attending the focus group discussion. Taking part in the study would help us to 
develop strategies for better health care in the future.
Thank you very much for considering this matter.
Yours sincerely,
Professor Andrew Finlay 
Professor of Dermatology
Note: Please do not send your consent form. We will ask you to sign it on the day of a 
focus group discussion.
Please state if you would like to take part in a focus group discussion. Yes / No
Name:----------------------------------  Signature:--------------------------------------
Address:--------------------------------------------------------------------------------------------------
--------------------------------------- Telephone Number: (optional)------------------------------
Date: 15/05/2008 
Version 1.2
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Version: 1.2
Participant Information Sheet 
(For Focus Group Discussion)
Study Title: A cross-sectional prospective study to investigate the influence of long­
term diseases on major life changing decisions.
Cardiff University 
3rd Floor
Welsh Institute of Dermatology 
Heath Park 
Cardiff CF14 4XN 
Wales UK
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D ear P a rtic ip a n t,
We would like to invite you to take part in this study to help us understand how long­
term diseases influence major life changing decisions. This “Participant Information 
Sheet” will provide you with in depth detailed knowledge about this research, such as 
aims and objectives, method, selection criteria, data protection and your rights. Please 
take your time to read and understand this information. Please do not hesitate to ask 
any question if  you need further explanation of any aspect o f this research.
What is the Purpose of the study?
Long-term diseases have enormous Quality of Life impact on patients’ lives and cause 
serious impact on day to day living. Decisions about the most important issues in life 
are often not easy. Long-term disorders may result in patients taking different 
decisions. Up to now, little is known about this. The main aim of this study is to 
identify the influences o f long-term disease on major life changing decisions and a 
questionnaire will be created for future research.
What is the study procedure?
No drugs are being tested and there is no blood or other laboratory tests.
This research study consists of
A. Individual interviews
B. Group discussions
C. Postal survey
Patients with skin diseases will be invited either for individual interview or for a 
group discussion. The postal questionnaire survey will be used for patients who suffer 
from heart, joint, kidney, diabetes or chest problems.
What will happen to me if  I take part?
You are only invited to take part in a group discussion. The group will consist of 10 
patients. The investigator will lead the group discussion and patients will share their 
experiences with other participants. The discussion will be recorded using a tape 
recorder. Please make sure that you have read and understood the attached separate 
“Additional information sheet for focus group”. The focus group session will take 
about 2 hours.
Why have I been invited?
You fulfil our “inclusion criteria” for this research and so we have selected you to 
receive an invitation to take part in this study. Points o f our inclusion criteria are as 
follows:
•  Patients who have been suffering from long-term disease for more than one 
year
•  16 years of age and over
•  Patients who can read and write in English
•  Agree to protect the confidentiality o f other focus group participants (if taking 
part in focus group discussion)
•  Are willing to share personal experiences in a tape recorded focus group 
discussion (if taking part in focus group discussion)
Do I have to take part?
This research is absolutely voluntary. It is up to you to decide whether or not to take 
part. If you do decide to take part you will be given this information sheet to keep and 
be asked to sign a consent form. If you decide to take part you are still free to 
withdraw at any time and without giving a reason. A decision to withdraw at any 
time, or a decision not to take part, will not affect the standard o f care you receive.
How will I be treated if I do not take part?
Not taking part will not affect the standard o f care that you receive.
What are the possible risk and benefits of taking part?
There are no harmful aspects o f this study. This research is based on 
interviews/discussion and written responses. There is no clinical or medical risk. Your 
participation will help to develop a new patients’ life changing decision taking 
questionnaire. This will enable health care providers to form appropriate strategies 
that would help patients with their long-term decision taking, resulting in improved 
Quality of Life.
Will my taking part in the study be kept confidential?
All the information gathered from you will be kept strictly confidential. Records of 
voice tape recording o f individual interviews/focus groups and written postal replies 
will remain in a secure locked cabinet in the Department of Dermatology, University 
Hospital of Wales. Every patient will be allotted a “code number” for identification. 
Responses will be transferred to a University computer without any personal details. 
Access to University Hospital computers is protected and only the researchers will 
have access to the participant’s records. Immediately after the completion of this 
research, recorded material will be destroyed under the supervision of supervisors and 
other staff members. Patients will be informed once the data is destroyed. The name 
and address of participants will not be disclosed. Published results will not reveal any 
personal information.
What if there is a problem?
If you have any complaint, you can contact any o f the following;
1. Professor Andrew Finlay 029 20744721
2. Professor Sam Salek 029 20876017
3. University Hospital of Wales Patient Advice and Liaison Service (PALS)
029 2074 2233
Who is organising and funding the research?
This research is funded and jointly organised by the School o f Pharmacy and 
Department of Dermatology, School of Medicine, Cardiff University.
Who has reviewed the study?
This research has been examined and thoroughly reviewed by:
•  Cardiff University (Research and Commercial Division)
•  Cardiff and Vale NHS Trust Research and Development Office
•  South East Wales Local Research Ethics Committee
What if I do have any questions?
If you have any questions about this study, the following investigators will be pleased 
to answer your questions.
1. Professor Andrew Finlay
2. Professor Sam Salek
3. Dr Zaheer Uddin Bhatti
4. Sister Anne Thomas
029 20744721 
029 20876017 
029 20745875 
029 20742672
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S tu d y  T itle: A cross-sectional prospective study to investigate the influence^of long­
term diseases on major life changing decisions.
This information sheet will provide you with step by step information about focus 
groups.
What is a focus group?
A focus group is a group o f people who meet with a meeting leader and discuss the 
meeting topic.
What are focus groups for?
Focus groups are organised in order to let researchers understand better through that 
the members o f the groups know about it.
Who is in the planned focus group?
10 people, who have long-term skin disease, will be included in each focus group. 
Who will lead the focus group?
One of the researchers (Dr. Bhatti) will conduct the focus group discussion; along 
with the researcher the Dermatology specialist research sister will also be present.
What is the procedure of this focus group discussion?
At the start, the focus group members will introduce themselves. Dr. Bhatti will open 
the discussion by suggesting a topic. Dr. Bhatti will encourage people to share their 
views about the influence o f their skin condition on their lives. First, there will be a 
general discussion. Secondly, Dr Bhatti will encourage people and will direct 
discussion to more specific areas. Conversation will be recorded using a tape recorder.
Duration of focus group?
Each focus group session will last for up to 2 hours. Actual discussion will last for 1 
hour and 30 minutes.
Where will the focus group discussion be held?
The discussion will be held in Glamorgan House, Department of Dermatology, 
University Hospital o f Wales, Heath Park, CF14 4XN. Participants will be 
reimbursed travel expenses in attending the meeting.
C a r d i f f
UNIVERSITY
P R I F Y S G O L
CaeRDY|§>
A p p en d ix  P
D epartm ent of D erm atology 
Head of Department Professor A Y Finlay 
Yr Adran Dermatoleg
Pennaeth Adran YrAthro A Y Finlay
1 8 8 3 - 2 0 0 8
125
Y ea r s  B L Y N E g )
Date: 15/05/2008 
Version 1.1
Centre: Cardiff and Vale NFIS Trust 
Code Number:
CONSENT FORM
(For Focus Groups)
Cardiff University 
3rd Floor
Welsh Institute of Dermatology 
Heath Park 
Cardiff CF14 4XN 
Wales UK
Tel Ffdn + 44 (0 )2 9  2 0 7 4  472 1  
Fax Ffacs + 4 4 (0 )29  2 0 7 4  4312  
E-mail E -bost FinlayAY@cardiff.ac.uk 
www.dermatology.org.uk
Prifysgol Caerdydd  
3yd d  Uawr
Sefydliad D erm atoleg Cymru 
M ynydd Bychan  
Caerdydd CF14 4XN 
Cymru DU
Study Title: A cross-sectional prospective study to investigate the influence of long-term 
d iseases on m ajor life changing decisions.
Name of R esearcher: P rofessor AY Finlay
Please initial box
1. I confirm that I have read and understand the participant information shee t dated 
15/05/2008 (Version 1.2) and the additional information sh ee t for focus groups dated 
15/05/2008 (Version 1.1) for the above study. I have had the opportunity to consider the 
information, ask  questions and have had these  answ ered satisfactorily.
2. I understand that my participation is voluntary and that I am  free to withdraw at any time, 
without giving any reason , without my medical care or legal rights being affected.
3. I am willing to sh are  personal experiences in a tape recorded group discussion.
4. I ag ree to protect the confidentiality of other focus group participants.
5. I understand that relevant sections of my medical notes and data collected during the 
study may be looked at by individuals from regulatory authorities or from the Cardiff and 
Vale NFIS Trust, w here it is relevant to my taking part in this research. I give permission for 
these  individuals to have a c c e s s  to my records.
6. I ag ree to take part in the above study.
□
□
□
□
□
□
Name of Patient Date Signature
Name of Person taking consent Date Signature
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Participant Personal Details
Cardiff University 
3rd Floor
Welsh Institute of Dermatology 
Heath Park 
Cardiff CF14 4XN 
Wales UK
Tel Ffdn + 4 4 (0 )2 9  2 0 7 4  4 721  
Fax Ffacs + 4 4 (0 )2 9  2 0 7 4  4312  
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Study T itle: A cross-sectional prospective study to investigate the influence of long­
term diseases on major life changing decisions.
Dear Participant,
Please complete the simple questionnaire and circle the appropriate answer. Thank 
you very much for your help.
G ender: Male/ Female
M arita l S tatu s: Single / Married / Divorced / Widowed
E d u cation : School / College / University
E m p lo y m en t S ta tu s: Employed / Unemployed / Retired / Early retirement
I f  you  are u n e m p lo y e d , re tired  o r  to o k  early  retirem en t, p lea se  sta te  y o u r  reason
Long-term disease / other reasons
A ge: Y ears__________
D iagn osis:
D u ra tio n  o f  th e  d isea se: Years
Appendix R
Version 1
Date: 29.01.2010
Confidential 
Copy Right9 material
Stage 3: Content validity of a new questionnaire 
“Questionnaire Items Rating Sheets”
Name:
Speciality:
This document is not to be reproduced or photocopied without the permission of the authors
Guidelines for panel members
Introduction: The developmental version of the questionnaire (version 1, date 
29.01.2010) requires content validity. For this purpose member of a panel of judges must 
rate each item for its language clarity, completeness, relevance and scaling. For 
standardisation, all panel members should have the same understanding of these criteria. 
It is important that all members consider the following criteria for content validation 
process:
A. Language clarity: the sentences and wording should be clear, understandable, 
straightforward and simple. Make sure phrases and wordings should be unambiguous and 
jargon free and should be understood by a person who has a mental aptitude of a 12 year 
old child.
B. Completeness: The sentences should be complete and not broken and should end 
properly.
C. Relevance: Each item should be relevant to subject area and targeted population.
D. Scaling: 4 point Adjectival scale is used for scaling system, starting from 0 to 4 (0=No 
influence, 1=Slight influence, 2=Moderate influence, 3=Strong influence, 4=A very strong 
influence). Panel members should rate the scaling system as to whether the response 
option fit the question (i.e. statement/item) or not.
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Date: 04.02.2010 
Project ID: 08/CMC/4212 
Ethics ID: 08/WSE03/16
Project Title: A Cross-Sectional Prospective Study to Investigate the 
Influence of Chronic Diseases on Major Life Changing Decisions.
Cardiff University 
3rd Floor
Welsh Institute of Dermatology 
Heath Park 
Cardiff CF14 4XN 
Wales UK
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Dear Dr
M a jo r  L ife  C h a n g in g  D ecision s S tu d y  G rou p
Thank you for your continuing efforts with the study. We are enclosing following 
documents related to our next stage o f the study “stage 3: face and content validity”.
1. Developmental version o f the new questionnaire (version: 1, date 29.01.2010)
2. Content validation rating sheets
Please rate each questionnaire item for its language clarity, completeness, relevance 
and scaling. Documents are self explanatory and you can also put your suggestions for 
more detailed discussion on Thursday 25 February 2010 meeting. Dr Bhatti will also 
provide you another similar set o f documents for your member of staff (specialist 
nurse) for their input. On completion please ask them to contact Dr Bhatti on 
02920745875 Email: bhattizu@cardiff.ac.uk for collection. Contact details are also 
available in the end o f the content validation rating sheets.
The meeting will be held on T h u rsd a y , 25 F eb ru a ry  2 0 1 0  from 12:00 to 2 :00  pm  in
the Department o f Dermatology Library, Top floor, Glamorgan House, Heath Park, 
UHW. (With sandwiches as usual)
The draft meeting agenda is enclosed.
Many thanks
Professor Andrew Y Finlay 
Department o f Dermatology 
School o f Medicine 
Cardiff University 
Heath Park 
Cardiff CF14 4XN 
Tel: 029 2074 4721 
Email: finlavav@cf.ac.uk
Professor Sam Salek
Centre for Socioeconomic Research
Welsh School of Pharmacy
Cardiff University, Redwood Building
Cardiff CF10 3NB
Tel: 029 2087 6017 
Email: salekss@cf.ac.uk
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S tu dy  T itle: A cross-sectional prospective study to investigate the influence of long­
term diseases on major life changing decisions.
D ear P a rtic ip a n t,
We would like to invite you to take part in this study to help us understand how long­
term diseases influence major life changing decisions. This “Participant Information 
Sheet” will provide you with in depth detailed knowledge about this research, such as 
aims and objectives, method, selection criteria, data protection and your rights. Please 
take your time to read and understand this information. Please do not hesitate to ask 
any question if  you need further explanation of any aspect of this research.
What is the Purpose of the study?
Long-term diseases have enormous Quality of Life impact on patients’ lives and cause 
serious impact on day to day living. Decisions about the most important issues in life 
are often not easy. Long-term disorders may result in patients taking different 
decisions. Up to now, little is known about this. The main aim of this study is to 
identify the influences o f long-term disease on major life changing decisions and a 
questionnaire will be created for future research.
What is the study procedure?
No drugs are being tested and there is no blood or other laboratory tests. The 
questionnaire survey will be used for patients who suffer from skin, heart, joint, 
kidney, diabetes or chest problems.
What will happen to me if I take part?
You are invited to take part in the questionnaire survey. Patients suffering from skin, 
heart, joint, kidney, diabetes or chest problems will receive this survey pack.
Why have I been invited?
You fulfil our “inclusion criteria” for this research and so we have selected you to 
receive an invitation to take part in this study. Points of our inclusion criteria are as 
follows:
■ Patients who have been suffering from long-term disease for more than one 
year
■ 16 years of age and over
■ Patients who can read and write in English
Do I have to take part?
This research is absolutely voluntary. It is up to you to decide whether or not to take 
part. If you do decide to take part you will be given this information sheet to keep and 
be asked to sign a consent form. If you decide to take part you are still free to 
withdraw at any time and without giving a reason. A decision to withdraw at any 
time, or a decision not to take part, will not affect the standard of care you receive.
How will I be treated if I do not take part?
Not taking part will not affect the standard o f care that you receive.
What are the possible risk and benefits of taking part?
There are no harmful aspects o f this study. This research is based on 
interviews/discussion and written responses. There is no clinical or medical risk. Your 
participation will help to develop a new patients’ life changing decision taking 
questionnaire. This will enable health care providers to form appropriate strategies 
that would help patients with their long-term decision taking, resulting in improved 
Quality of Life.
Will my taking part in the study be kept confidential?
All the information gathered from you will be kept strictly confidential. Records of 
voice tape recording of individual interviews/focus groups and written replies will 
remain in a secure locked cabinet in the Department o f Dermatology, University 
Hospital of Wales. Every patient will be allotted a “code number” for identification. 
Responses will be transferred to a University computer without any personal details. 
Access to University Hospital computers is protected and only the researchers will 
have access to the participant’s records. Immediately after the completion of this 
research, recorded material will be destroyed under the supervision o f supervisors and 
other staff members. Patients will be informed once the data is destroyed. The name 
and address of participants will not be disclosed. Published results will not reveal any 
personal information.
What if there is a problem?
If you have any complaint, you can contact any of the following;
1. Professor Andrew Finlay
2. Professor Sam Salek
029 20744721 
029 20876017
3. University Hospital o f Wales Patient Advice and Liaison Service (PALS)
029 2074 2233
Who is organising and funding the research?
This research is funded and jointly organised by the School of Pharmacy and 
Department of Dermatology, School o f Medicine, Cardiff University, in partnership 
with the Welsh Heart Research Institute, Department of Nephrology and 
Transplantation, Department of Rheumatology, Department of Respiratory Medicine, 
Adult Cystic Fibrosis Services and Diabetes and Endocrinology Department. This 
research group is also known as “Major Life Changing Decisions-Study Group” 
(MLCD-Study Group).
Who has reviewed the study?
This research has been examined and thoroughly reviewed by:
■ Cardiff University (Research and Commercial Division)
■ Cardiff and Vale NHS Trust Research and Development Office
■ South East Wales Local Research Ethics Committee
What if I do have any questions?
If you have any questions about this study, the following investigators will be pleased 
to answer your questions.
1. Professor Andrew Finlay 029 207 44721
2. Professor Sam Salek
3. Dr Zaheer Uddin Bhatti
4. Sister Anne Thomas
029 208 76017 
029 207 45875 
029 207 42672
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Study Title: A cross-sectional prospective study to investigate the influence of long-term 
d iseases on major life changing decisions.
Name of R esearcher: P ro fessor AY Finlay
I confirm that I have read  and understand the participant information sh ee t dated 09.04.2010 
(Version 1.4) for the above study. I hereby give written consent to participate in the study that 
involves m e completing a questionnaire.
Name of Patient Date Signature
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S tu dy  T itle: A cross-sectional prospective study to investigate the influence of long­
term diseases on major life changing decisions.
Dear Participant,
Please complete the simple questionnaire and circle the appropriate answer. Thank 
you very much for your help.
G ender: Male/ Female
M arita l S ta tu s: Single / Married / Divorced / Widowed
E du cation : School / College / University
E m p lo y m en t S ta tu s: Employed / Unemployed / Retired / Early retirement
I f  you  are u n e m p lo y e d , re tired  or  to o k  early  re tirem en t, p lease  sta te  y o u r  reason
Long-term disease / other reasons
Age: Y ears__________
D iagn osis: _________________________________________________________
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D epartm ent of Derm atology 
Head of Department Professor A Y Finlay 
Yr Adran Dermatoleg 
Pennaeth Adran YrAthro A Y Finlay
Date: 1 5 /0 5 /2 0 0 8  
V ersion  1.1
C ode N u m b er:
Participant Personal Details
1 8 8 3 - 2 0 0 8
Y e a r s  B L Y N E ^
D u ra tio n  o f  th e  d isease: Years
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(M L C D P )
Tel Ffon + 4 4 (0 )2 9  2 0 7 4  472 1  
Fax Ffacs + 4 4 (0 )2 9  2 0 7 4  4312  
E-mail E -bost nnlayAV@cardiff.ac.uk 
www.dermatology.org.uk 
Prifysgol Caerdydd  
3 yd d  Uawr
Sefydliad D erm atoleg Cymru 
M ynydd Bychan  
Caerdydd CF14 4XN 
Cymru DU
Please give us your views about the questionnaire you have just filled in by answering 
the following six questions. The MLCDP is a newly designed questionnaire and your 
opinion will greatly help its further development.
1. How long (in minutes) did it take you to complete the questionnaire?
 Minutes
2. Did you find the questionnaire easy to complete?
Yes □  No □
3. Did you find the response options for the statements in questionnaire straight 
forward?
Yes □ No □
4. In general, how clear and understandable were the instructions and statements?
Very clear D  Clear □  Not clear CD Very unclear □
5. Did you find the statements comprehensive enough to measure your disease 
influence on important life decisions?
Yes □ No □
6. If your answer to question 5 is “No”, please write down below the life aspects you 
think should be added to the questionnaire.
T h a n k  y ou  v ery  m u ch  fo r  y o u r  help
Appendix X: Correlation matrix for the 34 items of the MLCDP (version la )
A1 A2 A3 A4 B1 B2 B3 B4 B5 B6 B7 B8 B 10 C1 C 2 C 4 C 5
A1 1 .0 0 0 .2 2 8 .346 .2 3 0 .1 7 9 - .0 2 2 .039 .1 7 5 .0 0 7 .0 9 6 .1 1 7 .1 2 9 .1 2 3 .141 .2 2 2 .201 .043
A2 .2 2 8 1 .0 0 0 .442 .236 .1 5 4 .1 5 5 .243 .0 0 5 .2 9 6 .2 6 5 .0 9 2 .2 8 6 .0 6 6 .2 3 6 .0 2 2 .3 1 6 .0 2 0
A3 .346 .4 4 2 1 .0 0 0 .1 9 3 .1 4 0 .032 .198 - .0 3 7 .1 5 8 .222 .0 3 0 .098 .0 6 5 .3 9 0 .0 6 8 .2 5 7 -.0 4 8
A4 2 3 0 .2 3 6 .193 1 .0 0 0 .3 0 2 .243 .329 .0 4 2 .2 0 7 .1 1 8 .141 .1 7 7 -.0 0 6 .201 -.0 6 5 .5 3 3 .0 5 8
B1 .1 7 9 .1 5 4 .140 .3 0 2 1 .0 0 0 .416 .5 9 2 .0 6 2 .1 9 0 .4 8 8 .257 .174 .2 4 5 .2 1 6 .1 1 4 .1 8 8 .038
B2 -.0 2 2 .1 5 5 .0 3 2 .2 4 3 .4 1 6 1 .0 0 0 .4 5 9 .3 9 0 .332 .211 .2 2 7 .2 5 6 .4 5 2 .164 .178 .1 9 9 .246
B3 .0 3 9 .243 .198 .3 2 9 .5 9 2 .459 1 .0 0 0 .0 7 6 .2 7 5 .452 .244 .142 .2 1 3 .1 6 3 .1 3 9 .2 0 0 .067
B4 .175 .0 0 5 -.0 3 7 .0 4 2 .0 6 2 .390 .0 7 6 1 .0 0 0 -.0 0 3 -.1 2 8 .1 5 8 .057 .319 - .0 3 5 .0 6 5 .044 .281
B5 .0 0 7 .2 9 6 .1 5 8 .2 0 7 .1 9 0 .3 3 2 .2 7 5 - .0 0 3 1 .0 0 0 .317 .1 6 8 .4 8 0 .1 6 3 .1 5 6 .0 5 5 .201 .016
B6 .0 9 6 .2 6 5 .2 2 2 .1 1 8 .4 8 8 .211 .452 -.1 2 8 .317 1 .0 0 0 .288 .3 8 0 .099 .1 8 2 .117 .0 9 0 -.0 0 9
B7 .117 .0 9 2 .0 3 0 .141 .2 5 7 .227 .244 .1 5 8 .1 6 8 .2 8 8 1 .0 0 0 .175 .023 -.0 0 3 .1 4 8 .011 .016
B8 .129 .2 8 6 .098 .1 7 7 .1 7 4 .2 5 6 .142 .0 5 7 .4 8 0 .380 .1 7 5 1 .0 0 0 .055 .1 3 9 .164 .177 -.0 2 7
B 10 .1 2 3 .066 .0 6 5 -.0 0 6 .2 4 5 .452 .213 .3 1 9 .163 .099 .023 .055 1 .0 0 0 .239 .252 .1 8 8 .191
C1 .141 .2 3 6 .390 .201 .2 1 6 .164 .163 - .0 3 5 .1 5 6 .182 -.0 0 3 .139 .239 1 .0 0 0 .414 .294 .1 2 5
C 2 .222 .022 .068 -.0 6 5 .1 1 4 .178 .139 .0 6 5 .055 .117 .148 .164 .252 .414 1 .0 0 0 .0 7 8 .027
C 4 .201 .3 1 6 .257 .5 3 3 .1 8 8 .1 9 9 .200 .044 .201 .090 .011 .177 .1 8 8 .294 .078 1 .0 0 0 .001
C 5 .043 .020 -.0 4 8 .0 5 8 .0 3 8 .246 .0 6 7 .281 .0 1 6 -.0 0 9 .0 1 6 -.0 2 7 .191 .125 .0 2 7 .001 1 .0 0 0
C 6 .126 .119 .2 6 9 .188 .0 6 9 .103 .075 .1 3 0 .004 -.0 1 2 -.021 -.0 1 8 .156 .340 .093 .250 .2 2 6
C 7 .5 0 2 .1 5 7 .136 .2 7 8 .171 .090 .091 .3 4 7 .001 -.0 1 6 .070 .043 .158 .069 .061 .238 .1 0 5
D1 .077 -.0 1 4 .088 .0 2 2 .0 7 6 .166 .184 .1 1 2 .241 .0 7 8 .1 2 9 .0 7 9 .2 7 2 .1 5 6 .0 8 8 .1 0 6 .154
D2 .027 -.0 5 9 -.1 0 9 -.0 2 7 .0 6 8 .165 .051 .2 3 0 .095 .006 .144 .031 .1 6 0 .000 .0 4 8 .0 7 9 .165
D3 .1 3 0 .0 6 8 .026 .117 .093 .109 .131 .1 8 5 .078 .024 .087 .098 .1 2 2 .1 1 3 .010 .175 .165
D 4 .2 9 8 .0 6 2 .172 .235 .2 3 6 .142 .110 .1 2 6 .161 .160 .153 .131 .175 .1 5 8 .185 .2 8 0 .094
D 5 .049 -.0 1 3 .000 .202 .1 6 8 .224 .058 .245 .116 .105 .082 .074 .227 .116 -.0 3 0 .237 .201
D 8 .104 .3 7 4 .351 .3 1 6 .1 6 3 .1 6 5 .2 2 6 .0 1 6 .2 1 2 .1 0 5 .1 6 9 .1 7 0 .0 4 2 .2 3 6 .071 .2 9 7 .049
D 9 .081 .281 .262 .3 0 6 .1 5 3 .307 .160 .041 .215 .128 .043 .182 .165 .226 .1 1 5 .513 .0 9 2
D 10 .0 0 2 .1 0 5 .1 2 3 .2 0 4 .0 2 4 .1 4 2 .0 5 2 .0 6 4 .2 5 3 .111 .2 0 6 .141 .0 9 4 .1 2 9 -.0 6 4 .066 .0 8 6
D11 .011 .1 2 5 -.0 0 9 .074 .2 2 4 .252 .221 .121 .137 .097 .132 .101 .152 .069 .048 .043 .182
D 12 .137 .076 .052 .053 .1 2 0 .172 .190 .1 2 5 .114 .111 .092 .197 .2 4 8 .154 .1 0 4 .148 .171
D 13 .111 .0 2 6 .091 .138 .1 8 2 .185 .194 .2 0 9 .135 .142 .1 6 5 .144 .1 7 3 .134 .121 .1 2 8 .1 9 3
D 14 .213 .0 4 5 .015 .171 .0 9 6 .081 .049 .0 9 6 .060 .155 .190 .259 .0 6 5 .0 6 8 .241 .1 8 6 .104
E1 .115 .1 1 7 -.0 0 3 .1 8 6 .277 .268 .262 .0 9 0 .1 9 6 .216 .0 3 0 .227 .205 .156 .0 8 8 .092 .0 4 9
E2 .113 .0 9 0 .075 .074 .221 .344 .277 .1 9 8 .224 .206 .1 3 5 .184 .2 9 7 .090 .019 .0 6 6 .121
E3 .035 .1 2 0 -.0 2 4 .102 .2 2 6 .144 .129 -.0 5 6 .126 .144 .208 .090 -.0 1 2 .049 -.0 0 9 .064 -.0 3 0
Appendix X: Continuation of Correlation Matrix (34 Items)
C 6 C 7 D1 D 2  . D 3 D 4 D 5 D 8 D 9 D 1 0 D 11 D 1 2 D 1 3 D 1 4 E1 E 2 E 3
.1 2 6 .5 0 2 .0 7 7 .0 2 7 .1 3 0 .2 9 8 .0 4 9 .1 0 4 .081 .0 0 2 .011 .1 3 7 .111 .2 1 3 .1 1 5 .1 1 3 .0 3 5
.1 1 9 .1 5 7 - .0 1 4 - .0 5 9 .0 6 8 .0 6 2 - .0 1 3 .3 7 4 .281 .1 0 5 .1 2 5 .0 7 6 .0 2 6 .0 4 5 .1 1 7 .0 9 0 .1 2 0
.2 6 9 .1 3 6 .0 8 8 - .1 0 9 .0 2 6 .1 7 2 .0 0 0 .351 .2 6 2 .1 2 3 - .0 0 9 .0 5 2 .091 .0 1 5 - .0 0 3 .0 7 5 - .0 2 4
.1 8 8 .2 7 8 .0 2 2 - .0 2 7 .1 1 7 .2 3 5 .2 0 2 .3 1 6 .3 0 6 .2 0 4 .0 7 4 .0 5 3 .1 3 8 .171 .1 8 6 .0 7 4 .1 0 2
.0 6 9 .171 .0 7 6 .0 6 8 .0 9 3 .2 3 6 .1 6 8 .1 6 3 .1 5 3 .0 2 4 .2 2 4 .1 2 0 .1 8 2 .0 9 6 .2 7 7 .221 .2 2 6
.1 0 3 .0 9 0 .1 6 6 .1 6 5 .1 0 9 .1 4 2 .2 2 4 .1 6 5 .3 0 7 .1 4 2 .2 5 2 .1 7 2 .1 8 5 .081 .2 6 8 .3 4 4 .1 4 4
.0 7 5 .091 .1 8 4 .051 .131 .1 1 0 .0 5 8 .2 2 6 .1 6 0 .0 5 2 .221 .1 9 0 .1 9 4 .0 4 9 .2 6 2 .2 7 7 .1 2 9
.1 3 0 .3 4 7 .1 1 2 .2 3 0 .1 8 5 .1 2 6 .2 4 5 .0 1 6 .041 .0 6 4 .121 .1 2 5 .2 0 9 .0 9 6 .0 9 0 .1 9 8 - .0 5 6
.0 0 4 .001 .241 .0 9 5 .0 7 8 .161 .1 1 6 .2 1 2 .2 1 5 .2 5 3 .1 3 7 .1 1 4 .1 3 5 .0 6 0 .1 9 6 .2 2 4 .1 2 6
- .0 1 2 - .0 1 6 .0 7 8 .0 0 6 .0 2 4 .1 6 0 .1 0 5 .1 0 5 .1 2 8 .111 .0 9 7 .111 .1 4 2 .1 5 5 .2 1 6 .2 0 6 .1 4 4
- .0 2 1 .0 7 0 .1 2 9 .1 4 4 .0 8 7 .1 5 3 .0 8 2 .1 6 9 .0 4 3 .2 0 6 .1 3 2 .0 9 2 .1 6 5 .1 9 0 .0 3 0 .1 3 5 .2 0 8
- .0 1 8 .0 4 3 .0 7 9 .031 .0 9 8 .131 .0 7 4 .1 7 0 .1 8 2 .141 .101 .1 9 7 .1 4 4 .2 5 9 .2 2 7 .1 8 4 .0 9 0
.1 5 6 .1 5 8 .2 7 2 .1 6 0 .1 2 2 .1 7 5 .2 2 7 .0 4 2 .1 6 5 .0 9 4 .1 5 2 .2 4 8 .1 7 3 .0 6 5 .2 0 5 .2 9 7 - .0 1 2
.3 4 0 .0 6 9 .1 5 6 .0 0 0 .1 1 3 .1 5 8 .1 1 6 .2 3 6 .2 2 6 .1 2 9 .0 6 9 .1 5 4 .1 3 4 .0 6 8 .1 5 6 .0 9 0 .0 4 9
.0 9 3 .061 .0 8 8 .0 4 8 .0 1 0 .1 8 5 - .0 3 0 .071 .1 1 5 - .0 6 4 .0 4 8 .1 0 4 .121 .241 .0 8 8 .0 1 9 - .0 0 9
.2 5 0 .2 3 8 .1 0 6 .0 7 9 .1 7 5 .2 8 0 .2 3 7 .2 9 7 .5 1 3 .0 6 6 .0 4 3 .1 4 8 .1 2 8 .1 8 6 .0 9 2 .0 6 6 .0 6 4
.2 2 6 .1 0 5 .1 5 4 .1 6 5 .1 6 5 .0 9 4 .201 .0 4 9 .0 9 2 .0 8 6 .1 8 2 .171 .1 9 3 .1 0 4 .0 4 9 .121 - .0 3 0
1 .0 0 0 .4 2 6 .061 - .0 1 0 .1 0 3 .3 8 4 .1 8 3 .2 0 5 .4 1 9 .0 2 2 .0 2 7 .1 6 4 .1 8 3 .0 0 3 .0 3 6 .1 1 6 .0 6 2
.4 2 6 1 .0 0 0 .0 6 6 .0 9 4 .1 1 0 .2 6 7 .1 9 3 .0 6 8 .1 8 5 .0 0 8 .0 3 7 .1 3 9 .1 2 4 .181 .0 8 7 .0 7 7 .011
.061 .0 6 6 1 .0 0 0 .2 8 6 .2 8 5 .0 9 8 .0 5 2 .0 8 8 .1 9 2 .0 8 7 .0 7 9 .3 7 3 .2 7 9 .1 6 4 .0 8 5 .2 2 7 .1 1 3
- .0 1 0 .0 9 4 .2 8 6 1 .0 0 0 .2 0 2 .0 6 0 .0 9 5 .0 3 5 .0 9 3 .0 0 5 -.0 3 1 .151 .2 5 6 .0 2 7 .0 4 4 .2 1 4 .1 2 8
.1 0 3 .1 1 0 .2 8 5 .2 0 2 1 .0 0 0 - .0 0 7 .1 0 4 .1 5 5 .2 1 4 .1 1 6 .1 8 2 .5 2 0 .4 0 5 .1 1 3 .2 8 7 .2 3 7 .0 4 8
.3 8 4 .2 6 7 .0 9 8 .0 6 0 - .0 0 7 1 .0 0 0 .3 8 0 .1 2 0 .2 6 8 - .0 3 2 - .0 2 8 .1 8 2 .1 6 9 .0 5 3 .0 9 2 .2 2 2 .0 6 5
.1 8 3 .1 9 3 .0 5 2 .0 9 5 .1 0 4 .3 8 0 1 .0 0 0 .1 0 5 .2 2 4 .2 2 7 .0 2 8 .0 9 4 .1 4 2 .0 0 7 .0 9 3 .2 3 9 .021
.2 0 5 .0 6 8 .0 8 8 .0 3 5 .1 5 5 .1 2 0 .1 0 5 1 .0 0 0 .4 0 0 .251 .1 9 8 .1 2 8 .1 0 4 .1 0 8 .041 .0 8 8 .1 6 6
.4 1 9 .1 8 5 .1 9 2 .0 9 3 .2 1 4 .2 6 8 .2 2 4 .4 0 0 1 .0 0 0 .1 7 9 .1 3 2 .2 6 5 .2 0 6 .1 7 4 .0 7 3 .131 .2 1 2
.0 2 2 .0 0 8 .0 8 7 .0 0 5 .1 1 6 - .0 3 2 .2 2 7 .251 .1 7 9 1 .0 0 0 .051 .0 2 9 .0 1 4 .0 1 9 .1 0 9 .0 3 6 .0 9 9
.0 2 7 .0 3 7 .0 7 9 -.0 3 1 .1 8 2 - .0 2 8 .0 2 8 .1 9 8 .1 3 2 .051 1 .0 0 0 .4 0 4 .3 3 0 .3 1 3 .3 8 8 .4 3 4 .1 9 4
.1 6 4 .1 3 9 .3 7 3 .151 .5 2 0 .1 8 2 .0 9 4 .1 2 8 .2 6 5 .0 2 9 .4 0 4 1 .0 0 0 .6 2 5 .2 2 2 .4 5 0 .4 6 0 .1 7 4
.1 8 3 .1 2 4 .2 7 9 .2 5 6 .4 0 5 .1 6 9 .1 4 2 .1 0 4 .2 0 6 .0 1 4 .3 3 0 .6 2 5 1 .0 0 0 .3 0 6 .471 .4 7 6 .1 9 8
.0 0 3 .181 .1 6 4 .0 2 7 .1 1 3 .0 5 3 .0 0 7 .1 0 8 .1 7 4 .0 1 9 .3 1 3 .2 2 2 .3 0 6 1 .0 0 0 .2 3 3 .1 8 2 .0 7 6
.0 3 6 .0 8 7 .0 8 5 .0 4 4 .2 8 7 .0 9 2 .0 9 3 .041 .0 7 3 .1 0 9 .3 8 8 .4 5 0 .471 .2 3 3 1 .0 0 0 .5 7 5 .3 1 5
.1 1 6 .0 7 7 .2 2 7 .2 1 4 .2 3 7 .2 2 2 .2 3 9 .0 8 8 .131 .0 3 6 .4 3 4 .4 6 0 .4 7 6 .1 8 2 .5 7 5 1 .0 0 0 .3 6 4
.0 6 2 .011 .1 1 3 .1 2 8 .0 4 8 .0 6 5 .021 .1 6 6 .2 1 2 .0 9 9 .1 9 4 .1 7 4 .1 9 8 .0 7 6 .3 1 5 .3 6 4 1 .0 0 0
Appendix Y: Correlation matrix for 29 items of the MLCDP
A1 A2 A3 A4 B1 B2 B3 B4 B5 B6 B7
GOCD B10 _ C1 C4
A1 1.000 .228 .346 .230 .179 -.022 .039 .175 .007 .096 .117 .129 .123 .141 .201
A2 .228 1.000 .442 .236 .154 .155 .243 .005 .296 .265 .092 .286 .066 .236 .316
A3 .346 .442 1.000 .193 .140 .032 .198 -.037 .158 .222 .030 .098 .065 .390 .257
A4 .230 .236 .193 1.000 .302 .243 .329 .042 .207 .118 .141 .177 -.006 .201 .533
B1 .179 .154 .140 .302 1.000 .416 .592 .062 .190 .488 .257 .174 .245 .216 .188
B2 -.022 .155 .032 .243 .416 1.000 .459 .390 .332 .211 .227 .256 .452 .164 .199
B3 .039 .243 .198 .329 .592 .459 1.000 .076 .275 452 .244 .142 .213 .163 .200
B4 .175 .005 -.037 .042 .062 .390 .076 1.000 -.003 -.128 .158 .057 .319 -.035 .044
B5 .007 .296 .158 .207 .190 .332 .275 -.003 1.000 .317 .168 .480 .163 .156 .201
B6 .096 .265 .222 .118 .488 .211 .452 -.128 .317 1.000 .288 .380 .099 .182 .090
B7 .117 .092 .030 .141 .257 .227 .244 .158 .168 .288 1.000 .175 .023 -.003 .011
B8 .129 .286 .098 .177 .174 .256 .142 .057 .480 .380 .175 1.000 .055 .139 .177
B10 .123 .066 .065 -.006 .245 .452 .213 .319 .163 .099 .023 .055 1.000 .239 .188
C1 .141 .236 .390 .201 .216 .164 .163 -.035 .156 .182 -.003 .139 .239 1.000 .294
04 .201 .316 .257 .533 .188 .199 .200 .044 .201 .090 .011 .177 .188 .294 1.000
C5 .043 .020 -.048 .058 .038 .246 .067 .281 .016 -.009 .016 -.027 .191 .125 .001
C6 .126 .119 .269 .188 .069 .103 .075 .130 .004 -.012 -.021 -.018 .156 .340 .250
C7 .502 .157 .136 .278 .171 .090 .091 .347 .001 -.016 .070 .043 .158 .069 .238
D2 .027 -.059 -.109 -.027 .068 .165 .051 .230 .095 .006 .144 .031 .160 .000 .079
D3 .130 .068 .026 .117 .093 .109 .131 .185 .078 .024 .087 .098 .122 .113 .175
D5 .049 -.013 .000 .202 .168 .224 .058 .245 .116 .105 .082 .074 .227 .116 .237
D8 .104 .374 .351 .316 .163 .165 .226 .016 .212 .105 .169 .170 .042 .236 .297
D9 .081 .281 .262 .306 .153 .307 .160 .041 .215 .128 .043 .182 .165 .226 .513
D11 .011 .125 -.009 .074 .224 .252 .221 .121 .137 .097 .132 .101 .152 .069 .043
D12 .137 .076 .052 .053 .120 .172 .190 .125 .114 .111 .092 .197 .248 .154 .148
D13 .111 .026 .091 .138 .182 .185 .194 .209 .135 .142 .165 .144 .173 .134 .128
D14 .213 .045 .015 .171 .096 .081 .049 .096 .060 .155 .190 .259 .065 .068 .186
E1 .115 .117 -.003 .186 .277 .268 .262 .090 .196 .216 .030 .227 .205 .156 .092
E2 .113 .090 .075 .074 .221 .344 .277 .198 .224 .206 .135 .184 .297 .090 .066
Appendix Y: Continuation of Correlation matrix (29 Items)
C5 C6 C7 D2 D3 D5
GOO D9 D11 D12 D13 D14 E1 E2
.043 .126 .502 .027 .130 .049 .104 .081 .011 .137 .111 .213 .115 .113
.020 .119 .157 -.059 .068 -.013 .374 .281 .125 .076 .026 .045 .117 .090
-.048 .269 .136 -.109 .026 .000 .351 .262 -.009 .052 .091 .015 -.003 .075
.058 .188 .278 -.027 .117 .202 .316 .306 .074 .053 .138 .171 .186 .074
.038 .069 .171 .068 .093 .168 .163 .153 .224 .120 .182 .096 .277 .221
.246 .103 .090 .165 .109 .224 .165 .307 .252 .172 .185 .081 .268 .344
.067 .075 .091 .051 .131 .058 .226 .160 .221 .190 .194 .049 .262 .277
.281 .130 .347 .230 .185 .245 .016 .041 .121 .125 .209 .096 .090 .198
.016 .004 .001 .095 .078 .116 .212 .215 .137 .114 .135 .060 .196 .224
-.009 -.012 -.016 .006 .024 .105 .105 .128 .097 .111 .142 .155 .216 .206
.016 -.021 .070 .144 .087 .082 .169 .043 .132 .092 .165 .190 .030 .135
-.027 -.018 .043 .031 .098 .074 .170 .182 .101 .197 .144 .259 .227 .184
.191 .156 .158 .160 .122 .227 .042 .165 .152 .248 .173 .065 .205 .297
.125 .340 .069 .000 .113 .116 .236 .226 .069 .154 .134 .068 .156 .090
.001 .250 .238 .079 .175 .237 .297 .513 .043 .148 .128 .186 .092 .066
1.000 .226 .105 .165 .165 .201 .049 .092 .182 .171 .193 .104 .049 .121
.226 1.000 .426 -.010 .103 .183 .205 .419 .027 .164 .183 .003 .036 .116
.105 .426 1.000 .094 .110 .193 .068 .185 .037 .139 .124 .181 .087 .077
.165 -.010 .094 1.000 .202 .095 .035 .093 -.031 .151 .256 .027 .044 .214
.165 .103 .110 .202 1.000 .104 .155 .214 .182 .520 .405 .113 .287 .237
.201 .183 .193 .095 .104 1 . 0 0 0 .105 .224 .028 .094 .142 .007 .093 .239
.049 .205 .068 .035 .155 .105 1.000 .400 .198 .128 .104 .108 .041 .088
.092 .419 .185 .093 .214 .224 .400 1.000 .132 .265 .206 .174 .073 .131
.182 .027 .037 -.031 .182 .028 .198 .132 1.000 .404 .330 .313 .388 .434
.171 .164 .139 .151 .520 .094 .128 .265 .404 1.000 .625 .222 .450 .460
.193 .183 .124 .256 .405 .142 .104 .206 .330 .625 1.000 .306 .471 .476
.104 .003 .181 .027 .113 .007 .108 .174 .313 .222 .306 1.000 .233 .182
.049 .036 .087 .044 .287 .093 .041 .073 .388 .450 .471 .233 1.000 .575
.121 .116 .077 .214 .237 .239 .088 .131 .434 .460 .476 .182 .575 1.000
